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Chapter	1		
	
General	introduction
	 
	
	
	
	
Figure	1.	The	history	of	facial	cartilage	reconstruction.	
 	
Deformities	 of	 the	 head	 and	 neck	 area	 have	 incredible	 impact	 on	 facial	 appearance	 and	
function.	 They	 are	 the	 result	 of	 congenital	 disease,	 trauma	 (including	 burns)	 or	 tumor	
destruction,	 subsequent	 ablative	 surgery	 and/or	 radiotherapy.	 Reconstruction	 of	 such	
deformities	is	extremely	demanding	and	requires	considerable	skill	and	finesse.	The	main	goal	
is	to	create	a	three-dimensional	(3D)	tissue	with	optimal	functional	and	aesthetic	outcomes.	
To	achieve	that,	the	reconstructive	surgeon	must	consider	both	soft-tissue	coverage	as	well	
as	the	underlying	cartilaginous	support.		
Soft	tissue	coverage	and	supporting	structures	are	both	missing	in	major	defects	in	the	
head	and	neck	area.	Traditionally,	facial	reconstruction	was	particularly	concerned	about	soft	
tissue	repair	(i.e.	skin	coverage)	instead	of	the	reestablishment	of	the	underlying	structural	
support.	The	earliest	example	of	 such	 reconstruction	could	be	 found	 in	 the	Hindu	Book	of	
Revelation	 -	 Sushruta	 Samhita	 -	 a	medical	 text	 book	 from	 ancient	 India	 600	 BC.	 Sushruta	
described	various	local	skin	flap	techniques	for	reconstruction	of	the	nose	and	earlobe.	[1]	The	
method	described	by	 Sushruta	 continued	 to	be	practiced	without	 substantial	 variation	 for	
centuries	 and	 variation	 on	 his	 Indian	 forehead	 flap	 rhinoplasty	 is	 still	 used	 for	 soft-tissue	
coverage	of	the	nose	today.	Besides	local	skin	flaps,	the	introduction	of	the	pedicled	distant	
flap	 by	 Tagliacozzi	 (16th	 century)	 [2,	 3]	 and	 the	 introduction	 of	 free	 microvascular	 tissue	
transfer	during	the	late	1950s	[4],	have	extended	possibilities	for	soft	tissue	reconstruction	in	
the	head	and	neck	area.		
Successful	 surgical	 reconstruction	 of	 head	 and	 neck	 defects	 are	 however,	 not	 only	
dependent	on	adequate	 soft	 tissue	coverage.	 Importantly,	 these	defects	 require	 structural	
support	for	contour	as	well	as	resistance	forces	of	scar	contraction.	In	the	early	20th	century,	
it	was	Gillies	who	understood	that	facial	reconstruction	required	structural	support	in	addition	
to	healthy	soft-tissue	coverage.	He	was	the	first	to	use	allogenic	(maternal)	costal	cartilage	for	
ear	reconstruction	[5]	and	composite	chondrocutaneous	grafts	for	nasal	reconstruction	[6].	
Currently,	 application	 of	 an	 autologous	 cartilage	 graft	 remains	 the	 standard	 of	 facial	
reconstructive	 surgery.	 The	 foundation	 of	 current	 autologous	 cartilage	 reconstruction	
techniques	in	the	head	and	neck	area	are	largely	based	on	the	methods	described	by	Tanzer	
[7],	Brent	[8],	and	Nagata	[9]	for	ear	reconstruction	as	well	as	the	methods	described	by	Burget	
and	Menick	[10-12]	for	nasal	reconstruction.	They	recommend	a	multi-stage	repair	strategy	
using	 an	 autologous	 cartilaginous	 framework	 for	 underlying	 support	 as	 well	 as	 to	 give	
desirable	face	contour.	In	short,	autologous	cartilage	is	harvested	from	the	ear,	nasal	septum	
or	ribs,	and	sculpted	into	a	solid	framework.	The	cartilaginous	framework	is	then	implanted	
subcutaneously	or	-	in	case	of	soft-tissue	shortage	-	covered	by	local	flap,	pedicled	distant	flap	
or	free	flap.	[13]	Although	autologous	cartilage	grafting	has	been	used	successfully	in	cartilage	
reconstructive	 surgery,	 the	 procedure	 requires	 a	 high	 degree	 of	 surgical	 expertise,	 is	
associated	with	 limited	availability	of	autologous	cartilage	and	can	cause	severe	donor	site	
morbidity.		
For	many	years	there	has	been	considerable	interest	to	simplify	current	approaches	
and	thereby	improve	surgical	outcome.	In	order	to	eliminate	the	variability	of	the	surgeon’s	
creative	 ability	 to	 make	 a	 realistic	 framework	 from	 autologous	 cartilage,	 the	 idea	 of	 a	
prefabricated	 framework	 was	 introduced.	 The	 first	 presentation	 of	 such	 framework	 was	
initiated	back	in	the	1940s	by	Peer	[14]	after	the	introduction	of	viable	diced	cartilage	grafting	
	 
[15].	By	using	a	prefabricated	mould,	diced	autologous	cartilage	was	formed	into	the	shape	of	
an	ear	[16]	and	later	nasoseptum	[17,	18]	and	fused	into	a	living	prefabricated	cartilaginous	
framework.	However,	due	 to	 its	heterogeneous	outcome,	disappointing	 long-term	survival	
and	severe	donor	site	morbidity,	diced	cartilage	grafting	has	never	achieved	widespread	use.	
In	addition,	its	clinical	use	was	soon	forgotten	after	introduction	of	prefabricated	alloplastic	
material	 implants.	 Nowadays,	 its	 use	 is	 only	 destined	 for	 specific	 nasal	 reconstruction	
therapies,	such	as	dorsal	nasal	augmentation	and	nasal	tip	reconstruction.	From	the	60’s	until	
now,	numerous	alloplastic	material	implants	have	been	used	in	reconstructive	surgery	(e.g.	
silicones	and	silicon-based	elastomers,	polymers	such	as	Medpor®,	Proplast®	Mersilene®,	and	
Gore-Tex®).	 [19]	 Their	 use	 in	 the	 head	 and	 neck	 area	 is	 however	 questioned,	 since	 these	
implants	poorly	integrate	and	are	prone	to	induce	a	foreign	body	reaction	and	frequently	lead	
to	implant	extrusion	in	this	area	(3.1-8.9%).	[20,	21]		
	
	
	
	
	
Figure	2.	Cartilage	tissue	engineering.	
 	
The	idea	of	a	prefabricated	framework	was	further	elaborated	via	novel	biological	engineering	
techniques	 first	 introduced	 by	 Vacanti	 and	 Langer	 [22]	 named	 tissue	 engineering.	 Tissue	
engineering	has	the	potential	to	overcome	limitations	of	current	treatments,	reestablishing	
unique	biological	and	functional	properties	of	the	tissue.	It	endeavors	to	develop	functional	
living	cartilage	by	using	cells,	inductive	signals	and	a	prefabricated	scaffold	or	framework.	In	
short,	cartilage	tissue	engineering	starts	with	a	small	tissue	biopsy,	from	which	the	residing	
cells	are	isolated.	Thereafter,	cells	are	proliferated	in	vitro	under	controlled	conditions,	seeded	
into	a	prefabricated	scaffold	and	implanted	subcutaneously.	(Figure	2)	Tissue	engineering	is	a	
promising	solution	for	restoring	missing	or	damaged	cartilage	in	the	head	and	neck	area,	as	it	
translates	 complex	 biological	 science	 into	 a	 living	 prefabricated	 cartilaginous	 framework.	
Future	 surgical	 techniques	 are	 thereby	 simplified,	 improving	 surgical	 outcomes.	 Besides,	
tissue	engineering	aims	to	circumvent	the	resulting	donor-site	morbidity	by	engineering	rather	
than	 harvesting	 cartilage	 tissue.	 Therefore,	 in	 this	 work,	 I	 aim	 to	 develop	 a	 cell-based	
cartilaginous	framework	for	the	surgical	repair	of	cartilage	defects	in	the	head	and	neck	area	
by	using	a	tissue	engineering	strategy.	
	
Cartilage	form	and	function	
Cartilage	plays	an	important	role	in	the	form	and	function	of	the	face	as	it	provides	flexibility	
and	mechanical	support	to	soft	tissues.	However,	mechanical	properties	of	facial	cartilage	are	
sparsely	investigated,	and	limited	data	are	available	on	human	ear	[23,	24]	and	nasal	cartilages	
[25-30].		
Cartilage	 rigidity	 and	 elasticity	 are	 due	 primarily	 to	 the	 properties	 of	 its	 complex	
extracellular	matrix	(ECM).	It	constitutes	by	a	complex	network	of	various	macromolecules.	
The	most	abundant	ECM	macromolecule	is	collagen,	making	up	60-80%	of	the	dry	weight	of	
cartilage,	followed	by	approximately	20-30%	of	proteoglycans	(PGs).	Collagen,	mostly	collagen	
type	2,	form	a	highly	organized	fiber	network	defining	form	and	tensile	strength.	[31]	Within	
this	 collagen	 network,	 PGs	 are	 intertwined,	 of	 which	 aggrecan	 is	 most	 common.	 Their	
negatively	 charged	 glycosaminoglycan	 (GAG)	 side	 chains	 are	 responsible	 for	 compressive	
strength	by	attracting	large	amounts	of	water	to	the	cartilage	ECM.	Basically,	60-80%	of	the	
wet	weight	of	cartilage	is	water.	[32]	Finally,	elastin,	the	main	component	of	elastic	fibers,	is	
variably	found	in	the	cartilage	ECM	and	provides	elastic	recoil	and	resilience	to	the	tissue.	[31]	
Other	matrix	constituents,	only	form	a	small	fraction	of	the	total	dry	weight	of	cartilage	and	
are	not	further	discussed.		
Depending	 on	 the	 exact	 composition	 and	 organization	 of	 the	 ECM,	 three	 major	
cartilage	subtypes	can	be	distinguished	with	variable	flexibility	and	mechanobiology:	hyaline,	
elastic	 and	 fibrous	 cartilage.	 (Figure	 3)	 The	 most	 prevalent	 cartilage	 subtype	 is	 hyaline	
cartilage.	It	is	characterized	by	a	homogeneous	ECM	that	mainly	consists	of	collagen	type	2	
fibers,	 PGs	 and	water.	 In	 the	head	and	neck	 area,	 hyaline	 cartilage	 is	 located	 in	 the	nasal	
septum,	trachea	and	larynx.	Outside	this	area,	hyaline	cartilage	is	mainly	found	at	the	articular	
surfaces	of	 joints	and	on	the	ventral	ends	of	 ribs.	Besides,	 it	 is	also	 transitorily	 involved	 in	
skeletal	development	through	the	process	of	endochondral	ossification.	Elastic	cartilage	also	
consists	of	a	refined	network	of	collagen	type	2	fibers,	PGs	and	water.	It	additionally	contains	
insoluble	elastin	fibers.	Elastic	cartilage	is	found	in	the	pinna	of	the	ear,	Eustachian	tube	and	
	 
epiglottis.	Fibrous	cartilage	is	mostly	found	in	regions	of	the	body	that	are	subjected	to	tensile	
stresses	such	as	the	menisci,	pubic	symphysis	and	annulus	fibrosus	of	intervertebral	discs.	The	
ECM	is	characterised	by	a	dense	network	of	collagen	type	1	and,	to	a	 lesser	extent,	type	2	
fibers,	thereby	increasing	the	rigidity	of	the	tissue.	[33]		
All	mature	cartilage	subtypes	consist	of	only	a	relatively	small	amount	of	specialized	
cells	 (1-5%),	 termed	 chondrocytes.	 [34]	 They	 are	 essential	 for	 producing,	maintaining	 and	
remodelling	the	ECM.	Nutritional	and	oxygen	supply	of	chondrocytes	is	mainly	achieved	by	
the	perichondrium,	a	dense	connective	tissue	that	covers	most	cartilages	in	the	head	and	neck	
area.	This	process	is	achieved	through	diffusion.	In	cartilage	types	lacking	a	perichondrium,	
such	as	hyaline	articular	and	fibrous	cartilage,	diffusion	of	nutrients	and	oxygen	is	provided	by	
synovial	fluid	[35],	vertebral	endplates	[36],	and	-	in	case	of	the	meniscus	and	pubic	symphysis	
-	effectuated	by	limited	blood	supply	[37,	38].		
	
	
	
	
	
	
Figure	3.	Cartilage	subtypes.	
Depending	 on	 the	 exact	 composition	 and	 organization	 of	 the	 ECM,	 three	 major	 cartilage	 subtypes	 can	 be	
distinguished:	 hyaline,	 elastic	 and	 fibrous	 cartilage.	 P	 =	 Perichondrium	 ;	 C	 =	 Chondrocyte	 ;	 CP	 =	 Chondro-
progenitor	;	C1	=	Collagen	type	1	;	C2	=	Collagen	type	2	;	E	=	Elastin.	
 	
Cartilage	tissue	engineering	
Tissue	 engineering	 is	 described	 as	 “the	 interdisciplinary	 field	 that	 applies	 the	principles	 of	
engineering	and	life	sciences	toward	the	development	of	biological	substitutes	that	restore,	
maintain,	or	improve	tissue	function”.	[22]	Tissue	engineering	attempts	to	mimic	functional	
tissue	that	has	features	similar	to	native	tissue.	The	development	of	such	an	engineered	tissue	
requires	a	careful	selection	of	three	major	components,	also	known	as	the	“tissue	engineering	
triad”:	 (1)	cells;	 (2)	a	supporting	structure	or	scaffold;	and	(3)	 inductive	factors	that	trigger	
tissue	regeneration	cascades.	 (Figure	2)	These	components	are	discussed	more	extensively	
below.	
	
Cell	sources	
Defining	an	appropriate	cell	source	for	cartilage	tissue	engineering	is	a	major	challenge.	The	
ideal	cell	source	is	one	that	is	abundantly	available,	can	be	easily	isolated	or	expanded,	and	
forms	 cartilage	 tissue	 that	 is	 similar	 to	 that	 of	 native	 tissue.	 The	most	 obvious	 choice	 are	
chondrocytes	 themselves.	 Therefore,	 chondrocytes	 from	 several	 anatomical	 locations	 (e.g.	
joint,	rib,	nose,	ear,	meniscus)	have	been	investigated	for	their	applicability.	[39-60]	Typically,	
autologous	chondrocytes	are	isolated	by	enzymatic	digestion	from	small	cartilage	biopsies,	to	
minimize	 donor	 site	 morbidity.	 However,	 large	 numbers	 of	 chondrocytes	 are	 required	 to	
generate	a	construct	of	reasonable	size.	Therefore,	after	cell-isolation,	cells	are	expanded	in	
vitro	until	 a	 sufficient	 cell	 number	 is	 obtained.	Unfortunately,	 culture-expansion	 results	 in	
chondrocyte	 dedifferentiation:	 they	 change	 phenotypically	 to	 a	 fibroblast-like	morphology	
and	 lose	 their	 chondrogenic	gene-expression	 capacity,	which	usually	 results	 in	 fibrous	and	
mechanically	inferior	cartilage.	[61]	In	recent	years,	considerable	progress	has	been	made	to	
remedy	current	limitations.	Multiple	biological	and	biophysical	cues	have	been	introduced	to	
inhibit	 the	 process	 of	 chondrocyte-dedifferentiation	 and	 improve	 chondrocyte	
redifferentiation,	as	discussed	below.	
Next	 to	 chondrocytes,	 mesenchymal	 stem	 cells	 (MSCs)	 have	 been	 introduced	 and	
demonstrated	to	be	an	attractive	cell	source	for	cell-based	cartilage	repair.	[62]	These	cells	
are	easily	available	 from	several	 tissues,	 including	bone	marrow,	adipose	tissue,	synovium,	
peripheral	 blood,	 dental	 pulp,	 placenta,	 umbilical	 cord,	 and	 skeletal	muscle.	 [63]	Of	 these	
MSCs,	 adipose-tissue-derived	MSCs	 (AMSCs)	 and	 bone-marrow-derived	MSCs	 (BMSCs)	 are	
best	 characterized.	 They	 can	 undergo	 multiple	 population	 doublings	 without	 losing	 their	
chondrogenic	 potential	 and	 have	 the	 capacity	 to	 differentiate	 into	 cartilage	 tissue	 under	
appropriate	culture	conditions.	[64-68]	A	potential	limitation	to	their	application	in	cell-based	
cartilage	repair	 is	 that	differentiated	MSCs	become	hypertrophic,	a	process	called	terminal	
differentiation.	Hypertrophic	MSCs	produce	cartilage	tissue	that	is	unstable	and	predisposed	
for	tissue	mineralisation	and	ossification	in	vivo.	[69-72]	Taken	together,	the	individual	use	of	
chondrocytes	or	MSCs	is	at	present	not	yet	ideal	for	cell-based	cartilage	repair	in	the	head	and	
neck	area.		
As	 an	 alternative	 to	 the	 individual	 use	 of	 cells,	 the	 concept	 of	 co-culture	 was	
introduced.	[73]	It	became	clear	that	combination	of	chondrocytes	and	MSCs	extenuate	many	
disadvantages	of	individually	studied	cell	types.	In	particular,	co-cultures	of	chondrocytes	and	
MSCs	demonstrated	improved	chondrogenesis	[74]	as	well	as	reduced	hypertrophy	and	tissue	
	 
mineralization	[73,	75].	Moreover,	by	decreasing	the	amount	of	chondrocytes	required	(≤	20%	
of	the	total	cell	mixture),	culture-expansion	was	no	longer	necessary,	which	allowed	the	use	
of	 freshly	 isolated	 primary	 chondrocytes	 leading	 to	 improved	 cartilage	 formation.	 [76]	
Unfortunately,	co-culture	research	has	mainly	focused	on	articular	cartilage	repair.	The	effect	
of	non-articular	chondrocytes	in	co-culture,	such	as	ear	[77-79]	or	nasal	chondrocytes	(NCs)	
[80],	are	sadly	underexposed,	although	they	seem	essential	for	cell-based	cartilage	repair	in	
the	head	and	neck	area.		
In	 depth	 understanding	 of	 the	 cellular	 interaction	 pathways	 between	 MSCs	 and	
chondrocytes	is	still	under	debate	in	literature:	It	is	thought	that	the	co-culture	effect	is	either	
credited	to	(1)	chondrocyte-driven	MSC-differentiation	or	ascribed	to	(2)	chondrocytes,	whose	
cartilage-forming	capacity	and	proliferation	activity	are	enhanced	in	the	presence	of	MSCs.	
[81]	In	recent	years,	the	trophic	and	paracrine	functions	of	MSCs	appeared	most	critical	in	this	
process,	rather	than	the	simple	chondrogenic	differentiation	of	MSCs	alone.	However,	little	is	
known	as	to	whether	their	trophic	function	is	a	general	characteristic	of	MSCs	or	dependent	
on	the	origin	of	the	MSC	source.		
	
Scaffolds	
For	 successful	 cartilage	 regeneration,	 the	 properties	 of	 the	 3D	 matrix	 are	 of	 equivalent	
importance:	(1)	it	must	provide	temporary	or	permanent	cell-support	while	maintaining	size	
and	shape	when	subjected	to	the	forces	of	the	implanted	environment;	and	(2)	it	needs	to	
mimic	the	natural	microenvironment	to	provide	specific	structural,	mechanical	and	biological	
cues	to	cells,	which	guide	tissue	remodelling.	[82]	Currently,	several	3D-scaffolds	have	been	
developed	 and	 investigated	 for	 their	 use	 in	 cartilage	 tissue	 engineering.	 [83]	 They	 can	 be	
roughly	 classified	 into	 synthetic	 and	 natural	 scaffolds.	 Synthetic	 scaffolds	 that	 are	 most	
intensely	studied	in	the	field	of	cartilage	tissue	engineering	are	the	biodegradable	polymers,	
such	as	polylactic	acid	(PLA),	polyglycolic	acid	(PGA),	and	their	co-polymers.	[84]	Their	main	
benefit	is	that	they	can	be	fabricated	in	large	quantities	under	controlled	conditions	and	have	
predictable	and	reproducible	physical	properties.	Although	these	materials	are	advantageous	
to	work	with,	 they	are	prone	 to	 induce	a	 foreign	body	 reaction	which	can	 inhibit	 cartilage	
regeneration	and	lead	to	tissue	extrusion.	[83]	Next	to	synthetic	materials,	natural	scaffolds	
have	been	introduced,	such	as	hydrogels	(e.g.	alginate,	chitosan,	collagen,	gelatine,	hyaluronic	
acid,	fibrin),	bacterial	nanocellulose,	and	decellularized	ECM.	[85]	Unlike	synthetic	scaffolds,	
natural	polymers	are	distinguished	by	low	risk	of	toxicity	and	a	reduced	foreign	body	reaction.	
[85]	On	the	contrary,	their	properties	are	less	reproducible	and	more	heterogeneous.	Also,	
purification	issues	relevant	to	clinical	use,	represent	a	major	challenge.	Unfortunately,	to	date,	
no	ideal	scaffold	has	emerged	as	a	promising	scaffold	for	future	clinical	application	for	cell-
based	cartilage	repair	in	the	head	and	neck	area.	This	thesis	focuses	on	natural	scaffolds.	In	
particular,	this	thesis	focusses	on	the	quality	and	suitability	of	alginate,	bacterial	nanocellulose	
and	decellularized	ECM	for	tissue-engineering	purposes	in	the	head	and	neck	area.	
Alginate	is	a	hydrogel	and	formed	from	polysaccharides	derived	from	brown	algae.	It	
consists	of	a	mixture	of	β-D-mannuronic	acid	(M)	and	α-L-guluronic	acid	(G)	residues.	[86]	Both	
cell	 adhesion	 and	 hydrogel	 stiffness	 can	 be	 influenced	 by	 M	 to	 G	 ratio.	 [87]	 Alginate	
mechanical	stiffness	is	however	low	and	range	from	1	to	1000	kPa.	[88]	Although	alginate	itself	
 	
is	 too	weak	to	withstand	scar	contraction	forces	after	direct	subcutaneous	 implantation,	 it	
enables	a	homogeneous	cell	distribution	and	prevents	cells	from	floating	out	while	permitting	
nutrient	diffusion	and	oxygen	transfer	to	the	cells	in	order	to	create	an	environment	to	form	
new	cartilage	matrix	with	sufficient	properties.	[89]	Therefore,	alginate	 is	an	excellent	cell-
carrying	gel	for	cell-based	cartilage	repair	in	the	head	and	neck	area.		
Bacterial	nanocellulose	 is	the	extracellular	product	of	the	Gluconacetobacter	xylinus	
bacterium.	 These	 gram-negative	 aerobic	bacteria	produce	pure	nanocellulose	 fibrils	 in	 the	
presence	 of	 sugar	 and	 oxygen.	 [90]	 More	 recently,	 medical	 devices	 made	 from	 bacterial	
nanocellulose	were	introduced	into	the	clinic	as	wound	and	burns	dressings	(e.g.	Dermafill®,	
Bioprocess®,	XCell®	and	Biofill®),	surgical	meshes	(e.g.	Xylos®,	Macro-Porous	Surgical	Mesh®	and	
Securian®)	 and	 dura	mater	 substitutes	 (Synthecel	 Dura	 Repair®).	 Bacterial	 nanocellulose	 is	
extremely	hydrophilic	and	can	hold	as	much	as	100	times	its	dry	weight	of	water.	[91]	This	
property,	 combined	 with	 the	 distinct	 physical	 and	 mechanical	 properties	 of	 bacterial	
nanocellulose,	 including	 its	 insolubility,	 rapid	 biodegradability,	 tensile	 strength,	 elasticity,	
durability,	 nontoxic	 and	 non-allergenic	 features,	make	 bacterial	 nanocellulose	 a	 candidate	
biomaterial	for	cartilage	TE	in	the	head	and	neck	area.	[92]		
Recently,	 natural	 acellular	 ECM	 scaffolds	 have	 become	 increasingly	 popular.	 These	
acellular	 ECM	 scaffolds	 are	 acquired	 by	 a	 process	 called	 decellularization:	 a	 method	 that	
requires	chemical,	physical	and/or	enzymatic	treatments.	[93]	Decellularized	ECM	scaffolds	
provide	a	3D	ECM	structure	with	immediate	functional	support	without	evoking	an	adaptive	
immune	response	upon	implantation	due	to	the	absence	of	donor	cellular	antigens.	[94]	To	
date,	 various	 cartilaginous	 structures	 have	 already	 been	 decellularized	 including	 tracheal	
cartilage	 [94-99],	 articular	 cartilage	 [100-103],	 intervertebral	discs	 [104,	105]	and	meniscal	
cartilage	[106-109].	So	far,	little	research	has	been	executed	on	decellularized	ECM	in	the	head	
and	neck	area	such	as	nasal	cartilage	[106,	110]	or	ear	cartilage.	
	
Inductive	factors	
Cartilage	development	and	homeostasis	is	influenced	by	several	inductive	factors	that	induce,	
improve	or	accelerate	cartilage	regeneration.	They	include	both	biochemical	and	biophysical	
factors.	 (Reviewed	 by	 Wescoe	 et	 al.	 [111])	 Growth	 factors,	 especially	 those	 from	 the	
Transforming	Growth	Factor	beta	family,	Insulin-like	Growth	Factors	and	Fibroblast	Growth	
Factors,	 are	 signalling	 factors	most	extensively	 investigated	 in	 cartilage	 tissue	engineering.	
[112-114]	These	 factors	 regulate	cellular	migration,	adhesion,	proliferation,	differentiation,	
and	cell	survival,	and	ultimately	improve	cartilage	formation	and	stability.	[115]	The	easiest	
and	most	common	way	to	deliver	growth	factors	to	the	culture	environment	is	through	direct	
supplementation	to	culture	media.	However,	the	quantity	and	fast	release	of	such	inductive	
factors	may	 impede	 cartilage	 regeneration.	 In	 order	 to	more	 closely	 replicate	 the	 in	 vivo	
situation,	inductive	factors	have	been	more	gradually	delivered	using	drug-eluting	scaffolds	or	
gene	therapy.	Still,	 further	 research	needs	 to	study	efficacy	and	spatiotemporal	kinetics	of	
future	 delivery	 systems	 as	 well	 as	 safety	 and	 reliability	 of	 gene	 therapy.	 Recently,	 the	
endogenous	 delivery	 of	 inductive	 factors	 through	 co-culture	 was	 introduced.	 Mixed-cell-
cultures	provide	cell	populations	that	secrete	trophic	factors	to	regulate	local	cellular	activity	
for	cartilage	regeneration	more	similar	to	normal	cartilage	development.	[116]	
	 
Application	of	cartilage	tissue	engineering	in	clinical	practice	
In	past	decades,	application	of	tissue-engineering	technology	on	facial	reconstructive	surgery	
have	markedly	 increased.	However,	cartilage	regenerative	medicine	plays	a	relatively	small	
role	 in	 current	 clinical	 practice	 (mainly	 in	 tracheal	 reconstruction	 [117]	 or	 articular	 joint	
resurfacing	[118])	and	have	not	yet	been	described	for	facial	cartilage	reconstruction.	So	far,	
only	one	study	has	reported	proof-of-principle	for	human	nasal	reconstruction	using	tissue-
engineered	cartilage	in	five	patients.	[119]	Assumedly,	this	opened	the	way	to	future	clinical	
research	of	tissue-engineered	facial	cartilage	and	its	utility	in	facial	reconstructive	surgery.		
For	 translation	 toward	 clinical	 application	 of	 cell-based	 cartilage	 repair,	 it	 is	 important	 to	
provide	an	one-step	surgical	procedure	rather	than	multistage	surgery.	Such	a	procedure	aims	
to	generate	a	tissue-engineered	construct	intraoperatively,	prohibiting	the	need	for	 in-vitro	
culture	 expansion.	 One-step	 surgery	 would	 not	 only	 improve	 patient	 safety	 and	 cost-
effectiveness	but	also	reduce	the	risk	of	regulatory	and	ethical	issues	related	to	in-vitro	culture	
expansion.
 	
THESIS	AIM	AND	OUTLINE	
	
Cartilage	tissue	engineering	can	offer	promising	solutions	for	restoring	cartilage	defects	in	the	
head	and	neck	 area	 and	has	potential	 to	overcome	 limitations	of	 current	 treatments.	 The	
primary	objective	of	this	thesis	is	to	ultimately	improve	cartilage	regeneration	and	develop	an	
one-step	surgical	therapy	for	the	repair	of	facial	cartilage	defects.	Therefore,	I	focus	on	the	
generation	 of	 a	 cell-based	 cartilaginous	 framework	 and	 evaluate	 the	 suitability	 of	 cells	 or	
combination	of	cells	on	natural	scaffolds.	
	
Based	on	my	objectives,	the	following	research	questions	were	formulated:	
Q1	 What	are	the	biomechanical	and	biochemical	characteristics	of	native	facial	cartilages	
(i.e.	ear	and	nasal	cartilages)?	
Q2	 Which	cells	or	combination	of	cells	are	most	suitable	for	cell-based	cartilage	repair	in	
the	head	and	neck	area?	
Q3	 Which	natural	scaffolds	(i.e.	alginate,	bacterial	nanocellulose,	decellularized	ECM)	are	
a	suitable	candidate	for	future	cell-based	cartilage	repair	in	the	head	and	neck	area?	
	
Ideally,	 tissue-engineered	 cartilage	 should	 possess	 similar	 biomechanical	 and	 biochemical	
properties	to	the	native	tissue.	Chapter	two	and	three	establish	a	precise	biomechanical	and	
biochemical	characterization	of	native	human	ear	and	nasal	cartilages	(i.e.	nasoseptal	and	alar	
cartilages)	in	order	to	set	a	benchmark	against	which	to	evaluate	cartilage	tissue	engineering	
attempts.	
For	successful	cell-based	cartilage	repair	 in	 the	head	and	neck	area,	 selection	of	an	
appropriate	 cell	 source	 is	 crucial.	 In	 chapter	 four,	 the	 performance	 of	 culture-expanded	
chondrocytes	and	MSCs	 from	several	anatomical	 locations	 (i.e.	 chondrocytes	derived	 from	
ear,	nose	and	joint,	and	MSCs	derived	from	adipose	tissue	and	bone	marrow)	is	evaluated.	
Culture-expansion	 has	 however	 certain	 disadvantages:	 (1)	 it	 results	 in	 chondrocyte	
dedifferentiation,	 which	 usually	 results	 in	 fibrous	 and	 mechanically	 inferior	 cartilaginous	
tissue;	(2)	it	requires	a	two-step	surgical	procedure.	As	the	basic	principle	for	the	development	
of	 a	 one-step	 surgical	 repair	 procedure,	 co-cultures	 of	 primary	 chondrocytes	 and	MSCs	 is	
further	elucidated	in	chapter	five	and	six.	Chapter	five	describes	the	trophic	effect	of	AMSCs	
or	BMSCs	on	chondrocytes	and	whether	their	effect	 is	origin-dependent	or	a	general	MSC-
characteristic.	Chapter	six	evaluates	the	use	of	ECs	and	NCs	 in	combination	with	BMSC	for	
their	use	in	future	one-step	cell-based	cartilage	repair	in	the	head	and	neck	area.	
For	 successful	 cartilage	 regeneration,	 the	 properties	 of	 the	 3D	 scaffold	 are	 of	
equivalent	 importance.	 Scaffold	 design	 should	 herein	 substitute	 for	 the	 cell	 natural	
environment	 providing	 instantaneous	 cell	 support	 and	 guiding	 tissue	 development	 and	
remodelling.	Intuitively,	native	ECM	has	the	potential	to	be	the	most	ideal	scaffold	for	tissue	
engineering	and	regenerative	therapies.	Preservation	of	native	ECM	is	best	retained	through	
the	 process	 of	 decellularization.	 Chapter	 seven	 displays	 the	 preparation	 of	 decellularized	
cartilage	 scaffolds	 and	 extensively	 characterize	 their	 biochemical	 and	 biomechanical	
properties,	as	well	as	investigate	their	cytocompatibility.	
  
Another	way	to	-	at	least	partially	-	mimic	structural	and	functional	characteristics	of	native	
tissue	microenvironment	is	the	generation	of	ECM-inspired	scaffolds.	Alginate,	typically	used	
as	a	cell-laden	hydrogel,	 is	used	for	all	of	our	cell-culture	studies	since	it	supports	cartilage	
tissue	 regeneration	 and	 homeostasis.	 However,	 it	 appears	 to	 have	 inferior	 mechanical	
properties	 compared	 to	 native	 cartilage.	 Therefore	 a	 novel	 bilayer	 bacterial-nanocellulose	
scaffold	 is	 introduced	 in	 chapter	 eight.	 These	bacterial-nanocellulose	 scaffolds	 are	 seeded	
with	an	alginate-cell	suspension	and	evaluated	for	their	use	in	one-step	cell-based	cartilage	
repair.		
Finally,	the	last	chapter	of	the	thesis	will	provide	an	overview	of	the	main	results	and	
discuss	 the	 requirements	 for	 cell-based	 cartilage	 repair	 for	 future	 treatment	 of	 cartilage	
defects	in	the	head	and	neck	area.	In	particular,	recent	advances	and	remaining	questions	will	
be	debated.
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Chapter	2	
	
Mechanical	 and	 biochemical	 mapping	 of	 human	
auricular	 cartilage	 for	 reliable	 assessment	 of	 tissue-
engineered	constructs		
	
L.	Nimeskern,	M.M.	Pleumeekers,	D.J.	Pawson,	 J.L.M.	Koevoet,	 I.	Lehtoviita,	M.B.	Soyka,	C.	
Röösli,	D.	Holzmann,	G.J.V.M.	van	Osch,	R.	Müller,	K.S.	Stok		
	
Journal	of	Biomechanics,	2015.	48(10):	p.	1721-9.
  
ABSTRACT	
	
It	is	key	for	successful	ear	cartilage	tissue-engineering	to	ensure	that	the	engineered	
cartilage	mimics	the	mechanics	of	the	native	tissue.	This	study	provides	a	spatial	map	of	the	
mechanical	 and	 biochemical	 properties	 of	 human	 auricular	 cartilage,	 thus	 establishing	 a	
benchmark	for	the	evaluation	of	functional	competency	in	ear	cartilage	tissue	engineering.	
Stress-relaxation	indentation	(instantaneous	modulus,	Ein;	maximum	stress,	σmax;	equilibrium	
modulus,	Eeq;	relaxation	half-life	time,	t1/2;	thickness,	h)	and	biochemical	parameters	(content	
of	 DNA;	 sulfated-glycosaminoglycan,	 sGAG;	 hydroxyproline;	 elastin)	 of	 fresh	 human	 ear	
cartilage	were	evaluated.	Samples	were	categorized	into	age	groups	and	according	to	their	
harvesting	region	in	the	human	auricle	(for	ear	cartilage	only).	
Ear	 cartilage	 displayed	 significantly	 lower	 Ein,	 σmax,	 Eeq,	 sGAG	 content;	 and	
significantly	higher	t1/2,	and	DNA	content	than	nasal	cartilage.	Large	amounts	of	elastin	were	
measured	in	ear	cartilage	(>15%	elastin	content	per	sample	wet	mass).	No	effect	of	gender	
was	 observed	 for	 either	 ear	 or	 nasoseptal	 samples.	 For	 auricular	 samples,	 significant	
differences	 between	 age	 groups	 for	 h,	 sGAG	 and	 hydroxyproline,	 and	 significant	 regional	
variations	 for	 Ein,	 σmax,	 Eeq,	 t1/2,	 h,	 DNA	 and	 sGAG	 were	 measured.	 However,	 only	 low	
correlations	between	mechanical	and	biochemical	parameters	were	seen	(R<0.44).	
In	 conclusion,	 this	 study	 established	 the	 first	 comprehensive	 mechanical	 and	
biochemical	map	of	human	ear	cartilage.	Regional	variations	in	mechanical	and	biochemical	
properties	 were	 demonstrated	 in	 the	 auricle.	 This	 finding	 highlights	 the	 importance	 of	
focusing	 future	 research	 on	 efforts	 to	 produce	 cartilage	 grafts	 with	 spatially	 tunable	
mechanics.	 	
  
INTRODUCTION	
	
Surgical	 reconstruction	with	autologous	cartilage	or	alloplastic	 implants	 is	 the	only	existing	
treatment	 for	 auricular	 defects.	 The	 current	 gold-standard	 technique	 -	 autologous	 ear	
reconstruction	[120]	-	is	a	multi-staged	time-consuming	procedure	[9,	121],	that	ranks	among	
the	 most	 complicated	 of	 reconstructive	 surgeries	 [122].	 In	 short,	 autologous	 cartilage	 is	
harvested	from	the	ribs,	shaped	appropriately	and	implanted	subcutaneously.	Ear	cartilage	
tissue-engineering	(TE)	is	a	potential	alternative	that	endeavors	to	circumvent	the	resulting	
donor-site	morbidity	by	engineering	rather	than	harvesting	cartilage.	[58,	123-137]		
Ideally	tissue-engineered	ear	cartilage	should	possess	similar	mechanical	properties	to	
the	native	tissue	in	order	to	withstand	daily	load	(e.g.	wearing	spectacles,	helmets,	ear	phones,	
etc.)	 and	without	 causing	discomfort.	 [138]	 Selecting	autologous	material	 for	 ear	 cartilage	
surgical	reconstruction	is	difficult,	where	donations	come	from	the	nasal	septum,	auricle	and	
rib.	Whether	the	graft	qualifies	mechanically	for	surgical	implantation	is	usually	made	from	
simple	palpation.	Mechanical	properties	of	hyaline	(e.g.	nasoseptal,	costal,	articular	cartilage)	
and	fibrocartilage	(e.g.	intervertebral	disk)	have	been	extensively	documented.	[139-141]	The	
structure-function	 relationship	 linking	 composition	 and	 architecture	 to	 mechanical	
competency	has	been	established	 for	 these	 cartilage	 subtypes.	 [140,	 142]	 The	mechanical	
properties	 of	 ear	 cartilage	 are,	 however,	 sparsely	 investigated	 [143],	 and	 limited	 data	 are	
available	for	human	cartilage.	[24,	138]	Unlike	hyaline	and	fibrocartilage,	ear	cartilage	contains	
large	amounts	of	elastin	fibers.	Those	fibers	play	a	mechanical	role	in	tissues	such	as	arteries	
and	skin	[144,	145],	therefore	the	mechanical	properties	of	ear	cartilage	are	expected	to	vary	
from	other	cartilage	types	[138].		
Mechanical	evaluation	has	often	been	overlooked	in	ear	cartilage	TE	attempts.	Many	authors	
[58,	123,	125-137]	report	a	qualitative	mechanical	assessment,	while	a	few	publications	report	
quantitative	data	but	without	comparison	to	human	ear	cartilage	[146-150].	Indentation	has	
been	shown	previously	to	be	a	good	and	sensitive	first	approximation	for	direct	comparison	
between	native	and	tissue-engineered	constructs.	[151]	
In	 light	of	 this,	 the	aim	of	 this	work	 is	 to	establish	a	mechanical	characterization	of	
native	 human	 ear	 cartilage	 in	 order	 to	 set	 a	 benchmark	 against	 which	 to	 evaluate	 TE	
constructs.	Mechanical	and	biochemical	properties	of	fresh	ear	cartilage	are	determined	and	
compared	 to	 hyaline	 nasoseptal	 cartilage.	 Additionally	 spatial	 variation	 in	 mechanical	
properties,	 the	 influence	of	patient	gender	and	age,	 and	correlations	between	mechanical	
properties	and	biochemical	composition	are	investigated.	
	
	
  
MATERIALS	AND	METHODS	
	
Chemicals	were	obtained	from	Sigma-Aldrich,	USA	unless	stated	otherwise.	
	
Sample	harvesting	and	preparation	
Cadaveric	auricles	were	harvested	by	Science	Care	(Phoenix,	Arizona,	USA,	n=4)	and	Erasmus	
Medical	 Center	 (Rotterdam,	 the	Netherlands,	n=11)	 according	 to	 ethical	 guidelines	 of	 the	
respective	institution.	Additionally	ear	(EC)	and	nasoseptal	(NC)	cartilage	was	obtained	from	
patients	 (n=30,	 EC;	 n=69,	 NC)	 undergoing	 middle	 ear	 or	 cholesteatoma	 surgery	 (EC)	 and	
functional	septo-	or	septorhinoplasties	(NC)	at	University	Hospital	Zurich	(Zurich,	Switzerland),	
and	Ulm	University	Medical	Center	(Ulm,	Germany)	according	to	the	ethics	regulations	of	the	
respective	 institution.	EC	samples	were	harvested	from	15	male	and	12	female	donors,	NC	
samples	were	harvested	from	40	male	and	12	female	donors.	Samples	were	pooled	according	
to	anthropomorphic	age	(child,	<20	years;	young	adult,	20–34;	middle	adult,	35–49;	and	old	
adult,	 ≥50).	 [152]	 All	 samples	 were	 shipped	 at	 4°C	 in	 phosphate	 buffered	 saline	 (PBS)	
supplemented	with	antibiotic/antimycotic	(Gibco,	Invitrogen	Corporation,	California,	USA)	to	
ETH	 Zurich	 (Zurich,	 Switzerland).	 The	 perichondrium	 was	 removed	 from	 EC	 samples,	 and	
cylindrical	plugs	(5	mm,	1–2	mm	thick)	were	cut	perpendicular	to	the	surface.	Six	harvesting	
regions	were	defined	(anti-helix,	AH;	anti-tragus,	AT;	concha,	CO;	helix,	HE;	scapha,	SC;	tragus,	
TR).	(Figure	1A)	NC	plugs	were	similarly	prepared,	where	samples	originated	from	the	center	
of	 the	 nasal	 septum.	 (Figure	 1B)	 Differences	 in	 sample	 number	 for	 biomechanical	 and	
biochemical	assays	is	due	to	sample	loss	during	processing,	unusual	sample	shape	preventing	
mechanical	analysis	or	limitations	of	biochemical	assays.		
	
	
Figure	1.	Anatomy	of	human	ear	and	nasal	septum.	
(A)	Map	of	the	human	auricle.	Six	harvesting	regions	are	identified	based	on	the	ear	morphology:	anti-helix,	AH,	
anti-tragus,	AT,	concha,	CO,	helix,	HE,	scapha,	SC	and	tragus	TR.	Adapted	from	Atlas	der	Anatomie	des	Menschen,	
B.N.	 Tillmann,	 Springer–Lehrbuch.	 [153]	 (B)	 Harvesting	 site	 for	 nasoseptal	 cartilage.	 Adapted	 from	 Gray’s	
Anatomy	of	the	Human	Body,	Henry	Gray.	[154]	
	 	
  
Mechanical	evaluation	
Cartilage	samples	(EC:	n=183;	NC:	n=103)	were	placed	in	close-fitting	stainless	steel	cylindrical	
wells,	and	tested	with	a	materials	testing	machine	(Zwick	Z005,	Ulm,	Germany)	equipped	with	
a	10	N	load	cell,	built-in	displacement	control,	and	a	cylindrical,	plane-ended,	stainless	steel	
indenter	 (0.35	 mm).	 During	 testing	 samples	 were	 immersed	 in	 PBS	 supplemented	 with	
antibiotic/antimycotic,	 and	 stress	 relaxation	 indentation	 tests	 were	 performed	 at	 room	
temperature,	as	described	previously.	 [155,	156]	Briefly,	a	preload	of	3	mN	was	applied	to	
locate	the	sample	surface	and	measure	sample	thickness,	h,	and	held	for	5	min.	Five	successive	
strain	steps	(5%	of	h	per	step)	were	applied,	and	specimens	were	left	to	relax	for	20	min	at	
each	step.	An	in-house	Matlab®	script	converted	force	and	displacement	data	to	stress	and	
strain,	and	instantaneous	modulus	(Ein),	maximum	stress	(σmax),	equilibrium	modulus	(Eeq),	
relaxation	 half	 life	 time	 (t1/2)	 were	 determined.	 To	 estimate	 viscoelastic	 relaxation,	 t1/2	 is	
computed	 after	 the	 first	 strain	 application.	 It	 is	 defined	 as	 the	 time	 needed	 for	 stress	 to	
decrease	from	its	maximum	value	halfway	to	its	equilibrium	value.	[155]	
	
Biochemical	evaluation	
Following	 mechanical	 testing,	 each	 sample	 was	 cut	 into	 two	 and	 frozen	 at	 -80°C	 until	
processing.	Samples	were	defrosted,	and	wet	weight	of	each	half	was	measured.	One	half	was	
digested	overnight	at	60°C	with	papain	buffer	 (0.2	M	NaH2PO4,	0.01	M	EDTA,	pH	6.0	and	
freshly	 added	 250	 μg/mL	 papain,	 and	 5	mM	 L-cystein),	 and	 analyzed	 for	 DNA,	 sGAG,	 and	
hydroxyproline	content.	The	second	half	was	analyzed	for	elastin	content.	
	
DNA	content	
Amount	of	DNA	(EC:	n=223;	NC:	n=153)	was	determined	by	ethidium	bromide	 (GibcoBR1),	
using	 calf	 thymus	 DNA	 as	 a	 standard.	 Samples	 were	 analyzed	 with	 a	 spectrofluorometer	
(Wallac	1420	Victor	2;	Perkin-Elmer,	Wellesley,	USA),	using	an	extinction	 (340	nm)	and	an	
emission	(590	nm)	filter.	DNA	content	was	normalized	to	sample	wet	mass.	
	
Glycosaminoglycan	content	
Sulfated-glycosaminoglycan	content	(sGAG)	(EC:	n=223;	NC:	n=154)	was	quantified	using	the	
1,9-Dimethylmethylene	blue	(DMMB)	dye-binding	assay,	where	metachromatic	reaction	was	
monitored	using	a	spectrophotometer.	Absorption	ratios	of	540	nm	and	595	nm	were	used	to	
determine	sGAG	content	with	chondroitin	sulfate	C	(shark)	as	a	standard.	sGAG	values	were	
normalized	to	sample	wet	mass.	
	
Hydroxyproline	content	
Hydroxyproline	content	was	measured	to	estimate	collagen	quantity	(EC:	n=189;	NC:	n=140)	
using	the	Total	Collagen	Assay	(QuickZyme	Biosciences,	Leiden,	the	Netherlands)	according	to	
the	manufacturer's	instructions.	Briefly,	papain	digests	were	hydrolyzed	with	equal	volumes	
of	 12	 M	 HCL	 at	 95°C	 for	 18–20	 hours.	 Hydroxyproline	 content	 was	 measured	 using	 a	
modification	of	 the	Prockop	and	Udenfriend	method	 [157],	and	normalized	 to	sample	wet	
mass.		
	
  
Elastin	content	
Elastin	 content	 (EC:	 n=48)	 was	 measured	 using	 the	 Fastin	 Elastin	 Assay	 (Biocolor,	
Carrickfergus,	 UK)	 according	 to	 the	 manufacturer's	 instructions.	 Briefly,	 the	 sample	 was	
converted	to	water	soluble	α-elastin	by	three	12	hour	heat	extraction	cycles	at	100°C	in	0.25	
M	oxalic	acid	before	adding	the	kit's	dye.	Absorbance	was	measured	at	513	nm	on	an	Infinite	
F200	PRO	(Tecan,	Giessen,	the	Netherlands)	plate	reader.	α-elastin	from	bovine	neck	ligament	
(from	the	manufacturer)	was	used	as	a	standard.	Elastin	values	were	normalized	to	sample	
wet	 mass.	 Since	 NC	 samples	 contain	 no	 elastin	 [143],	 elastin	 was	 only	 quantified	 for	 EC	
samples.	
	
Histology	
EC	samples	from	all	ear	regions	and	young	and	old	adult	age	groups	were	embedded	in	OCT	
(Tissue-Teks	 O.C.T™	 Compound,	 Sakura).	 Samples	 were	 cryosectioned	 at	 a	 5	 mm	 slice	
thickness	and	stained	with	Sirius	red,	Resorcin-Fuchsin	and	Safranin-O	to	visualize	the	collagen	
network,	elastic	fibers	and	sGAG,	respectively.	
	
Statistical	analysis	
A	linear	mixed-effect	model,	where	donor	was	a	random	effect,	and	cartilage	subtype,	gender,	
age	 group	 and	 harvesting	 location	 were	 fixed	 effects,	 was	 used	 to	 analyze	 statistical	
differences	 between	 mechanical	 (Ein,	 σmax,	 Eeq,	 t1/2)	 and	 biochemical	 (DNA,	 sGAG,	
hydroxyproline)	results.	Additionally	bivariate,	correlation	analyses	between	mechanical	and	
biochemical	 parameters	 were	 performed	 for	 EC	 and	 NC	 samples.	 All	 calculations	 were	
performed	with	SPSS	(version	22.0,	IBM	Corp.,	New	York,	USA).	All	data	are	displayed	as	mean	
±	standard	deviation,	where	٭	indicates	significance	(p<0.05).	
	 	
  
RESULTS	
	
Results	show	that	subtype	 (EC	or	NC)	 is	significantly	different	 for	all	measured	values	 (Ein,	
σmax,	Eeq,	t1/2,	DNA,	sGAG),	except	hydroxyproline.	(Figure	2)	Measured	values	of	Ein,	σmax,	
Eeq,	t1/2,	DNA,	sGAG	and	hydroxyproline	showed	no	significant	differences	between	male	and	
female	 sex	 for	 both	 EC	 and	NC.	 All	male	 and	 female	 data	 points	were	 pooled	 for	 further	
analysis.	
	 Due	to	the	limited	number	of	EC	samples	available	in	child	and	middle	adult	groups,	
only	 young	 adult	 and	 old	 adult	 groups	 were	 used	 to	 investigate	 age	 differences.	 Results	
indicate	 age	 dependent	 differences	 in	 h,	 sGAG	 and	hydroxyproline	 (Figure	 3E,G,H),	where	
older	adults	had	thicker	EC	and	 lower	sGAG	and	hydroxyproline	content.	Age	groups	were	
pooled	for	all	parameters	showing	nonsignificant	effects	of	age,	i.e.	Ein,	σmax,	Eeq,	t1/2,	DNA	
and	elastin.	
	 	
	
	 Ein	 σmax	 Eeq	 t1/2	 h	 DNA	 sGAG	 HYP	 ELN	
	 	 	 	 	 	 	 	 	 	
Harvesting	location	 ●	 ●	 ●	 ●	 ●	 ●	 ●	 	 	
Age	 	 	 	 	 ●	 	 ●	 ●	 	
	
Table	1.	
Significant	effects	observed	for	ear	cartilage	samples.	Corresponding	values	for	each	region	and	age	group	are	
displayed	in	Figure	3.	
●	Indicates	significant	differences,	where	p<0.05.	
	
	
All	values	except	hydroxyproline	and	elastin	showed	significant	differences	with	harvesting	
location.	(Table	1)	Regional	variation	patterns	across	the	auricle	were	observed	for	Ein,	σmax	
and	Eeq	 (Figure	3A,B,C),	where	the	helix	 (HE)	values	were	 lowest,	and	the	anti-tragus	 (AT)	
highest.	This	was	 significantly	different	 from	all	 regions	except	 the	 tragus	 (TR).	A	different	
pattern	was	observed	for	t1/2	with	slower	relaxation	measured	in	the	AH	and	HE.	(Figure	3D)	
AT	was	thickest,	with	little	variation	seen	in	other	regions.	(Figure	3E)	Likewise	biochemical	
properties	(DNA	and	sGAG	content)	presented	regional	variations.	(Figure	3F,G).	DNA	content	
was	highest	in	the	scapha	(SC)	and	lowest	in	the	AT	and	TR.	The	highest	sGAG	content	was	
measured	 in	 the	AT	 and	TR.	No	 regional	 variations	were	observed	 for	 hydroxyproline	 and	
elastin	content.	(Figure	3H,I)		
  
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	2.	Mechanical	and	biochemical	properties	of	ear	and	nasal	cartilage.	
(A–D)	Summary	of	mechanical	(Ein,	σmax,	Eeq,	t1/2)	and	(E–H)	biochemical	parameters	(DNA,	sGAG,	HYP	and	
ELN)	measured	for	ear	and	nasoseptal	cartilage.	Cartilage	subtype	is	significantly	different	for	all	measured	
variables,	except	hydroxyproline	(p<0.05).	As	nasoseptal	cartilage	is	known	to	contain	no	elastin	[143],	elastin	is	
quantified	for	ear	samples	only.	
  
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	3.		
(A–E)	Summary	of	mechanical	(Ein,	σmax,	Eeq,	t1/2)	and	(F–I)	biochemical	parameters	(DNA,	sGAG,	HYP	and	ELN)	
measured	for	ear	cartilage.	Harvesting	location	is	significantly	different	for	Ein,	σmax,	Eeq,	t1/2,	h,	DNA	and	sGAG,	
as	indicated	by	the	tables	adjacent	to	the	graphs	(*	indicates	p<0.05).	The	color	coded	maps	display	the	average	
values	 measured	 in	 each	 ear	 region.	 Age	 groups	 are	 significantly	 different	 for	 h,	 sGAG	 and	 hydroxyproline	
(p<0.05),	see	(E,	G	and	H).	Samples	for	the	child	and	middle-age	adults	age	groups	could	only	obtained	from	the	
CO	and	the	SC	regions.	
  
Similarly,	NC	samples	showed	no	significant	differences	with	age	or	gender	for	all	measured	
parameters.	Correlation	coefficients	between	mechanical	and	biochemical	parameters	
(Table	2)	show	that	for	EC,	DNA,	sGAG	and	elastin	correlated	significantly	with	Ein,	σmax,	Eeq,	
and	DNA	correlated	significantly	with	t1/2,	and	hydroxyproline	with	Ein.	For	NC,	DNA	
correlated	significantly	with	Ein,	σmax,	and	Eeq,	and	sGAG	correlated	significantly	with	t1/2.	All	
correlations	between	mechanical	and	biochemical	measures	yielded	low	correlation	
coefficients;	specifically,	for	Eeq	and	sGAG	content,	R=0.32,	p<0.05,	n=171,	and	for	Eeq	and	
elastin	content,	R=0.44,	p<0.05,	n=41.		 		
	
	
R	 	 h	 DNA	 sGAG	 HYP	 ELN	
	 	 	 	 	 	 	
EC	 Ein	 0.55●	 -0.23●	 0.31●	 0.16●	 0.39●	
	 σmax	 0.61●	 -0.25●	 0.26●	 -0.10●	 0.44●	
	 Eeq	 0.54●	 -0.27●	 0.32●	 -0.10●	 0.44●	
	 t1/2	 0.10●	 -0.24●	 -0.11●	 -0.02●	 -0.17●●	
	 	 	 	 	 	 	
NC	 Ein	 0.48●	 -0.31●	 0.05	 -0.03●	 -	
	 σmax	 0.63●	 -0.33●	 0.07	 -0.12●	 -	
	 Eeq	 0.44●	 -0.25●	 0.04	 -0.09●	 -	
	 t1/2	 -0.01●	 -0.18●	 -0.32●	 -0.10●	 -	
	
Table	2.	
Pearson	coefficients	(R)	observed	between	the	measured	mechanical	(Ein,	σmax,	Eeq	and	t1/2)	and	biochemical	
parameters	(DNA,	sGAG,	hydroxyproline	and	elastin)	for	EC	and	NC	samples.	
●	Indicates	significant	differences,	where	p<0.05.	
	
	
Sirius	red,	Resorcin-Fuchsin	and	Safranin-O	staining	of	histological	sections	of	native	human	
EC	for	all	ear	regions	and	for	young	and	old	adult	groups	show	high	cell	density	in	EC	samples.	
(Figure	4)	Lighter	Safranin-O	staining	for	old	adult	reflects	lower	sGAG	content	measured	by	
the	DMMB	assay.	(Figure	3)		
	
	
  
	
Figure	4.	Histological	staining	of	ear	cartilage.	
(A)	Sirius	red,	Resorcin-Fuchsin	and	Safranin-O	staining	of	histological	sections	of	native	human	ear	cartilage	for	
all	ear	regions	and	for	young	and	old	adult	age	groups.	The	high	cell	density	of	ear	cartilage	can	be	observed	(B).	
The	lighter	sirius	red	and	Safranin-O	staining	in	the	old	adult	samples	reflect	the	lower	collagen	and	sGAG	content	
measured	by	DMMB	assay	(see	Figure	3).	The	Resorcin-Fuchsin	staining	demonstrates	the	high	elastin	content	
of	the	cartilage	and	the	surrounding	perichondrium.	 	
  
DISCUSSION	
	
There	has	been	a	long	and	ongoing	wish	to	cultivate	human	cartilage	in	a	shape	or	manner	
that	can	be	used	in	reconstructive	and	plastic	surgery.	Autologous	material	 is	preferred	for	
grafting,	 and	 cartilage	 donations	 come	 from	 the	 nasal	 septum,	 auricle	 and	 rib.	 Surgically,	
clinicians	or	surgeons	are	looking	for	a	material	where	the	decision	whether	the	graft	qualifies	
for	 implant	 is	 usually	 made	 by	 palpation;	 i.e.	 compressive	 stiffness.	 Bending	 and	 tensile	
properties	would	be	more	reflective	of	functional	material	properties,	but	also	require	large	
sample	dimensions.	With	growing	interest	in	TE	materials,	the	primary	interest	was	to	obtain	
a	 benchmark	 of	 mechanical	 performance	 against	 which	 to	 evaluate	 TE	 strategies,	 and	
therefore,	a	stress-relaxation	indentation	and	biochemical	map	of	human	native	ear	cartilage	
is	presented.	
	 Ear	 cartilage	 has	 significantly	 lower	 strength,	 stiffness	 and	 sGAG	 content;	 and	
significantly	higher	relaxation	time	and	DNA	content	compared	to	nasoseptal	cartilage.	Ear	
cartilage	also	contains	>15%	elastin	content	per	sample	wet	mass;	and	significant	differences	
between	 age	 groups	 were	 observed	 for	 thickness	 and	 matrix	 components	 (sGAG	 and	
hydroxyproline),	 and	 significant	 regional	 variations	 were	 observed	 for	 all	 mechanical	
parameters,	DNA	and	sGAG	content.	Relatively	large	Eeq	values	(10–15	MPa)	were	measured	
for	nasoseptal	cartilage	compared	to	typical	values	reported	in	literature	for	articular	cartilage	
(1–2	MPa).	 [158]	Although	articular	and	nasoseptal	 cartilage	are	classified	as	hyaline,	 they	
present	different	architectures	(no	Benninghoff	arcade	in	nasoseptal	cartilage)	and	functions	
(articular	provides	joint	lubrication	and	stress	distribution,	while	nasoseptal	cartilage	provides	
mechanical	support),	which	could	explain	the	different	moduli.	
	 Stress-relaxation	 indentation	 is	 able	 to	 capture	 both	 instantaneous	 (Ein)	 and	
equilibrium	behavior	(Eeq)	of	cartilage.	[159]	In	literature,	reports	of	quantitative	mechanics	
for	 TE	 constructs	 are	 given	 for	 confined	 compression	 [148,	 160],	 unconfined	 compression	
[150]	and	tension	[149,	161].	While	no	comparison	can	be	made	with	tension,	the	indentation	
results	in	this	study	Eeq	compare	well	with	compressive	equilibrium	or	apparent	modulus	in	
literature.	TE	constructs	are	inferior	to	native	tissue,	where	all	values	are	less	than	1	MPa	[146,	
148,	150,	160]	compared	to	2.2	±	1.2	MPa	in	the	softest	region	(HE)	up	to	7.2	±	4.7	MPa	in	the	
stiffest	region	(AT)	in	this	work.	
	 Chondrocytes	from	ear	and	nasoseptal	cartilage	have	different	proliferations	rates	and	
gene	expression	profiles.	 [40,	56]	 In	 this	work,	higher	DNA	and	 lower	sGAG	contents	were	
observed	in	ear	cartilage.	Higher	DNA	content	is	likely	a	direct	consequence	of	high	cellularity	
[143],	confirmed	by	histology.	Hydroxyproline	content,	an	indicator	for	collagen	content,	was	
not	significantly	different	between	ear	(60.0	±	25.7	nmol/mg)	and	nasoseptal	cartilage	(53.5	±	
19.0	nmol/mg),	but	nasoseptal	cartilage	displayed	an	almost	two	times	higher	sGAG	content.	
The	effect	of	this	was	observed	mechanically;	i.e.	significantly	higher	Ein,	σmax,	and	Eeq	in	NC.	
Indeed	 sGAG	 side-chains	 are	 negatively	 charged,	 which	 generates	 an	 osmotic	 swelling	
pressure	that	attracts	interstitial	fluid.	Under	compression,	load	applied	on	hyaline	cartilage	
is	carried	simultaneously	by	the	solid	matrix	(collagen	network	with	its	fixed	charge	density)	
and	resistance	to	fluid	flow	induced	by	compression.	[162]	Higher	sGAG	content	observed	in	
nasoseptal	cartilage	was	consistent	with	higher	mechanical	properties.	Ear	cartilage,	on	the	
  
other	hand,	presents	a	significantly	higher	t1/2,	again	indicating	that	different	mechanisms	are	
at	play	in	these	cartilage	subtypes;	ear	cartilage	has	a	more	elastic	behavior,	i.e.	lower	viscous	
dissipation	 of	 strain	 energy,	 and	 differences	 in	 architecture	 and	 composition.	 [143]	 The	
presence	of	elastin	is	most	likely	responsible	for	these	differences.	
	 Differences	 in	 post-maturity	 growth	 rate	 of	 the	 auricle	 between	 male	 and	 female	
donors	 have	 been	 reported	 in	 literature	 [163],	 however	 this	 was	 not	 reflected	 in	 the	
parameters	measured	here,	where	no	significant	differences	were	observed.	For	the	purpose	
of	establishing	a	benchmark	 for	TE	ear	cartilage,	a	distinction	between	male	and	female	 is	
considered	unnecessary.	
	 Within	 ear	 cartilage	 samples,	 significant	 age-related	 differences	 were	 identified.	
Increasing	h	with	age	was	observed	while	sGAG	and	hydroxyproline	contents	decreased.	Age-
related	 augmentation	 of	 tissue	 thickness	 is	 consistent	with	 previous	 reports	 of	 continued	
growth	of	the	auricle	during	adult	life.	[163-165]	This	is	likely	due	to	altered	quality	of	the	fiber	
network,	specifically	elastic	fibers	become	increasingly	fragmented	and	heterogeneous	with	
age.	 [164]	Additionally,	 cleavage	of	 collagen	 fibers	has	been	 linked	 in	articular	 cartilage	 to	
increased	thickness	[166],	and	a	similar	mechanism	could	exist	in	ear	cartilage.	Age-related	
decreases	in	sGAG	and	hydroxyproline	content	were	not	reflected	in	mechanical	properties.	
While	sGAG	and	collagen	fiber	network	are	known	to	govern	mechanical	behavior	in	articular	
cartilage	[162],	it	is	hypothesized	that	in	ear	cartilage	the	contribution	of	sGAG	and	collagen	
to	mechanical	properties	is	reduced	due	to	the	elastin	network.	A	large	contribution	would	
likely	come	from	this	extensive	network,	since	it	is	mechanically	critical	in	other	tissues.	[144,	
145]	Elastin	is	responsible	for	elasticity	in	human	skin	[144],	elastic	recoil	of	lung	tissue	[167],	
and	reversible	extensibility	in	large	elastic	arteries	[168].	
	 Measured	parameters	were	observed	to	vary	significantly	between	different	regions	
of	the	ear;	where	AT	was	stiffest	and	HE	was	softest.	DNA	and	sGAG	content	displayed	similar	
variations,	 with	 correlative	 trends	 to	mechanical	 parameters.	 No	 regional	 variations	were	
observed	for	hydroxyproline	and	elastin	content.	This	suggests	that	unlike	hyaline	cartilage,	
an	 altered	 mechanical–chemical–architectural	 relationship	 exists	 in	 elastic	 cartilage,	 and	
tissue	composition	alone	cannot	fully	explain	local	mechanics.	Literature	on	hyaline	cartilage	
[158,	 159,	 162,	 169-175]	 supports	 the	 idea	 that	 ear	 cartilage	 mechanics	 are	 linked	 to	
architecture	and	composition.	Functionally,	specific	local	mechanical	properties	are	necessary	
for	three	dimensional	structure.	The	human	auricle	has	large	vestigial	musculature	anchoring	
the	 head	 (extrinsic)	 and	 connecting	 regions	 of	 the	 auricle	 (intrinsic).	 [122]	 Local	 variation	
highlights	 the	need	 for	TE	strategies	aimed	at	producing	scaffolds	and	grafts	with	spatially	
tunable	mechanics.	[155]	However	since	these	differences	are	quite	small	it	may	also	be	worth	
investigating	whether	 thickness	 variation	 is	 sufficient	 to	provide	 the	necessary	mechanical	
integrity	in	TE	constructs.	
	 Significant	 correlations,	despite	weak	Pearson	coefficients,	were	observed	between	
biochemical	 and	 mechanical	 parameters.	 sGAG	 content	 has	 been	 linked	 to	 mechanical	
behavior	 in	articular	 cartilage	 [162],	while	DNA	content	does	not.	Nonetheless,	higher	 cell	
density	implies	that	extracellular	matrix	occupies	a	lower	volume	fraction,	and	assuming	that	
chondrocytes	 present	 lower	 mechanical	 properties	 than	 the	 matrix	 [176],	 increased	 cell	
density	would	result	in	lower	mechanics	and	explain	the	negative	correlations.	
  
Limitation	of	this	work	 includes	the	 lack	of	control	of	sample	thickness	during	preparation,	
since	perfectly	cylindrical	samples	cannot	be	obtained.	 Indentation	testing	[158]	requires	a	
well-defined	surface	only	around	the	indenter;	and	since	maximizing	sample	number	was	key,	
the	sample	height	was	kept	to	that	with	only	the	perichondrium	removed.	Although	significant	
correlations	were	observed	between	thickness	and	mechanical	properties	(R	between	0.4	and	
0.7,	p<0.05,	Table	2),	 sample	and	 indenter	geometries	were	used	which	 limit	 their	bias	on	
measured	properties.	[177]	The	test	setup	could	additionally	be	modeled	using	an	appropriate	
finite	 element	 approach.	 Since	 ear	 cartilage	 displays	 a	 different	 tissue	 composition	 and	
architecture	 to	 articular	 cartilage,	 it	 cannot	 be	 assumed	 that	 models	 used	 for	 articular	
cartilage	would	yield	relevant	results	for	ear	cartilage.	Only	very	recently,	a	first	model	has	
been	proposed	for	ear	cartilage.	[24]	
	 Furthermore,	 tests	were	performed	at	 room	 (20°C)	 rather	 than	physiological	 (37°C)	
temperature.	Literature	indicates	no	change	in	mechanical	properties	for	articular	cartilage	
between	20°C	and	37°C	[178],	and	room	temperature	is	routinely	used	[179].	
	 Although	numerous	attempts	 to	develop	 tissue-engineered	ear	 cartilage	have	been	
reported,	nearly	no	data	is	available	on	the	native	mechanical	properties.	One	reason	is	likely	
the	difficulty	accessing	fresh	tissue.	Although	samples	obtained	for	this	work	were	collected	
over	 four	 years,	 it	 was	 not	 possible	 to	 obtain	 equal	 sample	 numbers	 for	 all	 groups.	
Additionally,	hydroxyproline	content	as	an	indicator	of	collagen	content	is	not	ideal	since	both	
collagen	and	elastin	contain	hydroxyproline	(12.5%	and	2%	of	protein	mass	respectively	[180],	
therefore	a	fraction	of	hydroxyproline	measured	in	ear	cartilage	is	due	to	elastin.	
	 In	 conclusion,	 this	 study	 establishes	 the	 first	 mechanical	 and	 biochemical	 map	 of	
human	ear	 cartilage,	enabling	 reliable	assessment	of	engineered	ear	 cartilage	 sufficient	 to	
sustain	daily	loading,	while	also	ensuring	cartilage	grafts	are	not	stiffer	than	necessary.	The	
extensive	 elastic	 fiber	 network	 of	 ear	 cartilage	 is	 a	 key	 functional	 component.	 Regional	
variations	are	demonstrated,	and	biochemical	composition	alone	does	not	fully	account	for	
observed	mechanical	variation	indicating	a	probable	contribution	from	local	architecture.	It	
would	 be	 of	 interest,	 in	 future,	 to	 have	 numerical	 models	 for	 ear	 cartilage	 and	 an	
understanding	of	the	role	of	elastin.	(Table	3)	
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Table	3.	
Mean	±	standard	deviation	measured	for	mechanical	(Ein,	σmax,	Eeq	and	t1/2)	and	biochemical	parameters	(DNA,	
sGAG,	hydroxyproline	and	elastin)	for	ear	samples.		
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ABSTRACT	
	
In	 the	human	ear	and	nose	cartilage	plays	a	key	role	 in	establishing	 its	 form	and	 function.	
Interestingly,	there	is	a	noticeable	paucity	on	biochemical,	structural	and	mechanical	studies	
focussed	on	facial	cartilages.	Such	studies	are	needed	to	provide	elementary	knowledge	that	
is	useful	for	tissue	engineering	of	cartilage.	Therefore,	in	this	study	a	comparison	is	made	of	
the	biochemical,	structural	and	mechanical	differences	between	ear,	ala	nasi	and	septum	on	
the	extracellular	matrix	level.	
Cartilage	 samples	 were	 harvested	 from	 cadaveric	 donors	 (n=10).	 Each	 sample	was	
indented	 10	 times	 with	 a	 nano-indentor	 to	 determine	 the	 effective	 Young´s	 modulus.	
Structural	 information	 of	 the	 cartilage	 was	 obtained	 by	 Multiple-photon	 laser	 scanning	
microscopy	capable	of	revealing	matrix	components	at	subcellular	resolution.	Biochemistry	
was	performed	to	measure	sulphated-glycosaminoglycan	(sGAG),	DNA,	elastin	and	collagen	
content.	
Significant	 differences	 were	 seen	 in	 stiffness	 between	 ear	 and	 septal	 cartilage	
(p=0.011),	and	ala	nasi	and	septal	cartilage	(p=0.005).	Elastin	content	was	significantly	higher	
in	 ear	 cartilage.	 Per	 cartilage	 subtype,	 effective	 Young’s	 modulus	 was	 not	 significantly	
correlated	with	cell	density,	sGAG	or	collagen	content.	However,	in	septal	cartilage,	low	elastin	
content	was	associated	with	higher	stiffness.	Laser	microscopy	showed	a	distinct	difference	
between	ear	cartilage	and	cartilage	of	nasal	origin.	
Proposed	methods	 to	 investigate	 cartilage	on	 the	 extracellular	 level	 provided	 good	
results.	Significant	differences	were	seen	not	only	between	ear	and	nasal	cartilage	but	also	
between	the	ala	nasi	and	septal	cartilage.	Albeit	its	structural	similarity	to	septal	cartilage,	the	
ala	nasi	has	a	matrix	stiffness	comparable	to	ear	cartilage.	
	 	
  
INTRODUCTION	
	
Cartilage	plays	a	key	role	with	respect	to	form	and	function	of	facial	features.	When	cartilage	
of	the	nose	or	ear	is	damaged	by	injury	it	does	not	have	the	capacity	to	regenerate.	This	means	
that	an	ear	or	nose	remains	mutilated	once	its	cartilage	structure	is	disrupted.	A	reconstructive	
procedure	is	then	necessary	to	create	a	new	framework	with	a	good	three-dimensional	(3D)	
structure	capable	of	withstanding	normal	mechanical	forces.	Practically,	the	reconstruction	of	
the	ala	nasi	or	minor	ear	defects	is	most	often	performed	using	auricular	or	septal	cartilage	
grafts.	[181,	182]	In	more	extensive	cases	costal	cartilage	can	be	used,	offering	more	material	
for	harvest	and	providing	a	more	rigid	support.	Ear,	septal	or	costal	cartilage	can	be	used	for	
reconstruction	 but	 the	 availability	 of	 material	 for	 transplantation	 is	 generally	 limited	 and	
donor	site	morbidity	remains	a	risk.	This	is	especially	the	case	in	burn	patients	who	often	suffer	
from	extensive	damage	to	the	nose	and	ears	due	to	their	protruded	position	and	thin	skin	
coverage.	 [181,	 183,	 184]	 As	 such,	 regenerative	 medicine	 offers	 exciting	 possibilities	 to	
overcome	these	problems.	New	developments	in	the	field	of	tissue	engineering	have	already	
found	their	way	to	the	clinic.	Yanaga	and	colleagues	for	example	performed	several	clinical	
experiments	in	which	newly	developed	cartilage	from	autologous	chondrocytes	isolated	from	
the	ear	was	used	for	ear	framework	reconstruction.	[182,	185]	With	increased	attention	for	
tissue	engineered	alternatives	we	need	structural	information	on	the	tissues	we	are	seeking	
to	replicate.	However,	there	is	little	data	in	literature	on	the	mechanical	characteristics	and	
differences	 in	 composition	 and	 structure	 between	 the	 various	 facial	 cartilage	 types,	 in	
particular	the	ear,	alar	and	septal	cartilage.		
Although	 they	 share	 a	 common	 embryonic	 origin,	 facial	 cartilage	 soon	 differentiates	 into	
distinct	cartilage	subtypes	according	to	their	specific	structural	function.	In	the	early	stage	of	
developing	 vertebrates,	 the	 embryonic	 region	 that	 is	 to	 become	 the	 head	 and	 neck	 is	
transiently	divided	into	segments	known	as	the	pharyngeal	arcs	(PA’s).	The	ear	has	a	combined	
origin	and	is	derived	from	PA1	and	PA2	that	form	the	hillocks	of	His	at	six	weeks	development.	
Eventually	these	six	hillocks	fuse	together	to	form	the	outer	ear.	[186,	187]	PA1	grows	further	
outwards	to	form	the	lower	mandibular	process	and	upper	maxillary	process.	The	latter	later	
forms	the	frontal	prominence	and	the	medial	and	lateral	nasal	processes	which	will	form	into	
the	alar	nasi	and	after	final	fusion	into	the	septum.	[188]	
Mature	ear	cartilage	consists	of	an	 intricate	network	of	elastin	fibers	and	collagen	bundles	
surrounded	by	a	layer	of	perichondrium.	This	high	elastin	content	makes	it	unique	among	the	
various	cartilage	subtypes	in	the	facial	region.	The	anatomy	of	the	human	nose	on	the	other	
hand	consists	of	several	separate	structural	elements.	A	major	part	is	the	septum	providing	
support	for	the	bridge	of	the	nose	and	on	either	side	the	septolateral	and	lobular	cartilages	to	
support	 the	ala	nasi.	The	 lateral	area	 further	comprises	of	 several	 sesamoid	cartilages	and	
accessory	cartilages.	In	contrast	with	ear	cartilage,	the	nasal	structures	are	all	made	of	hyaline	
cartilage.	Hyaline	cartilage	consists	mainly	of	collagen,	in	particular	type	II	and	is	divided	into	
several	zones.	[189]	
The	extracellular	matrix	(ECM)	structure	and	its	biochemical	composition	are	essential	
to	 the	 mechanical	 function	 of	 cartilage.	 Standard	 biochemistry	 assays	 can	 be	 used	 to	
determine	 the	 concentration	 of	 the	main	 tissue	 components.	 In	 order	 to	 visualise	 the	 3D	
  
structure	of	 the	ECM,	multiple-photon	 laser	 scanning	microscopy	has	been	used	 for	other	
tissues	such	as	articular	cartilage.	[190]	This	method	is	capable	of	revealing	essential	matrix	
components	 i.e.	 chondrocytes,	 collagen	 and	 elastin	 fibers,	 label-free,	 with	 sub-cellular	
resolution	and	deep	penetration.	[191]	
The	reported	stiffness	of	facial	cartilage	types	varies	considerably.	Because	different	
techniques	are	used	 to	measure	 the	cartilage	 it	 is	difficult	 to	give	a	general	value.	Besides	
tensile	or	indentation	measurements	having	different	limitations	and	advantages	[192],	it	is	
also	 important	 to	discern	 the	different	magnitudes	or	 scale	of	mechanical	 testing.	 For	 the	
assessment	of	gross	mechanical	traits,	important	for	maintaining	of	large	shapes	especially	in	
surgical	reconstruction,	various	techniques	have	been	described.	[26,	29,	147,	160]	The	same	
applies	for	atomic	force	microscopy	(AFM),	where	extensive	research	has	been	conducted	on	
surface	micro	mechanics	of	cartilage.	[193-195]	However,	the	mechanical	conditions	of	the	
scaffold’s	cellular	environment,	between	AFM	and	gross	mechanical	testing	have	important	
influence	 on	 the	 behaviour	 of	 cells	 [196]	 and	 as	 such	 are	 fundamental	 to	 adequate	
regeneration	 of	 cartilage	 [158].	 Therefore,	 insight	 in	 the	 local	 mechanical	 properties	 and	
structure	on	the	ECM	level	is	required	to	provide	the	right	environment	for	cell	differentiation.	
The	device	used	 in	 this	 study	 allows	 indentation	on	 the	micrometre	 scale	 at	 higher	depth	
ranges	providing	essential	mechanical	information	on	the	different	cartilage	subtypes.		
Understanding	the	fundamentals	of	tissue	structures	is	essential	for	adequate	tissue	
engineering.	 From	 practice,	 surgeons	 are	 familiarized	 with	 the	 gross	 mechanical	 traits	 of	
cartilage	in	reconstructive	surgery.	Mechanical	behaviour	however	is	essentially	determined	
on	 the	 microscopic	 scale	 through	 an	 intricate	 symbiosis	 of	 cells	 and	 their	 surrounding	
structures.	 In	 this	 paper,	 we	 aim	 to	 provide	 fundamental	 information	 on	 the	 differences	
between	the	facial	cartilage	types	on	a	structural	and	mechanical	level	with	the	use	of	novel	
technology	to	evaluate	these	parameters	on	the	ECM	level.	Although	without	direct	practical	
implications,	 it	 may	 also	 offer	 surgeons	 new	 insights	 and	 inspiration	 in	 optimizing	 their	
reconstructive	efforts	by	providing	better	understanding	on	 the	nature	of	 the	 tissues	 they	
work	with.	With	the	advancement	of	regenerative	medicine,	surgeons	will	come	to	a	point	
where	this	knowledge	will	prove	invaluable.	
	 	
  
MATERIALS	AND	METHODS	
	
Chemicals	were	obtained	from	Sigma-Aldrich,	USA	unless	stated	otherwise.	
	
Samples	
Cartilage	samples	were	harvested	from	fresh	frozen	cadaveric	donors	(n=8	male;	n=2	female),	
average	age	66.5	±	6	years	at	UMCU	(University	Medical	Center	of	Utrecht,	the	Netherlands)	
according	 to	 the	ethical	guidelines	of	 the	 institution.	From	each	donor	2	adjacent	samples	
from	the	ear	concha,	medial	nasoseptal	cartilage	and	lateral	alar	cartilage	were	removed	with	
a	 4	 mm	 biopsy	 puncher.	 The	 samples	 were	 shipped	 at	 -20°C	 to	 either	 the	 VUmc	 (Vrije	
Universiteit	Medical	Center,	Amsterdam,	the	Netherlands)	for	biomechanical	and	microscopic	
evaluation	or	EMC	 (Erasmus	Medical	Center,	Rotterdam,	 the	Netherlands)	 for	biochemical	
evaluation.	 Samples	 were	 thawed	 prior	 to	 experiments	 and	 remaining	 tissue	 and	
perichondrium	were	surgically	removed.	
	
Indentation	
To	 determine	 mechanical	 properties	 indentation	 measurements	 were	 performed	 using	 a	
novel	 commercial	 nano-indenter	 (Piuma,	Optics11,	 the	Netherlands).	 The	 device	 utilizes	 a	
ferrule-top	 cantilever	 probe	 [197]	 to	 apply	 load	 and	 simultaneously	 measure	 indentation	
depth	using	a	fiber	optic	based	readout.	(Figure	1A	and	C)	In	this	set	up	a	78	µm	diameter	
spherical	 probe	 was	 used	 capable	 of	 applying	 forces	 ranging	 from	 0.1	 µN	 to	 7.5	 mN	 at	
indentation	depths	ranging	1	to	17	µm.	Cantilever	bending	calibrations	were	performed	prior	
to	each	series	of	experiments	by	indenting	a	rigid	surface	and	equating	cantilever	bending	to	
probe	displacement.	Each	sample	was	indented	10	times	on	the	same	anatomical	location	in	
a	grid	pattern	with	100um	distance	between	measurements.	The	resulting	stress	strain	curves	
(Figure	 1B)	were	 analysed	 using	 the	mathematic	model	 derived	 by	Oliver	 and	 Pharr	 for	 a	
spherical	 indenter	 to	determine	 the	effective	Young´s	modulus	 (E*).	 [198]	The	 indentation	
protocol	 was	 carefully	 optimized	 to	 minimize	 viscoelastic	 effects	 from	 influencing	 the	
measurements.	(Data	not	shown)	
	
Biochemical	evaluation	
Prior	to	biochemical	analysis,	wet	weight	was	determined	of	all	cartilage	samples	which	were	
then	digested	overnight	at	60°C	in	a	papain	solution	(0.2	M	Na2H2PO4,	0.01	M	EDTA.2H2O,	
250	µg/mL	papain,	5	mM	L-cystein,	pH	6.0).	The	amount	of	DNA	measured	in	each	papain-
digested	cartilage	sample	was	determined	by	Ethidium	bromide	(GibcoBR1),	using	calf	thymus	
DNA	as	a	standard.	Samples	were	analysed	with	a	spectrofluorometer	(Wallac	1420	Victor	2;	
Perkin-Elmer,	Wellesley,	USA),	using	an	extinction	filter	(340	nm)	and	an	emission	filter	(590	
nm).		
A	1,9-Dimethylmethylene	Blue	(DMMB;	pH	3.0)	assay	was	performed	to	measure	the	
sulphated-glycosaminoglycan	(sGAG)	content	in	each	papain-digested	cartilage	sample.	The	
metachromatic	reaction	of	DMMB	was	monitored	using	a	VersaMax	spectrophotometer	at	
530	and	590	nm.	Shark	chondroitin	sulphate	C	was	used	as	a	standard.		
  
Hydroxyproline	content	was	measured	to	estimate	collagen	quantity	using	the	Total	Collagen	
Assay	 (QuickZyme	 Biosciences,	 Leiden,	 the	 Netherlands)	 according	 to	 the	 manufacturer's	
instructions.	Briefly,	papain	digests	were	hydrolysed	with	equal	volumes	of	12	M	HCL	at	95°C	
for	18–20	hours.	Hydroxyproline	content	was	measured	using	a	modification	of	the	Prockop	
and	Udenfriend	method	[157],	and	normalized	to	sample	wet	mass.	
Elastin	content	of	the	cartilage	samples	was	measured	using	the	FastinTM	Elastin	Assay	
(Biocolor,	 Carrickfergus,	 UK)	 according	 to	 manufacturer’s	 instructions.	 Briefly,	 cartilage	
samples	were	converted	to	water-soluble	α-elastin	by	3	overnight	heat	extraction	cycles	at	
100°C	in	0.25M	oxalic	acid	before	adding	the	kit’s	dye.	Absorption	was	measured	at	513	nm	
on	a	VeraMax	plate	reader.	α-elastin	from	bovine	neck	ligament	(provided	by	manufacturer)	
was	used	as	a	standard.	
	
Multiphoton	Microscopy	
Structural	 information	 of	 the	 cartilage	 was	 obtained	 by	 Multiple-photon	 laser	 scanning	
microscopy	 using	 intrinsic	 optical	 signals	 from	 unprocessed	 cartilage.	 The	 imaging	 setup	
consisted	 of	 a	 commercial	 two-photon	 laser-scanning	 microscope	 (2PLSM,	 TrimScope	 I,	
Lavision	BioTec	GmbH)	and	a	femtosecond	laser	source.	(Figure	1D)	The	laser	source	was	a	
femtosecond	Ti-sapphire	laser	(Coherent	Chameleon	Ultra	II)	generating	~200	femtosecond	
pulses	at	800	nm	with	linear	polarization	and	repetition	rate	of	80	MHz.	The	laser	beam	was	
focused	on	the	cartilage	sample	by	a	25×/1.10	large	N.A.	water-dipping	objective	(Nikon	APO	
LWD),	providing	transverse	resolution	~0.5	µm	and	axial	resolution	of	~2	µm.	The	laser	power	
on	the	sample	was	adjusted	in	the	range	5–50	mW	to	attain	sufficient	signal-to-noise	ratio	and	
avoid	tissue	photodamage.	The	laser	beam	was	transversely	scanned	over	the	sample	by	a	
pair	 of	 galvo	 mirrors.	 Depth	 scanning	 was	 accomplished	 by	 moving	 the	 objective	 with	 a	
stepper	motor.	
The	 second	 harmonic	 (SHG)	 and	 two-photon	 fluorescence	 (2PF)	 photons	 were	
generated	 by	 collagen	 (SHG,	 2PF)	 and	 elastin	 (2PF)	 fibers	 as	well	 as	 by	 intracellular	 auto-
fluorescent	 proteins	 and	were	 collected	 in	 the	 epi-detection	 geometry.	 The	 SHG	 and	 2PF	
photons	 were	 filtered	 from	 the	 800	 nm	 excitation	 photons	 by	 a	 dichroic	mirror	 (Chroma	
T695lpxrxt),	then	split	into	SHG	and	2PF	channels	by	a	dichroic	mirror	(Chroma	425lp),	passed	
through	interference	filters	for	SHG	(Chroma	Z400/10X)	and	2PF	(Chroma	HQ500/140M-2P)	
and	detected	by	high-sensitivity	GaAsP	photomultiplier	tubes	(Hamamatsu	H7422-40).	(Figure	
1	E,F)	
Data	 acquisition	 was	 performed	 with	 the	 TriMScope	 I	 software	 (“Imspector	 Pro”),	
images	 stacks	 were	 stored	 in	 16-bit	 tiff-format	 and	 further	 processed	 and	 analysed	 with	
“ImageJ”	software	(MacBioPhotonics).	
	
	 	
  
Statistical	analysis	
Biochemical	 differences	 were	 analysed	 using	 Mixed	 Models	 with	 Bonferroni	 correction.	
Differences	 in	 effective	 Young’s	 modulus	 between	 groups	 were	 determined	 through	
Generalized	 Estimating	 Equations.	 To	 measure	 the	 correlation	 between	 stiffness	 and	
biochemical	content	a	Bivariate	Correlations	Model	was	used.	All	analyses	were	performed	
using	PASW	Statistics	22.0	(SPSS	inc.	Chicago,	USA).	A	p-value	of	less	than	0.05	was	considered	
significant.	
	
	
	
	
	
	
	
	
Figure	1.	Overview	of	indentation	and	multi-photon	laser	microscopy	technology.	
(A)	Set-up	of	cantilever	indentation	device.	(B)	Example	of	indentation	curve	of	a	cartilage	measurement.	Red	
tangent	represents	the	slope	of	the	unloading	curve	to	determine	the	effective	Young’s	modulus.	(C)	Graphic	
detail	of	the	indenter	tip.	The	ball	forms	the	tip	of	the	indenter	(Ø	78	µm).	(D)	Optical	set-up	of	multi-photon	
laser-scanning	microscope	 TriMScope	 I.	 (E)	 SHG	 channel	 showing	 collagen	bundels.	 (F)	 2PF	 channel	 showing	
elastin	fibers.	IR-PD	=	Infrared	laser	diode	;	IR-L	=	Infrared	laser	;	OF	=	Optical	Fiber	;	CIT	=	Cantilever	Indentation	
Tip.	Ti	=	Titanium	;	GS	=	X-Y	Galvo	Scanner	mirrors	;	SL	=	Scan	Lens	;	TL	=	Tube	Lens	;	DM	=	Dichroic	Mirror	;	MO	
=	Microscope	Objective	;	BP	=	Band-Pass	filters	;	L	=	Lenses	in	front	of	the	PMTs	;	PMT	=	PhotoMultiplier	Tubes.	
	 	
  
RESULTS	
	
Indentation	
Indentation	revealed	significant	differences	(p=0.011)	in	stiffness	between	ear	cartilage	(1.14	
±	0.71	MPa)	and	septal	cartilage	(2.65	±	1.78	MPa),	and	ala	nasi	cartilage	(1.26	±	0.51	MPa),	
and	septal	cartilage	(p=0.005).	(Figure	2)	Comparison	of	ala	nasi	with	ear	cartilage	showed	no	
significant	differences	however.	The	stiffness	per	cartilage	type	varied	considerably	between	
donors.	(Data	not	shown)		
	
	
Figure	2.	Biomechanical	properties	of	ear,	alar	and	septal	cartilages.	
Indentation	revealed	significant	differences	 in	stiffness	between	ear	cartilage	and	septal	cartilage	(*p=0.011),	
and	 ala	 nasi	 cartilage	 and	 septal	 cartilage	 (**p=0.005).	 No	 significant	 differences	 between	 ala	 nasi	 and	 ear	
cartilage	were	seen.	
	
	
Biochemistry	
Cell	density	based	on	DNA	content	was	significantly	higher	in	ala	nasi	cartilage	(2.35	±	1.20	
µg/mg	dry	weight)	than	in	cartilage	from	the	ear	(1.13	±	0.23	µg/mg	dry	weight)	or	septum	
(0.94	 ±	 0.52	 µg/mg	 dry	 weight)	 (p=0.005	 and	 p=0.001	 respectively).	 (Figure	 3A)	 Auricular	
cartilage	(141.40	±	27.2	µg/mg	dry	weight)	had	a	significantly	higher	elastin	content	than	ala	
nasi	(60.12	±	18.35	µg/mg	dry	weight)	and	septum	(17.38	±	16.71	µg/mg	dry	weight).	(Figure	
3B)	Water	and	collagen	content	were	not	significantly	different	between	the	cartilage	types.	
(Figure	3C)	In	the	nose,	septum	(96.00	±	23.21	µg/mg	dry	weight)	appeared	to	have	slightly	
higher	sGAG	content	(than	ala	nasi	(64.61	±	30.42	µg/mg	dry	weight).	(Figure	3D)	
	
	
	
	
	
	
	
	
	
	
  
	
Figure	3.	Biochemical	analysis	shows	distinct	differences	in	composition	between	cartilage	
types.		
Although	ala	nasi	cartilage	and	septum	bear	strong	similarities	in	tissue	architecture	they	significantly	differ	in	
DNA	and	sGAG	content	(p=0.001	and	p=0.024	respectively).	The	nasal	cartilages	contain	very	limited	elastin.	This	
might	be	partially	attributable	to	connective	tissue	remnants	though	caution	was	taken	to	remove	these	as	much	
as	possible.	*,	**	or	***	indicates	p-value	smaller	than	0.05,	0.01	or	0.001	respectively	compared	to	the	other	
cartilage	types.	
	
Per	cartilage	subtype,	the	effective	Young’s	modulus	was	not	significantly	correlated	with	cell	
density,	 sGAG	 or	 collagen	 content.	 However,	 in	 septal	 cartilage,	 low	 elastin	 content	 was	
associated	with	higher	stiffness.	(Table	1)	
	
Multiphoton	Microscopy	
The	cartilage	samples	of	two	donors	were	imaged	in	the	mid	segment	in	the	sagittal	plane.	
The	 second	 harmonic	 (SHG)	 and	 two-photon	 fluorescence	 (2PF)	 microscopy	 generated	
showed	a	distinct	difference	between	ear	cartilage	and	the	cartilage	of	nasal	origin.	(Figure	4)	
Not	only	the	absence	of	elastin	fibers	(green)	was	evident,	also	the	general	structure	of	nasal	
cartilages	was	different	from	the	ear.	Cartilage	from	the	nasal	area	gives	a	much	more	diffuse	
image	compared	to	the	dense	fibrous	network	of	the	ear	cartilage.	Chondrons,	agglomerates	
of	chondrocytes	within	their	pericellular	matrix,	appeared	larger	 in	the	ala	nasi	than	in	the	
septum	in	both	donors.	
	 	
  
Young’s	modulus	 DNA	 sGAG	 COL	 ELN	
	 	 	 	 	 	
Ear	 R	 0.040	 -0.302	 0.080	 0.096	
	 p	 0.913	 0.396	 0.826	 0.838	
	 n	 10	 10	 10	 7	
	 	 	 	 	 	
Ala	nasi	 R	 -0.427	 0.327	 -0.549	 -0.217	
	 p	 0.219	 0.357	 0.100	 0.641	
	 n	 10	 10	 10	 7	
	 	 	 	 	 	
Septum	 R	 0.405	 0.105	 0.408	 -0.951●	
	 p	 0.246	 0.774	 0.242	 0.049	
	 n	 10	 10	 10	 7	
	
Table	1.	
Pearson	coefficients	(R)	observed	between	the	measured	Young’s	modulus	and	biochemical	parameters	(DNA,	
sGAG,	COL	and	ELN)	for	ear,	ala	nasi	and	nasoseptal	cartilage	samples.	
●	Indicates	correlation	is	significant	at	a	0.05	level	(2-tailed).	
	
	
Figure	4.	Multi-photon	laser	scanning	microscopy.	
Experiments	were	performed	with	cartilage	donor	samples	3	and	5	(S3	and	S5).	Green	=	Elastin	;	Red	=	Collagen.	
The	fibrous	structures	in	the	ear	cartilage	are	clearly	discernible	compared	to	the	diffuse	green	background	signal	
in	the	nasal	cartilage	samples.		
	 	
  
DISCUSSION	
	
To	our	 knowledge	 this	 is	 the	 first	 study	 that	 compares	 the	biochemical,	 3D	 structural	 and	
mechanical	differences	between	all	three	facial	cartilage	types	in	human	donors.	By	measuring	
differences	 in	cartilage	composition,	structure,	and	stiffness	on	the	ECM	level	we	aimed	to	
identify	 significant	 aspects	 of	 facial	 cartilage	 architecture	 necessary	 for	 adequate	 tissue	
engineering.	
This	 is	 relevant	 for	 tissue	 engineering	 of	 cartilage,	 which	 has	 received	 massive	
attention	the	last	decade.	A	variety	of	different	cell	types	and	scaffolds	have	been	proposed	
for	auricular	or	nasal	cartilage	engineering.	[52,	56,	58,	199-201]	Although	promising	results	
have	been	obtained,	most	regenerated	tissues	generally	are	only	a	very	marginal	substitution	
of	the	original	tissue.	This	study	reveals	that	there	are	significant	differences	between	cartilage	
types	on	the	ECM	scale,	even	if	they	are	similar	in	mechanical	properties.	
The	composition	of	ear	cartilage	is	known	to	be	different	compared	to	septal	cartilage	in	that	
it	contains	elastic	fibers.	[201]	We	could	measure	small	amounts	of	elastin	in	nasal	cartilage	
with	biochemical	analyses.	This	is	in	line	with	a	study	in	white	New	Zealand	rabbit’s	where,	
using	 immunohistochemical	 staining,	high	elastin	 content	was	 found	 specifically	 in	 the	ear	
cartilage	matrix	compared	to	only	moderate	elastin	content	 in	the	nasal	septal	pericellular	
regions.	[143]	The	fact	that	the	matrix	comprises	for	an	substantial	part	of	elastin	suggests	
that	this	may	offer	an	important	attribution	to	the	mechanical	qualities	of	ear	cartilage.	[138]	
The	effective	Young’s	modulus	was	significantly	lower	in	auricular	and	ala	nasi	cartilage	
than	in	nasal	septum	cartilage.	However,	stiffness	between	ear	and	ala	nasi	cartilage	was	not	
statistically	different,	although	there	was	a	clear	difference	in	elastin	content.	These	findings	
match	the	observations	of	Griffin	and	colleagues	who	found	similar	differences	 in	stiffness	
between	ala	nasi	and	septal	cartilage.	[28]	
In	a	recent	paper	Nimeskern	and	colleagues	[202]	explored	how	elastin	influences	the	
mechanical	 behaviour	 of	 cartilage.	 They	 found	 different	 viscoelastic	 behaviours	 of	 bovine	
hyaline	 articular	 cartilage	 and	 ear	 cartilage,	with	 ear	 cartilage	 being	more	 elastic	whereas	
articular	cartilage	demonstrated	a	higher	resistance	to	instantaneous	loading.	Upon	enzymatic	
treatment	 to	 remove	 elastin	 and/or	 sGAG,	 they	 demonstrated	 that	 the	 compressive	
mechanical	properties	of	ear	cartilage	appeared	to	be	mainly	due	to	the	elastin	fiber	network	
whereas	 these	 properties	 were	 provided	 by	 collagen	 in	 articular	 cartilage.	Moreover,	 the	
influence	of	sGAG	on	mechanical	behaviour	appeared	different	between	the	cartilage	types:	
in	ear	cartilage	sGAG	had	no	major	influence	on	mechanics	whereas	in	articular	cartilage	sGAG	
had	 a	 clear	 influence.	 Although	 a	 different	 tissue,	 this	 apparent	 discrepancy	 between	 the	
expected	role	of	elastin	and	the	actual	mechanical	properties	was	also	noted	in	dermal	scar	
tissue.	[203]	This	demonstrates	the	complex	role	of	tissue	composition	in	mechanical	function	
of	the	tissue.	
The	 differences	 in	 mechanical	 behaviour	 between	 the	 cartilage	 types	 could	 be	
determined	not	only	by	their	biochemical	compositions	but	also	by	tissue	architecture.	Using	
Multiple-photon	laser	scanning	microscopy,	the	3D	structure	of	the	different	cartilage	types	
could	be	depicted	in	high	detail.	Interestingly,	the	ala	nasi,	although	very	similar	in	appearance	
  
to	the	septal	cartilage	and	low	in	elastin	content,	demonstrated	mechanical	behaviour	that	is	
more	comparable	to	ear	cartilage.		
While	similar	 in	general	appearance,	we	observed	that	chondron	size	seemed	to	be	
different	 between	 ala	 nasi	 and	 septum	 cartilage.	 Sample	 size	 was	 small	 however	 and	 no	
statistical	evidence	was	gathered	to	support	this	side	finding.	
Donor	variability	is	large	and	general	comparison	of	our	data	with	literature	is	difficult	
as	no	 research	has	previously	been	performed	comparing	 these	 three	cartilage	 types	both	
mechanically,	structurally	and	biochemically.	Our	data	match	the	observations	of	Nimeskern	
and	colleagues	[201]	that	septal	cartilage	is	stiffer	and	contains	higher	sGAG	than	auricular	
cartilage	but	lower	DNA,	indicative	for	lower	cell	concentration.	Our	findings	also	match	the	
results	of	a	study	performed	by	Griffin	and	colleagues	[28]	who	measured	lower	stiffness	of	
the	ala	nasi	cartilage	compared	to	the	septum.	For	tissue	engineering	purposes	the	scale	at	
which	 the	 indentation	 experiments	 were	 performed	 gives	 a	 good	 reference	 for	 the	
appropriate	scaffold	stiffness	on	the	cellular	level.	SHG	proved	a	good	tool	to	non-invasively	
depict	the	collagen	and	elastin	bundle	architecture	in	3D.		
This	information	could	be	translated	to	serve	as	a	structural	template	for	3D	printing	
of	scaffolds	and	together	with	the	data	on	mechanics	and	biochemical	content	provide	a	new	
step	towards	scaffold	optimisation	for	facial	cartilage	reconstruction.	
We	 used	 cartilage	 samples	 from	 donors	 at	 higher	 age	 (average	 66.5	 ±	 6	 years).	
Mechanical	behaviour	and	histology	might	differ	in	younger	patients	due	to	calcifications	and	
structural	changes	during	aging.	Ears	for	example	continue	to	expand	in	volume	throughout	a	
lifetime	which	 is	 attributed	 to	 alterations	 in	 the	 elastic	 fibers	 during	 aging.	 [164]	 For	 the	
septum	however	Richmon	and	colleagues	[26]	found	no	significant	differences	in	mechanical	
properties	between	age	or	gender.	Although	samples	were	taken	from	the	same	anatomical	
location	 in	 all	 donors,	minor	 variation	might	have	occurred.	 This	 is	 a	 limitation,	 as	 several	
studies	 indicate	 that	 within	 the	 separate	 cartilage	 types	 there	 are	 regional	 differences	 in	
content.	[28]	Despite	their	localisation	and	comparable	role	as	soft	tissue	support	suggesting	
similar	characteristics,	the	facial	cartilages	are	in	fact	quite	different	from	another.	The	specific	
function	of	cartilage	tissue,	for	example	compression	for	articular	cartilage	and	flexibility	for	
ear	cartilage,	may	demand	different	mechanical	testing	regimes.	We	chose	micro-indentation	
to	 explore	 the	 stiffness	 of	 the	 ECM,	 in	 regard	 of	 our	 findings	 perhaps	 a	 combination	 of	
mechanical	tests	is	necessary	to	be	able	to	elicit	the	different	structural	roles	of	the	various	
cartilage	 components.	 In	 the	 future	 it	 might	 be	 interesting	 to	 also	 include	 macroscopic	
mechanical	testing,	as	gross	mechanical	traits	are	also	influenced	by	other	factors	such	as	the	
perichondrium	and	anatomical	form.	[29,	204]		
From	a	surgical	perspective,	it	is	interesting	to	note	that	tissue	composition	and	mechanical	
behaviour	are	not	always	related	as	expected.	We	did	not	find	an	explanation	for	the	lower	
stiffness	of	ala	nasi	cartilage.	It	does	support	the	concept	that	tissue	transplants	from	different	
origins	can	serve	as	structural	surrogate	in	reconstructive	surgery.	The	use	of	concha	tissue	
for	ala	nasi	reconstruction	is	an	excellent	example	thereof.	Other	fields	that	are	not	covered	
in	this	paper	but	are	important	to	consider	are	cellular	interaction	including	proteomics	and	
metabolism,	 as	 cell	 survival	 and	 behaviour	 are	 key	 to	 tissue	 engineering	 and	 long-term	
successful	 transplantation.	 The	 finding	 that	 the	 facial	 cartilage	 types	 not	 only	 structurally	
  
differ	but	also	vary	in	cell	content	may	hold	implications	for	surgical	reconstruction,	as	tissues	
with	higher	cells	concentrations	potentially	demand	a	more	nutrient	rich	environment	when	
transplanted.	The	merging	of	knowledge	from	practical	experience	and	fundamental	research	
in	our	opinion	will	prove	essential	 in	a	world	where	tissue	engineering	 is	rapidly	becoming	
reality,	a	development	that	should	not	be	overlooked	by	surgeons.	
In	 conclusion,	 understanding	 the	 complete	 composition	 of	 tissue,	 both	 structural,	
mechanical	and	biochemical,	 is	essential	 in	order	 to	 regenerate	an	appropriate	 scaffolding	
environment	for	facial	cartilage	regeneration.	This	is	particularly	reflected	by	the	finding	that	
albeit	it’s	3D	structural	similarity	to	septal	cartilage,	the	ala	nasi	has	a	matrix	stiffness	that	is	
more	 comparable	 to	 ear	 cartilage.	 In	 that	 light,	 the	 role	 of	 elastin	 remains	 to	 be	 further	
elicited,	and	perhaps	we	should	question	whether	its	name	is	not	misleading	in	regard	of	its	
contribution	to	tissue	mechanics.	
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ABSTRACT	
	
Cartilage	 has	 limited	 self-regenerative	 capacity.	 Tissue	 engineering	 can	 offer	 promising	
solutions	for	reconstruction	of	missing	or	damaged	cartilage.	A	major	challenge	herein	is	to	
define	an	appropriate	cell	source	that	is	capable	of	generating	a	stable	and	functional	matrix.	
This	 study	evaluated	 the	performance	of	culture-expanded	human	chondrocytes	 from	ear,	
nose	 and	 articular	 joint	 as	 well	 as	 bone-marrow-derived	 and	 adipose-tissue-derived	
mesenchymal	stem	cells	both	in	vitro	and	in	vivo.		
All	 cells	 (at	 least	 three	donors	per	 source)	were	 culture-expanded,	 encapsulated	 in	
alginate	 and	 cultured	 for	 five	 weeks.	 Subsequently,	 constructs	 were	 implanted	
subcutaneously	for	eight	additional	weeks.	Before	and	after	implantation,	glycosaminoglycan	
(sGAG)	and	collagen	content	were	measured	using	biochemical	assays.	Mechanical	properties	
were	 determined	 using	 stress-strain-indentation	 tests.	 Hypertrophic	 differentiation	 was	
evaluated	with	qRT-PCR	and	subsequent	endochondral	ossification	with	histology.		
Articular	chondrocytes	had	higher	chondrogenic	potential	in	vitro	than	the	other	cell	
sources,	 as	 assessed	 by	 gene-expression	 and	 sGAG-content	 (p<0.001).	 However,	 after	
implantation,	articular	chondrocytes	did	not	further	increase	their	matrix.	In	contrast,	ear	and	
nasal	 chondrocytes	 continued	 producing	 matrix	 in	 vivo	 leading	 to	 higher	 sGAG-content	
(p<0.001)	 and	 elastic	 modulus.	 For	 constructs	 containing	 nasal	 chondrocytes,	 matrix-
deposition	was	associated	with	the	elastic	modulus	(R2=0.477,	p=0.039).	Although	all	cells	-	
except	articular	chondrocytes	 -	expressed	markers	 for	hypertrophic	differentiation	 in	vitro,	
there	was	no	bone	formed	in	vivo.		
Our	work	shows	that	cartilage	formation	and	functionality	depends	on	the	cell	source	
used.	Articular	chondrocytes	possess	the	highest	chondrogenic	capacity	in	vitro,	while	ear	and	
nasal	chondrocytes	are	most	potent	in	vivo,	making	them	attractive	cell	sources	for	cartilage	
repair.	
	
  
INTRODUCTION	
	
Cartilage	is	a	highly	specialized	avascular	connective	tissue	located	at	a	variety	of	anatomical	
locations	 such	 as	 the	 ear,	 nose,	 trachea,	 ribs	 and	 articular	 joints.	 In	 general,	 cartilage	
predominantly	consists	of	an	extracellular	matrix	(ECM),	which	is	produced,	maintained	and	
remodeled	 by	 a	 relatively	 small	 amount	 of	 specialized	 cells	 (1-10%).	 [34]	 The	 exact	
composition	of	the	ECM	is	mainly	dependent	on	the	tissue’s	function	and	thus	three	major	
subtypes	can	be	distinguished:	hyaline,	fibrous	and	elastic	cartilage.	It	is	well	known	that	due	
to	 its	 avascular	 origin,	 cartilage	 itself	 has	 a	 limited	 self-regenerative	 capacity.	 As	 a	 result,	
cartilage	 deficits	 can	 lead	 to	 severe	 pain,	 disability	 and	 aesthetic	 impairment.	 Currently,	
surgical	 repair	 of	 cartilage	 requires	 either	 autogeneic	 cartilage	 grafts	 or	 artificial	 material	
implants.	 However,	 these	 conventional	 treatments	 are	 (1)	 associated	 with	 a	 limited	
availability	of	autogeneic	tissue,	(2)	can	cause	donor	site	morbidity,	and	-	in	case	of	artificial	
implants	-	(3)	are	prone	to	generate	a	foreign	body	reaction.		
To	overcome	these	problems,	tissue	engineering	(TE)	can	offer	a	promising	solution	for	
restoring	missing	or	damaged	 cartilage.	 TE-approaches	have	 focused	on	 the	production	of	
functional	 cartilage	 that	 has	 features	 similar	 to	 native	 tissue.	 In	 cartilage	 TE,	 small	 tissue	
biopsies	are	harvested,	thus	generating	minimal	donor	site	morbidity.	Cells	are	isolated	from	
the	biopsies	and	stimulated	to	proliferate	in	culture	providing	large	quantities	of	cells.	These	
cells	are	subsequently	stimulated	to	produce	cartilage	tissue	which	should	structurally	and	
morphologically	resemble	native	tissue.	One	of	the	major	challenges	in	cartilage	TE	is	defining	
an	appropriate	cell	source.	The	most	obvious	cell	source	is	cartilage	itself.	Hyaline	articular	
cartilage	 is	most	 frequently	 used	 for	 cartilage	 TE,	 although	 some	 experiments	 have	 been	
published	on	the	use	of	non-articular	cartilages	(e.g.	nasal,	ear	and	costal	cartilage).	[205]	Next	
to	 chondrocytes,	 mesenchymal	 stem	 cells	 (MSCs)	 with	 their	 multi-lineage	 differentiation	
potential	and	easy	availability	from	bone	marrow	or	adipose	tissue	have	been	demonstrated	
as	an	attractive	cell	source	for	cartilage	TE.	[64,	66]	
To	date,	we	and	others	have	evaluated	the	use	of	chondrocytes	and	MSCs	of	several	
anatomical	locations	for	their	applicability	in	cartilage	regenerative	medicine.	[39,	42-44,	46-
59,	206-209]	However,	precise	comparison	of	the	performance	of	culture-expanded	human	
cells	is	lacking.	This	knowledge	is	important	to	be	able	to	select	an	optimal	cell	source	for	each	
application	of	cartilage	TE.	The	current	study	was	designed	to	evaluate	the	performance	of	
culture-expanded	cells	of	several	sources	for	generating	a	stable	and	functional	ECM	in	vitro	
and	 in	 vivo.	 Therefore,	 human	 chondrocytes	 from	 ear,	 nose	 and	 articular	 joint	 and	MSCs	
derived	from	bone	marrow	and	adipose	tissue	were	compared.	Cartilage	matrix	production	
was	 evaluated	 using	 qRT-PCR	 and	 biochemical	 assays	 during	 in	 vitro	 culture.	 Biochemical	
assays,	 histology	 and	 mechanical	 tests	 were	 used	 to	 determine	 tissue	 stability	 and	
functionality	of	cartilage	constructs	after	subsequent	subcutaneous	implantation	in	vivo.		
  
MATERIALS	AND	METHODS	
	
Chemicals	were	obtained	from	Sigma-Aldrich,	USA	unless	stated	otherwise.	
	
Cell	sources	
Ear	(EC:	n=5,	median	age	69,	range	17-75	years)	and	nasal	cartilage	(NC:	n=8,	median	age	24,	
range	 18-46	 years)	 were	 obtained	 from	 patients	 undergoing	 reconstructive	 subtotal	
septorhinoplasty.	For	articular	cartilage	(AC),	both	healthy	(n=2,	traumatic	amputation)	and	
diseased	 knee	 cartilage	 (n=7,	 osteoarthritis)	were	 harvested.	 Since	 no	 clear	 differences	 in	
chondrogenic	potential	were	visible	between	both	healthy	and	diseased	AC	(data	not	shown),	
we	combined	them	for	further	experiments	(total	n=9,	median	age	68,	range	43-88	years).	To	
obtain	 adipose-tissue-derived	 mesenchymal	 stem	 cells	 (AMSC),	 subcutaneous	 abdominal	
adipose	tissue	was	used	from	patients	undergoing	reconstructive	breast	surgery	(n=7,	median	
age	51,	range	34-71	years).	All	these	tissue	samples	were	obtained	as	waste	material	after	
surgery	with	approval	of	the	local	Medical	Ethics	Committee	(MEC-2011-371).	Finally,	bone-
marrow-derived	mesenchymal	stem	cells	(BMSC)	were	harvested	from	femoral-shaft	biopsies	
during	 total	 hip-replacement	 surgery,	 after	 informed	 consent	had	been	acquired	and	with	
approval	of	the	local	Medical	Ethics	Committee	(MEC-2004-142)	(n=11,	median	age	63,	range	
39-72	years).	
	
Cell	isolation	and	culture	
Expansion	
To	 isolate	 chondrocytes,	macroscopically	 intact	 cartilage	pieces	were	washed	after	 careful	
resection	of	the	perichondrium	(in	the	case	of	nasal	and	ear	cartilage).	Cartilage	pieces	were	
diced	into	small	fragments	and	incubated	for	one	hour	with	protease	(2	mg/mL),	followed	by	
overnight	 incubation	with	 collagenase	B	 (Roche	Diagnostics,	Mannheim,	Germany)	 in	 high	
glucose	(4.5	g/L)	Dulbecco's	modified	Eagle's	medium	(HG-DMEM;	Gibco,	Carlsbad,	USA)	with	
10%	fetal	calf	serum	(FCS;	Gibco),	50	µg/mL	gentamycin	(Gibco),	and	0.5	µg/mL	amphotericin	
B	(Fungizone;	Life	Technologies,	Breda,	the	Netherlands).	To	remove	small	parts	of	undigested	
cartilage,	the	cell	suspension	was	filtered	through	a	nylon	100-µm	mesh.	Prior	to	cell	seeding,	
cell	viability	was	tested	using	the	trypan	blue	exclusion	test,	and	cell	number	was	calculated	
with	 a	 hemocytometer.	 Chondrocytes	 were	 finally	 seeded	 at	 an	 initial	 density	 of	 7500	
cells/cm2	in	‘standard	chondrocyte	expansion	medium’	containing	HG-DMEM	supplemented	
with	10%	FCS,	50	µg/mL	gentamycin,	and	0.5	µg/mL	Fungizone.		
Bone-marrow-derived	heparinized	aspirates	were	seeded	at	a	density	of	2-5x105	nucleated	
cells/cm2	and	cultured	overnight	in	‘standard	MSC	expansion	medium’	containing	low	glucose	
(1.5	g/L)	Dulbecco's	modified	Eagle's	medium	(LG-DMEM),	supplemented	with	10%	FCS;	50	
µg/mL	gentamycin;	0.5	µg/mL	Fungizone;	10-4	M	L-ascorbic	acid	2-phosphate;	and	1	ng/mL	
basic	Fibroblast	Growth	Factor	2	(bFGF2;	AbD	Serotec,	Kidlington,	UK).	After	24	hours,	non-
adherent	cells	and	cell	debris	were	washed	out	and	adherent	BMSC	were	further	expanded	
using	‘standard	MSC	expansion	medium’.		
To	extract	AMSCs,	excised	human	adipose	tissue	was	washed	with	LG-DMEM,	minced,	
and	 suspended	 in	 0.1%	 collagenase	 type	 I	 solution	 (Invitrogen,	 Carlsbad,	 CA,	 USA)	 in	 the	
  
presence	of	1%	Bovine	Serum	Albumin	(BSA;	PAA	Laboratories	Gmbh,	Cölbe,	Germany)	in	LG-
DMEM.	After	60	minutes	of	enzymatic	digestion	in	an	orbital	shaker,	floating	adipocytes	were	
separated	 from	 the	 precipitating	MSC	 fraction	 by	 centrifugation	 (10	minutes,	 1500	 RPM),	
washed	with	‘standard	MSC	expansion	medium’,	and	filtered	through	a	100-μm	nylon	mesh.	
Before	cell	seeding,	the	amount	of	nucleated	cells	was	calculated	using	methylene	blue,	and	
cell	 number	was	 calculated	with	 a	 hemocytometer.	 The	 cell	 suspension	was	 seeded	 at	 an	
initial	density	of	40,000	cells/cm2	in	‘standard	MSC	expansion	medium’.	
All	cells	were	cultured	at	37oC	in	air	containing	5%	carbon	dioxide.	Medium	was	changed	twice	
a	week.	When	cell	cultures	reached	80%	confluence,	chondrocytes	and	MSCs	were	trypsinized	
using	0.05%	trypsin–EDTA.	Chondrocytes	were	seeded	at	a	7500	cells/cm2	and	MSCs	at	a	2300	
cells/cm2	cell	density	for	further	expansion	to	increase	cell	number.	All	third-passage	(P3)	cells	
which	were	approaching	subconfluence	were	detached	and	cultured	in	a	three-dimensional	
alginate	system	(as	described	below)	to	promote	chondrogenesis.		
In	 order	 to	 determine	 the	 proliferation	 rate	 of	 cultured	 ECs,	 NCs,	 ACs,	 BMSCs	 and	
AMSCs,	growth	kinetics	of	three	donors	from	each	cell	source	were	evaluated	in	monolayer	
expansion	using	the	number	of	population	doublings	(PD)	until	subconfluency	and	the	time	to	
reach	passage	four.	Therefore	we	have	calculated	the	PD/D	(Population	Doublings	per	Day)	by	
using	the	formula:	PD/D	=	(ln	(N2/N1)	/	ln	(2))/D;	where	N1	was	the	number	of	cells	at	the	
beginning	of	each	passage,N2	the	number	of	cells	at	subconfluency	and	D	the	amount	of	days	
to	reach	passage	four.		
	
Chondrogenic	differentiation	
For	three-dimensional	alginate	culture,	isolated	cells	from	four	donors	of	each	cartilage	source	
and	six	donors	from	each	of	the	MSC-sources	were	suspended	at	a	density	of	4x106	cells/mL	
in	clinical	grade	1.1%	low	viscosity	alginate	solution	dissolved	in	0.9%	NaCl	(Batch	MG-004,	
CellMed,	Alzenau,	Germany).	Afterwards,	the	cell-alginate	mixture	was	transferred	into	a	10-
mL	sterile	syringe	from	which	the	suspension	was	slowly	passed	through	a	23-gauge	needle	
to	produce	drops,	which	fell	into	a	102	mM	CaCl2.	Following	instantaneous	gelation,	the	beads	
were	allowed	to	further	gelate	for	a	period	of	10	minutes	in	the	CaCl2	solution.	After	being	
washed	once	with	0.9%	NaCl	and	HG-DMEM,	the	beads	were	transferred	to	24-well	plates.	
Controls	were	cultured	in	150	μL/bead	‘control	differentiation	medium’	containing	serum-free	
HG-DMEM	supplemented	with	50	µg/mL	gentamycin;	0.5	µg/mL	Fungizone;	1	mM	sodium	
pyruvate	 (Gibco);	 40	 μg/mL	 L-proline	 (Sigma-Aldrich);	 supplemented	 Insulin	 Transferrine	
Selenium	 (ITS+	 ;	 B&D	 Bioscience,	 Bedford,	 USA);	 10-7	M	 dexamethason;	 and	 25	 μg/mL	 L-
ascorbic	 acid	 2-phosphate.	 In	 the	 experimental	 condition	 (‘chondrogenic	 differentiation	
medium’)	10	ng/mL	Transforming	Growth	Factor	β1	(TGFβ1;	R&D	Systems,	Minneapolis,	USA)	
was	added	to	induce	chondrogenesis.	Medium	was	changed	twice	a	week.	After	two	and	five	
weeks,	 alginate	 beads	 were	 processed	 for	 biochemical	 or	 gene-expression	 analysis	 as	
described	below.	For	all	in-vitro	experiments	four	donors	for	the	chondrocyte	sources	and	six	
donors	for	the	MSC	sources	were	used,	with	at	least	duplicate	samples	per	analyses	for	each	
individual	donor.	
To	study	in-vivo	functionality	and	stability	of	cartilage	TE	constructs	after	in-vitro	cell-
culture,	larger	flat	constructs	were	created	from	cells	of	three	donors	of	each	cell	source	as	
  
previously	 described.	 [210]	 In	 short,	 alginate	 suspensions	 containing	 4x106	 cells/ml	 were	
injected	into	a	custom-designed	slab	mold	consisting	of	two	calcium-permeable	membranes	
(Durapore®	5.0	μm	membrane	filters,	Millipore)	rigidly	supported	by	stainless-steel	meshes	
and	separated	by	a	stainless-steel	casting	frame.	Part	of	these	constructs	were	harvested	after	
five	weeks	of	cell-culture	for	analyses	and	a	part	was	implanted	subcutaneously	on	the	dorsal	
side	of	athymic	mice.	For	the	in-vivo	experiments	a	total	of	six	constructs	per	cell	source	were	
used,	with	duplicate	samples	for	three	different	donors.	
	
Subcutaneous	implantation	in	vivo		
In	total,	seventeen	nine-week	old,	female	NMRI	nu/nu	mice	(Charles	River	Laboratories,	the	
Netherlands)	were	used	to	evaluate	the	performance	of	constructs	cultured	with	or	without	
TGFβ1.	Mice	were	 placed	 under	 general	 anesthesia	 using	 2.5%	 isofluorane.	 Two	 separate	
subcutaneous	incisions	of	approximately	1.0	cm	were	made	along	the	central	line	of	the	spine	
(one	at	the	shoulders	and	one	at	the	hips),	after	which	four	separate	subcutaneous	pockets	
were	prepared	by	blunt	dissection	of	the	subcutaneous	tissue.	For	implantation	the	alginate	
constructs	were	 randomly	assigned	 to	 these	 four	pockets.	Eight	weeks	after	 subcutaneous	
implantation,	 animals	 were	 sacrificed	 and	 samples	 were	 explanted	 for	 histological,	
biomechanical	and	biochemical	analyses.	Animal	experiments	were	carried	out	with	approval	
of	the	local	Animal	Experiments	Committee	of	the	Erasmus	MC	and	were	approved	as	outlined	
in	the	national	Animals	Act	(EMC	2429).	
	
Gene	expression	analyses	
For	total	RNA	isolation,	alginate	was	dissolved	in	ice-cold	55	mM	sodium	citrate	(150	μL/bead)	
and	20	mM	Ethylene	Diamintetraacetate	(EDTA)	in	150	mM	NaCl	and	centrifuged	at	2.5	G	for	
8	 minutes.	 Each	 pellet	 was	 subsequently	 suspended	 in	 1	 mL	 RNA-BeeTM	 (TEL-TEST,	
Fiendswood,	USA).	RNA	was	extracted	with	 chloroform	and	purified	 from	 the	 supernatant	
using	 the	 RNAeasy	 Micro	 Kit	 (Qiagen,	 Hilden,	 Germany)	 according	 to	 the	 manufacturer’s	
guidelines	by	on-column	DNA-digestion.	Extracted	total	RNA	was	quantified	using	NanoDrop®	
ND-1000	 Spectrophotometer	 (NanoDrop	 Technologies,	 Wilmington,	 USA)	 at	 260/280	 nm.	
Total	RNA	of	each	sample	was	reverse	transcribed	into	cDNA	using	RevertAidTM	First	Strand	
cDNA	Synthesis	Kit	(MBI	Fermentas,	Germany).	
For	quantitative	real-time	Polymerase	Chain	Reaction	(qRT-PCR)	analysis,	forward	and	
reverse	primers	were	designed	using	PrimerExpress	2.0	software	(Applied	Biosystems,	Foster	
City,	CA)	to	meet	TaqMan	or	SYBR	Green	requirements.	They	were	designed	to	bind	separate	
exons	 to	 avoid	 co-amplification	 of	 genomic	 DNA.	 Gene	 specificity	 of	 all	 primers	 was	
guaranteed	by	Basic	Local	Alignment	Search	Tool	(BLASTN),	as	listed	in	table	1.	The	following	
genes	were	analyzed:	Aggrecan	(ACAN),	Collagen	type	IIA1	(COL2A1),	Collagen	type	X	(COL10),	
Alkaline	Phosphatase	 (ALP),	and	Matrix	MetalloProteinase-13	 (MMP13).	GlycerAldehyde	3-
Phosphate	 DeHydrogenase	 (GAPDH),	 and	 Hypoxanthine	 PhosphoRibosylTransferase	 1	
(HPRT1)	were	used	as	housekeeping	genes.	The	expression	of	GAPDH	and	HPRT1	did	not	differ	
between	cell	sources	and	both	were	used	to	calculate	the	best	housekeeper	index.	[211]	Using	
repeated	 pair-wise	 correlation	 analysis,	 data	 were	 normalized	 by	 calculating	 the	 ‘best	
housekeeper	 index’.	 (Data	 not	 shown)	 Polymerase	 Chain	 Reactions	were	 performed	 using	
  
TaqMan®	Universal	PCR	Mastermix	 (Applied	Biosystems)	or	qPCR	Mastermix	Plus	 for	SYBR	
Green	 (Eurogentec,	 Nederland	 BV,	 Maastricht,	 the	 Netherlands)	 according	 to	 the	
manufacturers’	 guidelines	 and	 using	 an	 ABIPRISM®	 7000	 with	 SDS	 software	 version	 1.7	
(Applied	Biosystems,	Nieuwerkerk	a/d	IJssel,	the	Netherlands).	Amplification	efficiencies	for	
all	 assays	were	between	90-110%.	Relative	 gene	 expressions	 of	 triplicate	 samples	 of	 each	
donor	were	calculated	by	means	of	the	2-ΔCT	formula.	
	
	
Primers	and	probes	
	
GAPDH	 Fw:	ATGGGGAAGGTGAAGGTCG	
	 Rev:	TAAAAGCAGCCCTGGTGACC	
	 Fam-CGCCCAATACGACCAAATCCGTTGAC	
HPRT1	 Fw:	TATGGACAGGACTGAACGTCTTG	
	 Rev:	CACACAGAGGGCTACAATGTG	
	 Fam-CGCCCAATACGACCAAATCCGTTGAC	
ACAN	 Fw:	TCGAGGACAGCGAGGCC	
	 Rev:	TCGAGGGTGTAGCGTGTAGAGA	
	 Fam-ATGGAACACGATGCCTTTCACCACGA	
COL2A1	 Fw:	GGCAATAGCAGGTTCACGTACA	
	 Rev:	CGATAACAGTCTTGCCCCACTT	
	 Fam-CCGGTATGTTTCGTGCAGCCATCCT	
COL10	 Fw:	CAAGGCACCATCTCCAGGAA	
	 Rev:	AAAGGGTATTTGTGGCAGCATATT	
	 Fam-TCCAGCACGCAGAATCCATCTGA	
ALP	 Fw:	GACCCTTGACCCCCACAAT	
	 Rev:	GCTCGACTGCATGTCCCCT	
	 Fam-TGGACTACCTATTGGGTCTCTTCGAGCCA	
MMP13	 Fw:	AAGGAGCATGGCGACTTCT	
	 Rev:	TGGCCCAGGAGGAAAAGC	
	 Fam-CCCTCTGGCCTGCGGCTCA	
	
Table	1.	Sequences	of	primers	and	probes	for	qRT-PCR.	
	
	
Biochemical	evaluation	of	the	extracellular	matrix	
Sample	preparation	
At	room	temperature,	alginate	beads	and	discs	were	dissolved	in	55	mM	sodium	citrate	and	
20	mM	EDTA	in	150	mM	NaCl.	All	samples	were	then	digested	overnight	at	60oC	with	papain	
buffer	to	a	final	concentration	of	250	μg/mL	papain	(0.2	M	NaH2PO4,	0.01	M	EDTA,	pH	6.0	
and	freshly	added	250	μg/mL	papain,	and	5	mM	L-cystein),	and	later	subjected	to	biochemical	
analyses	to	determine	the	DNA,	glycosaminoglycan,	and	hydroxyproline	contents.	
	
DNA	content	
The	amount	of	DNA	measured	in	each	papain-digested	sample	was	determined	by	Ethidium	
bromide	 (GibcoBR1),	 using	 calf	 thymus	DNA	as	 a	 standard.	 Samples	were	 analyzed	with	 a	
  
spectrofluorometer	(Wallac	1420	Victor	2;	Perkin-Elmer,	Wellesley,	USA),	using	an	extinction	
filter	(340	nm)	and	an	emission	filter	(590	nm).		
	
Glycosaminoglycan	content	
Sulfated	glycosaminoglycans	(sGAGs)	were	quantified	using	the	1,9-Dimethylmethylene	blue	
(DMMB)	dye-binding	assay.	To	be	suitable	for	cell	cultures	containing	alginate,	the	DMMB-
pH-level	was	decreased	to	pH	1.75,	as	described	previously.	[212]	The	metachromatic	reaction	
of	DMMB	was	monitored	using	a	spectrophotometer.	Absorption	ratios	of	540	and	595	nm	
were	used	to	determine	the	sGAG	content	with	chondroitin	sulphate	C	(shark)	as	a	standard.	
For	each	sample,	the	amount	of	sGAG	was	corrected	for	the	amount	of	DNA.	
	
Hydroxyproline	content	
The	hydroxyproline	content	was	quantified	using	a	method	described	previously.	[213]	Briefly,	
the	papain	digests	were	hydrolyzed	with	equal	volumes	of	12	M	HCL	at	108oC	for	18–20	hours.	
Samples	were	 then	 dried	 and	 redissolved	 in	 150	 µL	water.	 Hydroxyproline	 contents	were	
measured	 using	 a	 colorimetric	 method	 (extinction,	 570	 nm),	 with	 chloramine-T	 and	
dimethylaminobenzaldehyde	as	reagents	and	hydroxyproline	(Merck,	Damstadt,	Germany)	as	
a	standard.	
	
Histological	evaluation	of	the	extracellular	matrix	
After	 eight	weeks	 of	 subcutaneous	 implantation,	 alginate	 discs	were	 harvested,	 set	 in	 2%	
agarose,	fixed	in	4%	formalin	in	PBS	and	embedded	in	paraffin.	Paraffin-embedded	sections	
(6	μm)	were	deparaffinized	and	rehydrated.		
	
Immunohistochemistry	for	collagen	type	II,	elastin	and	human	vimentin	
To	allow	the	use	of	monoclonal	mouse	antibodies	on	constructs	which	have	been	implanted	
in	athymic	mice,	we	used	a	method	to	couple	the	first	and	second	antibody	before	applying	
them	on	the	sections	to	prevent	unwanted	binding	of	the	anti-mouse	antibodies	to	mouse-
immunoglobulins.	 [214]	 In	short,	primary	antibodies	were	pre-coupled	overnight	with	goat	
anti-mouse	 biotin	 at	 4oC	 (Jackson	 Laboratories,	 Bar	Harbor,	USA),	 followed	by	 a	 two-hour	
incubation	 in	 0.1%	 normal	 mouse	 serum	 (CLB,	 Amsterdam,	 the	 Netherlands)	 in	 order	 to	
capture	the	unbound	second	antibody.		
Antigen	 retrieval	 for	 the	 collagen	 type	 II	 (Developmental	 Studies	 Hybridoma	 Bank,	
Iowa,	 USA)	 antibody	was	 performed	 through	 incubation	with	 0.1%	 pronase	 in	 PBS	 for	 30	
minutes	at	37oC,	continued	with	a	30	minutes	incubation	with	1%	hyaluronidase	in	PBS	for	at	
37oC.	Antigen	retrieval	for	elastin	(BA4)	required	incubation	with	0.25%	trypsin	in	PBS	for	20	
minutes	at	37oC.	Non-specific	binding	sites	were	blocked	with	10%	goat	 serum	 in	PBS	and	
sections	were	stained	with	the	pre-treated	primary	antibodies	against	collagen	type	II	(1:100)	
or	elastin	 (1:1000)	 for	60	minutes.	Sections	were	than	 incubated	with	enzyme-streptavidin	
conjugate	(Label,	1:100,	Biogenex,	HK-321-UK,	California,	USA)	 in	PBS/1%	BSA,	 followed	by	
incubation	 with	 Neu	 Fuchsin	 substrate	 (Chroma,	 Köngen,	 Germany).	 Positive	 staining	 for	
collagen	II	and	elastin	was	confirmed	with	the	use	of	native	ear	cartilage.	A	mouse	monoclonal	
negative	control	antibody	(mIgG1:	X0931,Dako)	was	used	as	an	isotype	control.	
  
To	study	whether	cells	 in	the	alginate	constructs	harvested	after	 in-vivo	 implantation	were	
originated	from	human	origin,	a	monoclonal	mouse	anti-human	vimentin	antibody	was	used	
(AMF-17b,	Developmental	Studies	Hybridoma	Bank,	Iowa,	USA),	as	described	previously.	[56]	
In	short,	slides	were	incubated	in	3%	aqueous	hydrogen	peroxidase	solution,	in	order	to	inhibit	
endogenous	peroxidase	and	allow	for	peroxidase-antiperoxidase	staining.	Antigen	retrieval	
required	incubation	in	Rodent	Decloaker®	for	60	minutes	at	95oC.	Non-specific	binding	sites	
were	blocked	with	Rodent	Block	M®	followed	by	a	30	minute	staining	with	vimentin	(1:40,	
V6630).	 Thereafter,	 the	 MM-polymer-HRP®	 secondary	 antibody	 was	 used,	 succeeded	 by	
incubation	with	3’diaminobenzidine	chromogen	solution.	Tissue	specificity	was	confirmed	by	
the	 absence	 of	 staining	 on	 sections	 of	 mouse	 liver	 tissue.	 A	 mouse	monoclonal	 negative	
control	antibody	was	used	as	an	isotype	control.	
	
Von	Kossa/Thionin/Resorcin-Fuchsin	staining	
To	evaluate	tissue	calcification,	a	Von	Kossa	staining	was	performed.	Slides	were	immersed	in	
5%	silver	nitrate	solution	for	10	minutes,	rinsed	in	MiliQ	and	exposed	to	light	for	another	10	
minutes.	Sections	were	counterstained	with	Nuclear	fast	red	(Merck).	
sGAGs	were	visualized	using	0.4%	Thionin	in	0.01	M	aqueous	sodium	acetate	(pH	4.5)	for	5	
minutes	at	room	temperature.	To	check	whether	we	stained	sGAGs	rather	than	the	remaining	
alginate,	sections	were	pre-treated	with	20	mM	EDTA.	As	EDTA	treatment	did	not	change	the	
intensity	 and/or	 localization	 of	 Thionin	 on	 our	 slides,	 we	 confirmed	 that	 alginate	 did	 not	
interfere	with	our	sGAG-staining	protocol.	The	presence,	as	well	as	the	arrangement	of	the	
elastic	fibers,	were	visualized	using	Weigert’s	Resorcin-Fuchsin	staining	(Klinipath,	Duiven,	the	
Netherlands).		
We	used	a	semi-quantitative	scoring	system	-	The	Bern	Score	[215]	-	to	evaluate	the	
chondrogenic	capacity	of	alginate-encapsulated	cells	after	subcutaneous	implantation.	(Table	
2)	In	short,	the	scoring	system	evaluates	cartilage	formation	based	on	three	elements:	(1)	the	
uniformity	 and/or	 intensity	 of	 the	 Thionin	 and	 collagen	 type	 II	 staining;	 (2)	 the	 distance	
between	 cells	 and	 the	 extent	 of	 matrix	 produced;	 and	 (3)	 the	 cellular	 morphology.	 Each	
category	has	scores	ranging	from	0	to	3,	resulting	in	a	possible	minimum	collective	score	of	0	
and	 a	maximum	 of	 9.	 Samples	 that	were	 either	 not	 visible	 anymore	 after	 eight	weeks	 of	
subcutaneous	implantation	or	were	dissolved	during	formalin	fixation	were	scored	0.	
	 	
  
Scoring	categories	 Score	
	 	
(1)	 Uniformity	and	darkness	of	the	stain	 	
	 No	stain	 0	
	 Weak	stain	of	poorly	formed	matrix	 1	
	 Moderately	even	stain	 2	
	 Even	dark	stain	 3	
	 	 	
(2)	 Distance	between	cells	/	amount	of	matrix	accumulated	 	
	 High	cell	densities	with	no	matrix	in	between	(no	spacing	between	cells)	 0	
	 High	cell	densities	with	little	matrix	in	between	(cells	<1	cell-size	apart)	 1	
	 Moderate	cell	density	with	matrix	(cells	approximately	1	cell-size	apart)	 2	
	 Low	cell	density	with	moderate	distance	between	cells	(>1	cell)	and	an	extensive	matrix	 3	
	 	 	
(3)	 Cell	morphologies	represented	 	
	 Condensed/necrotic/pycnotic	bodies	 0	
	 Spindle/fibrous	 1	
	 Mixed	spindle/fibrous	with	rounded	chondrogenic	morphology	 2	
	 Majority	rounded/chondrogenic	 3	
	 	 	
	 Maximum	score	 9	
	
Table	2.	The	Bern	Score:	Histological	evaluation	of	engineered	cartilage	constructs.	
	
	
Biomechanical	analysis	
For	mechanical	characterization	of	engineered	cartilage	constructs	after	 in-vitro	and	 in-vivo	
cell	culture,	we	used	2.5	mm	thick	and	5	mm	diameter	constructs.	The	samples	were	placed	
in	a	close-fitting	Ø5	mm	stainless	steel	cylindrical	wells.	Mechanical	testing	was	performed	
with	a	materials	testing	machine	(Zwick	Z005,	Ulm,	Germany)	equipped	with	a	10	N	load	cell,	
a	built-in	displacement	control,	and	a	cylindrical,	plane	ended,	stainless	steel	indenter	(Ø1.2	
mm).	During	mechanical	testing	the	samples	were	immersed	in	PBS.	Stress-strain	testing	was	
performed:	the	samples	were	compressed	to	a	final	height	of	0.5	mm	at	a	loading	rate	of	5	
mm	 per	 minute.	 An	 in-house	 Matlab®	 script	 was	 used	 to	 locate	 the	 sample	 surface	 and	
measure	 the	 sample	 thickness.	 The	 sample	 surface	 was	 identified	 by	 detecting	 the	
corresponding	slope	discontinuity	of	the	force-displacement	curve	using	its	second	derivative.	
Force-displacement	curves	were	then	converted	to	stress-strain	curves.	Compressive	modulus	
at	40%	strain	(E40%),	defined	as	the	derivative	of	the	stress-strain	curve	at	40%	strain,	was	
determined	for	every	sample	(n=98).	
	
Statistical	analysis	
All	 data	were	 analyzed	with	 PASW	Statistics	 20.0	 (SPSS	 inc.	 Chicago,	USA).	 The	mean	 and	
standard	deviations	are	presented.	For	statistical	evaluation,	a	mixed	linear	model	was	used.	
Cell	 source,	 time	point	and	 treatment	 (TGFβ1)	were	defined	as	 fixed	 factors	 in	 the	model.	
Donor	and	sample	number	were	treated	as	random	factors.	Values	of	p<0.05	were	considered	
statistically	 significant.	 For	 histological	 scoring	we	used	 the	Kruskal-Wallis	 followed	by	 the	
  
Mann-Whitney-U	tests	for	their	statistical	analysis	(p<0.05).	 In	order	to	determine	whether	
mechanical	properties	were	enhanced	by	 the	deposition	of	matrix	components,	a	multiple	
regression	 analyses	 was	 performed	 using	 sGAG	 and	 collagen	 deposition	 as	 independent	
variables	(p<0.05).		
  
RESULTS	
	
Cell	expansion	
The	cell	sources	showed	clear	differences	in	growth	rate.	NCs	proliferated	significantly	faster	
than	ECs,	ACs	and	AMSCs	(p<0.05).	NCs	had	gone	through	8.9	±	1.7	population	doublings	(PD)	
in	four	passages	taking	28	±	5	days,	ECs	had	gone	through	6.8	±	1.3	in	38	±	6	days	and	ACs	
through	3.9	±	1.1	PD	in	44	±	13	days.	It	took	39	±	8	days	for	BMSCs	and	48	±	8	days	for	AMSCs	
to	complete	four	passages.	(Table	3)	
	
	
	 PD/D	 Statistically	significantly	different	from	
	 	 	
EC	 0.18	±	0.04	 NC	(p=0.015)	;	AC	(p=0.008)	
NC	 0.32	±	0.07	 EC	(p=0.015)	;	AC	(p<0.001)	;	AMSC	(p=0.013)	
AC	 0.10	±	0.05	 EC	(p=0.008)	;	NC	(p<0.001)	;	BMSC	(p=0.001)	
BMSC	 0.25	±	0.09	 AC	(p=0.001)	
AMSC	 0.16	±	0.04	 NC	(p=0.013)	
	
Table	3.	Population	Doubling	Time	of	different	cell	types	over	four	passages.	
NCs	proliferated	faster	than	ECs,	ACs	and	AMSCs.	The	proliferation	rate	of	BMSCs	did	not	differ	from	AMSCs.	
Data	are	shown	as	mean	±	SD.	PD/D	=	Population	Doublings	per	Day	(PD/D	=	(ln	(N2/N1)	/	ln	(2))/D)	;	EC	=	Ear	
Chondrocytes	(n=3	donors)	;	NC	=	Nasal	Chondrocytes	(n=3	donors)	;	AC	=	Articular	Chondrocytes	(n=3	donors)	;	
BMSC	 =	 bone-marrow-derived	 Mesenchymal	 Stem	 Cells	 (n=3	 donors)	 ;	 AMSC	 =	 adipose-tissue-derived	
Mesenchymal	Stem	Cells	(n=3	donors).		
	
	
Chondrogenic	differentiation	in	vitro	
After	 cell-expansion,	 cells	 were	 encapsulated	 in	 clinical-grade	 alginate	 to	 promote	
chondrogenesis.	Alginate	beads	cultured	without	TGFβ1	had	maintained	their	DNA	content	
after	five	weeks	of	culture.	Addition	of	TGFβ1	significantly	increased	the	total	amount	of	DNA	
in	 alginate	 beads	 seeded	with	 ECs	 and	 NCs	 (p<0.001),	 which	was	 also	 significantly	 higher	
compared	to	the	other	cell	sources	(p<0.05),	indicating	that	those	cells	were	able	to	proliferate	
after	encapsulation	 in	alginate.	The	other	cell	conditions	remained	at	a	stable	cell	content.	
(Figure	1A)		
Chondrocytes	 did	 express	 low	 levels	 of	 COL2A1	 and	 ACAN	 without	 TGFβ1.	 After	
chondrogenic	induction	(with	TGFβ1),	the	COL2A1	and	ACAN	gene	expression	levels	increased	
in	all	cell	source	used.	Both	genes	were	most	highly	expressed	by	ACs	(p<0.001),	followed	by	
BMSCs.	 (Figure	 1B)	 This	 was	 already	 seen	 after	 two	 weeks	 of	 culture	 (data	 not	 shown),	
suggesting	that	chondrogenesis	was	not	only	enhanced	but	also	accelerated.	
Matrix	production	was	quantified	by	sGAG	and	collagen	content	of	alginate	beads	during	in-
vitro	culture.	Without	TGFβ1	very	little	sGAG	was	formed	in	vitro.	Addition	of	TGFβ1	enhanced	
sGAG-production	 and	 after	 five	 weeks	 of	 culture	 ACs	 deposited	 significantly	 more	 sGAGs	
(p<0.01).	 When	 sGAG	 content	 was	 adjusted	 to	 the	 amount	 of	 DNA,	 similar	 but	 more	
pronounced	differences	were	observed	(ACs	produced	most	sGAGs:	60.89	±	53.04	μg	sGAG	/	
μg	DNA;	p<0.001).	sGAG	content	per	alginate	bead	in	constructs	containing	BMSCs,	ECs,	NCs		
  
	
	
	
	
Figure	1.	Cartilage	matrix	formation	by	several	cell	types	in	vitro.	
To	promote	chondrogenesis,	cells	were	encapsulated	 in	alginate	beads	and	cultured	without	(dotted)	or	with	
(black)	TGFβ1	for	5	weeks.	(A)	DNA	content	was	determined	before	culture	dotted	line),	being	on	average	0.53	
±	0.183	μg	DNA	per	alginate	bead,	and	after	5	weeks	of	culture.	The	amount	of	DNA	was	significantly	higher	in	
constructs	containing	ECs	or	NCs.	(B)	Relative	gene	expression	levels	of	COL2A1	and	ACAN	were	corrected	for	
the	 best	 housekeeper	 index.	 All	 cell	 sources	 expressed	ACAN	 and	COL2A1	 after	 chondrogenic	 induction.	 (C)	
Biochemical	 evaluation	 of	 sGAG	 and	 collagen	 content	 after	 chondrogenic	 induction	 in	 alginate	 beads.	 ACs	
deposited	most	 sGAGs.	 Collagen-production	was	 low	 in	 vitro.	 Data	 are	 shown	 as	mean	 ±	 SD.	 For	 statistical	
evaluation,	a	mixed	model	was	used.	*,	**	or	***	indicates	p-values	smaller	than	0.05,	0.01	or	0.001	respectively	
compared	to	the	control	condition	(asterisk	is	shown	in	the	bar)	or	compared	to	the	other	cell	sources	(asterisk	
is	shown	above	the	bar).	EC	=	Ear	Chondrocytes	(n=4	donors)	 ;	NC	=	Nasal	Chondrocytes	(n=4	donors)	 ;	AC	=	
Articular	Chondrocytes	 (n=4	donors)	 ;	BMSC	=	Bone-marrow-derived	Mesenchymal	Stem	Cells	 (n=6	donors)	 ;	
AMSC	=	Adipose-tissue-derived	Mesenchymal	Stem	Cells	 (n=6	donors).	Per	donor,	2-3	samples	were	used	for	
analyses.		
  
and	AMSCs	was	not	significantly	different,	although	a	large	donor	variation	was	observed.	Also	
with	 large	 variation	 between	 donors,	 AMSCs	 performed	 worse.	 The	 amount	 of	 collagen	
deposited	was	 just	above	background	 for	all	 cell	 sources	after	 five	weeks	of	 chondrogenic	
differentiation,	being	on	average	1.53	±	1.84	μg	collagen	per	alginate	bead.	(Figure	1C)	
		
Chondrogenic	differentiation	in	vivo	
To	 study	 the	 stability	 and	 quality	 of	 TE	 cartilage	 in	 vivo,	 alginate	 constructs	 were	 first	
differentiated	 in	 vitro	 for	 five	 weeks	 and	 subsequently	 implanted	 subcutaneously	 on	 the	
dorsal	side	of	athymic	mice	for	an	additional	eight	weeks	of	culture.	Constructs	seeded	with	
ECs	or	NCs,	pre-cultured	with	TGFβ1,	had	a	macroscopically	white	opaque	appearance	and	
were	 relatively	 strong	 on	 handling.	 Conversely,	 constructs	 pre-cultured	 without	 TGFβ1	 or	
constructs	 encapsulating	 ACs,	 BMSCs	 or	 AMSCs,	 were	 fragile	 and	 also	 did	 not	 resemble	
cartilaginous	tissue	macroscopically.	(Figure	2A	and	3A)	
	
	
Figure	2.	Cartilage	matrix	formation	by	several	cell	types	in	vivo.	
Prior	to	subcutaneous	implantation,	constructs	were	cultured	in	vitro	for	5	weeks	in	the	absence	of	TGFβ1.	(A)	
Macroscopic	 view	 of	 engineered	 cartilage	 constructs	 after	 8	 weeks	 of	 subcutaneous	 implantation.	 (B)	
Biochemical	 evaluation	 of	 the	 sGAG	 and	 collagen	 content	 after	 subcutaneous	 implantation.	 ECs	 and	 NCs	
deposited	most	sGAGs	 in	vivo.	Collagen-production	was	 increased	 in	vivo,	but	did	not	differ	between	the	cell	
sources.	The	grey	bars	represent	the	in	vivo	biochemical	data	of	constructs	cultured	in	vitro	for	5	weeks	in	the	
presence	of	TGFβ1	(Figure	3).	(C)	ECs	and	NCs	demonstrated	a	collagen-type-II-rich	matrix	in	almost	all	cartilage	
constructs.	Biochemical	data	are	shown	as	mean	±	SD.	For	statistical	evaluation,	a	mixed	model	was	used.	*,	**	
or	***	indicates	p-value	smaller	than	0.05,	0.01	or	0.001	respectively	compared	to	the	other	cell	sources.	EC	=	
Ear	 Chondrocytes	 (n=3	 donors)	 ;	 NC	 =	 Nasal	 Chondrocytes	 (n=3	 donors)	 ;	 AC	 =	 Articular	 Chondrocytes	 (n=3	
donors)	;	BMSC	=	Bone-marrow-derived	Mesenchymal	Stem	Cells	(n=3	donors)	;	AMSC	=	Adipose-tissue-derived	
Mesenchymal	Stem	Cells	(n=3	donors).	Per	donor,	2	samples	were	used	for	analyses.	
	
  
Prior	 to	 implantation,	 constructs	 pre-cultured	without	 TGFβ1	produced	 very	 little	 sGAG	 in	
vitro,	being	on	average	1,10	±	1,20	µg	sGAG	per	construct.	After	in	vivo	implantation,	these	
constructs	greatly	 increased	their	production	of	matrix	components,	although	they	did	not	
reach	 levels	 which	 equaled	 the	 matrix	 content	 found	 in	 constructs	 cultured	 with	 TGFβ1.	
(Figure	2B)	After	subcutaneous	implantation	preceded	by	chondrogenic	culture	(with	TGFβ1),	
ACs,	BMSCs	and	AMSCs	retained	their	sGAG	content	but	did	not	further	increase	it.	On	the	
contrary,	ECs	and	NCs	significantly	enhanced	matrix	formation	 in	vivo	(EC	7.26-fold	and	NC	
2.86-fold;	both	p<0.001)	leading	to	a	superior	sGAG-deposition	after	implantation	compared	
to	the	other	cell	sources	(both	p<0.001).	These	results	were	further	confirmed	by	a	Thionin-
staining	(data	not	shown).	Total	collagen	deposition	was	hugely	increased	after	implantation	
and	no	significant	differences	could	be	detected	between	the	different	cell	sources.	(Figure	
3B)		
Constructs	 containing	 ACs,	 BMSCs	 or	 AMSCs	 exhibited	 a	 very	 weak	 staining	 for	
cartilage-specific	collagen	type	II	(Figure	3C),	which	was	in	contrast	to	the	overall	production	
of	collagens	(Figure	3B),	thus	indicating	that	other	collagens	were	also	produced	(e.g.	collagen	
type	I	or	type	III).	The	cartilage	matrix	of	constructs	containing	ECs	and	NCs	showed	a	strong	
staining	 for	 collagen	 type	 II,	 although	 the	 dissimilar	 distribution	 of	 collagen-type-II	 fibers	
within	 the	 cartilage	 matrices	 were	 apparent.	 The	 semi-quantitative	 histological	 scores	 of	
constructs	containing	ECs	or	NCs	were	significantly	better	than	the	scores	of	the	other	cell	
sources.	(Figure	3C)		
The	 presence	 of	 elastin	 was	 determined	 to	 evaluate	 differentiation	 into	 elastic	
cartilage.	 There	 was	 no	 elastin	 detectable	 in	 any	 of	 the	 constructs	 with	 an	 elastin	
immunostaining	after	five	weeks	of	in-vitro	cell	culture.	(Data	not	shown)	After	subcutaneous	
implantation,	 elastin	 was	 only	 present	 in	 alginate	 constructs	 containing	 ECs,	 and	
predominantly	 found	 in	 constructs	which	were	pre-cultured	with	TGFβ1.	Most	elastin	was	
located	around	the	cell.	(Figure	3D)		
To	ensure	that	these	cartilage	constructs	were	from	human	origin,	a	human-specific	
vimentin	stain	was	used	on	histological	 sections.	 It	 confirmed	that	 the	cartilage	constructs	
were	indeed	of	human	origin	(Figure	3E),	while	the	surrounding	fibrous	tissue	was	not	(data	
not	shown).		
	
  
	
Figure	3.	Cartilage	matrix	formation	by	several	cell	types	in	vivo.		
Prior	to	subcutaneous	implantation,	constructs	were	cultured	in	vitro	for	5	weeks	in	the	presence	of	TGFβ1.	(A)	
Macroscopic	 view	 of	 engineered	 cartilage	 constructs	 after	 8	 weeks	 of	 subcutaneous	 implantation.	 (B)	
Biochemical	 evaluation	 of	 the	 sGAG	 and	 collagen	 content	 after	 subcutaneous	 implantation.	 ECs	 and	 NCs	
deposited	most	sGAGs	 in	vivo.	Collagen-production	was	 increased	 in	vivo,	but	did	not	differ	between	the	cell	
sources.	(C)	ECs	and	NCs	demonstrated	a	collagen-type-II-rich	matrix	in	almost	all	cartilage	constructs,	leading	to	
significantly	better	semi-quantitative	Bern’s	scores	 than	the	other	cell	 sources.	 (D)	Elastin	was	not	 formed	 in	
  
vitro.	After	subcutaneous	implantation,	only	constructs	containing	ECs	were	able	to	produce	elastin.	Most	elastin	
fibres	were	found	around	the	cell.	Elastin	=	Immunohistochemical	staining	for	elastin	;	RF	=	Resorchin	Fuchsin,	
chemical	staining	for	elastin.	(E)	All	cartilage	constructs	were	of	human	origin.	Biochemical	data	are	shown	as	
mean	±	SD.	For	statistical	evaluation,	a	mixed	model	was	used.	Histological	data	are	shown	as	the	median	of	
individual	data	points.	For	statistical	evaluation,	a	Kruskal-Wallis	 test	was	used	 followed	by	Mann-Whitney-U	
comparison.	*,	**	or	***	indicates	p-values	smaller	than	0.05,	0.01	or	0.001	respectively	compared	to	the	other	
cell	 sources.	 EC	 =	 Ear	 Chondrocytes	 (n=3	 donors)	 ;	 NC	 =	 Nasal	 Chondrocytes	 (n=3	 donors)	 ;	 AC	 =	 Articular	
Chondrocytes	 (n=3	 donors)	 ;	 BMSC	=	Bone-marrow-derived	Mesenchymal	 Stem	Cells	 (n=3	 donors)	 ;	AMSC	=	
Adipose-tissue-derived	Mesenchymal	Stem	Cells	(n=3	donors).	Per	donor,	2	samples	were	used	for	analyses.	
	
	
	
Cartilage	stability	
Hypertrophic	differentiation	is	an	unwanted	phenomenon	in	cartilage	regeneration,	resulting	
in	cartilage	that	can	remodel	into	bone	when	implanted	in	vivo.	To	evaluate	hypertrophy	in	
vitro,	we	have	studied	gene	expression	of	a	panel	of	three	hypertrophic	markers	during	five	
weeks	of	cell	culture	(i.e.	COL10,	ALP	and	MMP13;	Figure	4A).	Cultured	with	TGFβ1	COL10	
expression	was	highest	in	NCs	(p<0.05)	and	BMSCs	(p<0.001),	and	was	minimally	expressed	by	
ACs.	MMP13	was	expressed	by	all	cells	and	significantly	highest	in	NCs.	ALP	was	significantly	
higher	 in	 constructs	with	BMSCs	 compared	 to	 the	other	 cell	 sources	 (p<0.05).	 In	 addition,	
constructs	with	BMSCs	 already	 expressed	high	COL10	and	ALP	after	 two	weeks	 of	 culture	
indicating	early	hypertrophic	differentiation.	(Data	not	shown)	
Although	BMSCs	expressed	all	hypertrophic	markers	in	vitro,	they	did	not	mineralize	or	form	
bone	after	eight	weeks	of	subcutaneous	implantation.	Also,	no	signs	of	tissue	calcification	or	
bone	formation	were	observed	in	construct	containing	AMSCs.	On	the	contrary,	100%	(3/3)	of	
the	cell-free	constructs	and,	unexpectedly,	58.3%	(7/12)	of	constructs	encapsulating	ACs	did	
calcify	 in	vivo.	Also,	calcification	was	more	often	seen	 in	constructs	pre-cultured	 in	control	
medium	 (without	 TGFβ1)	 compared	 to	 constructs	 cultured	 in	 chondrogenic	medium	 (with	
TGFβ1).	(Figure	4B)		
	
Cartilage	structure	and	functionality	
The	elastic	modulus	of	constructs	was	low	in	vitro,	irrespective	of	the	cell	source	used,	being	
on	average	7.42	±	2.10	kPa.	However,	after	subcutaneous	implantation,	mechanical	properties	
improved	in	constructs	containing	either	ECs	(23.68	±	10.20)	or	NCs	(55.12	±	59.25),	but	was	
not	 perceived	 in	 constructs	 containing	 ACs,	 BMSCs	 or	 AMSCs.	 (Figure	 5)	 Since	 tissue	
calcification	misrepresents	the	biomechanical	properties	of	the	cartilage	matrix;	we	excluded	
calcified	cartilage	constructs	from	further	analyses.	
To	determine	whether	the	mechanical	properties	were	enhanced	by	the	deposition	of	
matrix	 components,	 a	 multiple	 regression	 analyses	 was	 performed	 for	 all	 cell	 sources	
separately	using	sGAG	and	collagen	deposition	as	independent	variables.	Only	for	constructs	
containing	 NCs,	 matrix	 components	 significantly	 associated	 with	 the	 biomechanical	
functionality	of	the	constructs	(R2=0.477,	F=4.558,	p=0.039).	For	these	constructs,	only	sGAG-
deposition	 associated	 significantly	 with	 the	 biomechanical	 properties	 of	 the	 cartilage	
constructs	independently	(sGAG:	β=0.689,	p=0.013;	collagen:	β=0.044,	p=0.851).	
  
	
	
Figure	4.	Stability	of	cartilage	constructs	in	vitro	and	in	vivo.		
(A)	 Relative	 gene	expression	 levels	 of	COL10,	ALP	 and	MMP13	were	 examined	 after	 5	weeks	of	 culture	 and	
corrected	for	the	best	housekeeper	index.	Hypertrophic	genes	were	highest	expressed	by	BMSCs	and	NCs.	Data	
are	shown	as	mean	±	SD.	For	statistical	evaluation,	a	mixed	model	was	used.	*,	**	or	***	 indicates	p-values	
smaller	than	0.05,	0.01	or	0.001	respectively	compared	to	the	control	condition	(asterisk	is	shown	in	the	bar)	or	
compared	to	the	other	cell	sources	(asterisk	is	shown	above	the	bar).	EC,	NC	and	AC:	n=4	donors	each;	BMSC,	
AMSC:	n=6	donors	each.	(B)	Von	Kossa	staining	was	used	to	evaluate	construct	calification	in	vivo.	MSCs	did	not	
calcify	 the	 construct	 in	 vivo.	Non-seeded	alginate	 and	constructs	 encapsulating	ACs	did	 calcify.	 For	 each	 cell	
source	we	had	a	total	of	6	alginate	constructs:	duplicate	samples	of	3	different	donors.	EC	=	Ear	Chondrocytes	;	
NC	=	Nasal	Chondrocytes;	AC	=	Articular	Chondrocytes;	BMSC	=	Bone-marrow-derived	Mesenchymal	Stem	Cells;	
AMSC	=	Adipose-tissue-derived	Mesenchymal	Stem	Cells.		
	
	
	
  
	
	
Figure	5.	Biomechanical	evaluation	of	constructs	with	different	cell	types	
Biomechanical	 properties	 enhanced	 after	 in	 vivo	 implantation.	 ECs	 and	 NCs	 tended	 to	 exhibit	 superior	
mechanical	properties	 in	vivo	compared	to	the	other	cell	sources.	Since	tissue	calcification	misrepresents	the	
biomechanical	properties	of	the	cartilage	matrix;	we	excluded	calcified	cartilage	constructs	for	further	analyses	
(grey	bar	 represents	 the	mechanical	properties	of	both	calcified	and	non-calcified	constructs).	Biomechanical	
data	are	shown	as	mean	±	SD.	EC	=	Ear	Chondrocytes	(n=3	donors)	;	NC	=	Nasal	Chondrocytes	(n=3	donors)	;	AC	
=	Articular	Chondrocytes	(n=3	donors)	;	BMSC	=	Bone-marrow-derived	Mesenchymal	Stem	Cells	(n=3	donors)	;	
AMSC	 =	 Adipose-tissue-derived	Mesenchymal	 Stem	 Cells	 (n=3	 donors).	 Per	 donor,	 2	 samples	were	 used	 for	
analyses.	
	
  
DISCUSSION	
	
For	successful	regeneration	of	cartilage	tissue,	selection	of	the	most	appropriate	cell	source	is	
crucial.	This	study	demonstrates	that	cartilage	matrix	formation	and	functionality	is	cell	source	
dependent;	articular	chondrocytes	(ACs)	possess	the	highest	chondrogenic	capacity	in	vitro,	
while	 ear	 chondrocytes	 (ECs)	 and	 nasal	 chondrocytes	 (NCs)	 are	most	 potent	 for	 cartilage	
regeneration	after	subcutaneous	implantation	in	vivo.		
To	date,	we	and	others	have	evaluated	 the	use	of	 chondrocytes	and	mesenchymal	
stem	 cells	 (MSCs)	 of	 several	 anatomical	 locations	 for	 their	 applicability	 in	 cartilage	
regenerative	medicine.	[39,	42-44,	46-59,	206-209]	However,	these	studies	often	used	non-
expanded	 cells	 isolated	 from	 animals.	 Moreover,	 a	 detailed	 direct	 comparison	 between	
various	 chondrocyte	 and	 MSC-sources	 was	 lacking.	 Therefore,	 this	 study	 is	 the	 first	 to	
systematically	 compare	 the	 quality	 and	 tissue	 stability	 of	 engineered	 cartilage	 constructs	
produced	by	culture-expanded	ACs,	NCs,	ECs,	BMSCs	and	AMSCs	of	human	origin.		
We	have	used	culture-expanded	human	cells,	to	closely	simulate	the	clinical	situation.	
For	clinical	application,	the	use	of	autogeneic	cells	is	favorable,	since	these	cells	do	not	elicit	a	
tissue	 rejection	 response.	However,	 it	has	been	difficult	 to	obtain	appropriate	numbers	of	
cells,	 as	 donor	 tissue	 is	 limited	 and	 harvesting	 can	 cause	 large	 donor	 site	 morbidity.	
Consequently,	 monolayer	 cell-expansion	 has	 become	 an	 essential	 step	 in	 the	 process	 of	
cartilage	TE.	To	fulfil	this	requirement,	we	culture-expanded	all	cells	for	four	passages.	It	was	
obvious	that	different	cells	went	through	a	different	number	of	population	doublings	during	
these	 four	 passages;	 ACs	 had	 gone	 through	 the	 least	 number	 of	 population	 doublings	
confirming	earlier	findings	of	slow	proliferation	of	ACs.	[44,	48,	54,	57]		
To	be	able	to	use	expanded	cells	for	the	reconstruction	of	cartilage	defects,	cells	should	
be	stimulated	to	regain	their	cartilage-matrix-forming	capacity.	Several	research	groups	have	
shown	 that	 expanded	 cells	 can	 regain	 their	 chondrogenic	 potential	 under	 specific	 culture	
conditions:	(1)	the	use	of	a	3D-culture	system	(2)	and/or	the	administration	of	chondrogenic	
factors,	 such	 as	 TGFβ.	 [216]	 In	 order	 to	 generate	 a	 3D-culture	 environment,	 we	 have	
encapsulated	all	 cells	 in	 clinical	 grade	alginate,	 since	 alginate	enables	 a	homogeneous	 cell	
distribution,	prevents	cells	from	floating	out	while	permitting	nutrient	diffusion	and	oxygen	
transfer	 to	 the	 encapsulated	 cells	 and	 promotes	 the	 synthesis	 of	 cartilage-specific	 matrix	
components,	such	as	sGAGs	and	collagen	type	II.	[89]	Surprisingly,	we	showed	that	alginate	
appears	to	have	the	tendency	to	calcify	 in	vivo,	 since	20%	of	all	constructs	calcified	during	
subcutaneous	implantation.	Especially,	cell-free	constructs	and	constructs	encapsulating	ACs	
suffered	from	this	phenomenon.	Also,	calcification	was	more	often	seen	 in	constructs	pre-
cultured	in	medium	without	TGFβ1.	To	our	knowledge,	calcium-cross-linked	alginate	calcifies	
through	binding	the	surrounding	phosphate	ions	to	form	calcium	phosphate	crystals.	Those	
crystals	are	stable	 in	neutral	to	basic	environments	and	do	not	appear	at	pH	less	than	6.8.	
[217]	We	believe	that	the	calcified	constructs	were	possibly	generated	a	neutral	to	alkaline	
environment	prior	to	implantation,	since	these	constructs	were	either	not	metabolically	active	
(non-seeded	alginate)	or	had	a	low	metabolic	activity	due	to	stable	cartilage	formation	(ACs)	
or	due	to	the	deficiency	of	TGFβ1.	Obviously,	in	these	constructs,	calcification	did	not	seem	to	
be	a	consequence	of	instable	cartilage	formation,	but	was	more	likely	a	typical	characteristic	
  
of	 alginate	 itself.	 Surprisingly	 and	 in	 contrast	 to	 our	 previous	work	with	MSCs	 in	 collagen	
scaffolds	[71]	or	 in	pellets	without	scaffold	[218],	constructs	containing	MSCs	(both	BMSCs	
and	AMSCs)	never	mineralized	 in	vivo,	although	signs	of	endochondral	differentiation	were	
observed	 prior	 to	 implantation.	 The	 absence	 of	 endochondral	 ossification	 during	 in	 vivo	
implantation	was	accompanied	by	 lack	of	neovascularization	or	vessel	 ingrowth	within	 the	
matrix,	which	 is	known	to	be	extremely	 important	 for	endochondral	ossification	[219].	We	
believe	that	alginate	prevented	this	process,	by	the	fact	that	endothelial	cells	lack	receptors	
to	 bind	 to	 alginate	 polymers,	 prohibiting	 neovascularization	 or	 vessel	 ingrowth.	 [220]	
Therefore,	 it	 seemed	 that	 alginate	 could	 be	 an	 excellent	 cell-carrying	 gel	 for	 cartilage	
regeneration	although	 future	work	needs	 to	 clarify	which	approach	 is	 required	 to	exclude	
alginate	calcification	after	in	vivo	implantation.	
In	addition	to	a	3D-culture	environment,	specific	growth	and	differentiation	factors	will	
help	to	regain	and	induce	a	chondrocyte-like	phenotype.	In	vitro,	culture-expanded	cells	of	all	
sources	studied	 failed	 to	differentiate	 towards	 the	chondrogenic	 lineage	 in	 the	absence	of	
TGFβ1,	as	assessed	by	an	almost	negligible	deposition	of	sGAGs	and	the	inferior	expression	of	
both	ACAN	and	COL2A1	in	alginate	constructs.	The	presence	of	TGFβ1	induced	chondrogenic	
differentiation	in	vitro,	where	ACs	exhibit	a	superior	chondrogenic	capacity	in	vitro,	compared	
to	 the	 other	 cell	 sources.	 The	 beneficial	 effect	 of	 culturing	 with	 TGFβ1	 during	 in-vivo	
chondrogenesis	 was	 present,	 although	 less	 obvious.	 Constructs	 cultured	 without	 TGFβ1	
increased	their	production	of	matrix	components	after	in-vivo	implantation,	but	were	not	able	
to	reach	levels	found	in	constructs	cultured	with	TGFβ1.	
Even	 after	 four	 passages	 of	 culture-expansion,	 chondrocytes	 demonstrated	 some	 clear	
subtype	specific	differences.	Firstly,	ACs	possessed	the	highest	chondrogenic	capacity	in	vitro,	
but	were	not	able	 to	 further	 increase	 their	 cartilage	matrix	 in	 vivo.	 The	 inability	of	ACs	 to	
promote	cartilage	formation	in	vivo	may	be	due	to	the	lack	of	mechanical	loading	or	growth	
factor	 stimulation	 after	 subcutaneous	 implantation	 which	 may	 have	 led	 to	 a	 loss	 of	
chondrogenic	capacity.	ACs,	different	from	the	other	cell	sources,	are	exposed	to	mechanical	
loading	within	native	articular	cartilage	and	unloading	is	known	to	induce	sGAG-release	from	
the	cartilage	matrix	and	 to	 reduce	cell	proliferation	and	sGAG-synthesis	within	 the	matrix.	
[221]	Secondly,	chondrocytes	from	ear	cartilage	were	able	to	form	an	elastin	network	after	
subcutaneous	implantation	in	vivo.	Elastin	was	predominantly	found	in	constructs	which	were	
cultured	with	TGFβ1.	In-vitro	culture	did	not	demonstrate	elastin	deposition	at	all,	which	was	
in	accordance	with	our	previous	work.	[56]	The	capability	of	culture-expanded	ECs	to	produce	
elastin	 in	 vivo	 suggests	 that	 these	 cells	 retain	 their	 capability	 to	 form	 an	 elastic	 cartilage	
matrix.	 Both	 findings	 -	 the	 inability	 of	 ACs	 to	 promote	 cartilage	 formation	 in	 vivo	without	
mechanical	loading	and	the	ability	of	cultured	expanded	ECs	to	produce	elastin	-	indicate	that	
both	cell	types	preserved	their	subtype	specific	phenotype	after	culture	expansion,	confirming	
our	previous	study	where	gene	expression	profiles	of	culture	expanded	NCs	and	ECs	displayed	
clear	differences	that	were	related	to	their	developmental	origin.	[56]	
Besides	chondrocytes,	MSCs	have	been	demonstrated	to	be	an	attractive	cell	source	
for	cartilage	TE.	[62,	64,	66,	222]	Although	bone	marrow	offers	the	most	common	source	of	
MSCs,	 adipose	 tissue	 has	 been	 proven	 to	 be	 an	 attractive	 alternative	 in	 respect	 to	 the	
abundant	and	easily	accessible	pool	of	MSCs.	[67,	68]	We	have	demonstrated	that	both	BMSCs	
  
and	 AMSCs	 underwent	 chondrogenic	 differentiation	 in	 vitro	 and	 in	 vivo,	 although	 matrix	
production	was	less	than	in	constructs	containing	chondrocytes	(ACs,	NCs	or	ECs).	Constructs	
containing	 BMSCs	 had	 a	 higher	 chondrogenic	 potential	 than	 AMSCs,	 demonstrated	 by	 an	
increased	ACAN	and	COL2A1	gene-expression	and	an	 improved	sGAG-deposition.	With	 the	
exception	 of	 a	 few	 studies	 [223-226],	 this	 confirms	 other	 studies	 [55,	 207,	 227-235].	
Nevertheless,	 the	 assumptions	 that	 MSCs	 are	 fundamentally	 less	 chondrogenic	 than	
chondrocytes	and	that	BMSCs	are	more	in	favor	for	cartilage	regeneration	than	AMSCs,	seems	
unjustified.	It	appears	that	cell	culture	conditions	for	both	BMSCs	and	AMSCs	remain	to	be	
improved.	For	 instance,	 it	was	 found	 that	another	member	of	 the	TGFβ-superfamily,	Bone	
Morphogenetic	 Protein	 6,	 is	 obligatory	 to	 improve	 chondrogenic	 differentiation	 in	AMSCs.	
[236]	
Finally,	 in	 order	 to	 understand	 how	 the	 distribution	 and	 composition	 of	 matrix	
components	 resulted	 in	 a	 mechanically	 functional	 cartilage	 matrix,	 the	 compositional	
biomechanical	 relationship	 of	 the	 cartilage	 constructs	 was	 evaluated.	 After	 in-vivo	
implantation,	mechanical	properties	increased	in	constructs	containing	ECs	and	NCs.	Only	for	
constructs	 containing	 NCs,	 matrix	 components	 were	 significantly	 correlated	 to	 their	
biomechanical	 functionality.	 It	 is	 already	 known	 that	 sGAGs	 and	 collagens,	 the	 main	
components	 of	 the	 ECM,	 are	 both	 associated	with	 the	biomechanical	 properties	 of	 native	
cartilage:	(1)	the	negatively	charged	sGAGs	provide	an	osmotic	pressure	within	the	tissue	;	(2)	
the	architecture	of	the	collagen	network	capture	the	sGAGs	and	prevent	them	from	leaking	
out	of	the	tissue.	[237]	In	contrast,	the	elastic	fiber	network	in	constructs	containing	ECs	might	
have	influenced	the	biomechanical	properties	in	vivo	as	well,	although	the	exact	contribution	
of	 elastin	 to	mechanical	 functionality	 is	 not	 yet	 fully	 understood.	Besides	 the	existence	of	
matrix	components,	the	quality	of	the	matrix	is	not	only	determined	by	the	amount	of	matrix	
components	 deposited,	 but	 also	 influenced	 by	 the	 number	 of	 cross-links	 between	matrix	
molecules	(i.e.	collagen	cross	links).	[238]	The	distribution	of	matrix	components	in	the	ECM	
was	 clearly	 different	 between	 cell	 sources:	 ECs	 deposited	 most	 matrix	 components	
pericellularly,	whereas	NCs	deposited	 these	matrix	components	homogenously	 throughout	
their	matrix,	which	was	clearly	visible	on	the	immunohistochemical	collagen	type	II	staining.	
It	is	well-known	that	a	heterogeneous	distributed	matrix	alters	the	biomechanical	properties	
of	the	matrix,	as	the	physical	properties	are	determined	by	the	weakest	point	in	the	matrix	
[140].	
The	present	 study	has	 certain	 limitations.	 Firstly,	 cell	 density	plays	 a	 critical	 role	 in	
functional	 and	 stable	 cartilage	 formation.	 Others	 have	 demonstrated	 that	 cell	 densities	
greater	 than	 20x106	 cells	 per	 milliliter	 are	 desirable,	 while	 low	 cell	 densities	 resulted	 in	
decreased	cartilage	formation.	[239]	Therefore,	a	potential	drawback	of	our	study	is	that	we	
only	could	use	a	cell-seeding	density	of	4x106	cells	per	milliliter	of	alginate,	since	the	size	of	
our	experimental	set-up	did	not	enable	higher	densities.	Secondly,	as	mentioned	before,	we	
have	culture-expanded	all	cells	until	passage	 four	 to	obtain	a	sufficient	number	of	cells.	 In	
order	to	be	able	to	compare	all	different	cell	sources,	we	have	used	standardized	protocols	
for	 the	 culture-expansion	 of	 both	 chondrocytes	 and	MSCs.	 Differences	 in	 expansion	 rates	
between	 the	 different	 cells	 were	 obvious.	 While	 culture-expansion	 is	 associated	 with	
chondrocyte	dedifferentiation	and	replicative	cell	senescence,	the	enforcement	of	population	
  
doublings	 instead	of	culture	passages	might	have	been	more	appropriate,	since	population	
doublings	 more	 accurately	 reflect	 cell	 growth	 and	 thus	 cell	 aging.	 However,	 since	 nasal	
chondrocytes	had	most	doublings	in	four	passages	but	still	produced	most	cartilage,	a	direct	
link	between	doublings	and	cartilage	formation	seems	unlikely.	How	all	the	parameters	such	
as	number	of	doublings,	expansion	speed,	initial	seeding	density,	growth	factors	present	in	
the	medium	or	 produced	 by	 the	 cells	 themselves	 exactly	 determine	 dedifferentiation	 and	
possible	loss	of	chondrogenic	capacity	during	monolayer	expansion	remains	to	be	elucidated.	
Finally,	we	have	demonstrated	large	donor	variation	in	constructs	containing	ACs	or	BMSCs.	
Nevertheless	these	differences	were	not	based	on	a	donor-age	effect	nor	explained	by	the	use	
of	healthy	versus	diseased	ACs.	Moreover,	donors	for	nasal	cartilage	appeared	younger	than	
other	sources.	Although	there	is	a	possibility	that	the	donor-age	has	influenced	the	general	
outcome	 of	 our	 study,	 improved	 chondrogenic	 and	 proliferative	 capacity	 of	 nasal	
chondrocytes	was	also	stated	by	others	in	literature.	[39,	48,	52]	
In	summary,	we	have	demonstrated	that	cartilage	matrix	formation	and	functionality	
are	cell	source	dependent.	ACs	possess	the	highest	chondrogenic	capacity	in	vitro,	while	ECs	
and	NCs	are	most	potent	for	cartilage	regeneration	after	subcutaneous	implantation,	making	
ECs	and	NCs	attractive	cell	sources	for	future	cell-based	cartilage	repair.	Only	for	constructs	
containing	 nasal	 chondrocytes,	 sGAG	 and	 collagen	 content	 were	 associated	 with	
biomechanical	functionality	of	the	constructs,	indicating	the	differences	in	matrix	component	
assembly	by	different	cell	sources.	The	inability	of	ACs	to	increase	cartilage	matrix	in	vivo	may	
be	due	to	a	 loss	of	chondrogenic	capacity	 in	 the	absence	of	mechanical	 loading	or	growth	
factor	 stimulation.	 Although	 MSCs	 are	 considered	 as	 a	 promising	 cell	 sources	 for	 the	
reconstruction	of	cartilage	defects,	it	appears	that	improvements	in	cell	culture	conditions	for	
both	BMSCs	and	AMSCs	are	needed.		
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ABSTRACT	
	
Combining	mesenchymal	 stem	 cells	 (MSCs)	 and	 chondrocytes	 has	 great	 potential	 for	 cell-
based	cartilage	repair.	However,	there	is	much	debate	regarding	the	mechanisms	behind	this	
concept.	 We	 aimed	 to	 clarify	 the	 mechanisms	 that	 lead	 to	 chondrogenesis	 (chondrocyte	
driven	MSC-differentiation	versus	MSC	driven	chondro-induction)	and	whether	 their	effect	
was	dependent	on	MSC-origin.	Therefore,	chondrogenesis	of	human	adipose-tissue-derived	
MSCs	 (hAMSCs)	and	bone-marrow-derived	MSCs	 (hBMSCs)	combined	with	bovine	articular	
chondrocytes	(bACs)	was	compared.	
hAMSCs	 or	 hBMSCs	were	 combined	with	 bACs	 in	 alginate	 and	 cultured	 in	 vitro	 or	
implanted	 subcutaneously	 in	 mice.	 Cartilage	 formation	 was	 evaluated	 with	 biochemical,	
histological	and	biomechanical	analyses.	To	further	investigate	the	interactions	between	bACs	
and	hMSCs,	(1)	co-culture,	(2)	pellet,	(3)	Transwell®	and	(4)	conditioned	media	studies	were	
conducted.		
The	 presence	 of	hMSCs	 -	 either	hAMSCs	 or	 hBMSCs	 -	 increased	 chondrogenesis	 in	
culture;	deposition	of	 sGAG	was	most	evidently	enhanced	 in	hBMSC/bACs.	This	effect	was	
similar	when	hMSCs	and	bAC	were	combined	 in	pellet	culture,	 in	alginate	culture	or	when	
conditioned	media	of	hMSCs	were	used	on	bAC.	 Species-specific	 gene-expression	analyses	
demonstrated	that	aggrecan	was	expressed	by	bACs	only,	indicating	a	predominantly	trophic	
role	for	hMSCs.	Collagen-10-gene	expression	of	bACs	was	not	affected	by	hBMSCs,	but	slightly	
enhanced	by	hAMSCs.	After	in-vivo	implantation,	hAMSC/bACs	and	hBMSC/bACs	had	similar	
cartilage	matrix	production,	both	appeared	stable	and	did	not	calcify.		
This	study	demonstrates	that	replacing	80%	of	bACs	by	either	hAMSCs	or	hBMSCs	does	
not	 influence	cartilage	matrix	production	or	stability.	The	remaining	chondrocytes	produce	
more	matrix	due	to	trophic	factors	produced	by	hMSCs.		
	
  
INTRODUCTION	
	
Cartilage	 has	 a	 very	 limited	 capacity	 for	 self-regeneration.	 Untreated	 lesions	 -	 caused	 by	
trauma,	 tumors,	congenital	malformation	or	age	related	degeneration	 -	persist	 indefinitely	
and	ultimately	require	surgical	 intervention.	However,	current	treatments	are	unsuccessful	
for	long-term	repair;	resulting	in	a	need	for	novel	repair	strategies.	Cell-based	cartilage	repair	
holds	promise	for	restoring	missing	or	destroyed	cartilage	and	has	the	potential	to	overcome	
limitations	of	current	treatments,	while	re-establishing	the	unique	biological	and	functional	
properties	of	the	tissue.		
One	of	the	major	challenges	herein	is	defining	an	appropriate	cell	source.	Current	cell-
based	surgical	treatments	for	cartilage	lesions	are	predominantly	based	on	the	use	of	either	
(1)	 chondrocytes	 or	 (2)	mesenchymal	 stem	 cells	 (MSCs).	 These	 cell-based	 procedures	 are	
however	 associated	 with	 specific	 disadvantages.	 Chondrocytes	 from	 several	 anatomical	
locations	(e.g.	joint,	rib,	nose,	ear,	meniscus)	have	been	investigated	for	their	application	in	
cartilage	 regeneration.	 [39-59]	However,	 to	 generate	 a	 construct	 of	 reasonable	 size,	 large	
numbers	 of	 chondrocytes	 are	 required,	 necessitating	 the	 use	 of	 culture-expansion.	 In	
monolayer	culture-expansion,	chondrocytes	dedifferentiate;	they	change	phenotypically	to	a	
fibroblast-like	 morphology	 and	 lose	 their	 chondrogenic	 gene-expression	 capacity.	
Chondrocyte-dedifferentiation	usually	 results	 in	 fibrous	and	mechanically	 inferior	cartilage,	
making	them	less	suitable	for	cell-based	cartilage	repair.	[61]	In	contrast,	multipotent	cells,	
like	MSCs,	achieved	considerable	attention	as	alternative	cells,	as	they	can	undergo	multiple	
population	doublings	without	 losing	 their	chondrogenic	potential	and	have	 the	capacity	 to	
differentiate	into	cartilage	tissue	under	appropriate	culture	conditions.	[64-68]	Furthermore,	
MSCs	are	easily	 available	 from	several	 tissues,	 including	bone	marrow	and	adipose	 tissue,	
which	makes	culture-expansion	unnecessary.	However,	the	single	use	of	MSCs	for	cell-based	
cartilage	 repair	 is	 currently	 debated,	 since	 the	 cartilage	 tissue	 formed	 is	 unstable	 and	
predisposed	to	mineralization	and	ossification	in	vivo.	[69-71,	240,	241]		
Currently,	 combining	 both	 cell	 sources	 holds	 great	 promise	 for	 cell-based	 cartilage	
repair	as	it	reduces	the	required	number	of	chondrocytes	and	diminishes	many	disadvantages	
of	both	individual	cell	types.	Moreover,	by	decreasing	the	amount	of	chondrocytes	required	
(≤	20%	of	the	total	cell	mixture),	culture-expansion	is	no	longer	necessary,	which	would	allow	
the	use	of	freshly	isolated	primary	chondrocytes	leading	to	improved	cartilage	formation.	[76]	
Unfortunately,	in	depth	understanding	of	the	cellular	interaction	pathways	between	MSCs	and	
chondrocytes	 is	under	debate	 in	 literature:	 It	 is	 thought	that	the	co-culture	effect	 is	either	
credited	by	(1)	chondrocyte	driven	MSC-differentiation	or	ascribed	to	(2)	chondrocytes,	whose	
cartilage-forming	capacity	and	proliferation	activity	are	enhanced	in	the	presence	of	MSCs.	
[81]	In	recent	years,	the	trophic	and	paracrine	functions	of	MSCs	appeared	most	critical	in	this	
process,	rather	than	the	simple	chondrogenic	differentiation	of	MSCs	alone.	However,	little	is	
known	as	to	whether	their	trophic	function	is	a	general	characteristic	of	MSCs	or	dependent	
on	the	origin	of	the	MSC	source.	MSCs	from	several	anatomical	locations	have	been	applied	
in	co-culture.	Independent	on	their	origin,	mixed	cell	cultures	of	chondrocytes	and	MSCs	have	
been	demonstrated	to	generally	 improve	chondrogenesis	as	well	as	to	reduce	hypertrophy	
and	tissue	mineralization.	 [75,	81,	242]	 In	contrast,	 three	co-culture	studies	using	adipose-
  
tissue-derived	 MSCs	 (AMSCs)	 showed	 limited	 or	 decreased	 effects	 of	 MSCs	 on	
chondrogenesis.	 [243-245]	 Such	 effect	 was	 hardly	 seen	 in	 co-culture	 studies	 using	 bone-
marrow-derived	MSCs	(BMSCs),	which	may	propose	that,	compared	to	BMSCs,	AMSCs	are	less	
efficient	 in	co-culture.	Due	to	methodological	heterogeneity	however,	a	direct	comparable	
analysis	between	AMSCs	and	BMSCs	in	co-culture	could	not	be	easily	made.	So	far,	only	three	
research	groups	have	directly	compared	the	effect	of	AMSCs	and	BMSCs	on	chondrocytes	in	
co-culture.	[80,	246,	247]	Unfortunately,	these	studies	demonstrate	conflicting	outcomes	and	
have	never	translated	to	animal	research.	
Therefore,	we	aim	to	investigate	whether	MSCs	undergo	chondrogenic	differentiation	
upon	contact	with	chondrocytes	or	by	trophic	effects	of	MSCs	on	chondrocytes.	Whether	the	
co-culture	effect	 is	dependent	on	MSC-origin	or	a	general	characteristic	of	MSCs,	 is	further	
elucidated.	 Therefore,	 chondrogenesis	 of	 human	 AMSCs	 (hAMSCs)	 and	 BMSCs	 (hBMSCs)	
combined	 with	 bovine	 articular	 chondrocytes	 (bACs)	 is	 compared.	 The	 xenogeneic	 set-up	
using	 hMSCs	 and	 bACs	 will	 allow	 conclusions	 about	 the	 cell	 type	 responsible	 for	
chondrogenesis.	As	cellular	interactions	can	be	influenced	or	overruled	by	exogenous	growth	
factors,	no	growth	factors	are	added	to	the	culture	system	to	study	cartilage	formation	of	the	
co-cultures	 in	 vitro.	 Moreover,	 cartilage	 formation	 will	 be	 evaluated	 after	 immediate	
subcutaneous	 implantation	of	 the	constructs	 in	mice.	To	 further	elucidate	 the	 interactions	
between	MSCs	and	ACs,	different	in-vitro	culture	systems	will	be	used:	(1)	co-culture	system	
of	hMSC/bACs	in	alginate,	(2)	pellet	co-culture	system	of	hMSC/bACs,	(3)	Transwell®	system	
of	singular	isolated	hMSCs	and	bACs	in	alginate,	and	(4)	conditioned	media	culture	systems	of	
conditioned	medium	of	hMSCs	on	bACs	and	vice	versa.	
  
MATERIALS	AND	METHODS	
	
Chemicals	were	obtained	from	Sigma-Aldrich,	USA	unless	stated	otherwise.	
	
Cell	sources	
All	 human	 samples	 were	 obtained	 after	 approval	 by	 the	 Erasmus	 MC	 Medical	 Ethical	
Committee.	Human	mesenchymal	stem	cells	(hMSCs)	were	isolated	from	either	adipose	tissue	
(hAMSCs)	or	bone-marrow	aspirates	(hBMSCs).	hAMSCs	were	obtained	from	subcutaneous	
abdominal	adipose	tissue	as	waste	material	without	the	need	for	informed	consent	(protocol	
#	MEC-2011-371)	(n=3	independent	donors:	F	52Y	;	F	51Y	;	F	53Y).	hBMSCs	were	isolated	from	
bone-marrow	 heparinized	 aspirates,	 after	 written	 informed	 consent	 had	 been	 acquired	
(protocol	#	MEC-2004-142	and	Albert	Schweitzer	Hospital	2011/7)	(n=3	independent	donors:	
M	67Y	;	F	75Y	;	M	22Y).	Both	hAMSCs	and	hBMSCs	were	seeded	and	cultured	overnight	 in	
medium	consisting	of	Minimum	Essential	Medium	Alpha	(MEM-α	;	Gibco,	USA),	supplemented	
with	10%	fetal	calf	serum	(FCS	;	Lonza,	the	Netherlands),	10-4	M	L-ascorbic	acid	2-phosphate,	
and	1	ng/mL	basic	Fibroblast	Growth	Factor	2	(bFGF2	;	AbD	Serotec,	UK).	[248-250]		
Articular	chondrocytes	(ACs)	were	selected,	to	study	the	trophic	effect	of	hAMSCs	or	
hBMSCs	 on	 chondrocytes.	 To	 obtain	 primary	 bovine	 articular	 chondrocytes	 (bACs),	
macroscopically	intact	cartilage	was	harvested	from	the	metatarsophalangeal	joints	of	calves	
≤	6	months	old	(T.	Boer	&	Zn.,	Nieuwerkerk	aan	den	IJssel,	the	Netherlands),	and	washed	with	
saline	(n=4	pools	of	3	donors	each).	To	isolate	cells,	cartilage	pieces	were	incubated	for	1	hour	
with	2	mg/mL	protease	(type	XIV	derived	from	Streptomyces	griseus),	followed	by	overnight	
incubation	 with	 1.5	 mg/mL	 collagenase	 B	 (Roch	 Diagnostics,	 Germany)	 in	 High	 Glucose	 -	
Dulbecco's	Modified	Eagle's	Medium	(HG-DMEM	;	Gibco)	with	10%	FCS,	50	µg/mL	gentamycin	
(Gibco),	 and	 0.5	 µg/mL	 amphotericin	 B	 (Fungizone	 ;	 Life	 Technologies,	 Breda,	 the	
Netherlands).	To	extract	small	parts	of	undigested	cartilage,	the	cell	suspension	was	filtered	
through	a	nylon	100-µm	mesh.	Prior	to	cell	culture,	cell	viability	was	tested	using	the	trypan	
blue	exclusion	test,	and	cell	number	was	calculated	with	a	hemocytometer.		
	
Chondrogenesis	
For	 in-vitro	 and	 in-vivo	 studies,	 all	 cells	 were	 encapsulated	 in	 alginate	 (Batch	 MG-004,	
CellMed,	Germany),	 a	hydrogel	 known	of	 its	high	biocompatibility	 [251]	and	chondrogenic	
capacity	[89].	Moreover,	alginate	hydrogels	enable	homogeneous	cell	distribution	and	allow	
paracrine	factors	to	access	all	cells	equally	[89],	making	them	suitable	scaffolds	for	following	
research	purposes.		
Second-passaged	 hMSCs	 and	 non-expanded	 primary	 bACs	 were	 harvested	 and	
cultured	 in	a	3D-alginate	hydrogel.	Cells	were	 suspended	at	a	density	of	4x106	 cells/mL	 in	
clinical	grade	1.1%	 low	viscosity	alginate	solution	dissolved	 in	0.9%	NaCl	as	single-cell-type	
populations	or	as	a	combination	of	80%	hMSCs	(either	hAMSCs	or	hBMSCs)	and	20%	bACs.	
(Table	1)	A	4:1	ratio	was	selected	based	on	our	previous	experience	[252]	and	that	of	others	
[74,	253].	
	
	 	
  
	
	
	
	
	
	
	
	
	
	
	
Table	1.	Construct	conditions.	
Cell	density	is	displayed	as	the	number	of	cells	(nc)	in	1	milliliter	of	alginate.	hAMSC	=	human	Adipose-tissue-
derived	Mesenchymal	Stem	Cell	;	hBMSC	=	human	Bone-marrow-derived	Mesenchymal	Stem	Cell	;	bAC	=	bovine	
Articular	Chondrocyte.	
	
	
Flat	constructs	(8	mm	diameter	;	2	mm	height)	were	processed	as	previously	described.	[40]	
In	short,	alginate	suspensions	were	injected	into	a	custom	designed	slab	mold	consisting	of	2	
calcium-permeable	 membranes	 (Durapore®	 5.0	 μm	 membrane	 filters,	 Millipore)	 rigidly	
supported	by	stainless-steel	meshes	and	separated	by	a	stainless-steel	casting	frame.	Alginate	
was	instantaneously	gelated	for	30	minutes	in	102	mM	CaCl2	and	thereafter	washed	with	0.9%	
NaCl	and	HG-DMEM.	Sterile	biopsy	punches	(Spengler,	Asnières	sur	Seine,	France)	were	used	
to	create	alginate	constructs	suitable	for	mechanical	testing.	Constructs	were	either	cultured	
in	vitro	or	directly	implanted	subcutaneously	in	mice.	(Figure	1A)	
	In	 vitro,	 constructs	 were	 cultured	 in	 ‘basic	 medium’	 containing	 serum-free	 HG-DMEM	
supplemented	 with	 50	 µg/mL	 gentamycin;	 0.5	 µg/mL	 Fungizone;	 1	 mM	 sodium	 pyruvate	
(Gibco);	 40	 μg/mL	 L-proline;	 supplemented	 Insulin	 Transferrine	 Selenium	 (ITS+	 ;	 B&D	
Bioscience,	 Bedford,	 MA,	 USA);	 10-7	 M	 dexamethason;	 and	 25	 μg/mL	 L-ascorbic	 acid	 2-
phosphate	without	the	addition	of	growth	factors.	For	each	condition	referred	to	in	table	1,	3	
independent	donors	were	used	in	triplicate	(total	n=54).	After	3	and	5	weeks,	constructs	were	
processed	for	biochemical	and	gene-expression	analysis.	
In-vivo	studies	were	completed	after	8	weeks	of	subcutaneous	implantation.	In	total,	
10	9-week-old,	female	NMRI	nu/nu	mice	(Charles	River	Laboratories,	the	Netherlands)	were	
used.	Two	separate	incisions	were	made	along	the	central	line	of	the	spine	(1	at	the	shoulders	
and	1	at	the	hips),	after	which	4	separate	subcutaneous	dorsal	pockets	were	prepared	by	blunt	
dissection.	 For	 each	 condition	 referred	 to	 in	 table	 1,	 3	 independent	 donors	were	 used	 in	
duplicate	 (total	 n=36).	 Moreover,	 cell-free	 constructs	 were	 used	 as	 controls	 (n=4).	 For	
implantation,	alginate	constructs	were	randomly	assigned	to	these	4	pockets.	After	8	weeks,	
animals	 were	 sacrificed	 and	 samples	 were	 explanted	 for	 histological,	 biomechanical	 and	
biochemical	analyses.	Animal	experiments	were	carried	out	to	the	guidelines	prescribed	by	
the	Dutch	National	Institutes	of	Health,	and	were	approved	by	the	Dutch	equivalent	of	the	
Institutional	 Animal	 Care	 and	 Use	 Committee,	 the	 Erasmus	 MC	 Dier	 Ethische	 Commissie	
(protocol	#	EMC	2429).		
	 Human	stem	cells	 Bovine	chondrocytes	
	 	 	
	 Source	 Cell	 density	(x106)	 Source	
Cell	 density	
(x106)	
hAMSC	 hAMSCs	 4	nc/mL	 x	 x	
hBMSC	 hBMSCs	 4	nc/mL	 x	 x	
bAC	 x	 x	 bACs	 4	nc/mL	
hAMSC/bAC	 hAMSCs	 3.2	nc/mL	 bACs	 0.8	nc/mL	
hBMSC/bAC	 hBMSCs	 3.2	nc/mL	 bACs	 0.8	nc/mL	
Control	bAC	 x	 x	 bACs	 0.8	nc/mL	
  
	
Figure	1.	Cellular	interaction.	
Cells	were	encapsulated	in	alginate	beads	separately	and	alginate	and	pellet	co-cultures	(A,	
control	 conditions).	 Furthermore,	 hMSCs	 and	 bACs	 were	 co-cultured	 in	 (B)	 a	 Transwell®	
system	as	well	as	in	(C)	medium	conditioned	by	the	other	cell	type,	to	further	understand	the	
complex	 cellular	 communication	 pathways	 between	hMSCs	 and	bACs.	 In	 purple:	hMSCs	 =	
human	Mesenchymal	Stem	Cells	;	in	green:	bACs	=	bovine	Articular	Chondrocytes.	
  
Cellular	interaction	
To	further	understand	the	complex	cellular	communication	pathways	between	MSCs	and	ACs,	
cell	types	(hAMSCs	(F	53Y)	 ;	hBMSCs	(M	22Y)	;	bACs	pool	of	3	donors)	were	co-cultured	as	
follows:	(1)	hMSCs	and	bACs	were	combined	and	cultured	in	alginate	as	previously	described;	
(2)	hMSCs	and	bACs	were	cultured	in	pellets,	allowing	direct	cell-cell	contact.	Furthermore,	
hMSCs	and	bACs	were	encapsulated	in	alginate	separately	and	co-cultured	in	(3)	a	Transwell®	
system	;	as	well	as	(4)	in	medium	conditioned	by	the	other	cell	type.	(Figure	1)	The	ratio	of	
hMSCs	to	bACs	in	each	culture	system	was	kept	80:20	for	all	conditions.	All	constructs	were	
cultured	under	 standardized	nutritional	 conditions.	Medium	was	 changed	3	 times	a	week.	
After	3	weeks,	alginate	beads	and	pellets	were	processed	for	biochemical	or	gene-expression	
analysis.	
	
(1) Co-culture	
hMSCs	 and	bACs	were	 suspended	 at	 a	 density	 of	 4x106	 cells/mL	 in	 clinical	 grade	 alginate	
solution	as	a	mixed-cell-type	population	at	a	80:20	ratio	as	described	above.	(Figure	1A)	
	
(2) Pellet	culture		
To	study	the	effects	of	direct	cell-cell	contact	in	co-cultures,	hMSCs	and	bACs	were	cultured	in	
pellets.	Therefore,	a	mixture	of	80%	hMSCs	and	20%	bACs	was	suspended	in	basic	medium	
and	a	total	number	of	2,5x105	cells	in	0.5	mL	were	transferred	into	polypropylene	tubes	and	
pellet	were	formed	by	centrifuging	at	200	G	for	8	minutes.	To	induce	proper	pellet	formation,	
addition	of	Transforming	Growth	Factor	β1	 (TGFβ1	 ;	R&D	Systems,	USA)	 for	24	hours	was	
required.	 This	 exposure	 was	 not	 sufficient	 to	 induce	 chondrogenesis	 in	 hMSCs	 (data	 not	
shown).	After	24	hours,	pellet	were	exposed	to	the	‘basis	medium’	without	addition	of	any	
growth	factors.	(Figure	1A)	
	
(3) Transwell®	system		
hMSCs	 and	bACs	were	 suspended	 at	 a	 density	 of	 4x106	 cells/mL	 in	 clinical	 grade	 alginate	
solution	 as	 single-cell-type	 populations	 and	 transferred	 into	 a	 10-mL	 sterile	 syringe.	
Thereafter,	 the	 cell-suspension	was	 slowly	 passed	 through	 a	 23-gauge	 needle	 to	 produce	
drops,	 which	 fell	 into	 a	 102	 mM	 CaCl2	 creating	 alginate	 beads.	 Following	 instantaneous	
gelation,	beads	were	allowed	to	further	gelate	for	a	period	of	10	minutes	in	the	CaCl2-solution.	
After	being	washed	once	with	0.9%	NaCl	and	HG-DMEM,	 the	beads	were	 transferred	 to	a	
Transwell®	system	(Corning	Life	Science,	USA).	The	Transwell®	inserts	separated	hMSCs	and	
bACs	by	a	porous	membrane	of	8	µm,	allowing	paracrine	signaling	between	hMSCs	and	bACs.	
(Figure	1B)	
	
(4) Conditioned	medium	
Alginate	beads	containing	hMSCs	or	bACs	were	produced	as	described	above	and	cultured	in	
medium	conditioned	by	the	other	cell	types.	To	obtain	bACs,	hAMSCs	and	hBMSCs	conditioned	
media,	alginate	beads	were	cultured	 in	 ‘basic	medium’	 for	3	days.	After	3	days	of	 culture,	
conditioned	media	were	collected,	enriched	with	1:1	‘basic	medium’	and	immediately	added	
  
to	alginate	cultures	of	the	other	cell	types.	Again,	a	80:20	ratio	between	hMSCs	and	bACs	was	
maintained.	(Figure	1C)	
	
Biochemical	evaluation	of	the	extracellular	matrix	
Alginate	constructs	were	digested	overnight	at	56oC	in	papain	(250	μg/mL	in	0.2	M	NaH2PO4,	
0.01	M	EDTA,	containing	5	mM	L-cystein	;	pH	6.0)	;	pellets	were	digested	overnight	at	56oC	in	
proteinase	K	(1	mg/mL	in	Tris/EDTA	buffer	containing	185	µg/mL	iodoacetamide	and	1	µg/mL	
pepstatin	 A	 ;	 pH	 7.6).	 After	 digestion,	 samples	were	 subjected	 to	 biochemical	 analyses	 to	
determine	 DNA,	 sulfated-glycosaminoglycan	 (sGAG),	 and	 hydroxyproline	 contents	 as	
described	previously.	[40]	In	short,	the	amount	of	DNA	was	determined	by	Ethidium	bromide	
(GibcoBR1),	 using	 calf	 thymus	 DNA	 as	 a	 standard.	 sGAGs	 were	 quantified	 by	 the	 1,9-
Dimethylmethylene	blue	(DMMB)	dye-binding	assay,	using	shark	chondroitin	sulphate	C	as	a	
standard.	To	be	suitable	for	cell	cultures	containing	alginate,	the	DMMB-pH-level	was	adjusted	
to	 pH	 1.75,	 as	 described	 previously.	 [212]	 For	 the	 hydroxyproline	 content,	 digests	 were	
hydrolysed,	dried	and	redissolved	in	150	µL	water.	Hydroxyproline	contents	were	measured	
using	chloramine-T	and	dimethylaminobenzaldehyde	as	reagents	and	hydroxyproline	(Merck,	
Germany)	 as	 a	 standard.	 Collagen	 content	 was	 subsequently	 estimated	 from	 the	
hydroxyproline	 content,	 assuming	 that	 one	 collagen	 triple	 helix	 molecule	 contains	 300	
hydroxyproline	residues.	
	
Histological	evaluation		
After	8	weeks	of	subcutaneous	implantation,	constructs	were	harvested,	set	in	2%	agarose,	
fixed	 in	4%	 formalin	 in	PBS	and	embedded	 in	paraffin.	Paraffin-embedded	sections	 (6	μm)	
were	deparaffinised	and	rehydrated.		
To	 evaluate	 tissue	 calcification,	 Von	 Kossa	 staining	 was	 performed.	 Slides	 were	
immersed	in	5%	silver	nitrate	solution	for	10	minutes,	rinsed	in	MilliQ	and	exposed	to	light	for	
another	 10	minutes.	 Excess	 silver	 nitrate	 was	 removed	with	 5%	 sodium-thiosulphate	 and	
slides	were	rinsed	in	distilled	water	afterwards.	Sections	were	counterstained	with	Nuclear	
fast	red	(Merck).	
To	 allow	 the	 use	 of	 monoclonal	 mouse	 antibody	 collagen	 type	 II	 (II-II6B3	 1:100;	
Developmental	Studies	Hybridoma	Bank,	USA)	on	constructs	which	had	been	 implanted	 in	
mice,	 the	primary	 antibody	was	pre-coupled	overnight	with	 goat	 anti-mouse	biotin	 at	 4oC	
(1:500	;	Jackson	Laboratories,	USA),	followed	by	a	2-hour	incubation	in	0.1%	normal	mouse	
serum	(CLB,	the	Netherlands),	to	prevent	unwanted	binding	of	the	anti-mouse	antibodies	to	
mouse	immunoglobulins.	[214]		
Antigen	 retrieval	was	 performed	 through	 incubation	with	 0.1%	pronase	 for	 30	minutes	 at	
37oC,	continued	with	a	30	minutes	 incubation	with	1%	hyaluronidase	at	37oC.	Non-specific	
binding	 sites	were	 blocked	with	 10%	 goat	 serum	and	 sections	were	 stained	with	 the	 pre-
treated	antibodies	 for	60	minutes.	Sections	were	than	 incubated	with	enzyme-streptavidin	
conjugate	(Label,	1:100,	Biogenex,	HK-321-UK,	USA)	in	PBS/1%	BSA,	followed	by	incubation	
with	Neu	Fuchsin	substrate	(Chroma,	Germany).		
	
	
  
Biomechanical	analysis	
In	order	 to	distinguish	 the	mechanical	 strength	of	alginate	 itself,	 cell	 containing	constructs	
were	prepared	and	directly	taken	for	mechanical	testing	as	described	previously.	[40]	In	short,	
for	mechanical	characterization	of	engineered	cartilage	constructs	after	 in	vivo	cell	culture,	
constructs	2.5	mm	thick	and	5	mm	in	diameter	were	used.	The	samples	were	placed	in	close-
fitting	 Ø	 5	mm	 stainless	 steel	 cylindrical	 wells.	Mechanical	 testing	 was	 performed	 with	 a	
materials	testing	machine	(Zwick	Z005,	Ulm,	Germany)	equipped	with	a	10	N	load	cell,	a	built-
in	displacement	control,	and	a	cylindrical,	plane	ended,	stainless	steel	indenter	(Ø	1.2	mm).	
During	 mechanical	 testing	 the	 samples	 were	 immersed	 in	 PBS.	 Stress-strain	 testing	 was	
performed:	the	samples	were	compressed	to	a	final	height	of	0.5	mm	at	a	loading	rate	of	5	
mm	 per	 minute.	 An	 in-house	 Matlab®	 script	 was	 used	 to	 locate	 the	 sample	 surface	 and	
measure	 the	 sample	 thickness.	 Force-displacement	 curves	were	 then	 converted	 to	 stress-
strain	curves.	Measurements	of	compressive	modulus	at	40%	strain,	E40%,	were	determined	
for	every	sample.	
	
Gene-expression	analyses	
For	total	RNA	isolation,	alginate	was	dissolved	in	ice-cold	55	mM	sodium	citrate	and	20	mM	
Ethylene	Diamintetraacetate	 (EDTA)	 in	150	mM	NaCl	and	centrifuged.	Each	 cell-pellet	was	
subsequently	 suspended	 in	1	mL	RNA-BeeTM	 (TEL-TEST,	USA).	 For	 total	RNA	 isolation	 from	
pellets,	pellets	were	manually	homogenized	and	suspended	in	300	μL/pellet	RNA-BeeTM.	RNA	
was	extracted	with	chloroform	and	purified	from	the	supernatant	using	the	RNAeasy	Micro	
Kit	 (Qiagen,	 Germany)	 according	 to	 the	 manufacturer’s	 guidelines	 by	 on-column	 DNA-
digestion.	Extracted	total	RNA	was	quantified	using	NanoDrop®	ND-1000	Spectrophotometer	
(NanoDrop	Technologies,	Wilmington,	DE,	USA)	at	260/280	nm.	Total	RNA	of	each	sample	was	
reverse	 transcribed	 into	 cDNA	 using	 RevertAidTM	 First	 Strand	 cDNA	 Synthesis	 Kit	 (MBI	
Fermentas,	Germany).	
For	quantitative	real-time	Polymerase	Chain	Reaction	(qRT-PCR)	analysis,	forward	and	
reverse	primers	were	designed	using	PrimerExpress	2.0	software	(Applied	Biosystems,	USA)	
to	meet	TaqMan	or	SYBR	Green	requirements.	Gene	specificity	of	all	primers	was	guaranteed	
by	Basic	Local	Alignment	Search	Tool	(BLASTN).	Analysed	genes	are	listed	in	table	2.	qRT-PCR	
was	 performed	 using	 qPCR	Mastermix	 Plus	 for	 SYBR	Green	 (Eurogentec,	 the	Netherlands)	
according	 to	 the	manufacturers’	 guidelines	 and	 using	 ABIPRISM®	 7000	with	 SDS	 software	
version	1.7	(Applied	Biosystems,	The	Netherlands).	Relative	gene	expressions	were	calculated	
by	means	of	the	2-ΔCT	formula.		
	 	
  
Primers	and	probes	
	
Human	specific	genes	
hsGAPDH	 Fw:	AGCTCACTGGCATGGCCTTC	
	 Rev:	CGCCTGCTTCACCACCTTCT	
hsACAN	 Fw:	CAGCCACCACCTACAAACGCAG	
	 Rev:	CTGGGTGGGATGCACGTCAGC	
hsCOL2A1	 Fw:	ACGAGGCCTGACAGGTCCCA	
	 Rev:	GCCCAGCAAATCCCGCTGGT	
	 	
Bovine	specific	genes	
bsGAPDH	 Fw:	GTCAACGGATTTGGTCGTATTGGG	
	 Rev:	TGCCATGGGTGGAATCATATTGG	
bsACAN	 Fw:	GGACACTCCTTGCAATTTGAGAA	
	 Rev:	CAGGGCATTGATCTCGTATCG	
COL2A1	 Fw:	GGCAATAGCAGGTTCACGTACA	
	 Rev:	CGATAACAGTCTTGCCCCACTT	
	
Table	2.	Sequences	of	primers	for	qRT-PCR.	
GAPDH	=	GlycerAldehyde	3-Phosphate	DeHydrogenase	 ;	ACAN	=	Aggrecan	 ;	COL2A1	=	Collagen	 type	2	 ;	hs	=	
human-specific	;	bs	=	bovine-specific.	
	
	
Statistical	analysis	
All	data	were	analyzed	with	PSAW	statistics	20.0	(SPSS	inc.	Chicago,	USA).	For	in	vitro	alginate	
co-cultures,	the	mean	and	standard	deviation	represents	at	least	three	independent	donors	
per	cell	source	performed	 in	triplicate.	For	statistical	evaluation,	a	mixed	 linear	model	was	
used	followed	by	a	Bonferroni's	post-hoc	comparisons	test.	Condition	and	time	point	were	
defined	as	 fixed	 factors	 in	 the	model.	Donor	and	sample	number	were	 treated	as	 random	
factors.	For	in	vivo	alginate	co-cultures,	the	mean	and	standard	deviation	represents	at	least	
three	independent	donors	per	cell	source	performed	in	duplicate.	For	the	evaluation	of	the	
cellular	communication	pathways	between	MSCs	and	ACs,	the	mean	and	standard	deviation	
represents	one	donor	per	 cell	 source	performed	 in	 sextuple.	 For	 statistical	evaluation,	 the	
Kruskal-Wallis	 followed	by	 the	Mann-Whitney-U	tests	was	used	 followed	by	a	Bonferroni's	
post-hoc	 comparisons	 test.	 For	 all	 tests,	 values	 of	 p<0.05	 were	 considered	 statistically	
significant.	
  
RESULTS	
	
Cartilage	regeneration	in	co-cultures		
In	vitro	outcomes	
After	3	weeks,	DNA	content	of	alginate	constructs	containing	either	co-cultures	of	hMSCs	and	
bACs	or	single-cell-type	populations,	did	not	change	in	relation	to	their	initial	DNA	content.	
(Figure	2A)	Because	the	amount	of	DNA	had	not	changed	significantly	in	any	of	the	conditions,	
matrix	deposition	was	expressed	per	construct	and	per	initially	seeded	primary	ACs.	After	5	
weeks,	 DNA	 content	 did	 significantly	 decrease	 in	 constructs	 containing	 hBMSCs	 only	
(p<0.001),	 but	 remained	 unchanged	 in	 the	 remaining	 culture	 conditions.	 (Supplementary	
figure	1)	
Since	 constructs	 were	 cultured	 in	 the	 absence	 of	 chondrogenic	 factors,	 constructs	
containing	 solely	 hAMSCs	 or	 hBMSCs	 produced	 very	 little	 sGAG	 (Figure	 2B)	 and	 collagen	
(Figure	2C).	To	demonstrate	the	additional	effect	of	hMSCs	in	mixed-cell-type	populations,	a	
control	 condition	 -	 containing	 similar	 numbers	 of	 bACs	 (0.8*106	 nc/mL)	 without	 the	
supplementation	 of	hMSCs	 -	was	 evaluated	 (Figure	 2	 dotted	 lines).	 The	 addition	 of	 either	
hAMSCs	or	hBMSCs	to	bACs	demonstrated	a	significant	increase	in	the	production	of	sGAG	
over	their	controls	(hAMSC/bACs	p=0.018	;	hBMSC/bACs	p<0.001).	Compared	to	constructs	
containing	single-cell-type	populations,	the	deposition	of	sGAG	was	most	evidently	enhanced	
in	 co-cultures	 combining	hBMSCs	 and	bACs	 (p<0.001).	 Constructs	 containing	hAMSC/bACs	
deposited	 significantly	 less	 sGAG	 compared	 to	hBMSC/bACs	 (p<0.001)	 and	 equal	 amounts	
compared	 to	 constructs	 containing	bACs	 only.	 (Figure	 2B)	 The	 production	 of	 collagen	was	
enhanced	in	co-cultures	of	both	hAMSC/bACs	and	hBMSC/bACs	compared	to	single-cell-type	
populations	(hAMSC/bACs	p=0.002	;	hBMSC/bACs	p<0.001).	(Figure	2C)	Normalization	of	the	
total	sGAG	content	to	the	initially	seeded	primary	ACs	revealed	even	more	distinct	differences	
between	 co-cultures	 and	 single-cell-type	 populations:	 hBMSC/bACs	 produced	 significantly	
more	sGAG	compared	to	bACs	only	and	co-cultures	of	hAMSC/bACs	(both	p<0.001)	;	collagen	
production	 was	 significantly	 enhanced	 in	 both	 co-cultures	 (hAMSC/bACs	 p=0.013	 ;	
hBMSC/bACs	p<0.001).	 (Figure	 2B	 and	 2C)	 Similar	 results	were	 obtained	 after	 5	weeks	 of	
culture.	 (Data	 not	 shown)	 These	 results	 demonstrate	 that	 co-cultures	 of	hMSCs	 and	bACs	
improve	cartilage	formation	in	vitro,	depending	on	the	hMSC-source	used	(hBMSC	≥	hAMSC).	
	
  
	
Figure	2.	Cartilage	matrix	formation	in	constructs	containing	hMSCs	and/or	bACs,	3	weeks	
after	in-vitro	culture.		
(A)	The	DNA	content	of	none	of	the	constructs	had	changed	compared	to	their	initial	DNA	content	prior	to	cell-
culture	(dotted	line).	Biochemical	evaluation	of	the	sGAG	(B)	and	collagen	(C)	content,	3	weeks	after	culture	in	
alginate.	The	left	graphs	demonstrate	the	amount	of	matrix	components	per	construct,	whereas	for	the	right	
graphs	matrix	 production	 is	 normalized	 to	 the	 initially	 seeded	 primary	 ACs.	 A	 control	 condition	 -	 containing	
similar	amounts	of	bACs	(0.8*106	nc/ml)	without	supplementation	of	hMSCs	-	was	evaluated	to	determine	the	
additional	effect	of	hMSCs	(3.2*106	nc/ml)	on	bACs	in	co-cultures	(dotted	line).	*,	**	or	***	indicates	p-values	
smaller	than	0.05,	0.01	or	0.001	respectively	compared	to	the	control	condition.	Data	are	shown	as	mean	±	SD.	
For	statistical	evaluation,	a	mixed	model	was	used	followed	by	a	Bonferroni's	post-hoc	comparisons	test.	hAMSC	
=	human	Adipose-tissue-derived	Mesenchymal	Stem	Cell	(n=3	experiments	with	3	independent	donors)	;	hBMSC	
=	human	Bone-marrow-derived	Mesenchymal	Stem	Cell	(n=3	experiments	with	3	independent	donors)	;	bAC	=	
bovine	Articular	Chondrocyte	(n=3	experiments	with	3	pools	of	donors).	Per	experiment,	3	samples	were	used	
for	analyses.		
	
	
In	vivo	outcomes	
Cell-free	alginate	constructs	(controls	;	n=4)	and	alginate	constructs	containing	hBMSC/bACs,	
hAMSC/bACs	 or	hBMSC,	hAMSC	 or	bAC	 only,	were	 generated	 and	 immediately	 implanted	
subcutaneously	in	athymic	mice.	After	8	weeks,	all	but	5	(n=3	hAMSC,	n=2	hBMSC)	of	the	40	
constructs	could	be	identified	and	harvested.	Unfortunately	however,	the	remaining	hMSC-
constructs	(either	hAMSCs	or	hBMSCs)	and	cell-free	alginate	constructs	were	lost	during	the	
embedding	process.	Constructs	containing	bACs	or	hBMSC/bACs	resembled	cartilage	tissue	in	
both	 color	 and	 texture,	 while	 the	 appearance	 of	 constructs	 containing	 hAMSC/bACs	 was	
  
particularly	donor-dependent.	(Figure	3)	None	of	the	constructs	had	mineralized	or	ossified.	
Also,	 vascularization	 within	 the	 construct,	 was	 never	 observed.	 Cells	 were	 more	
heterogeneously	 distributed	 in	 constructs	 containing	 either	 hAMSC/bACs	 or	 hBMSC/bACs	
compared	to	bACs	only.	Collagen	type	II	was	abundantly	present	in	constructs	containing	bAC	
or	 hBMSC/bACs.	 Again,	 hAMSC/bACs	 contained	 collagen	 type	 II	 in	 a	 donor-dependent	
manner.	(Figure	3)	
	
	
	
Figure	 3.	 Macroscopic	 appearance	 and	 immunohistochemical	 analyses	 of	 constructs	
containing	hMSCs	and/or	bACs,	8	weeks	after	subcutaneous	implantation	in	mice.	
Macroscopic	appearance	(top	row)	of	cartilage	constructs,	as	well	as	a	collagen	type	 II	 immunohistochemical	
staining	(bottom	rows),	8	weeks	after	subcutaneous	implantation.		
hAMSC	=	human	Adipose-tissue-derived	Mesenchymal	Stem	Cell	(n=3	experiments	with	3	independent	donors)	
;	hBMSC	=	human	Bone-marrow-derived	Mesenchymal	Stem	Cell	(n=3	experiments	with	3	independent	donors)	
;	bAC	=	bovine	Articular	Chondrocyte	(n=3	experiments	with	3	pools	of	donors).	Per	experiment,	2	samples	were	
used	for	analyses.	
	
	
In	vivo,	DNA-	and	sGAG-content	were	not	detected	in	cell-free	alginate	constructs.	(Data	not	
shown)	 hAMSC/bACs	 and	 hBMSC/bACs	 contained	 similar	 quantities	 of	 cartilage	matrix	 as	
constructs	containing	bACs	only.	Moreover	sGAG	formation	in	co-cultures	was	independent	
of	 the	 origin	 of	 the	 hMSC-source	 used	 (p=0.916).	 (Figure	 4A)	 Collagen	 production	
demonstrated	 a	 similar	 trend,	 again	 without	 statistical	 significant	 differences	 between	
hAMSC/bACs	 and	 hBMSC/bACs	 (p=1.000).	 (Figure	 4B)	 Normalization	 of	 the	 data	 to	 their	
initially	seeded	primary	ACs	revealed	more	distinct	differences	between	mixed-cell-type	and	
single-cell-type	 populations:	 hAMSC/bACs	 and	 hBMSC/bACs	 produced	 significantly	 more	
sGAG	and	collagen	per	initially	seeded	primary	ACs	compared	to	bACs	(hAMSC/bACs	p<0.01	;	
hBMSC/bACs	p<0.05).	 (Figure	4)	After	subcutaneous	 implantation,	 the	elastic	modulus	was	
  
highest	 in	 constructs	 containing	 hAMSC/bACs	 and	 hBMSC/bACs,	 albeit	 this	 did	 not	 reach	
statistical	significance	due	to	the	large	variation	between	samples.	(Figure	4C)	These	results	
confirm	our	in-vitro	results	by	showing	that	co-cultures	of	hMSCs	and	bACs	improve	cartilage	
formation.	However,	in	vivo	this	phenomenon	seems	independent	of	the	hMSC-source	used,	
although	large	donor	variation	is	observed.	
	
	
	
	
	
Figure	4.	Cartilage	matrix	formation	in	constructs	containing	hMSCs	and/or	bACs,	8	weeks	
after	subcutaneous	implantation	in	mice.	
Biochemical	(sGAG	(A)	and	collagen	(B)	content)	and	biomechanical	evaluation	(C),	8	weeks	after	subcutaneous	
implantation.	The	left	graphs	in	A	and	B,	demonstrate	the	amount	of	matrix	components	per	construct,	whereas	
for	the	right	graphs	matrix	production	is	normalized	to	the	initially	seeded	primary	ACs.	A	control	condition	-	
containing	 similar	 amounts	 of	bACs	 (0.8*106	 nc	 /ml)	without	 supplementation	 of	hMSCs	 -	was	 evaluated	 to	
determine	 the	additional	effect	of	hMSCs	 (3.2*106	nc	 /ml)	on	bACs	 in	 co-cultures	 (dotted	 line).	 *,	 **	or	***	
indicates	p-values	 smaller	 than	0.05,	0.01	or	0.001	 respectively	 compared	 to	 the	 control	 condition.	Data	are	
shown	as	box-whisker	plots.	For	statistical	evaluation,	a	Kruskal-Wallis	followed	by	the	Mann-Whitney-U	test	was	
used	 followed	 by	 a	 Bonferroni's	 post-hoc	 comparisons	 test.	 hAMSC	 =	 human	 Adipose-tissue-derived	
Mesenchymal	Stem	Cell	(n=3	experiments	with	3	independent	donors)	;	hBMSC	=	human	Bone-marrow-derived	
Mesenchymal	Stem	Cell	(n=3	experiments	with	3	independent	donors)	;	bAC	=	bovine	Articular	Chondrocyte	(n=3	
experiments	with	3	pools	of	donors).	Per	experiment,	2	samples	were	used	for	analyses.	
  
Differentiation	versus	chondro-induction	
Using	a	xenogeneic	in-vitro	culture	system	enabled	us	to	determine	the	contribution	of	each	
individual	cell	type	(i.e.	hBMSCs,	hBMSCs	or	bACs)	to	cartilage	matrix	production	using	species-
specific	gene-expression	analyses.		
First,	GAPDH-gene	expression	was	analyzed	after	5	weeks	of	in-vitro	culture.	hAMSC/bACs	and	
hBMSC/bACs	 contained	 cells	 from	 both	 bovine	 (AC)	 and	 human	 (AMSC	 or	 BMSC)	 origin.	
(Figure	 5A)	 Then,	 chondrogenic	 gene	 expression	was	 evaluated	 by	 the	ACAN	 and	 COL2A1	
genes.	In	a	growth-factor-free	environment,	hAMSCs	and	hBMSCs	hardly	expressed	hsACAN	
and	 hsCOL2A1.	 Besides,	 chondrogenic	 genes	 were	 hardly	 expressed	 in	 hAMSC/bACs	 or	
hBMSC/bACs	either.	Conversely,	hAMSC/bACs	or	hBMSC/bACs	-	containing	solely	20%	bovine	
articular	 chondrocytes	 -	 expressed	as	much	or	 even	higher	 levels	 of	bsACAN	 compared	 to	
100%	bACs	(hAMSC/bACs	vs	bACs	p>0.05	;	hBMSC/bACs	vs	bACs	p<0.001).	hAMSC/bACs	and	
hBMSC/bACs	expressed	COL2A1,	although	gene-expression	of	hsCOL2A1	was	negligible.	This	
means	that	the	COL2A1	expressed	was	from	bovine	origin.	(Figure	5B)	These	data	indicate	that	
the	 formed	 cartilage	matrix	 was	 from	 bAC-origin,	 which	 suggests	 a	more	 trophic	 role	 for	
hMSCs	herein.		
	
Cellular	interactions	
To	further	understand	the	complex	cellular	interaction	between	hMSCs	and	bACs,	cells	were	
encapsulated	in	separate	alginate	constructs	and	co-cultured	in	a	Transwell®	system	as	well	
as	 in	 medium	 conditioned	 by	 the	 other	 cell	 type.	 (Figure	 6A	 and	 7A)	 In	 addition	 cell	
combination	were	also	cultured	in	pellets,	allowing	direct	cell-cell	contact.		
Alginate	 constructs	 containing	 solely	 bACs,	 hAMSCs	 or	 hBMSCs	 cultured	 in	 ‘basic	
medium’	maintained	their	DNA	content	over	the	3	weeks	of	culture.	Exposure	to	paracrine	
factors	of	bAC	via	Transwell®	system	or	bAC-conditioned	medium,	did	not	alter	the	amount	of	
DNA	in	alginate	constructs	seeded	with	either	hAMSCs	or	hBMSCs.	(Figure	6B)	The	presence	
of	 factors	 secreted	by	hMSC	significantly	 increased	 the	 total	 amount	of	DNA	 in	 constructs	
containing	 bACs	 (p<0.01).	 This	 effect	 was	 independent	 on	 the	 origin	 of	 the	 hMSCs	 (i.e.	
hAMSCs,	 hBMSCs)	 and	 co-culture	 system	 used	 (i.e.	 Transwell®	 system,	 hMSC-conditioned	
medium).	(Figure	7B)	This	suggests	MSC	have	paracrine	effects	on	chondrocytes.	
Alginate	 constructs	 containing	hAMSCs	or	hBMSCs,	 formed	 very	 little	 sGAG	after	 3	
weeks	 of	 culture.	 sGAG-production	 remained	 similarly	 low	 when	 hMSC-constructs	 were	
cultured	in	the	presence	of	paracrine	factors	of	bAC	via	Transwell®	system	or	bAC-conditioned	
medium.	 (Figure	 6B)	 The	 production	 of	 sGAG	 was	 higher	 in	 constructs	 containing	 bACs.	
Exposure	to	paracrine	factors	of	hMSC	significantly	increased	sGAG-production,	irrespective	
to	the	hMSC-source	used	(i.e.	hAMSCs,	hBMSCs,	p<0.01).	Since	the	amount	of	DNA	was	also	
enhanced	in	these	constructs,	sGAG	content	was	adjusted	to	the	amount	of	DNA,	still	showing	
pronounced	 differences.	 sGAG	 formation	was	 significantly	 increased	 in	 Transwell®	 system	
compared	to	constructs	cultured	with	bAC-conditioned	medium	(p<0.01).	(Figure	7B)	Similar	
trends	 were	 observed	 at	 COL2A1	 gene-expression	 level.	 (Figure	 7D)	 This	 provides	 further	
indications	that	the	effect	of	the	combination	of	hMSCs	and	bACs	on	chondrogenesis	is	due	to	
paracrine	effect	of	hMSCs	on	chondrocytes.	
	
  
	
Figure	5.	Gene-expression	analysis,	5	weeks	after	in	vitro	culture.		
Data	are	 shown	as	mean	CT-values	±	SD	of	housekeeping	genes	 (A)	 and	average	 relative	gene-expression	of	
chondrogenic	genes	(B).	nd	=	not	detected	(ct-value	>	35.00)	;	hsGAPDH	=	human-specific	GAPDH	;	bsGAPDH	=	
bovine-specific	GAPDH	;	hsACAN	=	human-specific	ACAN	;	bsACAN	=	bovine-specific	ACAN	;	hsCOL2A1	=	human-
specific	 COL2A1	 ;	hAMSC	 =	 human	 Adipose-tissue-derived	Mesenchymal	 Stem	 Cell	 (n=3	 experiments	with	 3	
independent	donors)	;	hBMSC	=	human	Bone-marrow-derived	Mesenchymal	Stem	Cell	(n=3	experiments	with	3	
independent	 donors)	 ;	 bAC	 =	 bovine	 Articular	 Chondrocyte	 (n=3	 experiments	 with	 3	 pools	 of	 donors).	 Per	
experiment,	3	samples	were	used	for	analyses.		
	
Based	 on	 previous	 results,	 we	 further	 wanted	 to	 evaluate	 signs	 of	 hypertrophy	 in	 these	
constructs,	 since	 hypertrophic	 differentiation	 is	 an	 unwanted	 phenomenon	 in	 cartilage	
regeneration.	bACs	cultured	in	‘basic	medium’	expressed	hardly	any	COL10	after	3	weeks	of	
culture.	 In	 addition,	 when	 bACs	 were	 exposed	 to	 paracrine	 factors	 of	 hMSC	 either	 via	
Transwell®	 system	or	hMSC-conditioned	medium,	COL10-gene-expression	was	upregulated	
and	significantly	increased	in	constructs	exposed	to	paracrine	factors	of	hAMSCs	(Transwell®	
system	 p=0.004	 ;	 hAMSC-conditioned	medium	 p=0.028).	 Although	 COL10-gene-expression	
was	slightly	upregulated	in	constructs	exposed	to	paracrine	factors	of	hBMSC,	no	significant	
  
differences	could	be	observed	in	comparison	with	constructs	cultured	in	‘basic	medium’	(both	
Transwell®	system	and	hBMSC-conditioned	medium	p>0.05).	(Figure	7D)	
This	indicates	that	hMSCs	have	the	ability	to	improve	cartilage	matrix	formation	in	co-
culture,	by	improving	bAC-proliferation	capacity	as	well	as	increasing	bAC-sGAG-production.	
Moreover,	when	exposed	to	paracrine	factors	of	hBMSC,	hypertrophic	differentiation	was	not	
significantly	enhanced	compared	to	untreated	bACs.	In	pellet	co-culture,	matrix	production	
was	similarly	produced	as	in	3D-alginate	constructs,	meaning	that	direct	cell-cell	contact	is	not	
required	for	co-cultures	of	hMSCs	and	bACs.	(Figure	7C)	
	
	
	
Figure	6.	Paracrine	effect	of	bACs	on	hAMSCs	and	hBMSCs.		
(A)	 Schematic	 overview.	 In	 purple:	hMSCs	 ;	 in	 green:	bACs.	 (B)	 The	DNA	 and	 sGAG	 content	 of	hAMSCs	 and	
hBMSCs	 in	the	presence	of	paracrine	factors	of	bACs	via	Transwell®	system	or	bAC-conditioned	medium.	The	
DNA	content	after	3	weeks	of	culture	was	compared	to	the	initial	DNA	content	prior	to	cell-culture	(dotted	line).	
*,	**	or	***	indicates	p-values	smaller	than	0.05,	0.01	or	0.001	respectively	compared	to	the	amount	of	DNA	
prior	 to	 cell	 culture.	 Data	 are	 shown	 as	 box-whisker	 plots	 of	 6	 samples	 of	 one	 experiment.	 For	 statistical	
evaluation,	a	Kruskal-Wallis	followed	by	the	Mann-Whitney-U	test	was	use	followed	by	a	Bonferroni's	post-hoc	
comparisons	 test.	 TW	 =	 Transwell	 ;	 CM	 =	 Conditioned	 Medium	 ;	 hAMSC	 =	 human	 Adipose-tissue-derived	
Mesenchymal	Stem	Cell	;	hBMSC	=	human	Bone-marrow-derived	Mesenchymal	Stem	Cell	;	bAC	=	bovine	Articular	
Chondrocyte.	
  
	
	
Figure	7.	Paracrine	effect	of	hAMSCs	and	hBMSCs	on	bACs.		
(A)	Schematic	overview.	In	purple:	hMSCs	;	in	green:	bACs.	(B)	The	DNA	and	sGAG	content	of	bACs	in	the	presence	
of	paracrine	 factors	of	hMSCs	via	Transwell®	system	or	hMSC-conditioned	medium.	The	DNA	content	after	3	
weeks	of	culture	was	compared	to	the	 initial	DNA	content	prior	to	cell-culture	(dotted	line).	(C)	Co-culture	 in	
alginate	constructs	and	pellet	culture,	allowing	direct	cell-cell	contact.	(D)	Relative	gene-expression	analysis,	3	
weeks	 after	 culture	 in	 alginate.	 *,	 **	or	 ***	 indicates	p-values	 smaller	 than	0.05,	 0.01	or	 0.001	 respectively	
compared	 to	 the	 amount	 of	 DNA	 prior	 to	 cell	 culture.	 #	 indicates	 significant	 differences	 from	 all	 conditions	
(p<0.01).	 Data	 are	 shown	 as	 box-whisker	 plots	 of	 6	 samples	 of	 one	 experiment.	 For	 statistical	 evaluation,	 a	
Kruskal-Wallis	followed	by	the	Mann-Whitney-U	test	was	use	followed	by	a	Bonferroni's	post-hoc	comparisons	
test.	TW	=	Transwell	;	CM	=	Conditioned	Medium	;	hAMSC	=	human	Adipose-tissue-derived	Mesenchymal	Stem	
Cell	;	hBMSC	=	human	Bone-marrow-derived	Mesenchymal	Stem	Cell	;	bAC	=	bovine	Articular	Chondrocyte.	
  
DISCUSSION		
	
Combining	chondrocytes	and	MSCs	holds	great	promise	 for	cell-based	cartilage	repair	as	 it	
reduces	 the	 required	 number	 of	 chondrocytes	 and	 diminishes	 many	 disadvantages	 of	
individually	 used	 cell	 types	 leading	 to	 enhanced	 cartilage	 matrix	 formation	 with	 low	
hypertrophic	 differentiation.	 In	 line	 with	 former	 research,	 hAMSC/bACs	 and	 hBMSC/bACs	
produced	similar	or	even	improved	quantities	of	cartilage	matrix	components	as	constructs	
containing	 bACs	 only,	 both	 in	 vitro	 and	 in	 vivo.	 Moreover,	 hypertrophic	 gene	 expression	
(COL10)	was	not	affected	by	hBMSCs,	but	slightly	enhanced	by	hAMSCs.	However,	constructs	
containing	either	hAMSC/bACs	or	hBMSC/bACs	appeared	stable	and	did	not	calcify	 in	vivo.	
This	 suggests	 that	 80%	 of	 bACs	 can	 be	 replaced	 by	 either	 hAMSCs	 or	 hBMSCs	 without	
influencing	cartilage	matrix	production	nor	stability.	Therefore,	mixed-cell-cultures	of	MSCs	
and	 chondrocytes	 could	 be	 very	 valuable	 for	 cell-based	 cartilage	 repair,	 as	 appropriate	
numbers	of	cells	are	more	easily	acquired	from	bone-marrow	aspirates	or	adipose	tissue	than	
from	cartilage	biopsies.		
The	cellular	mechanism	responsible	for	enhanced	cartilage	production	in	co-culture	is	
however	still	debated.	Numerous	cellular	communication	pathways	have	been	hypothesized	
in	 order	 to	 explain	 the	 beneficial	 effect	 in	 co-cultures	 [73].	 We	 found	 no	 evidence	 that	
cartilage	formation	was	the	consequence	of	chondrogenic	lineage	differentiation	of	hMSCs,	
as	stated	by	others	[80,	253-262].	In	contrast,	cartilage	matrix	clearly	originated	from	bACs,	
which	suggests	a	predominantly	trophic	role	for	hMSCs	in	these	constructs:	both	hAMSCs	and	
hBMSCs	improved	bAC-proliferation	as	well	as	bAC-sGAG-formation.	This	confirms	previous	
studies	were	the	co-culture	effect	has	been	ascribed	to	ACs,	whose	cartilage-forming	capacity	
and	proliferation	activity	appears	to	enhance	in	the	presence	of	MSCs.	[74,	246,	263-268]	The	
trophic	and	paracrine	function	of	MSCs	herein	appeared	essential	rather	than	MSCs	actively	
undergoing	chondrogenic	differentiation.	We	show	that	this	is	a	general	feature	that	applies	
to	both	AMSCs	and	BMSCs.		
To	date,	only	three	studies	have	compared	the	trophic	effect	of	several	MSC-sources	-	
such	as	AMSCs	and	BMSCs	-	on	ACs	in	co-culture.	[80,	246,	247]	Unfortunately,	these	studies	
demonstrate	conflicting	outcomes	and	have	never	translated	to	animal	research.	Therefore,	
to	our	knowledge,	we	are	the	first	to	systematically	compare	the	cartilage	forming	capacity	of	
either	hAMSC/bACs	and	hBMSC/bACs	 in	 vitro	and	 in	 vivo.	 In	 vitro,	hBMSC/bACs	 contained	
significantly	more	cartilage	matrix	components	than	hAMSC/bACs.	Cartilage	formation	after	8	
weeks	 of	 subcutaneous	 implantation	was,	 however,	 not	 different	 in	 constructs	 containing	
hAMSC/bACs	and	hBMSC/bACs,	although	large	donor	variations	were	observed,	in	particular	
in	hAMSC/bACs.	Our	results	support	a	general	trophic	or	immunomodulatory	role	for	hAMSCs	
and	hBMSCs	on	bACs	in	co-culture,	as	stated	by	Wu	[246]	and	Maumus	et	al	[247].	Although	
both	cell	sources	share	comparable	immunomodulatory	modalities,	they	do	not	necessarily	
behave	the	same.	In	monocultures	there	are	clear	differences	observed	between	hAMSCs	and	
hBMSCs.	 For	 instance,	 they	 possess	 distinctive	 proliferation	 capacities	 and	 a	 dissimilar	
potential	to	chondrogenically	differentiate.	[40]	Moreover,	both	cell	sources	secrete	different	
subsets	of	paracrine	factors:	compared	to	hBMSCs,	hAMSCs	secrete	significantly	more	VEGF-
D	[269],	IGF-1	[269,	270],	IL-8	[269]	and	IL-6	[269,	271],	and	significantly	less	SDF-1	[272]	and	
  
TFGβ1	[272].	In	co-cultures,	differences	between	hMSC-cell	sources	appear	less	clear.	Acharya	
et	 al.	 demonstrated	 enhanced	 chondrocyte	 proliferation	 capacity	 and	 improved	 sGAG	
formation	 in	 pellets	 containing	 hBMSC/bACs	 compared	 to	 hAMSC/bACs.	 [80]	 Besides,	 3	
independent	 co-culture	 studies	 using	 AMSCs	 only	 showed	 limited	 or	 decreased	 effects	 of	
MSCs	on	chondrogenesis.	[243-245]	Such	effect	was	hardly	seen	in	co-culture	studies	using	
BMSCs	only,	which	may	propose	that,	compared	to	BMSCs,	AMSCs	seem	less	efficient	in	co-
culture,	 Although	 we	 could	 not	 find	 a	 general	 beneficial	 effect	 of	 hBMSCs	 in	 co-cultures	
compared	 to	 hAMSCs	 in	 vitro	 and	 in	 vivo,	 we	 did	 show	 that	 in	 vitro,	 hBMSC/bACs	
outperformed	hAMSC/bACs	 and	 hypertrophic	 gene	 expression	was	 lower	 in	hBMSC/bACs.	
True	 dissimilarities	 between	hAMSCs	 and	hBMSCs	 in	 co-culture	 are	 unfortunately	 hard	 to	
expose,	 as	 hMSC-cultures	 are	 highly	 heterogeneous	 and	 distinct	 population	 subsets	 will	
probably	interfere	with	the	reciprocal	communication	pathways	in	co-culture.	Therefore,	the	
purification	of	distinct	subsets	of	hMSCs	might	enhance	the	particular	capability	of	hAMSCs	
and	hBMSCs	in	co-culture	by	eliminating	interfering	cells	with	limited	potential,	or	even	cells	
with	inhibitory	activity.	Future	research	still	needs	to	clarify	whether	the	trophic	role	of	MSCs	
in	co-culture	is	truly	a	general	MSC-characteristic	produced	by	a	distinct	subset	of	the	MSC-
population	or	dependent	on	the	original	origin	of	the	MSCs.	
Our	data	and	that	of	others	emphasize	the	importance	of	paracrine	signaling	pathways	
in	co-culture	comparatively	to	juxtacrine	or	gap-junctional	signaling.	Although	the	importance	
of	direct	cell-cell	contact	is	still	unclear	in	literature	[263],	such	signaling	pathways	remained	
less	 important	 in	our	 study,	 since	alginate	hydrogel	 impedes	direct	 cell-cell	 contact	and	 in	
pellet	culture	no	beneficial	effect	of	direct	cell-cell	contact	was	observed.	On	the	contrary,	
bACs	 produced	 less	 cartilage	matrix	 in	 Transwell®	 system	with	hMSCs	 and	 the	 amount	 of	
cartilage	matrix	was	further	reduced	in	hMSC-conditioned	medium.	Although	direct	cell-cell	
contact	seems	less	significant	than	paracrine	signaling,	it	seems	correspondingly	important	to	
secure	a	certain	cell-cell	distance	for	optimal	cell	communication.		
	 Furthermore,	for	optimal	cell	communication	and	subsequent	cartilage	regeneration,	
an	optimal	 cell	density	and	 ratio	of	MSCs	 to	ACs	 is	 imperative.	Additionally,	 for	 cell-based	
cartilage	repair,	it	would	be	ideal	to	only	use	low	numbers	of	primary	chondrocytes.	Although	
Puelacher	et	al	 already	 recommended	 cell	 densities	 greater	 than	20x106	cells	 per	milliliter	
[239],	we	could	not	increase	the	cell	seeding	density	over	4x106	cells	per	milliliter,	as	the	size	
of	our	experimental	set-up	did	not	enable	higher	densities.	Additionally,	we	have	replaced	
80%	of	 the	bACs	by	hMSCs	(at	a	4:1	ratio),	as	described	previously.	 [74,	246]	However,	no	
consensus	on	optimal	co-culture	ratios	is	yet	available.	Future	research	needs	to	clarify	if	we	
could	increase	cell	density	while	further	reduce	the	number	of	primary	chondrocytes	(increase	
the	MSC-chondrocyte-ratio)	without	inhibiting	cartilage	matrix	production	and	stability.		
The	species	mismatch	 limited	 the	 translation	of	presented	basic	 research	 to	clinical	
application.	However,	the	species	mismatch	was	chosen	to	be	able	to	discriminate	between	
the	 role	of	 the	different	 cell	 types.	We	do	not	expect	huge	differences	 in	 fully	human	co-
culture	 models,	 as	 both	 xenogeneic	 and	 autologous	 co-culture	 models	 have	 resulted	 in	
comparable	 outcomes,	 indicating	 that	 in	 both	 models	 comparable	 mechanisms	 are	 likely	
operational.	[74]	Our	results	confirmed	previously	published	results	of	hMSCs	combined	with	
  
xenogeneic	 chondrocytes.	 [74,	273-275]	Therefore,	 it	 appears	 to	be	an	excellent	model	 to	
study	cell-specific	contributions	to	tissue	formation.		
In	conclusion,	this	study	demonstrates	that	80%	of	chondrocytes	can	be	replaced	by	
either	 hAMSCs	 or	 hBMSCs	 without	 influencing	 cartilage	 matrix	 production	 nor	 stability.	
Besides,	our	results	support	a	general	trophic	role	for	hAMSCs	and	hBMSCs	on	chondrocytes	
in	co-culture	that	does	not	need	direct	cell-cell	contact.	These	data	provide	information	that	
can	be	used	to	further	optimize	cell-based	cartilage	repair.		
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Supplementary	figure	1.	Cartilage	matrix	formation	in	constructs	containing	hMSCs	and/or	
bACs,	5	weeks	after	in-vitro	culture.		
(A)	After	5	weeks,	the	DNA	content	of	constructs	containing	hBMSCs	significantly	decreased	compared	to	their	
initial	DNA	content	prior	to	cell-culture	(dotted	line).	Biochemical	evaluation	of	the	sGAG	(B)	and	collagen	(C)	
content,	5	weeks	after	culture	in	alginate.	The	left	graphs	demonstrate	the	amount	of	matrix	components	per	
construct,	whereas	for	the	right	graphs	matrix	production	is	normalized	to	the	initially	seeded	primary	ACs.	A	
control	condition	-	containing	similar	amounts	of	bACs	(0.8*106	nc/ml)	without	supplementation	of	hMSCs	-	was	
evaluated	to	determine	the	additional	effect	of	hMSCs	(3.2*106	nc/ml)	on	bACs	in	co-cultures	(dotted	line).	*,	
**	or	***	 indicates	p-values	smaller	than	0.05,	0.01	or	0.001	respectively	compared	to	the	control	condition.	
Data	are	shown	as	mean	±	SD.	For	statistical	evaluation,	a	mixed	model	was	used	followed	by	a	Bonferroni's	post-
hoc	comparisons	test.	hAMSC	=	human	Adipose-tissue-derived	Mesenchymal	Stem	Cell	(n=3	experiments	with	3	
independent	donors)	;	hBMSC	=	human	Bone-marrow-derived	Mesenchymal	Stem	Cell	(n=3	experiments	with	3	
independent	 donors)	 ;	 bAC	 =	 bovine	 Articular	 Chondrocyte	 (n=3	 experiments	 with	 3	 pools	 of	 donors).	 Per	
experiment,	3	samples	were	used	for	analyses.	
	 	
  
	 	
  
Chapter	6	
	
Cartilage	 regeneration	 in	 the	 head	 and	 neck	 area:	
Combination	 of	 ear	 or	 nasal	 chondrocytes	 and	
mesenchymal	stem	cells	improves	cartilage	production	
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ABSTRACT	
	
Cartilage	tissue	engineering	can	offer	promising	solutions	for	restoring	defected	cartilage	in	
the	head	and	neck	area	and	has	the	potential	to	overcome	limitations	of	current	treatments.	
However,	 to	 generate	 a	 construct	 of	 reasonable	 size,	 large	 numbers	 of	 chondrocytes	 are	
required,	 which	 limits	 its	 current	 applicability.	 Therefore,	 we	 evaluate	 the	 suitability	 of	 a	
combination	 of	 cells	 for	 cartilage	 regeneration:	 bone-marrow-derived	 mesenchymal	 stem	
cells	and	ear	or	nasal	chondrocytes.	
Human	bone-marrow-derived	mesenchymal	stem	cells	were	encapsulated	in	alginate	
hydrogel	 as	 single-cell-type	 populations	 or	 in	 combination	 with	 bovine	 ear	 or	 nasal	
chondrocytes	at	a	80:20	ratio.	Constructs	were	either	cultured	in	vitro	or	directly	implanted	
subcutaneously	 in	 mice.	 Cartilage	 formation	 was	 evaluated	 with	 biochemical	 and	
biomechanical	analyses.	The	use	of	a	xenogeneic	co-culture	system	enabled	the	analyses	of	
the	contribution	of	the	individual	cell	types	using	species-specific	gene-expression	analyses.	
In	vivo,	constructs	containing	a	combination	of	human	bone-marrow-derived	mesenchymal	
stem	 cells	 with	 bovine	 ear	 or	 nasal	 chondrocytes	 contained	 similar	 amounts	 of	 cartilage	
components	 to	 that	 of	 constructs	 containing	 chondrocytes	 only	 (i.e.	 bovine	 ear	 and	 nasal	
chondrocytes).	 In	 vitro,	 species-specific	 gene-expression	 analyses	 demonstrated	 that	
chondrogenic	gene	ACAN	was	expressed	by	the	chondrocytes	only,	which	suggests	a	more	
trophic	 role	 for	 human	 bone-marrow-derived	 mesenchymal	 stem	 cells.	 Furthermore,	 the	
additional	 effect	 of	 human	 bone-marrow-derived	 mesenchymal	 stem	 cells	 was	 more	
pronounced	in	combination	with	bovine	nasal	chondrocytes.	
By	supplementing	low	numbers	of	bovine	ear	or	nasal	chondrocytes	with	human	bone-
marrow-derived	mesenchymal	stem	cells,	we	were	able	to	engineer	cartilage	constructs	with	
similar	 properties	 to	 that	 of	 constructs	 containing	 chondrocytes	 only.	 This	 makes	 the	
procedure	more	feasible	for	future	applicability	in	the	reconstruction	of	cartilage	defect	in	the	
head	and	neck	area	since	less	chondrocytes	are	required.	 	
  
INTRODUCTION	
	
Cartilage	 defects	 in	 the	 head	 and	 neck	 area	 are	 a	 commonly	 encountered	 problem	 in	
reconstructive	surgery.	Currently,	these	defects	are	reconstructed	with	autologous	cartilage	
grafts	or	artificial	implants.	Although	autologous	cartilage	grafting	has	been	used	successfully,	
the	 procedure	 requires	 a	 high	 degree	 of	 surgical	 expertise,	 is	 associated	 with	 limited	
availability	of	autologous	cartilage	and	can	cause	severe	donor	site	morbidity.	Besides,	the	use	
of	artificial	implants	as	an	alternative	is	questioned	in	the	head	and	neck	area,	since	implants	
in	this	area	are	prone	to	induce	a	foreign	body	reaction	and	frequently	lead	to	extrusion.	[276]	
Cartilage	 tissue	 engineering	 (TE)	 can	 offer	 a	 promising	 solution	 for	 restoring	 missing	 or	
destructed	cartilage	and	has	the	potential	to	overcome	limitations	of	current	treatments,	re-
establishing	unique	biological	and	functional	properties	of	the	tissue.		
To	generate	a	construct	of	 reasonable	 size,	 large	numbers	of	 cells	are	 required.	Currently,	
cartilage	TE	 is	predominantly	based	on	 the	use	of	 two	distinct	 cell	 types:	 chondrocytes	or	
mesenchymal	 stem	 cells	 (MSCs).	 Each	 cell	 type	 is	 however	 associated	 with	 specific	
disadvantages.	Chondrocytes	of	several	anatomical	location	have	been	investigated	for	their	
applicability.	 [39,	40,	42,	44,	46-53,	55-60]	Yet,	 to	obtain	sufficient	numbers	of	autologous	
cells,	 culture-expansion	 seems	 an	 inevitable	 step	 in	 chondrocyte-based	 cartilage	 repair,	
resulting	 in	 generally	 more	 fibrous	 and	 mechanically	 inferior	 cartilage.	 [61]	 MSCs	 on	 the	
contrary,	are	easily	available	from	several	tissues,	can	undergo	multiple	population	doublings	
without	 losing	 their	 chondrogenic	 potential	 and	 have	 the	 capacity	 to	 differentiate	 into	
cartilage	tissue	under	appropriate	culture	conditions.	[64-68]	However,	their	use	is	currently	
debated,	as	the	formed	cartilage	tissue	is	unstable	and	predisposed	for	tissue	mineralisation	
and	ossification	in	vivo.	[69-72]	Taken	together,	the	individual	use	of	chondrocytes	or	MSCs	is	
at	present	not	ideal	for	cell-based	cartilage	repair	in	the	head	and	neck	area.		
At	present,	the	combination	of	both	cell	sources	holds	great	promise	for	cartilage	TE	
as	 it	 reduces	 the	 required	number	of	 chondrocytes	and	extenuates	most	disadvantages	of	
both	individual	cell	types.	Contiguous	thereto,	mixed-cell	cultures	of	chondrocytes	and	MSCs	
have	been	demonstrated	to	improve	chondrogenesis	[74]	as	well	as	to	reduce	hypertrophy	
and	tissue	mineralization	[73,	75].	Moreover,	by	decreasing	the	amount	of	chondrocytes	(≤	
20%	of	the	total	cell	mixture),	culture-expansion	is	no	longer	necessary,	which	allows	the	use	
of	 freshly	 isolated	 primary	 chondrocytes	 leading	 to	 improved	 cartilage	 formation.	 [76]	
Moreover,	 by	 using	 primary	 cells,	 the	 procedure	 is	more	 translatable	 towards	 a	 one-step	
clinical	application.		
To	date,	most	research	on	mixed-cell-based	cartilage	repair	has	been	performed	with	
chondrocytes	obtained	from	articular	cartilage.	So	far,	little	research	was	executed	on	mixed-
cell	 cultures	 of	 MSCs	 and	 non-articular	 chondrocytes,	 such	 as	 ear	 (ECs)	 [77-79]	 or	 nasal	
chondrocytes	(NCs)	[80].	Nonetheless,	the	translation	of	such	basic	research	into	a	one-step	
clinical	 application	 is	 yet	 unfeasible.	 Primarily	 as	 these	 studies	 made	 use	 of	 non-optimal	
culture	 conditions,	 such	 as	 the	 use	 of	 culture-expanded	 chondrocytes	 [77,	 78,	 80],	 or	 the	
paradoxical	use	of	additional	growth	factors	 [77,	80].	Moreover,	only	 few	studies	have	yet	
evaluated	the	cartilage-forming	capacity	of	MSC/ECs	[77,	79]	and	MSC/NCs	(none)	in	vivo.	In	
an	attempt	to	translate	experimental	research	towards	a	one-stage	cell-based	cartilage	repair	
  
procedure	for	cartilage	defects	in	the	head	and	neck	area,	the	in-vitro	and	in-vivo	capacity	of	
bone-marrow-derived	MSCs	mixed	with	primary	ECs	or	NCs	were	studied.	The	formation	of	
functional	 and	 stable	 non-mineralised	 cartilage	 was	 evaluated,	 along	 with	 the	 relative	
contribution	of	each	individual	cell	population	(i.e.	chondrocytes,	MSCs)	to	mixed-cell-based	
cartilage	repair.	
	
	
  
MATERIALS	AND	METHODS	
	
Chemicals	were	obtained	from	Sigma-Aldrich,	USA	unless	stated	otherwise.	
	
Cell	sources	
To	 obtain	 primary	 bovine	 chondrocytes	 from	 ear	 (bECs)	 and	 the	 cartilaginous	 part	 of	 the	
nasoseptal	 (bNCs)	 origin,	 macroscopically	 intact	 cartilage	 was	 harvested	 from	 calves	 ≤	 6	
months	old,	and	washed	with	saline	after	careful	resection	of	the	perichondrium	(n=3	pools	
of	 3	 donors).	 To	 isolate	 cells,	 cartilage	 pieces	 were	 incubated	 for	 1	 hour	 with	 2	 mg/mL	
protease,	followed	by	overnight	incubation	with	1.5	mg/mL	collagenase	B	(Roch	Diagnostics,	
Germany)	 in	 Dulbecco's	 Modified	 Eagle's	 Medium	 (DMEM;	 Gibco,	 USA).	 Non-expanded	
primary	chondrocytes	were	harvested	and	directly	cultured	in	3D-alginate	hydrogel.		
Human	bone-marrow-derived	mesenchymal	stem	cells	 (hBMSCs)	were	 isolated	from	bone-
marrow	heparinized	aspirates,	after	informed	consent	had	been	acquired	and	with	approval	
of	the	local	Medical	Ethics	Committee	(MEC-2004-142	and	Albert	Schweitzer	Hospital	2011/7)	
(n=3:	M	 67Y;	 F	 75Y;	M	 22Y)	 and	 seeded	 and	 cultured	 overnight	 in	medium	 consisting	 of	
Minimum	Essential	Medium	Alpha	(MEM-α;	Gibco),	supplemented	with	fetal	calf	serum,	L-
ascorbic	acid	2-phosphate,	and	1	ng/mL	basic	Fibroblast	Growth	Factor	2	(bFGF2;	AbD	Serotec,	
UK).	Second-passaged	cells	were	harvested	and	cultured	in	3D-alginate	hydrogel.		
	
Chondrogenesis	
For	3D-alginate	culture,	cells	were	suspended	at	a	density	of	4x106	cells/mL	in	clinical	grade	
1.1%	low	viscosity	alginate	solution	dissolved	in	0.9%	NaCl	(Batch	MG-004,	CellMed,	Germany)	
as	 single-cell-type	 populations	 or	 as	 combination	 of	 80%	hBMSCs	 and	 20%	bECs	 or	bNCs.	
(Table	1)		 	
	
	
	 Human	stem	cells	 Bovine	chondrocytes	
	 	 	
	 Source	 Cell	 density	(x106)	 Source	
Cell	 density	
(x106)	
hBMSC	 hBMSCs	 4	nc/mL	 x	 x	
bEC	 x	 x	 bECs	 4	nc/mL	
bNC	 x	 x	 bNCs	 4	nc/mL	
hBMSC/bEC	 hBMSCs	 3.2	nc/mL	 bECs	 0.8	nc/mL	
hBMSC/bNC	 hBMSCs	 3.2	nc/mL	 bNCs	 0.8	nc/mL	
Control	bEC	 x	 x	 bECs	 0.8	nc/mL	
Control	bNC	 x	 x	 bNCs	 0.8	nc/mL	
	
Table	1.	Construct	conditions.	
Cell	density	is	displayed	as	the	number	of	cells	(nc)	in	1	milliliter	of	alginate.	hBMSCs	=	human	Bone-marrow-
derived	Mesenchymal	Stem	Cells	;	bECs	=	bovine	Ear	Chondrocytes	;	bNCs	=	bovine	Nasal	Chondrocytes.	
	
  
Flat	constructs	(8	mm	diameter;	2	mm	height)	were	processed	as	previously	described.	[40]	
Constructs	were	either	cultured	in	vitro	or	directly	implanted	subcutaneously	in	mice.	In-vitro	
culture	was	performed	for	either	three	or	five	weeks	in	growth-factor-free	medium	consisting	
of	 DMEM	 supplemented	 with	 sodium	 pyruvate	 (Gibco),	 L-proline,	 supplemented	 Insulin	
Transferrine	 Selenium	 (B&D	 Bioscience,	 USA),	 dexamethasone,	 and	 L-ascorbic	 acid	 2-
phosphate.	Medium	was	changed	twice	a	week.	After	three	and	five	weeks,	constructs	were	
processed	for	biochemical	and	gene-expression	analysis.	
For	in-vivo	studies,	a	total	number	of	sixteen	nine-week-old	female	NMRI	nu/nu	mice	
(Charles	River	Laboratories,	the	Netherlands)	were	used.	Two	separate	incisions	were	made	
along	 the	central	 line	of	 the	spine,	after	which	 four	separate	subcutaneous	dorsal	pockets	
were	prepared	by	blunt	dissection.	After	eight	weeks,	animals	were	terminated	and	samples	
were	explanted	for	histological,	biomechanical	and	biochemical	analyses.	Animal	experiments	
were	carried	out	with	approval	of	the	Animal	Ethical	Committee	(EMC	2429).	
	
Biochemical	evaluation	of	the	extracellular	matrix	
Alginate	constructs	were	digested	overnight	at	56oC	in	papain	(250	μg/mL	in	0.2	M	NaH2PO4,	
0.01	M	EDTA,	containing	5	mM	L-cystein;	pH	6.0).	After	digestion,	samples	were	subjected	to	
biochemical	analyses	to	determine	the	DNA,	glycosaminoglycan	(GAG),	and	hydroxyproline	
contents,	 as	 described	 previously.	 [40]	 In	 short,	 the	 amount	 of	 DNA	 was	 determined	 by	
Ethidium	bromide	(GibcoBR1),	using	calf	thymus	DNA	as	a	standard.	Sulfated	GAGs	(sGAGs)	
were	 quantified	 by	 the	 1,9-Dimethylmethylene	blue	 (DMMB)	 dye-binding	 assay	 (pH	1.75),	
using	shark	chondroitin	sulphate	C	as	a	standard.	For	the	hydroxyproline	content,	digests	were	
hydrolysed,	dried	and	redissolved	in	150	µL	water.	Hydroxyproline	contents	were	measured	
using	chloramine-T	and	dimethylaminobenzaldehyde	as	reagents	and	hydroxyproline	(Merck,	
Germany)	as	a	standard.	
	
Histological	evaluation	of	the	extracellular	matrix	
After	 eight	 weeks	 of	 subcutaneous	 implantation,	 constructs	 were	 harvested,	 set	 in	 2%	
agarose,	fixed	in	4%	formalin	in	PBS	and	embedded	in	paraffin.	Paraffin-embedded	sections	
(6	μm)	were	deparaffinised	and	rehydrated.		
To	 allow	 the	 use	 of	 monoclonal	 mouse	 antibody	 collagen	 type	 II	 (II-II6B3	 1:100;	
Developmental	Studies	Hybridoma	Bank,	USA)	on	constructs	which	had	been	 implanted	 in	
mice,	 the	primary	 antibody	was	pre-coupled	overnight	with	 goat	 anti-mouse	biotin	 at	 4oC	
(1:500;	Jackson	Laboratories,	USA),	followed	by	a	two-hour	incubation	in	0.1%	normal	mouse	
serum	(CLB,	the	Netherlands),	to	prevent	unwanted	binding	of	the	anti-mouse	antibodies	to	
mouse	immunoglobulins.	[214]		
Antigen	retrieval	was	performed	through	incubation	with	0.1%	pronase	for	30	minutes	
at	37oC,	continued	with	a	30	minutes	incubation	with	1%	hyaluronidase	at	37oC.	Non-specific	
binding	 sites	were	 blocked	with	 10%	 goat	 serum	and	 sections	were	 stained	with	 the	 pre-
treated	antibodies	 for	60	minutes.	Sections	were	than	 incubated	with	enzyme-streptavidin	
conjugate	(Label,	1:100,	Biogenex,	HK-321-UK,	USA)	in	PBS/1%	BSA,	followed	by	incubation	
with	Neu	Fuchsin	substrate	(Chroma,	Germany).		
	 	
  
Biomechanical	analysis	
For	mechanical	 characterization,	 constructs	 of	 2.0	mm	 thick	 and	 5	mm	 in	 diameter	 were	
created.	 The	 samples	were	 placed	 in	 close-fitting	Ø	 5	mm	 stainless	 steel	 cylindrical	wells.	
Mechanical	testing	was	performed	with	a	materials	testing	machine	(Zwick	Z005,	Germany)	
equipped	with	a	10	N	load	cell,	a	built-in	displacement	control,	and	a	cylindrical,	plane-ended,	
stainless	steel	 indenter	(Ø	1.2	mm).	Stress-strain	testing	was	performed:	the	samples	were	
compressed	to	a	final	height	of	0.5	mm	at	a	loading	rate	of	5	mm	per	minute.	An	in-house	
Matlab®	 script	was	 used	 to	 locate	 the	 sample	 surface	 and	measure	 the	 sample	 thickness.	
Force-displacement	 curves	were	 then	 converted	 to	 stress-strain	 curves.	Measurements	 of	
compressive	modulus	at	40%	strain	(E40%)	were	determined.	
	
Gene-expression	analyses	
To	further	evaluate	the	contribution	of	each	individual	cell	type	(i.e.	hBMSCs,	bECs	or	bNCs)	
to	 cartilage	matrix	 formation,	 species-specific	 gene-expression	 analyses	was	 achieved.	 For	
total	RNA	isolation,	alginate	was	dissolved	in	ice-cold	55	mM	sodium	citrate	and	20	mM	EDTA	
in	150	mM	NaCl	and	centrifuged.	Each	cell-pellet	was	subsequently	suspended	in	1	mL	RNA-
BeeTM	 (TEL-TEST,	 USA).	 RNA	 was	 extracted	 with	 chloroform	 and	 purified	 from	 the	
supernatant	using	the	RNAeasy	Micro	Kit	(Qiagen,	Germany)	according	to	the	manufacturer’s	
guidelines	by	on-column	DNA-digestion.	Total	RNA	of	each	sample	was	reverse	transcribed	
into	cDNA	using	RevertAidTM	First	Strand	cDNA	Synthesis	Kit	(MBI	Fermentas,	Germany).	
For	quantitative	real-time	Polymerase	Chain	Reaction	(qRT-PCR)	analysis,	forward	and	
reverse	primers	were	designed	using	PrimerExpress	2.0	software	(Applied	Biosystems,	USA)	
to	meet	TaqMan	or	SYBR	Green	requirements.	Analysed	genes	are	listed	in	table	2.	RT-PCR	
was	 performed	 using	 TaqMan®	 Universal	 PCR	 Mastermix	 (Applied	 Biosystems)	 or	 qPCR	
Mastermix	 Plus	 for	 SYBR	 Green	 (Eurogentec,	 the	 Netherlands)	 according	 to	 the	
manufacturers’	guidelines	and	using	ABIPRISM®	7000	with	SDS	software	version	1.7	(Applied	
Biosystems,	the	Netherlands).	Relative	gene	expressions	were	calculated	by	means	of	the	2-
ΔΔCT	formula.		
	
Statistical	analysis	
All	data	were	analyzed	with	PSAW	statistics	20.0	 (SPSS	 Inc.,	USA).	The	mean	and	standard	
deviation	were	 presented.	 In-vitro	data	 represents	 at	 least	 three	 independent	 donors	 per	
condition	 performed	 in	 triplicate.	 For	 statistical	 evaluation	 of	 these	experiments,	 a	mixed	
linear	 model	 was	 used	 followed	 by	 Fisher's	 least	 significant	 post-hoc	 comparisons	 tests.	
‘Condition’	and	‘time	point’	were	defined	as	fixed	factors	in	the	model.	‘Donor’	and	‘sample	
number’	 were	 treated	 as	 random	 factors.	 For	 the	 in-vivo	 experiments	 six	 constructs	 per	
condition	were	 used,	with	 duplicate	 samples	 for	 three	 independent	 donors.	 For	 statistical	
evaluation	 of	 these	 experiments,	 one-way	 ANOVA	 was	 used	 followed	 by	 Fisher's	 least	
significant	 difference	 post-hoc	 comparisons	 tests.	 For	 all	 tests,	 values	 of	 p<0.05	 were	
considered	statistically	significant.	
	
	
	 	
  
Primers	and	probes	
	
Human	specific	genes	
hsGAPDH	 Fw:	AGCTCACTGGCATGGCCTTC	
	 Rev:	CGCCTGCTTCACCACCTTCT	
hsACAN	 Fw:	CAGCCACCACCTACAAACGCAG	
	 Rev:	CTGGGTGGGATGCACGTCAGC	
	 	
Bovine	specific	genes	
bsGAPDH	 Fw:	GTCAACGGATTTGGTCGTATTGGG	
	 Rev:	TGCCATGGGTGGAATCATATTGG	
bsACAN	 Fw:	GGACACTCCTTGCAATTTGAGAA	
	 Rev:	CAGGGCATTGATCTCGTATCG	
	
Table	2.	Sequences	of	primers	and	probes	for	qRT-PCR.	
GAPDH	=	GlycerAldehyde	3-Phosphate	DeHydrogenase	;	ACAN	=	Aggrecan	;	hs	=	human-specific	;	bs	=	bovine-
specific.	
	
	
  
RESULTS	
	
Cartilage	formation	in	vitro	
After	 three	weeks,	DNA	content	 significantly	decreased	over	 time	 in	 constructs	 containing	
hBMSCs	(p=0.019),	bECs	(p=0.010)	or	hBMSC/bECs	(p<0.001),	though	remained	stable	in	bNCs	
or	hBMSC/bNCs.	(Figure	1)	Similar	results	were	obtained	after	5	weeks.	(Supplementary	figure	
1)	
	
	
	
Figure	1.	Cell	content	of	constructs	containing	hBMSCs	and/or	chondrocytes,	3	weeks	after	
in-vitro	culture.		
DNA	content	was	determined	at	baseline	before	culture	(dotted	line),	being	on	average	4.29	±	0.96	μg	DNA	per	
construct,	and	after	3	weeks	of	culture.	*	indicates	a	p-value	smaller	than	0.05	compared	to	baseline.	Data	are	
shown	as	mean	±	SD.	For	statistical	evaluation,	a	mixed	model	was	used	followed	by	a	Fisher’s	least	significant	
post-hoc	comparisons	test.	hBMSC	=	human	Bone-marrow-derived	Mesenchymal	Stem	Cell	 (n=3	experiments	
with	3	different	donors)	;	bEC	=	bovine	Ear	Chondrocyte	(n=3	experiments	with	3	pools	of	donors)	;	bNC	=	bovine	
Nasal	Chondrocyte	(n=3	experiments	with	3	pools	of	donors).	Per	experiment,	3	samples	were	used	for	analyses.	
	
	
Since	constructs	were	cultured	in	the	absence	of	chondrogenic	factors,	constructs	containing	
solely	hBMSCs	produced	very	little	sGAG	(Figure	2A)	and	collagen	(Figure	2B).	To	demonstrate	
the	 additional	 effect	 of	 hBMSCs	 in	 mixed-cell-type	 populations,	 a	 control	 condition	 -	
containing	similar	numbers	of	chondrocytes	without	the	supplementation	of	hBMSCs	-	was	
evaluated	 (Figure	 2	 white	 lines).	 The	 additional	 effect	 of	 hBMSCs	 in	 mixed-cell-type	
populations	was	dependent	on	the	chondrocyte-source	used:	the	addition	of	hBMSCs	to	bNCs	
demonstrated	 a	 significant	 increase	 in	 the	 production	 of	 sGAG	 (p=0.012)	 and	 collagen	
(p=0.007)	compared	to	their	controls	;	no	additional	effects	were	observed	in	hBMSCs/bECs.	
hBMSC/bNCs	contained	significantly	more	sGAG	(p=0.026)	and	collagen	(p=0.040)	compared	
to	 hBMSC/bECs.	 Normalization	 of	 the	 data	 to	 their	 initial	 number	 of	 seeded	 primary	
chondrocytes	 (PCs)	 revealed	more	distinct	differences	between	mixed-cell-type	and	single-
cell-type	populations:	hBMSCs/bECs	 and	hBMSC/bNCs	produced	more	 cartilage	matrix	per	
initial	 seeded	 chondrocyte	 than	 chondrocytes	 only.	 (Figure	 2,	 right)	 Similar	 results	 were	
  
obtained	after	5	weeks.	(Data	not	shown)	These	results	demonstrate	that	hBMSCs	have	an	
additional	 effect	 on	 chondrocytes	 in	 mixed-cell-type	 populations	 in	 vitro,	 in	 particular	 in	
combination	with	bNCs.		
	
	
	
	
	
Figure	2.	Cartilage	matrix	formation	in	constructs	containing	hBMSCs	and/or	chondrocytes,	
3	weeks	after	in-vitro	culture.	
Biochemical	evaluation	of	the	sGAG	(A)	and	collagen	(B)	content,	3	weeks	after	culture	in	alginate.	The	left	graphs	
demonstrate	the	amount	of	matrix	components	per	construct,	whereas	for	the	right	graphs	matrix	production	is	
normalized	to	the	initial	number	of	seeded	PCs.	A	control	condition	-	containing	similar	amounts	of	chondrocytes	
(0.8	million/ml)	 without	 supplementation	 of	 hBMSCs	 -	 was	 evaluated	 to	 determine	 the	 additional	 effect	 of	
hBMSCs	(3.2	million/ml)	on	chondrocytes	in	co-cultures	(white	line).	*,	**	or	***	indicates	p-values	smaller	than	
0.05,	0.01	or	0.001	respectively	compared	to	the	control	condition.	Data	are	shown	as	mean	±	SD.	For	statistical	
evaluation,	 a	mixed	model	was	used	 followed	by	 a	 Fisher’s	 least	 significant	post-hoc	 comparisons	 test.	 PC	=	
Primary	Chondrocyte	;	hBMSC	=	human	Bone-marrow-derived	Mesenchymal	Stem	Cell	(n=3	experiments	with	3	
different	donors)	;	bEC	=	bovine	Ear	Chondrocyte	(n=3	experiments	with	3	pools	of	donors)	;	bNC	=	bovine	Nasal	
Chondrocyte	(n=3	experiments	with	3	pools	of	donors).	Per	experiment,	3	samples	were	used	for	analyses.		
	
	 	
  
Cell	behavior	in	co-cultures	
Using	a	xenogeneic	culture	system	enabled	us	to	determine	the	contribution	of	each	individual	
cell	 type	 (i.e.	hBMSCs,	bECs	 or	bNCs)	 to	 cartilage	matrix	 production	 using	 species-specific	
gene-expression	analyses.	 First,	GAPDH-gene	expression	was	analysed	after	5	weeks	of	 in-
vitro	culture.	hBMSC/bECs	and	hBMSC/bNCs	contained	cells	from	both	bovine	(EC	or	NC)	and	
human	 (BMSC)	 origin.	 (Table	 3)	 Then,	 chondrogenic	 gene	 expression	was	 analysed	 by	 the	
ACAN-gene.	In	a	growth-factor-free	environment,	hBMSCs	hardly	expressed	hsACAN.	Besides,	
hsACAN	 was	 hardly	 expressed	 in	 hBMSC/bECs	 or	 hBMSC/bNCs	 either.	 Conversely,	
hBMSC/bECs	 or	hBMSC/bNCs	 -	 containing	 solely	 20%	 bovine	 chondrocytes	 -	 expressed	 as	
much	or	even	higher	levels	of	bsACAN	compared	to	their	100%	controls:	hBMSC/bECs	vs	bECs	
3.96	±	6.13	fold	change;	hBMSC/bNCs	vs	bNCs	4.56	±	6.18	fold	change.	These	data	indicate	
that	the	formed	cartilage	matrix	was	from	chondrocyte	origin,	which	suggests	a	more	trophic	
role	for	hBMSCs	herein.	
	
		
	 hsGAPDH	 bsGAPDH	
	 	 	
hBMSC	 24.1	±	2.78	 nd	
bEC	 nd	 25.0	±	2.4	
bNC	 nd	 23.4	±	1.7	
hBMSC/bEC	 24.0	±	1.7	 26.0	±	2.7	
hBMSC/bNC	 24.8	±	1.7	 25.1	±	2.4	
	
Table	3.	Gene-expression	analyses,	5	weeks	after	in	vitro	culture.	
Data	are	shown	as	mean	CT-values	±	SD	of	housekeeping	genes.	nd	=	not	detected	(ct-value	>	35.00)	;	hsGAPDH	
=	 human-specific	 GAPDH	 ;	 bsGAPDH	 =	 bovine-specifiec	 GAPDH	 ;	 hBMSC	 =	 human	 Bone-marrow-derived	
Mesenchymal	 Stem	 Cell	 (n=3	 experiments	 with	 3	 different	 donors)	 ;	 bEC	 =	 bovine	 Ear	 Chondrocyte	 (n=3	
experiments	with	3	pools	of	donors)	;	bNC	=	bovine	Nasal	Chondrocyte	(n=3	experiments	with	3	pools	of	donors).	
Per	experiment,	3	samples	were	used	for	analyses.	
	
	
Cartilage	formation	in	vivo	
After	 8	 weeks	 of	 implantation	 all	 constructs	 were	 identified	 and	 harvested.	 Constructs	
containing	bNCs	or	hBMSC/bNCs	resembled	cartilage	tissue	in	both	color	and	texture,	while	
constructs	containing	hBMSCs,	bECs	or	hBMSC/bECs	were	still	fragile	and	did	not	express	a	
cartilaginous	appearance.	(Figure	3)	After	subcutaneous	implantation,	none	of	the	constructs	
had	mineralized	or	ossified.	Collagen	type	II	was	abundantly	present	in	constructs	containing	
bEC	or	bNCs	 (both	 single-cell-type	and	mixed-cell-type	populations),	but	was	not	visible	 in	
constructs	containing	hBMSCs	only.	(Figure	3).		
In	vivo,	hBMSC/bECs	and	hBMSC/bNCs	contained	similar	quantities	of	cartilage	matrix	
as	 constructs	 containing	 chondrocytes	only.	Moreover	 hBMSC/bNCs	produced	 significantly	
more	 sGAG	 (p=0.004)	 compared	 to	 hBMSC/bECs.	 (Figure	 4A)	 Collagen	 production	
demonstrated	 a	 similar	 trend,	 albeit	 without	 statistical	 significant	 differences.	 (Figure	 4B)	
Normalization	 of	 the	 data	 to	 their	 initial	 number	 of	 seeded	 PCs	 revealed	 more	 distinct	
  
differences	between	mixed-cell-type	and	single-cell-type	populations:	hBMSC/bNCs	produced	
significantly	more	sGAG	and	collagen	per	initial	seeded	PC	compared	to	bNCs	and	hBMSC/bECs	
(p<0.05).	(Figure	4,	right)		
After	 subcutaneous	 implantation,	 the	 elastic	 modulus	 was	 highest	 in	 constructs	
containing	bNCs,	although	large	variation	between	samples	was	observed.	(Figure	5)	
	
	
	
Figure	3.	Cartilage	matrix	formation	in	constructs	containing	hBMSCs	and/or	chondrocytes,	
8	weeks	after	subcutaneous	implantation	in	mice.	
Macroscopic	appearance	 (top	row)	of	cartilage	constructs,	as	well	as	a	collagen	type	 II	 immunohistochemical	
staining	 (bottom	 row),	 8	 weeks	 after	 subcutaneous	 implantation.	 hBMSC	 =	 human	 Bone-marrow-derived	
Mesenchymal	 Stem	 Cell	 (n=2	 experiments	 with	 2	 different	 donors)	 ;	 bEC	 =	 bovine	 Ear	 Chondrocyte	 (n=2	
experiments	with	3	pools	of	donors)	;	bNC	=	bovine	Nasal	Chondrocyte	(n=2	experiments	with	3	pools	of	donors).	
Per	experiment,	2	samples	were	used	for	analyses.		
	
  
	
	
Figure	4.	Cartilage	matrix	formation	in	constructs	containing	hBMSCs	and/or	chondrocytes,	
8	weeks	after	subcutaneous	implantation	in	mice.	
Biochemical	evaluation	of	the	sGAG	(A)	and	collagen	(B)	content,	8	weeks	after	subcutaneous	implantation.	The	
left	graphs	demonstrate	the	amount	of	matrix	components	per	construct,	whereas	for	the	right	graphs	matrix	
production	is	normalized	to	the	initial	number	of	seeded	PCs.	Data	are	shown	as	box-whisker	plots.	For	statistical	
evaluation,	a	one-way	ANOVA	was	used	followed	by	a	Fisher's	least	significant	difference	post-hoc	comparisons	
test.	 PC	 =	 Primary	 Chondrocyte	 ;	 hBMSC	 =	 human	 Bone-marrow-derived	 Mesenchymal	 Stem	 Cell	 (n=2	
experiments	with	2	different	donors)	;	bEC	=	bovine	Ear	Chondrocyte	(n=2	experiments	with	3	pools	of	donors)	;	
bNC	=	bovine	Nasal	Chondrocyte	(n=2	experiments	with	3	pools	of	donors).	Per	experiment,	2	samples	were	used	
for	analyses.		
	
	
	
	
	
	
	
	
	 	
  
	
Figure	5.	Biomechanical	behavior	in	constructs	containing	hBMSCs	and/or	chondrocytes,	8	
weeks	after	subcutaneous	implantation	in	mice.	
Biomechanical	properties	were	determined	8	weeks	after	subcutaneous	implantation.	Data	are	shown	as	box-
whisker	plots.	PC	=	Primary	Chondrocyte	;	hBMSC	=	human	Bone-marrow-derived	Mesenchymal	Stem	Cell	(n=2	
experiments	with	2	different	donors)	;	bEC	=	bovine	Ear	Chondrocyte	(n=2	experiments	with	3	pools	of	donors)	;	
bNC	=	bovine	Nasal	Chondrocyte	(n=2	experiments	with	3	pools	of	donors).	Per	experiment,	2	samples	were	used	
for	analyses.		
	
  
DISCUSSION	
	
The	combination	of	chondrocytes	and	MSCs	holds	great	promise	for	cell-based	cartilage	repair	
in	the	head	and	neck	area	as	it	reduces	the	required	number	of	chondrocytes	and	extenuates	
most	disadvantages	of	individually	used	cell	types	such	as	culture-expanded	chondrocytes	or	
MSCs.	Mixed-cell	cultures	have	been	demonstrated	to	improve	chondrogenesis	[74]	as	well	as	
to	reduce	hypertrophy	and	tissue	mineralization	 [73,	75].	Unfortunately,	most	 research	on	
mixed-cell-based	 cartilage	 repair	 was	 performed	with	 articular	 chondrocytes.	 So	 far,	 little	
research	in	this	field	has	been	performed	on	non-articular	chondrocytes,	such	as	ECs	[77-79]	
or	NCs	[80].	This	study	evaluates	the	two	most	relevant	cell	sources	for	cell-based	cartilage	
repair	in	the	head	and	neck	area	-	ECs	and	NCs	-	and	replaced	80%	of	the	chondrocytes	with	
hBMSCs.	 In	 line	with	previous	studies	on	mixed-cell-based	cartilage	repair,	hBMSC/bECs	or	
hBMSC	 /bNCs	 produced	 similar	 quantities	 of	 cartilage	 matrix	 components	 as	 constructs	
containing	chondrocytes	only.	Moreover,	the	cartilage	tissue	formed	seemed	stable	and	did	
not	calcify	 in	vivo.	This	suggests	that	80%	of	the	chondrocytes	can	be	replaced	by	hBMSCs	
without	 influencing	 cartilage	matrix	 production	 and	 stability.	 Therefore,	mixed	 cultures	 of	
BMSCs	and	ECs	or	NCs	could	be	very	advantageous	for	cell-based	cartilage	repair	in	the	head	
and	neck	area,	as	appropriate	numbers	of	cells	are	more	easily	acquired	from	bone-marrow	
aspirates	than	from	cartilage	biopsies.		
By	using	primary	 cells,	we	aimed	 to	 translate	 the	procedure	 towards	a	 single-stage	
clinical	 application.	 Currently,	 for	 articular	 cartilage	 repair,	 two	 clinical	 trials	 are	 already	
designed	as	single-stage	procedures.	[277,	278]	Unfortunately,	the	little	research	performed	
on	mixed-cell	cultures	using	BMSCs	and	ECs	[77-79]	or	NCs	[80],	impeded	the	translation	of	
such	 basic	 research	 to	 a	 clinical	 application,	 since	 these	 studies	made	 use	 of	 non-optimal	
culture	conditions.	First,	 instead	of	using	primary	chondrocytes,	most	research	[77,	78,	80]	
was	performed	with	culture-expanded	chondrocytes,	which	requires	a	two-stages	procedure:	
(1)	 a	 surgical	 procedure	 to	 harvest	 cartilage	 tissue	 for	 chondrocyte	 isolation	 and	 further	
culture-expansion	;	(2)	a	surgical	procedure	to	implant	the	cell-based	cartilage	graft.	Second,	
others	 have	 cultured	 their	 constructs	 in	 growth-factor-enriched	 medium.	 [77,	 80]	 Since	
growth	factors	stimulate	the	re-differentiation	and	differentiation	of	both	culture-expanded	
chondrocytes	 and	BMSCs,	 the	 use	 of	 growth	 factors	might	 have	 interfered	 the	 underlying	
mechanisms	of	cell-cell	interaction	in	their	culture	system.	Moreover,	clinical	use	of	growth	
factors	is	limited	by	the	problem	of	adequate	delivery	[279]	and	the	requirement	of	special	
regulatory	 approval	 by	 the	 Food	 and	Drug	Administration	or	 European	Medicines	Agency.	
Finally,	so	far	only	few	studies	have	evaluated	the	cartilage-forming	capacity	of	BMSC/ECs	[77,	
79]	and	BMSC/NCs	(none)	in	vivo.	Therefore,	in	an	attempt	to	translate	experimental	research	
towards	a	single-stage	clinical	application	in	the	future,	we	have	studied	the	in-vitro	and	in-
vivo	capacity	of	hBMSCs	mixed	with	primary	bECs	or	bNCs	cultured	 in	a	growth-factor-free	
environment.	
We	 made	 use	 of	 a	 xenogeneic	 culture	 system	 (i.e.	 bovine	 chondrocytes,	 human	
BMSCs).	 The	 species	 mismatch	 did	 not	 impede	 cartilage	 formation	 confirming	 previously	
published	 results	 of	 hBMSCs	 combined	 with	 xenogeneic	 chondrocytes.	 [74,	 273-275]	
Moreover,	 by	making	use	of	 a	 xenogeneic	 culture	 system	we	were	 able	 to	 determine	 the	
  
contribution	of	each	individual	cell	type	to	cartilage	matrix	production	using	species-specific	
gene-expression	analyses.	In	this	way,	we	proved	that	cartilage	matrix	formation	originated	
from	bovine	chondrocytes	and	that	hBMSCs	fulfilled	a	trophic	role	herein.	Although	numerous	
cellular	communication	pathways	have	been	hypothesized	in	order	to	explain	beneficial	effect	
of	mixed	cultures	[73],	this	outcome	was	in	accordance	with	previous	studies,	investigating	
the	effect	of	MSCs	on	articular	chondrocytes.	[74,	263,	275,	280]	We	found	no	evidence	that	
paracrine	 soluble	 factors	 released	 by	 chondrocytes	 enhanced	 the	 chondrogenic	
differentiation	 of	 hBMSCs,	 as	 stated	 by	 others.	 [255-259]	 Although	 the	 importance	 of	
juxtacrine	 or	 gap-junctional	 signalling	 is	 still	 unclear	 in	 literature	 [263],	 our	 mixed	 cells	
encapsulated	 in	 alginate	 hydrogels	 implicated	 that	 such	 signaling	 pathways	 are	 of	 less	
importance	than	paracrine	signaling	pathways,	since	the	alginate	hydrogel	hinders	direct	cell-
cell	contact.		
Besides	 the	 trophic	 effect	 of	 hBMSCs	 on	 chondrocytes	 we	 demonstrated	 that	 this	
effect	 was	 also	 depended	 on	 the	 chondrocyte	 source	 used.	 The	 differences	 between	 the	
chondrocyte	 sources	 was	 most	 obvious	 in	 the	 in-vitro	 experiments:	 bNCs	 were	 clearly	
stimulated	by	hBMSCs,	while	bECs	were	not	at	all	 influenced	by	them.	Although	the	 in-vivo	
experiments	showed	a	positive	effect	of	hBMSCs	on	both	bECs	and	bNCs,	it	was	obvious	that	
the	use	of	bNCs	 lead	to	constructs	with	a	higher	amount	of	sGAG	and	collagen	and	higher	
equilibrium	 modulus	 than	 bECs.	 Clear	 subtype-specific	 differences	 in	 cartilage	 forming	
potential	is	in	accordance	with	our	previously	published	work,	confirming	that	ECs	and	NCs	
have	 unique	 gene-expression	 profiles	 inducing	 dissimilar	 proliferation	 capacity,	 cartilage	
matrix	formation	and	elastin	fiber	deposition.	[40,	56]		
Before	this	method	can	be	successfully	applied	as	a	one-step	clinical	application,	there	
are	some	limitations	to	overcome.	First,	the	elastic	modulus	after	8	weeks	of	subcutaneous	
implantation	was	low	and	approximately	1%	of	that	of	native	human	ear	or	nasal	cartilage.	
[281]	 Although	 the	 biomechanical	 properties	 of	 the	 constructs	 were	 rather	 low,	 alginate	
enabled	 a	 homogeneous	 cell	 distribution	 and	 prevented	 cells	 from	 floating	 out	 while	
permitting	 nutrient	 diffusion	 and	 oxygen	 transfer	 to	 the	 cells	 in	 order	 to	 create	 an	
environment	to	form	new	cartilage	matrix	with	sufficient	properties.	[89]	Therefore,	injected	
into	a	mechanical	stable	scaffold,	alginate	could	be	an	excellent	cell-carrying	gel	 for	 future	
cell-based	cartilage	repair.	Secondary,	the	cell	density	used	in	this	study	might	not	be	optimal	
to	obtain	engineered	tissue	that	are	clinical	applicable.	Our	experimental	set-up	did	not	allow	
us	 to	 further	 increase	 cell	 density	 due	 to	 limitations	 in	 the	 number	 of	 cells	 available.	
Nevertheless	 it	 allowed	 us	 to	 study	 the	 interactions	 between	 the	 cell	 types.	 For	 clinical	
application,	 it	 would	 be	 ideal	 to	 only	 use	 low	 numbers	 of	 human	 primary	 chondrocytes	
supplemented	with	hBMSCs.	We	have	combined	hBMSCs	and	chondrocytes	at	a	4:1	ratio,	as	
the	 effect	 of	 hBMSCs	 on	 articular	 chondrocytes	 was	 already	 studied	 by	 us	 at	 such	 ratio.	
Although	others	have	used	a	4:1	ratio	for	their	research	as	well	[74,	253],	no	consensus	on	
optimal	 BMSCs-to-chondrocytes	 ratios	 have	 been	 established	 for	 ECs	 and	 NCs.	 Future	
research	 needs	 to	 clarify	 if	we	 could	 further	 reduce	 the	 amount	 of	 primary	 chondrocytes	
without	inhibiting	cartilage	matrix	production.	Finally,	for	future	clinical	application	the	use	of	
allogeneic	 hBMSCs	 can	 be	 considered	 as	 MSCs	 have	 been	 demonstrated	 to	 be	 immune	
  
privileged.	 [282]	Alternatively,	 instead	of	using	culture-expanded	hBMSCs	 it	might	even	be	
considered	to	use	the	mononuclear	fraction	of	freshly	isolated	autologous	bone	marrow.	[283]		
In	summary,	this	study	demonstrates	that	constructs	containing	a	combination	of	80%	
hBMSCs	and	20%	bECs	or	bNCs	produced	similar	quantities	of	cartilage	matrix	components	as	
constructs	containing	chondrocytes	only.	Therefore,	80%	of	the	chondrocytes	can	easily	be	
replaced	by	hBMSCs	without	 influencing	cartilage	matrix	production.	Using	this	procedure,	
the	chondrocytes	need	no	culture-expansion	in	vitro,	supporting	the	use	of	a	one-stage	cell-
based	cartilage	repair	procedure	for	cartilage	defects	in	the	head	and	neck	area.	
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Supplementary	figure	1.	Cartilage	matrix	formation	in	constructs	containing	hBMSCs	and/or	
chondrocytes,	5	weeks	after	in-vitro	culture.	
Biochemical	evaluation	of	the	sGAG	(A)	and	collagen	(B)	content,	5	weeks	after	culture	in	alginate.	The	left	graphs	
demonstrate	the	amount	of	matrix	components	per	construct,	whereas	for	the	right	graphs	matrix	production	is	
normalized	to	the	initial	number	of	seeded	PCs.	A	control	condition	-	containing	similar	amounts	of	chondrocytes	
(0.8	million/ml)	 without	 supplementation	 of	 hBMSCs	 -	 was	 evaluated	 to	 determine	 the	 additional	 effect	 of	
hBMSCs	(3.2	million/ml)	on	chondrocytes	in	co-cultures	(white	line).	*,	**	or	***	indicates	p-values	smaller	than	
0.05,	0.01	or	0.001	respectively	compared	to	the	control	condition.	Data	are	shown	as	mean	±	SD.	For	statistical	
evaluation,	 a	mixed	model	was	used	 followed	by	 a	 Fisher’s	 least	 significant	post-hoc	 comparisons	 test.	 PC	=	
Primary	Chondrocyte	;	hBMSC	=	human	Bone-marrow-derived	Mesenchymal	Stem	Cell	(n=3	experiments	with	3	
different	donors)	;	bEC	=	bovine	Ear	Chondrocyte	(n=3	experiments	with	3	pools	of	donors)	;	bNC	=	bovine	Nasal	
Chondrocyte	(n=3	experiments	with	3	pools	of	donors).	Per	experiment,	3	samples	were	used	for	analyses.		
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ABSTRACT	
	
Scaffolds	 are	widely	used	 to	 reconstruct	 cartilage.	 Yet,	 the	 fabrication	of	 a	 scaffold	with	a	
highly	organized	microenvironment	that	closely	resembles	native	cartilage	remains	a	major	
challenge.	Scaffolds	derived	from	acellular	extracellular	matrices	are	able	to	provide	such	a	
microenvironment.	Currently,	no	report	specifically	on	decellularization	of	full	thickness	ear	
cartilage	has	been	published.	In	this	study,	decellularized	ear	cartilage	scaffolds	were	prepared	
and	extensively	characterized.	Cartilage	decellularization	was	optimized	to	remove	cells	and	
cell	 remnants	 from	 elastic	 cartilage.	 Following	 removal	 of	 nuclear	 material,	 the	 obtained	
scaffolds	retained	their	native	collagen	and	elastin	contents	as	well	as	their	architecture	and	
shape.	 High	magnification	 scanning	 electron	microscopy	 showed	 no	 obvious	 difference	 in	
matrix	density	after	decellularization.	However,	glycosaminoglycan	content	was	significantly	
reduced,	 resulting	 in	 a	 loss	 of	 viscoelastic	 properties.	 Additionally,	 in	 contact	 with	 the	
scaffolds,	human	bone-marrow-derived	mesenchymal	stem	cells	remained	viable	and	are	able	
to	 differentiate	 towards	 the	 chondrogenic	 lineage	 when	 cultured	 in	 vitro.	 These	 results,	
including	 the	 ability	 to	 decellularize	 whole	 human	 ears,	 highlight	 the	 clinical	 potential	 of	
decellularization	as	an	improved	cartilage	reconstruction	strategy.		
	
	 	
  
INTRODUCTION	
	
Ear	cartilage	defects	-	either	caused	by	congenital	malformation,	trauma	or	tumor	destruction	
-	are	a	commonly	encountered	problem	in	reconstructive	surgery,	since	cartilage	has	a	limited	
capacity	for	self-regeneration	once	damaged.	Therefore,	ear	cartilage	defects	can	ultimately	
lead	to	physical	and	aesthetic	impairment.	Despite	the	great	demand	for	treating	ear	cartilage	
defects,	current	treatments	using	autologous	cartilage	are	challenging.	Not	only	because	they	
require	a	high	degree	of	surgical	expertise,	but	also	because	they	are	associated	with	limited	
availability	of	autologous	cartilage	and	can	cause	severe	donor	site	morbidity.		
For	successful	cartilage	reconstruction,	the	properties	of	the	three-dimensional	(3D)	
matrix	 is	 of	 major	 importance,	 in:	 (1)	 providing	 temporary	 or	 permanent	 support	 while	
maintaining	size	and	shape;	and	(2)	providing	specific	structural,	mechanical	and	biological	
cues	to	cells,	which	guide	tissue	remodeling.	[82,	284]	Ideally,	the	best	scaffold	for	cartilage	
reconstruction	should	mimic	the	extracellular	matrix	(ECM)	of	the	targeted	tissue	itself.	As	a	
result,	 several	 3D	 scaffolds,	 including	 both	 natural	 and	 synthetic	 materials,	 have	 been	
developed	and	investigated	for	their	use	in	cartilage	reconstruction.	[23,	83,	285]	A	frequently	
used	 alternative	 to	 autologous	 cartilage	 implants	 are	 synthetic	 materials	 such	 as	 porous	
polyethylene	[286,	287].	Although	this	material	 is	advantageous	to	work	with	it	 is	prone	to	
induce	a	foreign	body	reaction,	the	ensuing	extrusion	[124]	in	most	cases	resulting	in	removal	
of	 the	 entire	 implant.	 [288]	 Additionally,	 the	 biomechanical	 mismatch	 of	 the	 implants	
compared	to	normal	ear	cartilage	can	result	in	eventual	collapse	of	the	framework.	[289].	So	
far,	 no	 ideal	 scaffold	 has	 emerged	 since	 the	 complex	 3D	 composition	 and	 architecture	 of	
native	ECM	makes	 it	extremely	difficult	 to	precisely	mimic.	Recently,	natural	acellular	ECM	
scaffolds	have	become	increasingly	popular.	These	acellular	ECM	scaffolds	are	acquired	by	a	
process	called	decellularization:	a	method	that	requires	chemical,	physical	and/or	enzymatic	
treatments.	 [93]	Decellularized	ECM	scaffolds	provide	a	3D	ECM	structure	with	 immediate	
functional	support	without	evoking	an	adaptive	immune	response	upon	implantation	due	to	
absence	of	donor	cellular	antigens.	[94]		
To	date,	 various	 cartilaginous	 structures	have	 already	been	decellularized	 including	
tracheal	 cartilage	 [94-99],	 articular	 cartilage	 [100-103],	 nasal	 cartilage	 [106,	 110],	
intervertebral	 discs	 [104,	 105]	 and	meniscal	 cartilage	 [106-109].	 Currently,	 no	method	 to	
specifically	decellularize	full	thickness	ear	cartilage	that	belongs	to	the	elastic	cartilage	type,	
has	been	described	in	literature.	In	contrast	to	hyaline	and	fibrous	cartilage,	elastic	cartilage	
contains	additional	thick	elastic	 fibers,	making	 it	denser	and	therefore	more	challenging	to	
decellularize.	Furthermore,	the	ability	to	prepare	scaffolds	from	whole	cartilage	tissue	rather	
than	scaffolds	that	are	derived	from	ECM	[290,	291],	provides	the	opportunity	to	decellularize	
large	tissues	and	structures	that	hold	complex	native	shapes	such	as	ears.	
Therefore,	 the	 goal	 of	 this	 study	was	 to	 prepare	 decellularized	 ear	 cartilage	 scaffolds	 and	
extensively	characterize	their	biochemical	and	biomechanical	properties,	as	well	as	investigate	
their	 cytocompatibility.	 Furthermore,	 by	 preparing	 human	 ear	 cartilage	 scaffolds	 with	
desirable	size	and	shape,	we	show	the	potential	of	decellularized	cartilage	to	improve	human	
cartilage	reconstruction.	
	 	
  
MATERIALS	AND	METHODS	
	
All	chemicals	were	obtained	from	Sigma-Aldrich,	St.	Louis,	USA	unless	stated	otherwise.	
	
Preparation	of	decellularized	cartilage	scaffolds	
To	 obtain	 full	 thickness	 bovine	 ear	 cartilage	 (bEC),	 macroscopically	 intact	 cartilage	 was	
harvested	from	calves	(n=3)	less	than	8	months	old	(T.	Boer	&	Zn.,	Nieuwerkerk	aan	den	IJssel,	
the	Netherlands)	and	washed	with	phosphate	buffered	saline	(PBS)	after	careful	resection	of	
the	 perichondrium.	 Bovine	 articular	 cartilage	 samples	 (bAC)	 were	 harvested	 from	 the	
metacarpophalangeal	 joints	 (n=3)	 and	 included	 as	 controls	 to	 compare	 decellularization	
outcomes.	Samples	were	made	using	an	8	mm	dermal	biopsy	punch	(Spengler,	Asnières	sur	
Seine,	France)	and	kept	in	PBS	until	decellularization.	Human	ear	cartilage	(hEC)	was	obtained	
from	post	mortem	donors	(n=2;	M,	83	and	84	Y)	who	donated	their	bodies	to	medical	science	
at	 Erasmus	 Medical	 Center	 (EMC;	 Rotterdam,	 the	 Netherlands).	 Dermal	 tissue	 was	
macroscopically	 removed,	 followed	 by	 careful	 removal	 of	 the	 perichondrium	 and	 samples	
were	made	using	an	8	mm	dermal	biopsy	punch.	Untreated	(i.e.	native)	cartilage	samples	were	
immediately	stored	dry	at	-80°C	after	harvest	for	biochemical	analysis	or	in	4%	formaldehyde	
for	histological	analysis	and	scanning	electron	microscopy	(SEM).	
All	human	and	bovine	cartilage	samples	were	decellularized	according	to	the	protocol	
of	Kheir,	et	al.	[101],	which	was	further	optimized	to	specifically	decellularize	ear	cartilage.	
Briefly,	 the	 samples	 were	 subjected	 to	 2	 overnight	 dry	 freeze-thaw	 cycles	 followed	 by	 2	
overnight	freeze-thaw	cycles	at	-20°C	in	hypotonic	buffer	(10	mM	Tris-HCl	in	Mili-Q	water,	pH	
8.0)	following	a	24	hour	incubation	in	hypotonic	buffer	at	45°C.	Next,	samples	were	treated	
for	24	hours	with	an	ionic	detergent	consistent	of	0.1%	sodium	dodecyl	sulfate	(SDS),	0.1%	
ethylenediaminetetraacetic	 acid	 (EDTA)	 and	 10	 KUI/mL	 aprotinin	 in	 Mili-Q	 water.	 Then,	
samples	were	washed	twice	for	30	minutes	in	wash	solution	(PBS	with	10	KIU/mL	aprotinin)	
before	a	24	hour	wash	at	45°C	 in	wash	solution.	Since	the	protocol	of	Kheir	et	al.	was	not	
sufficient	to	reduce	or	remove	cellular	remnants,	an	elastase	solution	was	incorporated	into	
the	 protocol	 to	 improve	 the	 removal	 of	 cellular	 remnants.	 Therefore,	 the	 samples	 were	
treated	next	with	a	 low	concentration	elastase	solution	(0.2	M	Tris-HCl	 in	Mili-Q	water,	10	
KIU/mL	aprotinin	and	0.03	U/mL	elastase,	pH	8.6)	for	24	hours	at	37°C,	as	a	high	concentration	
elastase	would	 completely	damage	 the	matrix	 structure	due	 to	 the	 complete	depletion	of	
elastin	and	glycosaminoglycans	(GAGs).	(Supplementary	figure	1)	Next,	samples	were	washed	
twice	and	incubated	for	3	hours	at	37°C	in	nuclease	solution	(50	mM	Tris-HCl	in	Mili-Q	water,	
10	mM	MgCl,	50	µg/mL	bovine	serum	albumin	(BSA),	50	U/mL	DNAse	and	2.5	U/mL	RNAse,	
pH	 7.5).	 Samples	 were	 washed	 again	 in	 wash	 solution	 and	 treated	 for	 3	 hours	 in	
decontamination	solution	(0.1%	peracetic	acid	 in	PBS).	All	 incubation	and	wash	steps	were	
performed	with	agitation.	Finally,	the	samples	were	transferred	to	sterile	tubes	and	washed	
twice	for	30	minutes	in	sterile	PBS	before	starting	a	24	hour	wash	cycle	in	sterile	PBS	at	45°C.	
To	assess	the	decrease	in	wet	weight	after	decellularization,	samples	from	one	donor	of	both	
cartilage	 types	 were	 weighted	 directly	 after	 harvest	 and	 subjected	 to	 an	 individual	
decellularization	treatment	taking	into	account	volume	ratios	of	the	used	solutions.	After	the	
individual	treatment,	wet	weight	was	determined	again.	Samples	from	the	remaining	donors	
  
were	 decellularized	 in	 batches.	 Samples	 intended	 for	 histological	 analysis	 and	 SEM	 were	
stored	 in	4%	formaldehyde	and	samples	for	biochemical	analysis	were	stored	dry	at	 -80°C.	
Samples	 intended	 for	 biomechanical	 analysis	 were	 shipped	 to	 Eidgenössische	 Technische	
Hochschule	 (ETH;	 Zurich,	 Switzerland)	 in	 PBS	 containing	 protease	 inhibitors	 (Roche,	 Basel,	
Switzerland)	at	4°C.	Decellularized	bEC	scaffolds	 intended	for	seeding	 (n=1,	 in	6-fold)	were	
pre-conditioned	 for	 at	 least	2	hours	 in	Minimally	 Essential	Medium	Alpha	 (MEM-α;	Gibco,	
Carlsbad,	 USA)	 containing	 10%	 fetal	 calf	 serum	 (FCS;	 Lonza,	 Verviers,	 Belgium),	 50	 µg/mL	
gentamicin	(Gibco)	and	1.5	µg/mL	amphotericin	B	(Fungizone;	Gibco)	and	stored	at	4°C	until	
seeding.		
	
Biochemical	analysis	
Prior	to	biochemical	analysis,	wet	weight	was	determined	for	all	cartilage	samples.	For	DNA,	
sGAG	and	collagen	analysis,	samples	were	digested	overnight	at	60°C	in	a	papain	solution	(0.2	
M	Na2H2PO4,	 0.01	M	EDTA.2H2O,	 250	µg/mL	papain,	 5	mM	L-cystein,	 pH	6.0).	 Bovine	 and	
human	cartilage	samples	were	digested	in	400	and	500	µL	papain	solution,	respectively.	
To	assess	the	removal	of	nuclear	components,	the	DNA	content	of	the	cartilage	scaffolds	was	
measured	with	the	CyQUANT®	(Invitrogen)	proliferation	assay.	This	assay	is	able	to	detect	low	
amounts	of	DNA	and	has	a	detection	limit	of	10	ng	per	measurement.	In	short,	250	IU	heparin	
(LEO	Pharma,	Ballerup,	Denmark)	and	125	µg	RNAse	were	added	to	the	papain	digests	and	
incubated	for	30	minutes	at	37°C.	Finally,	0.375	µL	CyQUANT	GR	dye	was	added	to	each	papain	
digested	sample	and	fluorescence	was	immediately	measured	(excitation/emission:	480/520	
nm)	on	a	SpectraMax	Gemini	micro	plate	reader	(Molecular	Devices,	Sunnyvale,	USA),	using	
calf	thymus	DNA	as	a	standard.	
A	1,9-Dimethylmethylene	blue	(DMMB;	pH	3.0)	assay	[292]	was	performed	to	measure	
the	sulphated	GAG	content	of	the	cartilage	scaffolds.	The	metachromatic	reaction	of	DMMB	
was	monitored	using	a	VersaMax	spectrophotometer	at	530	and	590	nm.	Shark	chondroitin	
sulphate	C	was	used	as	a	standard.	
A	hydroxyproline	assay	[213]	was	performed	to	measure	the	total	amount	of	collagen	
of	the	cartilage	scaffolds.	In	short,	the	papain	digests	were	hydrolyzed	with	equal	volumes	of	
12	 M	 HCl	 at	 108°C	 for	 20	 hours,	 dried	 (Savant	 SPD	 121P	 SpeedVac;	 Thermo	 Scientific,	
Massachusetts,	USA)	and	re-dissolved	in	1.5	mL	Mili-Q	water.	Hydroxyproline	contents	were	
measured	 using	 a	 colorimetric	 method	 (extinction	 570	 nm),	 with	 chloramine-T	 and	
dimethylaminobenazldehyde	as	reagents.	Hydroxyproline	(Merck)	was	used	as	a	standard	to	
calculate	the	amount	of	collagen	per	sample.	
Elastin	content	of	the	cartilage	samples	was	measured	using	the	FastinTM	Elastin	Assay	
(Biocolor,	 Carrickfergus,	 UK)	 according	 to	 manufacturer’s	 instructions.	 Briefly,	 cartilage	
samples	were	converted	to	water	soluble	α-elastin	by	3	overnight	heat	extraction	cycles	at	
100°C	in	0.25M	oxalic	acid	before	adding	the	kit’s	dye.	Absorption	was	measured	at	513	nm	
on	a	VersaMax	plate	reader.	α-elastin	from	bovine	neck	ligament	(provided	by	manufacturer)	
was	used	as	a	standard.	
	
	 	
  
Histological	analysis	
Untreated	and	decellularized	samples	were	fixed	in	4%	formaldehyde	and	embedded	in	3%	
agarose,	 dehydrated	 in	 an	 ascending	 series	 of	 alcohol,	 then	 embedded	 in	 paraffin	 and	
sectioned	at	6	µm.	Sections	were	stained	with	Gill’s	Haematoxylin	and	Eosin	(H&E,	Merck),	
Safranin-O	 and	 Resorcin	 Fuchsin	 (RF,	 Klinipath,	 Duiven,	 the	 Netherlands).	 Additionally,	
collagen	type	II	and	elastin	were	immunohistochemically	visualized.	Antigen	retrieval	for	the	
collagen	 type	 II	 antibody	 (II-II	 6B3;	 DSHB,	 Iowa,	 USA)	was	 achieved	 by	 incubating	 in	 0.1%	
pronase	in	PBS	for	30	minutes	at	37°C.	Antigen	retrieval	of	elastin	(BA-4)	was	carried	out	by	
incubation	in	0.25%	trypsin	in	PBS	for	20	minutes	at	37°C.	10%	goat	serum	in	PBS	was	used	to	
block	non-specific	binding	sites.	Next,	sections	were	stained	for	1	hour	with	primary	antibodies	
against	 collagen	 type	 II	 (1:100)	or	 elastin	 (1:1000).	An	enzyme-streptavidin	 conjugate	 (HK-
321/325-UK;	Biogenex,	California,	USA)	in	PBS/1%	BSA	at	a	dilution	of	1:100	was	used	as	label	
and	visualized	by	Neu	Fuchsin	substrate	(Chroma,	Köngen,	Germany).	
Cell-seeded	 cartilage	 scaffolds	were	 immediately	 embedded	 in	 Tissue-Tek	OCT	 Compound	
(Sakura,	 Alphen	 aan	 den	 Rijn,	 the	 Netherlands)	 after	 harvest,	 sectioned	 at	 6	 µm,	 fixed	 in	
acetone	and	stained	with	H&E.	
For	SEM	analysis,	samples	were	dehydrated	 in	a	graded	alcohol	series,	 fractured	by	
pulling	at	the	distal	end	of	the	samples	and	dried	with	hexamethyldisilazane.	Samples	were	
then	 mounted	 on	 stubs,	 coated	 with	 palladium	 gold	 in	 a	 sputter	 coater	 (SC7620;	
Emitech/Quorum	Technologies,	Laughton,	UK)	and	visually	observed	with	a	scanning	electron	
microscope	(JSM-6510;	JEOL,	Tokyo,	Japan).	
	
Biomechanical	testing		
Biomechanical	 properties	 of	 cartilage	 scaffolds	 were	 assessed	 using	 stress-relaxation-
indentation	as	previously	described	[156].	In	short,	samples	(n=3	with	6	samples	per	donor)	
were	 placed	 in	 close-fitting	 stainless	 steel	 cylindrical	 wells	 of	 5	 mm	 in	 diameter,	 while	
immersed	in	PBS	supplemented	with	antibiotic/antimycotic	solution.	Mechanical	testing	was	
performed	with	a	materials	testing	machine	(Zwick	Z005,	Ulm,	Germany)	equipped	with	a	10	
N	 load	 cell,	 a	 built-in	 displacement	 control,	 and	 a	 cylindrical,	 plane	 ended,	 stainless	 steel	
indenter	(∅0.35mm).	A	preload	of	3	mN	was	first	applied	on	the	sample	to	locate	the	sample	
surface	and	measure	sample	thickness,	and	held	for	5	minutes.	Five	consecutive	strain	steps	
in	5%	increments	were	applied	up	to	a	maximum	strain	of	25%.	Samples	were	then	 left	to	
relax	for	20	minutes	at	each	step.	A	custom	MATLAB®	script	was	used	to	convert	the	force-
displacement	 data	 to	 stress-strain.	 Maximum	 stress	 (σmax)	 equilibrium	 modulus	 (Eeq),	
relaxation	time	(τ)	and	relaxation	half	time	(t½)	were	determined	from	the	stress-strain	plots	
to	determine	intrinsic,	flow-independent,	and	flow-dependent	mechanical	properties.	[155]	
	
Scaffold	cytocompatibility	
To	assess	toxicity	and	complete	removal	of	the	used	chemicals	during	decellularization,	the	
scaffolds	 were	 evaluated	 for	 their	 cytotoxicity	 with	 a	 methylthiazolyldiphenyltetrazolium	
bromide	(MTT)	assay.	Bone-marrow	derived	mesenchymal	stem	cells	(BMSCs)	were	isolated	
from	 bone	 marrow	 aspirates	 from	 patients	 undergoing	 total	 hip-replacement	 surgery	 (3	
males,	67±5	Y),	with	informed	consent	and	approval	of	the	Medical	Ethics	Committee	(Albert	
  
Schweitzer	Hospital	2011/7).	Cells	were	cultured	at	a	density	of	2300	cells/cm2	at	37°C	and	5%	
CO2	in	MEM-α,	containing	10%	FCS,	50	µg/mL	gentamicin,	1.5	µg/mL	Fungizone,	25	µg/mL	L-
ascorbic	 acid	 2-phosphate	 and	 1	 ng/mL	 basic	 Fibroblast	 Growth	 Factor	 2	 (bFGF2;	 R&D	
Systems,	Minneapolis,	USA),	from	now	on	referred	to	as	‘MSC-expansion	medium’.	For	toxicity	
tests,	BMSCs	were	plated	in	a	24-well	plate	at	a	density	of	40,000	cells/cm2	and	after	3	days	
of	culture	a	decellularized	cartilage	scaffold	was	added	to	each	well.	Wells	containing	only	
medium	or	only	BMSCs	were	included	as	controls.	After	4	days,	the	cells	and	scaffolds	were	
washed	 with	 PBS.	 Next,	 5	 mg/mL	 MTT-solution	 was	 added	 and	 incubated	 for	 3	 hours	
protected	from	light	at	37°C	and	5%	CO2.	Finally,	the	scaffolds	were	removed	from	the	wells	
and	 the	MTT-solution	was	 replaced	with	 100%	ethanol	 (Boom,	Meppel,	 the	Netherlands),	
transferred	 to	 a	 96-well	 plate	 and	 absorbance	 was	 measured	 at	 670	 and	 570	 nm	 on	 a	
VersaMax	(Molecular	Devices,	Sunnyvale,	USA).	Toxicity	experiments	were	conducted	twice	
with	 independent	 BMSC	 and	 cartilage	 donors,	 with	 3	 decellularized	 bovine	 samples	 per	
cartilage	type.		
To	 further	 assess	 the	 interaction	of	 cells	with	 the	decellularized	 cartilage	 scaffolds,	
BMSCs	were	seeded	on	the	scaffolds	by	rotation	in	a	tube	rotator	at	20	rpm	(VWR,	Radnor,	
Pennsylvania,	USA)	in	1.6	mL	cell	suspension	containing	2·106	BMSCs/scaffold	for	4	hours	at	
37°C.	After	seeding,	the	scaffolds	were	transferred	to	a	12-well	plate	(BD	Biosciences)	coated	
with	3%	agarose	(Eurogentec,	Liège,	Belgium)	to	prevent	attachment	of	BMSCs	to	the	culture	
well	and	cultured	in	2	mL	high	glucose	(4.5	g/L)	Dulbecco’s	Modified	Eagle	Medium	(DMEM-
HG;	 Gibco)	 containing	 50	 µg/mL	 gentamicin,	 1.5	 µg/mL	 Fungizone,	 Insulin-Transferrin-
Selenium	(ITS+1,	BD	Biosciences,	New	Jersey,	USA),	40	µg/mL	L-proline,	1mM	sodium	pyruvate	
(Gibco),	25	µg/mL	L-ascorbic	acid	2-phosphate,	10	ng/mL	Transforming	Growth	Factor	beta	1	
(TGFβ1;	 R&D	 Systems,	 Minneapolis,	 USA)	 and	 10-7	 M	 dexamethasone.	 To	 confirm	 the	
chondrogenic	capacity	of	the	seeded	BMSCs,	pellet	cultures	of	250,000	BMSCs/pellet	were	
included	as	positive	controls.	Therefore,	BMSCs	were	suspended	at	a	density	of	5·105	cells/mL.	
Aliquots	of	0.5	mL	cell-suspension	were	transferred	into	polypropylene	tubes	and	pellets	were	
formed	by	centrifuging	at	200	G	for	8	minutes.	Negative	controls	included	BMSCs	cultured	in	
monolayer	in	DMEM-HG	containing	10%	FCS,	50	µg/mL	gentamicin,	1.5	µg/mL	Fungizone	and	
25	µg/mL	L-ascorbic	acid	2-phosphate	in	the	absence	of	TGFβ1.	Samples	intended	for	gene-
expression	analysis	and	viability	analysis	were	cultured	for	21	days	at	37°C	and	5%	CO2	and	
medium	was	refreshed	twice	a	week.	
After	 culture,	 cell	 viability	 was	 evaluated	 with	 a	 LIVE/DEAD®	 assay	 (Invitrogen,	
Carlsbad,	USA)	according	to	manufacturer’s	instructions.	Fluorescent	imaging	was	performed	
on	a	Zeiss	LSM	510	with	the	excitation	laser	set	at	488	nm.	A	505-530	nm	band-pass	filter	was	
used	to	detect	living	cells	and	a	650	nm	low-pass	filter	for	detecting	dead	cells.	
To	 assess	 the	 chondrogenic	 differentiation	 of	 the	 BMSCs	 cultured	 on	 the	 scaffolds,	 gene	
expression	 analysis	 was	 performed.	 RNA	 was	 isolated	 from	 the	 seeded	 scaffolds	 by	 snap	
freezing	 in	 liquid	nitrogen	followed	by	pulverization	using	a	Mikro-Dismembrator	(B.	Braun	
Biotech	International	GmbH,	Melsungen,	Germany)	at	2800	rpm.	The	tissue	was	homogenized	
with	18	µL/mg	sample	RNA-Bee	TM	(Tel-Test	Inc,	Friendswood,	USA)	and	20%	chloroform.	RNA	
was	 isolated	 using	 the	 RNeasy	 Micro	 Kit	 (Qiagen,	 Hilden,	 Germany)	 according	 to	
manufacturer’s	 instructions.	Quantification	of	 total	extracted	RNA	was	determined	using	a	
  
NanoDrop	 ND-1000	 spectrophotometer	 (Thermo	 Fisher	 Scientific	 Inc.,	 Waltham,	 USA)	 at	
260/280	nm.	Next,	complementary	DNA	(cDNA)	was	synthesized	using	the	RevertAidTM	First	
Strand	 cDNA	 Synthesis	 Kit	 (Fermentas	 GmbH,	 Leon-Rot,	 Germany)	 according	 to	
manufacturer’s	 instructions.	 Finally,	 PCR	 analysis	 was	 accomplished	with	 a	 Bio-Rad	 CFX96	
Real-Time	 PCR	 Detection	 System	 using	 TaqMan®	 Universal	 PCR	 Master	 Mix	 (Applied	
Biosystems)	or	qPCRTM	Mastermix	Plus	for	SYBTR®	Green	I	(Eurogentec).	Gene	expression	of	
collagen	 type	 II	 (COL2A1,	 Forward:	 GGCAATAGCAGGTTCACGTACA;	 Reverse:	
CGATAACAGTCTTGCCCCACTT),	 SRY	 (sex	 determining	 region	 Y)-box	 9	 (SOX9,	 Forward:	
CAACGCCGAGCTCAGCA;	 Reverse:	 TCCACGAAGGGCCGC)	 and	 aggrecan	 (ACAN,	 Forward:	
TCGAGGACAGCGAGGCC,	 Reverse:	 TCGAGGGTGTAGCGTGTAGAGA)	 was	 evaluated.	
Glyceraldehyde-3-phosphate	dehydrogenase	(GAPDH,	Forward:	ATGGGGAAGGTGAAGGTCG;	
Reverse:	 TAAAAGCAGCCCTGGTGACC),	 Beta-2-Microglobulin	 (B2M,	 Forward:	
TGCTCGCGCTACTCTCTCTTT;	 Reverse:	 TCTGCTGGATGACGTGAGTAAAC)	 and	 hypoxanthine	
phosphoribosyltransferase	 1	 (HPRT1,	 Forward:	 TATGGACAGGACTGAACGTCTTG;	 Reverse:	
CACACAGAGGGCTACAATGTG),	 were	 used	 to	 determine	 a	 best-housekeeping-gene-index	
(BHKi)	 [211],	which	was	used	as	 reference	 for	 the	expression	of	 the	genes	of	 interest.	The	
relative	gene	expression	was	calculated	by	the	2-ΔCT	formula.		
	
Statistics	
The	mean	and	standard	deviation	(SD)	of	the	variables	of	interest	were	calculated	using	MS	
Excel	2013	and	PASW	Statistics	21.0	(SPSS	Inc.	Chicago,	USA)	for	3	independent	bovine	donors	
per	cartilage	type,	with	6	samples	per	donor.	For	statistical	evaluation,	a	mixed	linear	model	
was	used	followed	by	a	Bonferroni's	post-hoc	comparisons	test.	Treatment	and	cartilage	type	
were	defined	as	fixed	factors	in	the	model,	while	donor	was	considered	as	a	random	factor.	
Linear	 regression	analysis	was	performed	 to	evaluate	 the	 relationship	between	amount	of	
matrix	 components	 and	 biomechanical	 properties	 after	 decellularization.	 For	 analysis,	 the	
mechanical	properties	(i.e.	σmax,	t1/2	and	Eeq)	were	defined	as	the	dependent	variables	and	
matrix	 components	 (i.e.	 sGAG,	 collagen	 and	 elastin	 content)	 as	 independent	 variables.	
Differences	in	gene	expression	of	the	BMSCs	seeded	on	decellularized	cartilage	scaffolds	were	
determined	 by	Mann-Whitney	 U-tests	 with	 the	 genes	 of	 interest	 (i.e.	 SOX9,	 COL2A1	 and	
ACAN)	 set	 as	 test	 variables.	 Differences	 between	 human	 decellularized	 and	 untreated	
cartilage	samples	for	1	donor	 in	6-fold,	were	determined	by	Mann-Whitney	U-tests	as	well	
with	 the	 biochemical	 parameters	 (i.e.	 DNA,	 sGAG,	 collagen	 and	 elastin	 contents)	 as	 test	
variable.	Differences	were	considered	statistically	significant	for	p<0.05.		
	
	
	
	
	
	
	
	 	
  
RESULTS	
	
Decellularization	of	bovine	ear	cartilage	
Bovine	cartilage	samples	were	decellularized	according	to	the	protocol	of	Kheir,	et	al.,	[101]	
that	was	further	optimized	to	specifically	decellularize	bEC	by	the	addition	of	a	treatment	with	
a	low	concentration	elastase	solution.	Bovine	articular	cartilage	(bAC)	samples	were	taken	as	
controls,	since	AC	decellularization	has	been	performed	by	Kheir,	et	al.	(Supplementary	figure	
2)	After	decellularization,	bEC	scaffolds	and	bAC	control	scaffolds	retained	their	cartilage-like	
appearance,	although	samples	seemed	more	translucent	after	the	decellularization	process.	
After	decellularization,	wet	weight	reduced	by	26.1±4.9%	in	bEC	and	an	8.4±2.6%	wet	weight	
reduction	was	measured	in	bAC.	The	thickness	of	decellularized	bEC	scaffolds	was	significantly	
reduced	 (p<0.001)	by	23.5%	 (1.37	±	0.32	mm)	when	compared	 to	untreated	bEC	scaffolds	
(1.72	±	0.40	mm),	while	no	obvious	reduction	in	sample	diameter	was	observed.	(Figure	1A).		
To	 assess	 decellularization	 efficiency,	 cell	 content	was	 analyzed	 histologically	 (H&E	
stain)	and	biochemically.	DNA	content	was	significantly	reduced	(p<0.001)	and	undetectable	
(<10	 ng/sample)	 after	 decellularization,	 compared	 to	 untreated	 bEC.	 Similar	 results	 were	
obtained	in	the	decellularized	bAC	control	scaffolds;	DNA	was	significantly	reduced	(p<0.001)	
and	 undetectable	 after	 decellularization	 compared	 to	 untreated	bAC.	 Histological	 analysis	
showed	that	the	cell	remnants	were	diminished	after	decellularization	and	those	that	were	
still	 present	were	 clearly	 reduced	 in	 size	 and	weakly	 stained	 for	H&E.	 The	 ECM	 itself	was	
weakly	stained	compared	to	the	untreated	scaffolds,	although	the	overall	structure	of	the	ECM	
was	virtually	intact.	(Figure	1B)	
SEM	 analysis	 showed	 no	 obvious	 changes	 in	 the	 extracellular	 matrix	 after	
decellularization	compared	to	untreated	cartilage.	The	decellularized	bAC	and	bEC	scaffolds	
retained	their	dense	matrix	consistent	of	fine,	intact	collagen	fibers	similar	to	that	of	untreated	
cartilage.	 In	untreated	bEC,	the	thick	elastic	fibers	were	deeply	embedded	and	intertwined	
within	 a	 homogeneous	 collagen	 network	 and	 this	 3D	 organization	 was	 retained	 after	
decellularization.	(Figure	1C)		
	
Scaffold	characterization	
To	 characterize	 the	matrix	 properties	 of	 the	 decellularized	 bEC	 scaffolds,	 the	 sGAG,	 total	
collagen	 and	 elastin	 contents	 were	 measured	 biochemically	 in	 addition	 to	 histological	
evaluation.	 The	 sGAG	 content	 of	 decellularized	 bEC	 scaffolds	 significantly	 reduced	 to	 3%	
(p<0.001)	 compared	 to	untreated	bEC,	which	was	 confirmed	by	histological	 analysis	when	
stained	 for	 Safranin-O.	 The	 total	 collagen	 content	 of	 untreated	 bEC	 did	 not	 reduce	 after	
decellularization,	but	significantly	increased	(p=0.011).	This	phenomenon	appears	to	be	due	
to	the	normalization	of	the	collagen	content	to	the	sample	wet	weight,	since	wet	weight	was	
reduced	after	decellularization	while	the	collagen	content	most	likely	did	not.	As	sGAG	content	
was	strongly	reduced	by	the	decellularization	procedure,	the	relative	contribution	of	collagens	
to	the	overall	wet	weight	increased,	resulting	in	the	observed	increase	in	collagen	content.	
Furthermore,	immunohistochemical	analysis	confirmed	the	retention	of	collagen	type	II	after	
decellularization.	As	for	the	retention	of	elastin,	no	statistical	difference	was		
	
  
	
Figure	1.	Morphological	and	cellular	content	of	decellularized	bovine	cartilage.	
(A)	Photograph	of	cartilage	samples	(Ø	8	mm)	before	and	after	decellularization.	(B)	DNA	content	and	histological	
H&E	stain	after	decellularization	show	removal	of	nuclear	materials	and	reduction	in	cell	remnants.	Data	shown	
as	mean	±	SD	for	3	donors,	6	samples	per	donor.	Histological	 images	are	representative	for	all	donors.	bAC	=	
bovine	articular	;	bEC	=	bovine	ear	cartilage	;	UD	=	Undetectable.	(C)	Scanning	electron	microscopy	(SEM)	shows	
a	highly	organized	collagen	network	that	remains	intact	after	decellularization	(n=1).	
	
	
seen	between	the	elastin	content	of	decellularized	bEC	scaffolds	compared	to	untreated	bEC	
(p=0.535).	 Histological	 analysis	 revealed	 that	 after	 decellularization,	 elastin	 was	 mainly	
retained	directly	around	lacunae	when	stained	for	RF.	(Figure	2A)	
The	biomechanical	properties	of	decellularized	cartilage	scaffolds	were	assessed	using	
stress-relaxation-indentation.	 A	 statistically	 significant	 reduction	 of	 all	 compressive	
parameters	was	seen	in	decellularized	bEC	scaffolds	compared	to	the	untreated	bEC	samples	
(p<0.001);	 Equilibrium	modulus	 (Eeq)	 of	 the	 decellularized	 bEC	 scaffolds	 was	 8.7%	 of	 the	
untreated	bEC	scaffolds.	Similarly,	maximum	stress	(σmax)	and	relaxation	half	time	(t1/2)	were	
reduced	 to	 9.2%	 and	 32%	 of	 the	 untreated	 values,	 respectively.	 Specifically,	 σmax	 in	 the	
decellularized	bEC	scaffolds	was	0.54	±	0.36	MPa	and	5.83	±	2.18	MPa	in	untreated	bEC.	t1/2	in	
the	decellularized	bEC	samples	was	0.74	±	0.45	s.	compared	to	untreated	2.31	±	1.5	s.	(Figure	
2B)	 Similar	 changes	 in	matrix	 integrity	 and	 viscoelasticity	 were	 seen	 in	 the	 control	 group	
consisting	of	decellularized	bAC	scaffolds.	(Supplementary	figure	2)	
Linear	regression	analysis	was	used	to	correlate	ECM	components	and	biomechanical	
properties.	R2-values	showed	that	the	sGAG,	collagen	and	elastin	content	of	the	scaffolds	were	
responsible	for	more	than	50%	of	the	biomechanical	properties	of	decellularized	cartilage		
  
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	2.	Matrix	integrity	and	mechanical	properties	of	decellularized	bovine	ear	cartilage	
scaffolds.	
(A)	 sGAG,	 collagen	 and	 elastin	 contents	 of	 untreated	 and	 decellularized	 bovine	 ear	 cartilage	 scaffolds.	 Less	
intense	Safranin-O	(Saf-O)	staining	confirmed	sGAG	reduction,	while	immunohistochemistry	of	collagen	type	II	
(Coll-II,	counterstained	with	haematoxylin),elastin	and	resorcin	fuchsin	(RF)	stain	confirmed	retention	of	these	
matrix	 components.	 Histological	 images	 are	 representative	 for	 all	 donors.	 (B)	 Equilibrium	 modulus	 after	
decellularization.	Data	shown	as	mean	±	SD	for	3	donors,	6	samples	per	donor	for	sGAG	and	collagen	analysis.	
Elastin	data	is	shown	as	mean	±	SD	for	2	donors,	6	samples	per	donor	and	missing	values	are	excluded.	
	
	
scaffolds:	 Eeq	 (R2=	 0.64),	 t1/2	 (R2=0.51)	 and	σmax	 (R2=0.618).	 sGAG	 content	was	 statistically	
significantly	correlated	to	Eeq	(p=0.002),	σmax	(p=0.005)	and	t1/2	(p=0.001)	of	the	decellularized	
bEC	and	bAC	scaffolds.	
	
Decellularized	 ear	 cartilage	 scaffolds	 are	 not	 cytotoxic	 and	 allow	 chondrogenic	
differentiation	of	human	BMSCs	
To	assess	the	cytocompatibility	of	the	bEC	scaffolds,	the	metabolic	activity	of	plated	human	
BMSCs	in	the	presence	of	decellularized	bEC	scaffolds	was	measured	after	4	days	of	culture.	
No	 statistically	 significant	 effect	 on	 the	 metabolic	 activity	 of	 the	 BMSCs	 due	 to	 the	
decellularized	scaffolds	was	found	(p=0.559).	Relative	to	the	control	wells,	90.76	±	8.22%	of	
the	 cells	 were	 viable	 in	 the	 presence	 of	 a	 decellularized	 bEC	 scaffold,	 compared	 to	 the	
  
conditions	in	the	absence	of	a	scaffold.	This	indicates	that	decellularized	bEC	scaffolds	are	non-
cytotoxic	and	suitable	for	cell	seeding.	
To	evaluate	survival	of	human	BMSCs	in	contact	with	decellularized	bEC	scaffolds,	a	
LIVE/DEAD®	 assay	was	 performed	 after	 21	 days	 of	 culture.	 Living	 BMSCs	 emitted	 a	 bright	
green	fluorescence	and	showed	a	stretched	morphology.	Evaluation	of	z-stacks	indicated	that	
the	seeded	BMSCs	were	present	on	the	surface	of	the	scaffold.	Unseeded,	decellularized	bEC	
scaffolds	 served	 as	 a	 control	 and	 no	 sign	 of	 living	 cells	 was	 observed	 in	 these	 controls.	
Histological	sections	showed	that	after	21	days,	BMSCs	were	attached	to	the	decellularized	
scaffolds,	yet	no	migration	into	the	scaffolds	was	observed.	(Figure	3A)	
Gene-expression	analysis	of	GAPDH,	B2M	and	HPRT1,	confirmed	the	presence	of	BMSCs	on	
decellularized	bEC	scaffolds	after	cell-seeding.	In	decellularized,	non-seeded	control	scaffolds,	
the	 expression	 of	 either	 housekeeping	 gene	 was	 non-detectable	 (CT-values	 >40).	 The	
chondrogenic	potential	of	BMSCs	 in	pellet	 culture	was	confirmed	by	 the	expression	of	 the	
chondrogenic-specific	genes	SOX9,	COL2A1	and	ACAN,	while	low	expression	presented	after	
culturing	in	monolayer	(negative	control).	Gene	expression	levels	after	seeding	and	culturing	
on	decellularized	bEC	scaffolds,	were	similar	to	pellet	culture.	This	shows	that	decellularized	
bEC	scaffolds	support	the	retention	of	the	chondrogenic	capacity	of	human	BMSCs	 in	vitro.	
(Figure	3B)	
	
	
	
	
	
Figure	3.	Decellularized	cartilage	supports	chondrogenesis.	
(A)	 H&E	 stain	 of	 decellularized	 ear	 cartilage	 scaffolds	 seeded	 with	 BMSCs	 shows	 attachment	 but	 limited	
migration	(left).	Fluorescent	imaging	(right)	confirms	viability	after	21	days	of	culture.	Images	are	representative	
for	all	samples.	Control	image	consists	of	an	unseeded,	decellularized	bEC	scaffold.	(B)	Relative	expression	of	the	
chondrogenic	markers	 SRY	 (sex	 determining	 region	 Y)-box	 9	 (SOX9),	 Collagen	 type	 II	 (COL2A1)	 and	 aggrecan	
(ACAN)	 are	 similar	 to	 that	 of	 BMSCs	 in	 pellet	 culture	 (positive	 control).	 Dotted	 line	 represents	 the	 relative	
expression	after	culturing	in	monolayer	(negative	control).	Data	shown	as	mean	±	SD	for	1	donor	in	6-fold,	relative	
to	 the	 best	 housekeeper	 index	 (BHKi)	 determined	 by	 the	 expression	 of	 Glyceraldehyde-3-phosphate	
dehydrogenase	(GAPDH),	Beta-2-Microglobulin	(B2M)	and	hypoxanthine	phosphoribosyltransferase	1	(HPRT1).	
  
Decellularization	of	human	ear	cartilage	
To	investigate	the	potential	clinical	implementation	of	a	decellularized	scaffold	with	
desirable	size	and	shape,	human	ear	cartilage	(hEC)	was	decellularized	and	characterized.	On	
gross	examination,	the	size	and	shape	of	the	whole	human	ear	was	preserved	after	
decellularization.	(Figure	4A)	The	DNA	content	significantly	reduced	by	99.93%	(p=0.002)	
after	decellularization	compared	to	untreated	hEC.	Staining	for	H&E	revealed	the	removal	of	
most	nuclear	material,	with	minimal	disruption	of	the	ECM	structure.	(Figure	4B)	sGAG	and	
elastin	contents	were	significantly	reduced	in	the	decellularized	hEC	scaffolds	by	75.3%	
(p=0.002)	and	48.8%	(p=0.010),	respectively.	No	statistically	significant	reduction	was	seen	in	
the	total	collagen	content	(p=0.180)	after	decellularization	and	histological	staining	of	the	
decellularized	hEC	scaffolds	confirmed	the	biochemical	analysis.	(Figure	4C)	The	Eeq	of	the	
hEC	scaffolds	was	2.51±1.26	MPa	after	decellularization	and	high	magnification	SEM	of	the	
decellularized	hEC	scaffolds	showed	a	dense	collagen	matrix	intertwined	with	thick	elastic	
fibers.	(Figure	4D)	
	
	
	
Figure	4.	Human	ear	cartilage	decellularization.	
(A)	 The	 size	 and	 shape	 of	 a	 whole	 human	 ear	 is	 preserved	 after	 decellularization.	 (B)	 DNA	was	 statistically	
significantly	reduced	after	decellularization	and	a	reduction	in	cell	remnants	is	seen	on	histology	(H&E	stain).	(C)	
sGAG,	 collagen	 and	 elastin	 contents	 of	 untreated	 and	 decellularized	 human	 ear	 cartilage.	 Histological	 stains	
confirm	the	findings.	Data	shown	as	mean	±	SD	for	1	donor	in	6-fold.	(D)	High	magnification	scanning	electron	
microscopy	 (SEM)	 of	 decellularized	 ear	 cartilage	 shows	 thick	 elastic	 fibers	 deeply	 embedded	 in	 a	 complex	
collagen	network	(n=1).	C	=	Collagen	;	E	=	Elastin	;	*	=	cross-section	of	transected	elastic	fibers.	
  
DISCUSSION	
For	 successful	 cartilage	 regeneration	 3D-scaffolds	 are	 crucial.	 We	 were	 able	 to	 obtain	
decellularized	bovine	and	human	scaffolds	from	whole	full-thickness	ear	cartilage	(EC)	tissue.	
These	scaffolds	preserved	their	native	collagen	and	elastin	contents,	as	well	as	their	major	
architecture	and	 shape.	 Furthermore,	 these	decellularized	EC	 scaffolds	were	non-cytotoxic	
and	have	the	capacity	to	allow	chondrogenic	differentiation	of	human	BMSCs	in	vitro.	
To	date,	decellularized	scaffolds	are	extensively	used	for	the	reconstruction	of	various	
tissues	and	organs.	[293]	In	addition,	several	cartilaginous	structures	have	been	decellularized.	
These	 studies,	 however,	 mainly	 focus	 on	 hyaline	 (i.e.	 articular	 cartilage,	 nasal	 cartilage,	
tracheal	 cartilage)	or	 fibrous	 (i.e.	meniscal	 cartilage,	 annulus	 fibrosis)	 cartilaginous	 tissues.	
Other	 cartilage	 decellularization	 techniques	 described	 in	 literature	 are	 the	 fabrication	 of	
decellularized	 ECM-derived	 scaffolds,	 by	 either	 pulverizing	 cartilage	 tissue	 [290,	 291]	 or	
stacking	thin	cartilage	slices.	[294]	Although	these	seem	effective	methods	to	decellularize	the	
tissue,	its	major	drawback	is	that	it	completely	disrupts	the	native	tissue	architecture	and/or	
shape.	In	fact,	no	method	to	specifically	decellularize	full	thickness	EC	has	been	described	in	
literature	 yet.	 This	 study	 is	 the	 first	 to	 evaluate	 structural	 and	 functional	 properties	 of	
decellularized	full-thickness	EC	scaffolds	of	both	bovine	(bEC)	and	human	(hEC)	origin.	
Various	decellularization	protocols	are	proposed	for	cartilaginous	tissues,	each	aiming	
to	maximize	the	decellularization	effect,	while	reducing	any	adverse	effect	of	the	process	on	
the	 structural	 composition	 and	 functionality	 of	 the	 remaining	 ECM.	 Therefore,	
decellularization	outcome	was	evaluated	based	on:	(1)	the	removal	of	cellular	material	and	(2)	
matrix	integrity	which	was	characterized	by	its	components,	architecture	and	biomechanical	
properties.	 First,	 removal	 of	 native	 cellular	material	 is	 highly	 imperative,	 as	 it	 reduces	 the	
possibility	of	an	immune	reaction	in	case	of	in	vivo	implantation.	For	this	reason,	one	of	the	
criteria	for	successful	decellularization	is	to	reduce	the	DNA	content	to	 less	than	50	ng/mg	
tissue.	[295]	Unfortunately,	most	recently	developed	decellularization	protocols	for	cartilage	
do	not	meet	 this	 requirement	at	all	 [100,	105].	Decellularized	cartilage	scaffolds	 still	 show	
distinct	cell	remnants	on	histological	examination	[94-96,	99-101,	104,	105,	296-299]	or	need	
multiple	 decellularization	 cycles	 to	 remove	 nuclear	material,	 [101,	 299]	 leading	 to	 further	
degradation	 of	 the	 ECM.	 To	 specifically	 decellularize	 EC,	 the	 samples	 were	 decellularized	
according	 to	 the	protocol	 of	 Kheir	et	 al.	 [101]	which	was	 further	 optimized	 to	 ensure	 the	
decellularization	 outcome	 was	 satisfactory	 for	 EC	 and	 cell	 remnants	 reduced.	 The	
incorporation	of	an	additional	24	hour	incubation	with	a	low	concentration	of	elastase	(0.03	
U/mL),	 enabled	 the	 removal	 of	 nuclear	 material	 and	 a	 reduction	 of	 cell	 remnants	 in	
decellularized	bEC	scaffolds	and	near-complete	removal	in	decellularized	full	size	human	ear	
cartilage	scaffolds.	It	should	be	noted	though,	that	the	10	ng	detection	limit	of	the	DNA	assay,	
concerns	a	fraction	of	papain	digest	used	in	the	DNA	assay	(50	µL).	Because	the	DNA	content	
was	undetectable	in	that	fraction	of	the	decellularized	bEC	scaffolds,	it	is	reasonable	to	assume	
that	DNA	was	removed	from	the	entire	scaffolds	after	decellularization.		
Second,	 the	 balance	 between	 the	 removal	 of	 nuclear	 material	 and	 preserving	 the	
matrix	 integrity	 should	 be	 considered	 carefully.	 We	 showed	 that	 the	 decellularized	 EC	
scaffolds	 preserved	 their	 native	 collagen	 and	 elastin	 contents,	 as	 well	 as	 their	 major	
architecture	 and	 shape,	 while	 sGAG	 content	 significantly	 decreased	 during	 the	 process.	
  
Collagen,	 the	 most	 abundant	 protein	 present	 within	 the	 ECM,	 is	 of	 major	 importance,	
providing	mechanical	strength	and	guiding	chondrogenic	differentiation.	[300]	Additionally,	
the	number	of	collagen	cross-links	contributes	to	the	mechanical	properties	of	newly	formed	
cartilage.	[301]	Naturally,	we	expect	these	cross-links	to	be	greater	in	scaffolds	derived	from	
native	cartilage,	than	in	synthetic	scaffolds	or	ECM-derived	scaffolds.	Therefore,	the	retention	
of	collagen	during	decellularization	is	crucial.	Although	collagen	type	I-elastin-GAG	scaffolds	
were	produced	before	[302],	the	dense	elastic	network	that	is	interspersed	with	the	collagen	
fibrils	 is	 not	 as	 highly	 organized	 as	 that	 of	 native	 ear	 cartilage	 [164,	 303],	 while	 high	
magnification	 SEM	 showed	 that	 the	 decellularized	 EC	 retained	 the	 complex	 interaction	
between	 the	 elastic	 fibers	 and	 fine	 collagen	 network.	 Following	 decellularization,	 sGAG	
content	decreased	significantly	which	corresponds	with	previously	reported	findings	by	others	
[100,	 101]	 and	 was	 most	 likely	 caused	 by	 the	 SDS-treatment	 during	 decellularization.	
Consequently	 with	 the	 sGAG	 reduction,	 the	 viscoelastic	 material	 properties	 of	 the	
decellularized	 EC	 scaffolds	 also	 reduced,	 which	 is	 in	 agreement	 with	 findings	 previously	
reported	by	others.	[304]	Depletion	of	sGAGs	might	be	required	to	allow	cells	and	cell	residuals	
to	 leave	 the	 matrix.	 [305]	 Depending	 on	 the	 eventual	 application	 of	 the	 scaffold,	 sGAG	
depletion	might	also	improve	ingrowth	of	cells	with	chondrogenic	capacity	into	the	scaffold	
and	thereby	allowing	matrix	remodeling	and	revitalization	of	the	graft.	
To	completely	assess	functionality	of	the	decellularized	scaffold,	mechanical	properties	
were	evaluated,	since	it	should	provide	sufficient	mechanical	strength	to	compensate	for	that	
of	the	damaged	tissue.	After	decellularization,	biomechanical	properties	reduced	significantly.	
Nevertheless,	 the	 decellularized	 bEC	 scaffolds	 presented	 superior	 mechanical	 properties	
compared	to	that	of	other	commonly	used	natural	or	synthetic	biomaterials	for	cartilage	TE.	
For	 instance,	 low	 equilibrium	 moduli	 were	 found	 by	 unconfined	 compression	 in	 various	
hydrogels;	 maximum	 Eeq	 of	 0.03	 MPa	 in	 2%	 alginate	 constructs	 [210],	 0.3	 MPa	 in	 20%	
polyethylene	glycol	 and	0.5	MPa	 in	15%	agarose	 [306],	 showing	 that	 these	hydrogels	only	
reach	a	maximum	of	50%	of	the	Eeq	of	our	decellularized	EC	scaffolds.	Additionally,	the	Eeq	
of	synthetic	co-polymer	scaffolds	was	0.05-0.25	MPa	[307],	which	was	only	5.5-25%	found	in	
our	decellularized	bEC	scaffolds.		
To	assure	long	lasting	properties	and	fully	functional	cartilage,	eventual	revitalization	
of	the	scaffold	is	a	requirement.	It	is	therefore	important	that	we	can	prepare	scaffolds	that	
are	non-cytotoxic	after	decellularization	so	cells	can	attach	and	survive.	We	showed	that	our	
decellularized	scaffolds	were	non-cytotoxic	and	the	seeded	BMSCs	were	still	viable	after	21	
days	of	culture.	Furthermore,	the	scaffold	allowed	chondrogenic	differentiation	of	BMSCs.	We	
have	used	BMSCs	in	this	work	to	evaluate	the	cell	supportive	capacity	of	our	scaffold,	the	final	
choice	of	 cell	 sources	would	mainly	depend	on	 the	application	and	 could	be	any	 cell	with	
chondrogenic	 potential	 such	 as	 chondrocytes,	 perichondrium	 cells	 or	 adipose	 derived	
mesenchymal	 stem	cells.	 [40,	54]	Moreover,	 it	would	not	be	unlikely	 that	 seeding	prior	 to	
implanting	a	decellularized	scaffold	is	required,	as	it	is	the	scaffold	that	could	provide	support	
for	 cells	present	at	 the	 implantation	 site	 to	grow	 in.	To	 revitalize	and	 remodel	 the	matrix,	
migration	of	cells	throughout	the	matrices	needs	to	be	further	optimized.	In	this	respect,	the	
reduction	of	sGAGs	in	the	decellularized	scaffolds	will	be	advantageous	[305],	since	it	has	been	
reported	that	chondrocyte	adhesion	is	prevented	by	sGAGs.	[308]	Given	that	cell	adhesion	is	
  
essential	for	cell	migration,	partial	or	even	complete	depletion	of	sGAGs	could	be	beneficial	
to	 realize	 cartilage	 revitalization,	 as	 it	 has	 been	 shown	 that	 chondrogenic	 progenitor	 cells	
possess	 the	 capacity	 to	 migrate	 through	 degraded	 cartilage	 and	 repair	 ECM.	 [309]	 This	
indicates	 that	 optimization	 of	 cell	 migration	 could	 lead	 to	 matrix	 synthesis	 and	 restored	
biomechanical	properties	of	the	revitalized	cartilage.	Recovery	of	biomechanical	properties	
due	to	matrix	deposited	by	cells	was	previously	seen	by	Reiffel	et	al.	[160],	who	reported	de	
novo	cartilage	deposition	and	a	30-fold	increase	in	Eeq	3	months	after	in	vivo	implantation	of	
a	collagen	type	 I	hydrogel.	This	showed	that	 the	biomechanical	properties	 returned	to	 the	
native	situation.		
Finally,	the	decellularized	hEC	scaffolds	and	whole	human	ear	preserved	their	size	and	
shape	after	decellularization.	Also,	approximately	25%	more	sGAGs	were	retained	than	in	the	
decellularized	bEC.	The	maturity	of	the	hEC	matrix	might	cause	better	retention	of	sGAG.	In	
human	ears,	the	ECM	components	and	especially	elastic	fibers	structurally	change	over	the	
years.	[164]	When	stained	for	elastin,	the	elastic	fibers	in	our	bEC	are	mainly	directly	located	
as	 a	 band	 around	 the	 lacunae	whereas	 in	hEC,	 this	 network	 extends	more	 into	 the	 ECM,	
confirming	what	is	shown	previously	by	Ito	et	al.	[164]	This	difference	in	elastic	fibers	in	adult	
cartilage,	 could	 have	 protected	 the	 ECM	 from	 degradation	 during	 decellularization.	
Importantly,	this	retention	was	also	reflected	in	the	Eeq	of	the	hEC	scaffolds,	which	was	not	
reduce	compared	to	that	of	native	hEC	(3.3	±	1.3	MPa	for	Eeq)	measured	in	our	previous	work.	
[155]	This	shows	that	the	decellularization	process	can	also	be	translated	to	human	tissue	and	
provides	 the	 possibility	 to	 use	 decellularized	 ear	 cartilage	 as	 an	 improved	 reconstruction	
strategy.		
	 	In	conclusion,	decellularization	can	provide	scaffolds	made	of	natural	materials,	even	
allogeneic	or	xenogeneic,	for	reconstruction	of	defects	in	cartilaginous	structures.	We	have	
prepared	decellularized	ear	cartilage	scaffolds	with	an	architecture	and	matrix	composition	
that	closely	resembles	native	cartilage	and	that	have	the	capacity	to	support	chondrogenic	
differentiation	 of	 BMSCs.	 Furthermore,	 the	 translation	 of	 the	 decellularization	method	 to	
whole	 human	 ear	 cartilage	 shows	 the	 possibility	 to	 use	 decellularization	 as	 an	 improved	
reconstruction	 strategy	 for	 large	 cartilage	 defects	 that	 hold	 complex	 shapes.	 In	 order	 to	
implement	the	method	as	a	clinical	treatment,	long	term	in	vivo	studies	should	be	conducted	
to	assess	the	scaffold	functionality	and	characteristics	after	implantation.	
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Supplementary	figure	1.	Optimization	of	the	decellularization	protocol	for	ear	cartilage.	
The	 protocol	 of	 Kheir	 et	 al.	 [101]	was	 optimized	 by	 the	 incorporation	 of	 a	 low	 dose	 elastase	 to	 specifically	
decellularize	full	thickness	ear	cartilage,	since	decellularization	outcome	was	not	satisfactory	as	cell	remnants	
remained	 clearly	 visible	 on	 histological	 examination	 (haematoxylin	 and	 eosin	 stain).	 A	 high	 concentration	 of	
elastase	(3	U/mL)	resulted	in	complete	disruption	of	the	matrix	and	complete	removal	of	cell	remnants.	A	low	
concentration	elastase	(0.03	U/mL)	preserved	the	matrix	to	a	greater	extent,	while	allowing	for	a	clear	reduction	
in	cell	remnants.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Supplementary	 figure	 2.	 Matrix	 integrity	 and	 mechanical	 properties	 of	 bovine	 articular	
cartilage	scaffolds.	
Bovine	 articular	 cartilage	 samples	were	 decellularized	 and	 included	 as	 controls	 to	 compare	 decellularization	
outcome.	(A)	sGAG	content	reduced	while	collagen	content	was	retained.	Histological	images	are	representative	
for	all	donors.	Saf-O	=	Safranin-O	;	Coll-II	=	collagen	type	II	(counterstained	with	haematoxylin).	(B)	Equilibrium	
modulus	after	decellularization.	Data	shown	as	mean	±	SD	for	3	donors,	6	samples	per	donor.	
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ABSTRACT	
	
Tissue	 engineering	 provides	 a	 promising	 alternative	 therapy	 to	 the	 complex	 surgical	
reconstruction	of	auricular	cartilage	by	using	ear-shaped	autologous	costal	cartilage.	Bacterial	
nanocellulose	 is	 proposed	 as	 a	 promising	 scaffold	 material	 for	 auricular	 cartilage	
reconstruction,	as	it	exhibits	excellent	biocompatibility	and	secures	tissue	integration.	Thus,	
this	 study	 evaluates	 a	 novel	 bilayer	 bacterial	 nanocellulose	 scaffold	 for	 auricular	 cartilage	
tissue	 engineering.	 Bilayer	 bacterial	 nanocellulose	 scaffolds,	 composed	 of	 a	 dense	
nanocellulose	layer	joined	with	a	macroporous	composite	layer	of	nanocellulose	and	alginate,	
were	seeded	with	human	nasoseptal	chondrocytes	and	cultured	in	vitro	for	up	to	6	weeks.	To	
scale	up	for	clinical	translation,	bilayer	bacterial	nanocellulose	scaffolds	were	seeded	with	a	
low	number	of	freshly	isolated	(uncultured)	human	nasoseptal	chondrocytes	combined	with	
freshly	isolated	human	mononuclear	cells	from	bone	marrow	in	alginate	and	subcutaneously	
implanted	in	nude	mice	for	8	weeks.	3D	morphometric	analysis	showed	that	bilayer	bacterial	
nanocellulose	 scaffolds	 have	 a	 porosity	 of	 75%	 and	 mean	 pore	 size	 of	 50	 ±	 25	 mm.	
Furthermore,	endotoxin	analysis	and	in	vitro	cytotoxicity	testing	revealed	that	the	produced	
bilayer	bacterial	nanocellulose	 scaffolds	were	non-pyrogenic	 (0.15	±	0.09	EU/ml)	and	non-
cytotoxic	 (cell	 viability:	 97.8	 ±	 4.7%).	 This	 study	 demonstrates	 that	 bilayer	 bacterial	
nanocellulose	scaffolds	offer	a	good	mechanical	stability	and	maintain	a	structural	integrity	
while	providing	a	porous	architecture	that	supports	cell	ingrowth.	Moreover,	bilayer	bacterial	
nanocellulose	scaffolds	provide	a	suitable	environment	for	culture-expanded	NCs	as	well	as	a	
combination	 of	 freshly	 isolated	 nasoseptal	 chondrocytes	 and	 mononuclear	 cells	 to	 form	
cartilage	 in	 vitro	 and	 in	 vivo	 as	 demonstrated	 by	 immunohistochemistry,	 biochemical	 and	
biomechanical	analyses.	 	
  
INTRODUCTION	
	
Serious	auricular	defects	such	as	anotia	and	microtia,	along	with	auricle	damage	caused	by	
cancer	and	trauma,	demand	an	effective	treatment	for	auricular	cartilage	reconstruction.	For	
such	 cases,	 the	 field	 of	 tissue	 engineering	 (TE)	 provides	 a	 promising	 potential	 alternative	
therapy	to	the	conventional	and	complex	surgical	reconstruction	of	auricular	cartilage	by	using	
ear-shaped	autologous	costal	and	nasoseptal	cartilage	[124,	310,	311].	Bacterial	nanocellulose	
(BNC),	a	novel	biomaterial	with	excellent	biocompatibility	and	remarkable	tissue	integration	
capability	[312-316],	has	been	evaluated	for	several	TE	strategies	and	has	shown	to	support	
adhesion,	proliferation	and	differentiation	of	different	cell	types	[317-323].	BNC	is	a	natural	
biopolymer	 synthesized	 by	 various	 bacteria	 species,	 particularly	Gluconacetobacter	 xylinus	
[90,	 324].	 Its	 three-dimensional	 (3D)	 and	 interconnected	 network	 is	 composed	 of	 highly	
hydrated	nanofibrils	ranging	from	70	to	140	nm	in	width,	similar	to	collagen	fibrils	found	in	
extracellular	matrix	 (ECM)	 of	 several	 tissues,	with	 high	 tensile	 strength	 [319,	 325].	 BNC	 is	
considered	 a	 hydrogel	 since	 it	 is	 mostly	 composed	 of	 water	 in	 its	 native	 state	 (99%).	 All	
together,	 these	 outstanding	 properties	 make	 BNC	 an	 exceptional	 biomaterial	 for	 many	
biomedical	applications	[326-328],	including	auricular	cartilage	reconstruction	[316,	322,	329].	
Although	 several	 groups	 have	 attempted	 to	 engineer	 auricular	 cartilage	 [124],	 few	
successful	outcomes	have	been	reported	[330-332].	Development	of	artificial	auricular	grafts	
with	 adequate	 mechanical	 properties	 has	 been	 identified	 as	 a	 key	 factor	 for	 successful	
auricular	 cartilage	 TE	 [333].	Most	 studies	 that	 have	 used	 biodegradable	 scaffold	materials	
have	resulted	in	poor	structural	integrity	(i.e.	shape	and	size	stability)	of	the	auricular	scaffold	
after	implantation;	caused	by	the	short-lived	chemical	and	mechanical	stability	[136,	334-337].	
On	 the	 other	 hand,	 recent	 studies	 that	 have	 investigated	 the	 use	 of	 non-degradable	
biomaterials	for	auricular	cartilage	reconstruction	have	reported	a	better	structural	integrity	
of	 the	 implant	 [330,	 332,	 338]	 -	 likely	 caused	 by	 the	 chemical	 stability	 of	 the	 support	
biomaterial,	which	translates	into	long-lasting	mechanical	properties	even	after	implantation.	
As	opposed	to	the	many	biodegradable	scaffolds	previously	evaluated	for	auricular	cartilage	
TE,	 the	 long-term	 structural	 integrity	 of	 BNC	 scaffolds	 should	 not	 be	 compromised	 after	
implantation	since	humans	do	not	produce	enzymes	capable	of	breaking	down	cellulose	[339].	
Besides	 being	 a	 chemically	 stable	 material,	 BNC	 with	 increased	 cellulose	 content	 of	 17%	
(densified	 hydrogel)	 is	 a	 competitive	 scaffold	 material	 for	 repair,	 reconstruction	 or	
regeneration	 of	 auricular	 cartilage	 since	 it	matches	 the	 elastic	mechanical	 properties	 (e.g.	
equilibrium	modulus)	of	human	auricular	cartilage	[329],	can	be	fabricated	in	patient-specific	
auricular	 shapes	 [340]	 and	 exhibits	 excellent	 biocompatibility	 in	 vivo	 -	 causing	 a	 minimal	
foreign	body	response	[316].	
When	 densified,	 BNC	 hydrogel	 is	 a	 mechanically	 and	 biologically	 appropriate	
biomaterial	 for	 use	 in	 auricular	 cartilage	 reconstruction	 [316,	 329].	 However,	 its	 dense	
nanocellulose	 network	 prevents	 cells	 from	 penetrating	 the	 material.	 To	 circumvent	 this	
problem,	several	techniques	have	been	developed	to	support	cell	ingrowth	in	BNC	scaffolds	
by	 tuning	 pore	 size	 and	 pore	 interconnectivity	 during	 biosynthesis	 of	 BNC	 [341],	 via	 laser	
ablation	[318]	and	freeze-dry	processing	 [342,	343].	Such	macroporous	BNC	scaffolds	have	
been	shown	to	provide	an	adequate	environment	that	supports	ingrowth	and	differentiation	
  
of	 chondrocytes.	 For	 example,	 human	 primary	 articular,	 auricular	 and	 nasoseptal	
chondrocytes	 cultured	 in	macroporous	BNC	 scaffolds	 in	 vitro	 have	been	 shown	 to	adhere,	
migrate,	 proliferate	 and	 maintain	 their	 chondrogenic	 phenotype	 -	 as	 confirmed	 by	 the	
synthesis	of	cartilage-specific	ECM	[322,	343,	344].		
Engineering	stable	and	 functional	auricular	cartilage	tissue	also	depends	on	the	cell	
source	used.	Pleumeekers	et	al.	showed	that	human	auricular	and	nasoseptal	chondrocytes	
possess	a	high	chondrogenic	capacity	in	vivo,	making	them	attractive	cell	sources	for	auricular	
cartilage	 repair	 [345].	The	use	of	cells	 in	cartilage	 repair	 is	an	attractive	strategy	as	 it	may	
result	 in	 regeneration	 of	 the	 lost	 tissue.	 However,	 the	 clinical	 application	 of	 a	 cell-aided	
treatment	does	 feature	challenges	–	a	 limited	supply	of	autologous	chondrocytes	with	 the	
proper	 phenotype	 being	 the	most	 stringent	 one.	 To	 cancel	 out	 cell	 culture,	 including	 the	
concomitant	laboratory	logistics	and	the	double	surgery,	autologous	cells	should	be	isolated	
within	the	operating	room	and	applied	directly.	In	addition,	the	combination	of	chondrocytes	
with	a	less	limited	source	of	autologous	cells,	such	as	bone	marrow	mononuclear	cells	(MNCs),	
can	overcome	the	challenge	of	having	too	few	cells	and	may	even	increase	the	treatment’s	
performance	[346,	347].	By	resuspending	the	cells	in	alginate,	also	the	factor	of	cell	loss	after	
scaffold	 seeding	 can	 be	 diminished	 whilst	 simultaneously	 providing	 the	 cells	 with	 a	 3D	
environment	to	suppress	dedifferentiation	[348].	
Several	studies	that	have	evaluated	BNC	as	a	scaffold	material	for	auricular	cartilage	
TE	[316,	322,	329,	343]	have	contributed	to	the	design	and	development	of	BNC	scaffolds	with	
a	two-layer	(bilayer)	architecture.	This	study	investigates	the	in	vitro	and	in	vivo	performance	
of	bilayer	BNC	scaffolds,	composed	of	a	dense	nanocellulose	layer	joined	with	a	macroporous	
composite	 layer	 of	 nanocellulose	 and	 alginate,	 designed	 to	 be	 mechanically	 stable	 and	
maintain	a	long-term	structural	integrity	while	providing	a	porous	architecture	that	supports	
cell	ingrowth	and	neocartilage	formation.	Moreover,	this	study	explores	the	application	of	a	
clinically	relevant	strategy	by	seeding	a	low	number	of	freshly	isolated	(uncultured)	human	
chondrocytes	combined	with	freshly	isolated	human	MNCs,	in	order	to	test	the	translation	of	
this	auricular	cartilage	TE	technology	to	the	clinic.	
	 	
  
MATERIALS	AND	METHODS	
	
Chemicals	were	obtained	from	Sigma-Aldrich,	USA	unless	stated	otherwise.	
	
Fabrication	and	purification	of	bilayer	BNC	scaffolds	
Production	of	dense	and	porous	scaffold	layers	
BNC	hydrogel	 disks	with	 increased	 cellulose	 content	 (i.e.	 dense	 layer)	were	 produced	 and	
purified	 as	 described	 elsewhere	 [316].	 Briefly,	 a	 suspension	 of	Gluconacetobacter	 xylinus	
(ATCC®	700178,	LGC	Standards,	Sweden)	was	 inoculated	 in	250	ml	conical	 flasks	containing	
sterile	culture	medium	(described	by	Matsuoka	et	al.	[349])	and	cultured	at	30°C	for	18	days,	
until	large	BNC	cylinders	(Ø	48	mm	×	20	mm)	were	biosynthesized.	The	BNC	cylinders	were	
purified	in	a	built-in-house	perfusion	system	and	compressed	to	1	mm	in	height	to	increase	
the	 cellulose	 content.	 The	 compressed	 BNC	 pellicles	 were	 frozen	 to	 -80°C	 overnight	 and	
lyophilized	(Heto	PowerDry	PL3000,	Thermo	Fisher	Scientific,	MA,	USA)	for	3	days.	Dense	BNC	
disks	(Ø	8	mm	×	1	mm)	were	then	cut	with	a	sterile	biopsy	punch	(Miltex	GmbH,	Germany).	
The	criterion	 for	selecting	 the	thickness	of	 the	dense	BNC	 layer	 is	based	on	morphometric	
analysis	 from	MRI	 scans	 of	 human	 auricular	 cartilage,	 where	 Nimeskern	 et	 al.	 reported	 a	
cartilage	thickness	of	1.15	±	0.10	mm	[350].	
BNC/alginate	composite	scaffolds	(i.e.	porous	layer)	were	fabricated	by	a	freeze-drying	
process.	 First,	 purified	 BNC	 pellicles	 were	 homogenized	 with	 a	 blender,	 until	 a	 pulp	
consistency	was	obtained,	and	then	with	a	dispersing	element	(S25N-18G,	IKA,	Germany)	at	
25,000	 rpm	 for	 20	 minutes.	 Afterwards,	 the	 homogenized	 BNC	 suspension	 was	 steam	
sterilized	(100	kPa,	121°C	for	20	minutes)	and	the	cellulose	content	was	determined	using	a	
halogen	moisture	analyzer	(HB43,	Mettler-Toledo,	OH,	USA).	The	following	steps	were	carried	
out	in	sterile	conditions.	The	BNC	suspension	was	mixed	with	1.1%	w/w	clinical	grade	alginate	
dissolved	in	0.9%	NaCl	(CellMed	AG,	Germany)	to	get	a	final	composition	of	90%	dry	weight	
BNC	and	10%	dry	weight	alginate	compared	to	the	total	dry	weight.	The	weight	of	alginate	
solution	(WAlg)	added	to	a	known	weight	of	BNC	suspension	(WBNC)	was	calculated	by	using	
the	formula:	WAlg	=	WBNC	×	(%DWAlg	÷	%DWBNC)	×	(%CCi	÷	%ACi).	Where	%DWAlg	and	%DWBNC	
are	the	targeted	percent	dry	weight	of	alginate	(10%)	and	BNC	(90%)	compared	to	the	total	
dry	 weight;	 and	 %CCi	 and	 %ACi	 are	 the	 initial	 cellulose	 and	 alginate	 concentrations.	 The	
BNC/alginate	mixture	was	then	dispersed	at	25,000	rpm	for	15	minutes,	transferred	to	sterile	
containers	(TP52,	Gosselin,	France)	and	degased	in	a	vacuum	desiccator.	The	containers	were	
then	placed	inside	Nalgene®	cryo	freezing	containers	(Thermo	Fisher	Scientific)	and	frozen	to	
-80°C	overnight	at	a	rate	of	1°C/min.	The	frozen	BNC/alginate	mixtures	were	lyophilized	for	5	
days	to	sublimate	the	ice	crystals,	creating	a	macroporous	architecture.	The	dry	BNC/alginate	
sponges	were	then	sliced	to	2	mm-thick	slices	and	porous	BNC/alginate	composite	scaffolds	
(Ø	8	mm	×	2	mm)	were	cut	with	a	sterile	biopsy	punch	(Miltex	GmbH).	
	
Fabrication	of	bilayer	BNC	scaffolds	
A	novel	cellulose	solvent	system	(i.e.	ionic	liquid	EMIMAc)	was	used	to	attach	the	dense	and	
porous	 layers	 and	 achieve	 a	 strong	 interfacial	molecular	 bonding	between	 the	 layers.	 The	
following	 steps	 were	 carried	 out	 in	 sterile	 conditions.	 First,	 dry	 homogenized	 BNC	 was	
  
dissolved	in	ionic	liquid	1-ethyl-3-methylimidazolium	acetate	(EMIMAc)	at	a	concentration	of	
10	mg/ml.	The	cellulose	solvent	solution	was	preheated	to	80°C	and	then	smeared	on	 the	
dense	BNC	layers.	Subsequently,	the	porous	layers	were	aligned	on	top	of	the	dense	layers	
and	 the	 bilayer	 BNC	 scaffolds	 were	 placed	 on	 a	 heating	 plate	 at	 80°C	 for	 2	 minutes	 to	
accelerate	the	dissolution	of	nanocellulose	at	the	interface.	The	bilayer	BNC	scaffolds	were	
then	stabilized	in	100	mM	CaCl2	in	ethanol	to	precipitate	the	dissolved	cellulose	between	the	
layers	(i.e.	attach	the	layers),	while	simultaneously	crosslinking	the	alginate	to	bind	the	BNC	
in	the	porous	layer.	The	scaffolds	were	then	rehydrated	and	washed	in	non-pyrogenic	conical	
tubes	 (TPP,	 Switzerland)	 with	 endotoxin-free	 water	 (HyClone™	 cell	 culture-grade	 water,	
Thermo	Fisher	Scientific)	supplemented	with	20	mM	CaCl2	to	remove	residuals	of	the	ionic	
liquid	EMIMAc	and	endotoxins.	The	scaffolds	were	purified	under	orbital	motion	(320	rpm)	at	
37°C	 for	 14	days,	 during	which	 the	 endotoxin-free	water	 and	 conical	 tubes	were	 changed	
every	second	or	third	day.	Subsequently,	the	bilayer	BNC	scaffolds	(Ø	8	mm	×	3	mm)	were	
steam	sterilized	(as	described	above)	in	endotoxin-free	water	and	stored	until	use	at	4°C.	
	
Characterization	of	bilayer	BNC	scaffolds	
The	morphology	of	bilayer	BNC	scaffolds	was	characterized	by	scanning	electron	microscopy	
(SEM)	and	micro–computed	tomography	(microCT).	Moreover,	the	purity	of	the	bilayer	BNC	
scaffolds	was	 analyzed	 throughout	 the	 purification	 process	 by	 bacterial	 endotoxin	 testing,	
infrared	spectroscopy	analysis	and	in	vitro	cytotoxicity	testing.		
	
Scanning	electron	microscopy	
Samples	were	lyophilized	(as	described	previously),	thereafter	sputter	coated	with	a	gold	film	
and	analyzed	using	a	Leo	Ultra	55	field	emission	gun	SEM	(Carl	Zeiss,	Germany).	
	
Micro–computed	tomography	
Bilayer	 BNC	 scaffolds	 (n=3)	 were	 incubated	 in	 0.1	M	 CaCl2	 solution	 at	 room	 temperature	
overnight	and	subsequently	quenched	in	liquid	nitrogen	and	lyophilized	for	24	hours.	The	dry	
scaffolds	were	scanned	with	microCT	(µCT50,	Scanco	Medical	AG,	Switzerland)	at	45	kVp	and	
1	µm	nominal	resolution.	The	internal	microstructure	of	the	porous	layer	was	then	segmented	
automatically	using	a	constrained	Gaussian	filter	to	suppress	noise	and	a	global	threshold	(25%	
of	maximal	grayscale	value).	3D	morphometric	parameters	such	as	scaffold	porosity	(Sc.Po),	
volume-weighted	mean	pore	size	(Pore.Th),	scaffold	wall	thickness	(Wall.Th),	and	scaffold	wall	
number	 (Wall.N)	 were	 calculated	 using	 the	 manufacturer's	 morphometry	 software	 (IPL,	
Scanco	 Medical	 AG)	 according	 to	 the	 guidelines	 established	 for	 the	 assessment	 of	 bone	
microstructure.	[351]	
	
Bacterial	endotoxin	testing	
Endotoxin	 extraction	 from	 the	 bilayer	 BNC	 scaffolds	 was	 done	 in	 accordance	 to	 the	
international	 standard	 ISO	 10993-12:2009	 (Sample	 preparation	 and	 reference	 materials).	
After	 14	 days	 of	 purification,	 bilayer	 BNC	 scaffolds	 (n=3)	 were	 weighed	 and	 placed	 in	
depyrogenated	sample	containers	(Lonza,	Belgium).	Endotoxin-free	water	was	added	to	the	
containers	using	the	ratio	of	0.1	grams	of	BNC/ml	of	extraction	medium.	The	extraction	was	
  
done	at	37	±	1°C	for	72	±	2	hours	under	orbital	motion	at	160	rpm.	Endotoxin	analysis	was	
performed	 with	 the	 PyroGeneTM	 Recombinant	 Factor	 C	 assay	 by	 Lonza.	 This	 assay	 has	 a	
minimum	detection	 limit	of	0.005	Endotoxin	Units	 (EU)	per	milliliter.	According	to	the	USA	
Food	and	Drug	Administration	[352],	endotoxin	levels	in	medical	devices	are	not	to	exceed	0.5	
EU/ml	or	20	EU/device	[352].	
	
Attenuated	Total	Reflectance	Fourier	Transform	Infrared	spectroscopy	
Removal	of	EMIMAc	residues	from	the	bilayer	BNC	scaffolds	was	analyzed	with	Attenuated	
Total	 Reflectance	 Fourier	 Transform	 Infrared	 (ATR-FTIR)	 spectroscopy.	 Samples	 (n=2	 per	
group)	were	freeze-dried	after	day	1,	7	and	14	of	purification.	The	porous	layer	was	removed	
from	the	bilayer	BNC	scaffolds	to	expose	the	interface.	This	interface,	visible	on	the	dense	BNC	
layer,	was	analyzed	with	a	single	reflection	ATR	accessory	fitted	with	a	monolithic	diamond	
crystal	(GladiATR™,	Pike	Technologies,	WI,	USA).	The	sample	was	placed	on	the	small	crystal	
area	and	a	force	was	applied	on	the	sample	to	push	it	onto	the	diamond	surface.	ATR-FTIR	
spectroscopy	 measurements	 were	 made	 with	 a	 System	 2000	 FT-IR	 spectrometer	
(PerkinElmer,	MA,	USA)	in	the	mid-infrared	region,	4000	to	400	cm-1.	20	scans	were	taken	with	
a	resolution	of	4	cm-1.	Pure	EMIMAc	solution	and	pure	dried	BNC	films	were	used	as	controls.	
	
In-vitro	cytotoxicity	testing	
Removal	of	EMIMAc	residues	from	the	bilayer	BNC	scaffolds	was	also	evaluated	by	 in	vitro	
cytotoxicity	 testing,	according	to	the	 international	standard	 ISO	10993-5:2009.	Bilayer	BNC	
scaffolds	 (n=4	 per	 time	 point)	 were	 incubated	 in	 growth	 medium	 (RPMI	 1640	 medium	
supplemented	with	1%	fetal	bovine	serum	(FBS),	and	antibiotics	(100	U/ml	penicillin	and	100	
µg/ml	streptomycin);	Biochrom,	Germany)	for	24	hours	to	extract	potential	cytotoxic	residues.	
All	 incubations	were	 done	 in	 standard	 culture	 conditions	 (37°C,	 5%	 CO2	 and	 95%	 relative	
humidity).	Meanwhile,	sensitized	L929	cells	(ACC	2,	DSMZ,	Germany)	were	seeded	in	96-well	
cell	culture	plates	(1.0	×	104	cells	per	well)	and	incubated	for	24	hours	to	allow	cell	adhesion.	
The	medium	was	removed	and	100	µl	of	extract	or	control	solutions	was	added	to	each	well	
and	 incubated	 for	 24	 hours.	 Cell	 culture	 inserts	 (ThinCertTM,	 Greiner	 BioOne,	 Germany)	
incubated	in	growth	medium	served	as	negative	control	(n=8),	while	10%	dimethylsulfoxide	in	
growth	medium	served	as	positive	control	 (n=8).	After	24	hours	of	 incubation	 in	extract	or	
control	solutions,	the	medium	was	removed,	100	µl	medium	were	mixed	with	20	µl	of	CellTiter	
96®	AQueous	one	solution	reagent	(Promega,	WI,	USA)	MTS	and	added	to	each	well,	followed	
by	incubation	for	2	hours	at	37°C.	Growth	medium	with	reagent	solution	(without	cells)	served	
as	blank	(n=8).	After	incubation	with	the	reagent,	absorbance	was	measured	photometrically	
(Infinite	 M200	 Pro,	 Tecan	 AG,	 Switzerland)	 at	 a	 wavelength	 of	 490	 nm	 and	 a	 reference	
wavelength	of	680	nm.	The	average	absorbance	value	of	 the	negative	control	was	used	to	
compute	 the	cell	 viability,	where	 the	negative	control	was	 regarded	as	100%	viability.	The	
cytotoxic	potential	of	the	test	samples	was	classified	as	highly	cytotoxic	when	cell	viability	was	
below	50%,	slightly	cytotoxic	when	it	was	between	51%	and	70%	and	non-cytotoxic	when	cell	
viability	was	above	71%.	
	
	
  
Cell	study	I:	performance	of	bilayer	BNC	scaffolds	in	vitro	
Isolation	and	expansion	of	human	nasoseptal	chondrocytes	
Nasoseptal	 cartilage	 was	 obtained	 from	 1	 female	 patient	 (19	 years)	 undergoing	 routine	
reconstructive	septorhinoplasty	at	the	Department	of	Otorhinolaryngology	of	Ulm	University	
Medical	Center	(Ulm,	Germany),	as	waste	material	after	surgery,	with	approval	of	the	local	
medical	ethics	committee	(no.	152/08).	The	isolation	of	nasoseptal	chondrocytes	(NC)	from	
the	 cartilage	was	 done	 by	 enzymatic	 digestion	 of	 the	 tissue	with	 0.3%	 type	 II	 collagenase	
(Worthington	Biochemical,	NJ,	USA)	 in	 growth	medium	 (DMEM/Ham’s	 F-12	 supplemented	
with	10%	FBS	and	0.5%	gentamycin;	Biochrom)	for	16	hours	at	37°C	under	agitation.	Cells	were	
separated	by	filtration	through	a	100-µm	cell	strainer	and	resuspended	in	growth	medium.	
Subsequently,	cell	viability	was	determined	using	trypan	blue	staining	and	NCs	were	seeded	
in	culture	flasks	at	a	density	of	5,000	cells/cm2	for	expansion	in	monolayer	culture.	Once	a	cell	
confluence	of	about	85%	was	reached,	the	cells	were	trypsinized	and	cryopreserved.	
	
Cell	culture	of	human	chondrocytes	in	bilayer	BNC	scaffolds	
NCs	were	thawed	and	expanded	one	time	in	growth	medium	as	described	above.	Once	sub-
confluent,	cells	were	detached	and	resuspended	in	differentiation	medium	(NH	ChondroDiff	
Medium;	 Miltenyi	 Biotec,	 Germany)	 supplemented	 with	 0.5%	 gentamycin.	 Prior	 to	 cell	
seeding,	bilayer	BNC	scaffolds	(n=30)	were	incubated	in	differentiation	medium	for	24	hours.	
The	medium	was	discarded	and	50	µl	of	cell	suspension	containing	1.0×106	cells	was	seeded	
into	the	porous	scaffold	layer	(10,000	cells/mm3).	Cells	were	allowed	to	attach	to	the	scaffolds	
for	4	hours	in	standard	culture	conditions	(37°C,	5%	CO2	and	95%	relative	humidity),	before	
transferring	the	seeded	scaffolds	to	differentiation	medium.	Cell-seeded	bilayer	BNC	scaffolds	
were	cultured	for	up	to	6	weeks	and	the	medium	was	changed	twice	a	week.		
	
Histological	and	immunohistochemical	analyses	
During	 the	 in-vitro	 culture,	 constructs	were	harvested	weekly	 for	 qualitative	 evaluation	of	
neocartilage	 synthesized	 by	 the	 chondrocytes.	 The	 constructs	 were	 fixed	 in	 10%	 neutral	
buffered	formalin	solution	supplemented	with	20	mM	CaCl2	at	room	temperature	overnight,	
embedded	in	paraffin	and	sectioned	(5	μm).	For	assessment	of	sulfated	glycosaminoglycans	
(sGAG)	 and	 cell	 distribution	 within	 the	 bilayer	 BNC	 scaffolds,	 longitudinal	 sections	 were	
stained	with	Alcian	blue	and	counterstained	with	Mayer’s	hematoxylin.	Furthermore,	seeded	
scaffolds	 were	 processed	 for	 immunohistochemical	 staining	 to	 detect	 cartilage	 specific	
proteins	such	as	aggrecan	(AB1031;	Millipore,	MA,	USA),	type	II	collagen	(II-II6B3;	DSHB,	IA,	
USA)	and	the	dedifferentiation	marker	type	I	collagen	(ab34710;	Abcam,	UK).	An	enzymatic	
antigen	retrieval	step	was	performed	before	incubation	with	primary	antibodies.	For	aggrecan	
staining,	 slides	were	 incubated	 in	0.5	U/ml	 chondroitinase	ABC	 in	PBS	 for	20	min	at	32°C,	
followed	 by	 incubation	 with	 primary	 antibody	 for	 1	 hour	 at	 a	 1/100	 dilution.	 For	 type	 II	
collagen	 staining,	 slides	 were	 incubated	 in	 1%	 hyaluronidase	 in	 PBS	 and	 0.2%	 pronase	
(Calbiochem,	Germany)	in	PBS,	each	for	15	min	at	37°C,	followed	by	incubation	with	primary	
antibody	for	1	hour	at	a	1/4000	dilution.	For	type	I	collagen	staining,	slides	were	incubated	in	
proteinase	K	 (Dako,	Germany)	 for	5	minutes	at	 room	temperature,	 followed	by	 incubation	
with	primary	antibody	for	1	hour	at	a	1/400	dilution.	For	visualization	of	these	markers,	the	
  
LSAB+System-HRP	kit	(Dako),	which	is	based	on	the	labeled	streptavidin	biotin	method,	was	
used	 according	 to	 the	 manufacturer’s	 protocol.	 Sections	 were	 counterstained	 with	
hematoxylin.	
	
Gene	expression	analysis	
Samples	were	harvested	after	2,	4	and	6	weeks	of	in	vitro	culture,	snap-frozen	and	stored	at	-
80°C	 until	 analyzed.	 For	 total	 RNA	 isolation,	 frozen	 constructs	 were	 placed	 in	 2	 ml	
microcentrifuge	tubes	in	quadruples	and	100	µl	of	lysis	buffer	(10	µl	β-Mercaptoethanol	per	1	
ml	Buffer	RLT;	Qiagen,	Germany)	was	added	to	each	tube.	The	samples	were	disrupted	and	
homogenized	 for	 2	minutes	 using	 a	 TissueLyser	 LT	 (Qiagen).	 Subsequently,	 500	 µl	 of	 lysis	
buffer	was	 added	 to	 each	 tube	 and	 the	 cell	 lysate	was	 used	 for	 total	 RNA	 isolation	 using	
RNeasy	Mini	Kit	 (Qiagen),	 according	 to	manufacturer´s	protocol.	 Total	RNA	was	quantified	
using	a	multimode	microplate	reader	(Infinite	M200	Pro,	Tecan	AG)	at	260/280	nm.	cDNA	was	
synthesized	 from	 the	 extracted	 RNA	 using	 QuantiTect	 Reverse	 Transcription	 Kit	 (Qiagen),	
according	 to	manufacturer´s	 protocol,	 in	 a	 PeqSTAR	 thermocycler	 (96	 Universal	 Gradient,	
PeqLab,	Germany).	For	real-time	two-step	RT-PCR	analysis,	the	sense	and	antisense	primers	
used	are	listed	in	Table	1.	The	following	genes	were	analyzed:	aggrecan	(ACAN),	collagen	type	
IIA1	(COL2A1),	versican	(VCAN)	and	collagen	type	IA1	(COL1A1).	Glyceraldehyde	3-phosphate	
dehydrogenase	 (GAPDH)	was	 used	 as	 housekeeping	 gene.	 Real-time	 two-step	RT-PCR	was	
performed	using	the	Real	Time	ready	RNA	Virus	Master	assay	and	LightCycler®	2.0	instrument	
(Roche,	 Germany).	 Relative	 gene	 expression	 levels	 were	 calculated	 by	means	 of	 the	 2-ΔCT	
formula.	
	
	
	 UPL	probe#	 Sense	primer	 Antisense	primer	
	 	 	 	
Target	genes	
ACAN	 79	 5ʹ-TGCAGCTGTCACTGTAGAAACTT-3ʹ	 5ʹ-ATAGCAGGGGATGGTGAGG-3’	
COL1A1	 15	 5ʹ-ATGTTCAGCTTTGTGGACCTC-3ʹ	 5ʹ-CTGTACGCAGGTGATTGGTG-3ʹ	
COL2A1	 19	 5ʹ-CCCTGGTCTTGGTGGAAAC-3ʹ	 5ʹ-	TCCTTGCATTACTCCCAACTG-3ʹ	
VCAN	 54	 5ʹ-GCACCTGTGTGCCAGGATA-3ʹ	 5ʹ-CAGGGATTAGAGTGACATTCATCA-3ʹ	
	 	 	 	
Housekeeping	gene	
GAPDH	 60	 5ʹ-GCTCTCTGCTCCTCCTGTTC-3ʹ	 5ʹ-ACGACCAAATCCGTTGACTC-3ʹ	
	
Table	1.	Sequences	of	target	genes	and	reference	gene	for	real-time	two-step	PCR.	
	
	
Cell	study	II:	performance	of	bilayer	BNC	scaffolds	in	vivo	
Rapid	isolation	of	human	nasoseptal	chondrocytes	and	bone	marrow	mononuclear	cells	
Nasoseptal	cartilage	was	obtained	from	male	and	female	patients	(n=47;	mean	age	31	years;	
age	range	18-69	years)	undergoing	routine	reconstructive	septorhinoplasty	at	the	Department	
of	Otorhinolaryngology	of	Ulm	University	Medical	Center	(Ulm,	Germany)	as	waste	material	
  
after	surgery,	with	approval	of	the	local	medical	ethics	committee	(no.	152/08).	The	collected	
nasoseptal	 cartilage	was	washed	with	PBS	containing	penicillin-streptomycin	and	stored	 in	
standard	 culture	 medium	 at	 37°C,	 5%	 CO2,	 until	 further	 use.	 The	 47	 nasoseptal	 cartilage	
biopsies	were	divided	in	three	pools	for	the	chondrocyte	isolations.	Bone	marrow	aspirate	was	
collected	 from	 three	 donors	 (mean	 age	 70	 years,	 2	 males,	 1	 female)	 during	 total	 hip	
replacement	surgery,	after	acquiring	written	patient	consent.	The	isolations	of	NCs	from	the	
cartilage	 and	MNCs	 from	 the	 bone	marrow	were	 performed	 by	 CellCoTec	 (Bilthoven,	 the	
Netherlands).	Patented	clinically	applied	protocols	were	used	to	isolate	the	cells	within	the	
hour	 [347].	 In	 brief,	 cartilage	 pieces	 were	 digested	 enzymatically	 under	 mechanical	
stimulation.	Upon	rapid	digestion,	any	remaining	debris	was	filtered	out	with	a	100-µm	cell	
strainer.	For	the	collection	of	MNCs,	the	bone	marrow	aspirate	was	relieved	of	its	erythrocyte	
content	using	lysis	buffer.	Standard	cell	buffer	was	used	for	washing	steps.	Cell	numbers	and	
viability	were	measured	using	the	Bürker-Türk	method	with	trypan-blue	exclusion.	
	
Seeding	of	bilayer	BNC	scaffolds	with	MNCs	and	NCs	
First,	bilayer	BNC	scaffolds	were	freeze-dried	in	order	to	improve	cell	uptake	during	the	cell	
seeding.	To	further	improve	the	retention	of	cells	in	the	scaffolds,	cells	were	seeded	in	1.1	%	
w/w	alginate	solution	(CellMed	AG).	Cells	encapsulated	in	alginate	were	then	seeded	in	bilayer	
BNC	scaffolds	as	a	combination	of	80%	freshly	isolated	human	MNCs	and	20%	freshly	isolated	
human	NCs	at	a	total	cell	concentration	of	20	×	106	cells/ml	alginate	(MNC/NC,	n=4).	200	µl	of	
the	 cell-alginate	 suspension	was	 seeded	 into	 the	porous	 layer	of	 each	 scaffold.	A	 cell-free	
alginate	solution	acted	as	a	negative	control	(Cell-free,	n=4).	Subsequently,	the	alginate	was	
instantaneously	crosslinked	with	sterile	100	mM	CaCl2	for	10	minutes	and	washed	with	0.9%	
NaCl,	followed	by	high	glucose	DMEM	(Dulbecco's	Modified	Eagle's	Medium).	
	
Subcutaneous	implantation	of	constructs	in	mice	
To	 evaluate	 the	 stability	 of	 the	 bilayer	 BNC	 scaffolds	 and	 neocartilage	 formation	 in	 vivo,	
MNC/NC-seeded	and	cell-free	bilayer	BNC	scaffolds	were	implanted	subcutaneously	on	the	
dorsal	side	of	9-week-old	nude	female	mice	(n=2;	NMRI	nu/nu,	Charles	River	Laboratories,	the	
Netherlands).	Mice	were	placed	under	general	anesthesia	using	2.5%	isoflurane.	Two	separate	
subcutaneous	incisions	of	approximately	1	cm	were	made	along	the	central	line	of	the	spine	
(1	at	 the	 shoulders	and	1	at	 the	hips),	 after	which	4	 separate	 subcutaneous	pockets	were	
prepared	by	blunt	dissection	of	 the	 subcutaneous	 tissue.	 The	overall	 behavior	 and	wound	
healing	at	the	implant	sites	were	assessed	macroscopically	over	the	implantation	period.	Eight	
weeks	 after	 subcutaneous	 implantation,	 animals	 were	 terminated	 and	 samples	 were	
explanted.	Each	sample	was	cut	in	half	and	one	part	was	used	for	histology	and	the	other	part	
for	 biomechanical	 and	 biochemical	 analyses.	 Animal	 experiments	 were	 carried	 out	 with	
approval	 of	 the	 local	 Animal	 Experiments	 Committee	 of	 the	 Erasmus	MC,	 Rotterdam,	 the	
Netherlands	(EMC	2429).	
	
Histological	and	immunohistochemical	analyses	
After	8	weeks	of	subcutaneous	implantation,	constructs	were	harvested,	set	in	2%	agarose,	
fixed	in	10%	neutral	buffered	formalin	solution,	embedded	in	paraffin	and	sectioned	(6	μm).	
  
To	 examine	 proteoglycans	 present	 in	 the	 newly	 synthesized	 ECM,	 deparaffinized	 sections	
were	 stained	with	 Safranin	O	 and	 fast	 green.	 To	 allow	 the	 use	 of	 the	monoclonal	mouse	
antibody	collagen	type	II	(II-II6B3,	1:100;	DSHB)	on	constructs	which	had	been	implanted	in	
nude	mice,	we	coupled	the	first	and	second	antibody	before	applying	them	on	the	sections	to	
prevent	 unwanted	 binding	 of	 the	 anti-mouse	 antibodies	 to	 mouse	 immunoglobulins,	 as	
described	previously	 [214].	 In	 short,	 the	primary	antibody	was	pre-coupled	overnight	with	
goat	anti-mouse	biotin	at	4°C	(1:500;	Jackson	Laboratories,	ME,	USA),	followed	by	a	2	hour	
incubation	 in	 0.1%	 normal	 mouse	 serum	 (CLB,	 the	 Netherlands)	 in	 order	 to	 capture	 the	
unbound	 second	antibody.	Antigen	 retrieval	was	performed	 through	 incubation	with	0.1%	
pronase	 in	 PBS	 for	 30	 minutes	 at	 37°C,	 followed	 by	 a	 30	 minute	 incubation	 with	 1%	
hyaluronidase	in	PBS	at	37°C.	Non-specific	binding	sites	were	blocked	with	10%	goat	serum	in	
PBS	and	sections	were	stained	with	the	pre-treated	antibodies	for	60	minutes.	Sections	were	
then	 incubated	 with	 enzyme-streptavidin	 conjugate	 (1:100;	 Biogenex,	 California,	 USA)	 in	
PBS/1%	BSA,	followed	by	incubation	with	Neu	Fuchsin	substrate	(Chroma,	Germany).	Positive	
staining	for	type	II	collagen	was	confirmed	with	the	use	of	native	ear	cartilage.	A	monoclonal	
mouse	IgG1	antibody	(X0931;	Dako)	was	used	as	a	negative	control.	
	
Biochemical	analysis	
Sulfated	glycosaminoglycans	(sGAG)	were	quantified	using	the	1,9-Dimethylmethylene	blue	
(DMMB)	dye-binding	assay.	First,	alginate	was	dissolved	in	55	mM	sodium	citrate	and	digested	
overnight	at	56°C	in	papain	(250	µg/ml	in	0.2	M	NaH2PO4,	0.01	M	EDTA,	containing	5	mM	L-
cysteine;	pH	6.0).	To	be	suitable	for	cell	cultures	containing	alginate,	the	DMMB-pH-level	was	
decreased	to	pH	1.75,	as	described	previously	[353].	The	metachromatic	reaction	of	DMMB	
was	monitored	using	a	spectrophotometer.	Absorption	ratios	of	540	and	595	nm	were	used	
to	determine	the	sGAG	content	with	chondroitin	sulfate	C	derived	from	shark	as	a	standard.	
The	amount	of	sGAG	was	expressed	per	tissue	wet	weight	(n=4).	
	
Biomechanical	analysis	
Mechanical	 properties	 of	 the	 retrieved	 constructs	 (n=8,	 MNC/NC-seeded	 and	 cell-free	
scaffolds)	and	non-implanted	bilayer	BNC	scaffolds	containing	cell-free	alginate	solution	(n=5,	
non-implanted	 group)	were	 assessed	with	 uniaxial	materials	 testing	machine	 (Z005,	 Zwick	
GmbH,	Germany)	 equipped	with	 a	 10	N	 load	 cell,	 a	 cylindrical	 plane-ended	 stainless	 steel	
indenter	(Ø	0.35	mm)	and	a	built-in	displacement	control.	Bilayer	BNC	scaffolds	were	placed	
in	 close-fitting	 stainless	 steel	 cylindrical	 wells	 containing	 PBS	 supplemented	 with	 1%	
antibiotic/antimycotic	 solution.	 Stress	 relaxation	 testing	 was	 performed	 as	 described	
previously	 [354].	 Briefly,	 a	 preload	of	 3	mN	was	 first	 applied	 on	 the	 sample	 to	 locate	 the	
sample	surface	and	measure	sample	thickness,	and	held	for	5	minutes.	Five	successive	strain	
steps	were	then	applied	 in	5%	 increments	of	 the	original	sample	thickness,	and	specimens	
were	left	to	relax	for	20	minutes	at	each	step.	The	hold	time	was	defined	as	the	time	necessary	
to	reach	equilibrium.	Two	locations	were	tested	on	each	sample	(center	of	the	sample,	and	
1.2	mm	off-center).	Measurements	of	maximum	stress	 (σmax),	 instantaneous	modulus	 (Ein)	
and	 equilibrium	 modulus	 (Eeq)	 were	 computed	 from	 the	 stress-strain	 curves,	 which	 are	
normalized	for	sample	thickness.	Additionally,	a	relaxation	half-life	time	(t1/2),	defined	as	the	
  
time	 needed	 for	 the	 stress	 to	 decrease	 to	 half	 of	 its	 maximum	 value,	 was	 computed	 to	
estimate	the	viscoelastic	relaxation	after	the	first	strain	application,	as	described	previously	
[329].	
	
Statistical	analysis	
Statistical	 analyses	 were	 performed	 with	 Statgraphics	 Centurion	 Version	 17	 (Statpoint	
Technologies,	VA,	USA).	For	cytotoxicity	analysis,	comparison	of	means	was	assessed	by	one-
way	ANOVA,	followed	by	Tukey’s	HSD	test	for	post	hoc	comparisons.	For	biochemical	analysis,	
a	 two-sample	 Kolmogorov-Smirnov	 test	 was	 performed	 for	 comparing	 two	 groups.	 For	
biomechanical	analysis,	comparison	of	means	was	assessed	by	one-way	ANOVA	and	Tukey’s	
HSD	test.	When	the	data	did	not	meet	the	requirements	for	a	parametric	test,	a	Kruskal-Wallis	
test	was	performed,	followed	by	the	Mann–Whitney	test	for	post	hoc	comparisons.	Values	of	
p<0.05	were	 considered	 statistically	 significant.	 The	mean	and	 standard	deviation	 (SD)	are	
presented.	
	
	 	
  
RESULTS	
	
Production	and	morphological	characterization	of	bilayer	BNC	scaffolds	
	
	
	
Figure	1.	Fabrication	and	purification	process	of	bilayer	BNC	scaffolds	composed	of	a	dense	
nanocellulose	layer	joined	with	a	macroporous	composite	layer.		
BNC	hydrogel	disks	with	cellulose	content	of	17%	(i.e.	dense	 layer)	were	produced	by	compression,	whereas	
BNC/alginate	composite	scaffolds	(i.e.	porous	layer)	were	fabricated	by	a	freeze-drying	process.	A	novel	cellulose	
solvent	system	(i.e.	ionic	liquid	EMIMAc)	was	used	to	achieve	a	strong	interfacial	molecular	bonding	between	
the	dense	and	porous	layers.	The	bilayer	BNC	scaffolds	were	then	washed	with	endotoxin-free	water	for	14	days	
to	yield	non-pyrogenic	and	non-cytotoxic	scaffolds.	
	
	
Bilayer	BNC	scaffolds,	composed	of	a	dense	nanocellulose	layer	joined	with	a	macroporous	
composite	layer	of	nanocellulose	and	alginate,	were	successfully	fabricated.	(Figures	1	and	2)	
The	dense	and	porous	layers	were	stable	and	firmly	attached,	which	facilitated	the	handling	
of	 the	 scaffolds	 during	 the	 purification	 process	 and	 throughout	 the	 study.	 SEM	 images	
revealed	a	compact	BNC	network	structure	in	the	dense	layer	and	a	macroporous	structure	in	
the	porous	layer.	However,	information	about	the	pore	size	distribution	was	not	possible	to	
extract	 from	these	 images	(Figure	2B,	C).	Scanning	and	reconstruction	with	microCT	of	the	
micro-	 and	 macro-structures	 of	 the	 porous	 layer	 allowed	 computation	 of	 the	 3D	
morphometric	parameters	by	distance	transformation.	The	Sc.Po,	Pore.Th,	Wall.Th	and	Wall.N	
of	a	typical	porous	layer	of	a	BNC	bilayer	scaffold	was	75%,	50	±	25	µm,	18	±	10	µm	and	21	
mm-1,	respectively.	(Figure	2F,	G)	
	
  
	
Figure	2.	Scanning	electron	microscopy	and	microtomography	of	bilayer	BNC	scaffold.	
(A)	 Photograph	of	bilayer	BNC	 scaffold	 (side	view).	Comparison	between	 (B,C)	 scanning	electron	microscopy	
images	of	bilayer	BNC	scaffolds	and	(D)	3D	reconstructed	model	of	the	porous	 layer	using	microtomography.	
Similar	honeycomb	arrangement	of	sheet-like	structures	is	visible	in	both	images.	(E)	Higher	magnification	of	the	
area	marked	red	in	(D).	Morphometric	analysis	of	segmented	porous	layer:	(F)	Morphometric	parameters	(Sc.Po	
=	Scaffold	Porosity	;	Pore.Th	=	Volume-weighted	mean	pore	size	;	Wall.Th	=	Scaffold	Wall	Thickness	;	and	Wall.N	
=	Scaffold	Wall	Number)	and	(G)	histogram	of	pore	size	distribution.		
	
	
Purification	of	bilayer	BNC	scaffolds	
The	bilayer	BNC	scaffolds	were	successfully	purified	from	endotoxins,	as	shown	by	the	 low	
endotoxin	level	(0.15	±	0.09	EU/ml)	found	after	14	days	of	washing	with	endotoxin-free	water.	
(Table	2)	This	value	is	three	times	lower	than	the	endotoxin	limit	(0.5	EU/ml)	set	by	the	FDA	
for	medical	devices	[352].	The	result	from	endotoxin	analysis	verified	the	effectiveness	of	the	
purification	process	to	remove	endotoxins	from	the	bilayer	BNC	scaffolds.	
  
Sample#	 Dilution	 Results	(EU/ml)	
Spike	
recovery	(%)	 Status	
Mean	±	SD	
(EU/ml)	
	 	 	 	 	 	
1	 1/10	 0.26	 59	 Valid	 0.15	±	0.09	
2	 1/10	 0.10	 90	 Valid	 	
3	 1/10	 0.10	 55	 Valid	 	
	
Table	2.	
Results	 from	 bacterial	 endotoxin	 testing.	 Assay	 sensitivity	 0.005	 Endotoxin	 Units	 per	 ml	 (EU/ml).	 Valid	 test	
parameter:	each	sample	 is	 tested	with	a	positive	product	control	 (PPC)	of	0.1	EU/ml.	 If	 the	spike	 recovery	 is	
between	50	and	200	%	of	the	PPC,	the	result	is	valid.	According	to	the	FDA,	endotoxin	levels	in	medical	devices	
are	not	to	exceed	0.5	EU/ml	or	20	EU/device.	[352]	
	
	
The	removal	of	EMIMAc	residues	from	the	bilayer	BNC	scaffolds	was	analyzed	with	ATR-FTIR	
spectroscopy.	The	strong	peak	at	wavenumber	1566	cm-1,	observed	in	the	ATR	spectrum	of	
EMIMAc	 solution,	was	used	 to	detect	 EMIMAc	 residues	 in	 the	ATR	 spectra	of	 bilayer	BNC	
scaffolds.	This	peak	 is	composed	of	 two	overlapped	peaks	that	correspond	to	the	carboxyl	
group	of	the	acetate	and	an	underlying	ring	mode	of	the	cation,	as	shown	by	previous	studies.	
[355,	356]	A	small	peak	at	1566	cm-1	was	also	found	in	the	ATR	spectra	of	bilayer	BNC	scaffolds	
after	1	and	7	days	of	purification.	However,	the	absence	of	the	peak	at	1566	cm-1	in	the	ATR	
spectra	of	samples	that	were	washed	for	14	days	confirmed	the	removal	of	EMIMAc	residues	
from	 the	 bilayer	 BNC	 scaffolds.	 (Figure	 3A)	 In-vitro	 cytotoxicity	 testing	 supported	 this	
observation.	An	one-way	ANOVA	was	conducted	to	compare	the	effect	of	cytotoxic	residues	
extracted	 from	 BNC	 bilayer	 scaffolds	 (i.e.	 at	 7	 and	 14	 days	 of	 purification)	 and	 control	
conditions	on	cell	viability.	There	was	a	significant	effect	of	extracted	cytotoxic	residues	on	
levels	of	cell	viability	for	the	four	conditions,	F(3,	20)	=	120.42,	p<0.0001,	ω	=	0.97.	Post	hoc	
comparisons	using	the	Tukey	HSD	test	 indicated	that	the	mean	cell	viability	 for	the	14-day	
condition	 (97.8	 ±	 4.7%)	was	 significantly	 higher	 than	 the	 7-day	 (18.4	 ±	 3.6%)	 and	positive	
control	conditions	 (25.6	±	5.5%)	at	 the	p<0.05	 level.	Furthermore,	 there	was	no	significant	
difference	between	the	negative	control	and	14-day	conditions.	Thus,	the	cytotoxic	potential	
of	bilayer	BNC	scaffolds,	after	14	days	of	washing	with	endotoxin-free	water,	was	classified	as	
non-cytotoxic	(cell	viability	>	71%).	(Figure	3B)	
	
  
	
Figure	3.	Purification	and	cytotoxicity	testing	of	bilayer	BNC	scaffold.	
(A)	ATR	spectra	of	(1)	1-Ethyl-3-methylimidazolium	acetate	(EMIMAc)	;	bilayer	BNC	scaffolds	after	(2)	1	day,	(3)	
7	days	and	(4)	14	days	of	purification	in	endotoxin-free	water	;	and	(5)	pure	BNC.	(B)	In	vitro	cytotoxicity	testing	
of	bilayer	BNC	scaffolds	after	7	and	14	days	of	purification	in	endotoxin-free	water	(n=4	per	time	point).	Post	hoc	
comparisons	using	the	Tukey	HSD	test	indicated	that	the	mean	cell	viability	for	the	14-day	condition	(97.8	±	4.7%)	
was	significantly	higher	than	the	7-day	(18.4	±	3.6%)	and	positive	control	conditions	(25.6	±	5.5%)	at	the	*p<	0.05	
level.	 Furthermore,	 there	was	no	 significant	difference	between	 the	negative	 control	 and	14-day	 conditions.	
Thus,	the	cytotoxic	potential	of	bilayer	BNC	scaffolds	after	14	days	of	purification	was	classified	as	non-cytotoxic	
(cell	viability	>71%).	Error	bars	represent	the	standard	deviation	of	the	mean.	
	
	
Performance	of	bilayer	BNC	scaffolds	and	neocartilage	formation	in	vitro	
Gross	 examination	 of	 the	 cell-seeded	 constructs	 throughout	 the	 6	 weeks	 of	 cell	 culture	
revealed	that	the	adhesion	between	the	dense	support	layer	and	porous	layer	remained	good.	
Moreover,	 the	 size	and	shape	of	 the	bilayer	BNC	scaffolds	 remained	stable	during	 the	cell	
culture.	 Deposition	 of	 ECM	 by	 the	 NCs	 seeded	 in	 bilayer	 BNC	 scaffolds	 was	 assessed	
qualitatively	 by	 immunohistological	 staining.	 During	 3D	 culture,	 NCs	 produced	 and	
accumulated	 cartilage-specific	 ECM	 components	 in	 the	 bilayer	 BNC	 scaffolds.	 A	 positive	
staining	 for	 sGAGs	was	 found	 around	 clusters	 of	 chondrocytes	 in	 the	porous	 layer	 after	 2	
weeks	of	culture,	as	shown	by	the	Alcian	blue	staining.	(Figure	4A)	Moreover,	synthesis	and	
accumulation	of	sGAGs,	aggrecan	as	well	as	type	II	collagen	increased	visibly	during	3D	culture.	
(Figure	4A-C)	After	6	weeks	of	3D	culture,	a	homogeneous	production	of	chondrogenic	ECM	
was	observed	throughout	the	porous	layer,	even	at	the	center.	However,	fibrocartilage	ECM	
was	also	synthesized	by	the	NCs	in	the	bilayer	BNC	scaffolds,	as	demonstrated	by	the	positive	
immunostaining	of	type	I	collagen.	(Figure	4D)	
The	capacity	of	NCs	to	synthesize	cartilage-specific	ECM	components	when	seeded	in	
the	BNC	scaffold	was	also	 investigated	on	 the	basis	of	 the	expression	of	 the	chondrogenic	
marker	genes	ACAN	and	COL2A1.	To	assess	whether	the	NCs	were	able	to	redifferentiate	and	
maintain	their	chondrogenic	phenotype,	the	expression	not	only	of	the	chondrogenic	markers	
but	 also	 of	 the	 dedifferentiation	 markers,	 VCAN	 and	 COL1A1,	 was	 determined.	 Gene	
expression	 analyses	 confirmed	 the	 positive	 immunostains	 of	 aggrecan,	 type	 II	 and	 type	 I	
collagen.	NCs	cultured	in	bilayer	BNC	scaffolds	were	able	to	express	ACAN	and	COL2A1.	The	
expression	 of	 both	 chondrogenic	markers	 increased	 clearly	 during	 3D	 culture	 for	 up	 to	 6	
  
weeks.	ACAN	and	COL2A1	expression	after	6	weeks	was	3.4-	and	4.9-fold	higher,	respectively,	
compared	to	gene	expression	levels	at	week	2.	Expression	of	COL1A1	was	also	upregulated	
during	 3D	 culture,	where	 after	 6	weeks	was	 1.7-fold	 higher	 compared	 to	 gene	 expression	
levels	at	week	2.	On	the	other	hand,	expression	of	VCAN	 remained	relatively	close	to	zero	
during	the	6	weeks	of	3D	culture.	(Figure	4E,	F)	The	upregulation	of	the	chondrogenic	markers	
ACAN	 and	COL2A1	 was	 clearly	 enhanced	 compared	 to	 the	 expression	 of	 dedifferentiation	
markers,	revealing	the	chondrogenic	potential	of	the	NCs	in	the	bilayer	BNC	scaffolds.	
Cell	ingrowth	and	cell	distribution	in	the	bilayer	BNC	scaffolds	were	also	assessed	by	
histological	analysis.	As	demonstrated	in	figure	4A,	the	porous	layer	supported	the	ingrowth	
of	NCs	and	facilitated	a	homogeneous	cell	distribution.	However,	it	took	4	weeks	of	in-vitro	
culture	to	get	a	dense	and	homogenous	cell	distribution	since	there	was	a	substantial	loss	of	
cells	after	 seeding	 in	medium.	As	a	means	 to	 increase	 the	number	of	 cells	 retained	 in	 the	
scaffolds,	cells	were	seeded	in	alginate	solution.	This	significantly	improved	cell	retention	in	
the	scaffolds,	even	after	1	day	of	seeding.	(Data	not	shown)	
	
Performance	of	bilayer	BNC	scaffolds	and	neocartilage	formation	in	vivo	
The	stability	and	neocartilage	formation	in	MNC/NC-seeded	and	cell-free	bilayer	BNC	scaffolds	
were	evaluated	after	8	weeks	of	subcutaneous	implantation	in	nude	mice.	The	mice	survived	
until	the	end	of	the	study	period,	during	which	no	extrusion	of	constructs	was	observed.	At	8	
weeks	post-implantation,	a	thin	fibrous	capsule	surrounded	all	MNC/NC-seeded	and	cell-free	
bilayer	 BNC	 scaffolds	 -	 considered	 a	 normal	 non-pathological	 foreign	 body	 reaction.	
Macroscopic	examination	of	the	explants	revealed	that	the	shape	and	size	of	the	bilayer	BNC	
scaffolds	remained	stable	and	no	delamination	of	the	dense	and	porous	layers	was	observed	
in	 any	 of	 the	 constructs.	 Furthermore,	 bilayer	 BNC	 scaffolds	 seeded	 with	MNCs	 and	 NCs	
encapsulated	 in	 alginate	 had	 a	macroscopically	 cartilage-like	 appearance.	 These	MNC/NC-
seeded	 constructs	 were	 stiffer	 and	more	 stable	 upon	 handling,	 compared	 to	 bilayer	 BNC	
scaffolds	 seeded	 with	 cell-free	 alginate	 solution.	 The	 cells	 encapsulated	 in	 alginate	 were	
homogeneously	distributed	in	the	porous	layer	of	the	scaffolds	at	8	weeks	post-implantation,	
as	observed	by	the	histology	images.	(Figure	5B)	
Proteoglycan	 synthesis	 was	 examined	 using	 a	 Safranin-O	 staining.	 As	 expected,	 no	
positive	stain	for	Safranin-O	was	found	in	the	cell-free	bilayer	BNC	scaffolds.	Depositions	of	
proteoglycans	were	observed	in	the	MNC/NC-seeded	bilayer	BNC	scaffolds	after	8	weeks	of	
subcutaneous	 implantation,	as	shown	by	the	strong	Safranin-O	stain	surrounding	the	cells.	
(Figure	5B)	The	results	pointing	towards	chondrogenic	ECM	produced	by	the	cells	in	the	bilayer	
BNC	scaffolds	were	confirmed	by	the	positive	immunostaining	of	type	II	collagen,	which	was	
intensely	stained	in	areas	of	the	construct.	(Figure	5B)	Moreover,	a	Kolmogorov-Smirnov	test	
indicated	a	significant	difference	(p<0.05)	between	mean	sGAG	content	for	MNC/NC-seeded	
(0.87	 ±	 0.65	 μg	 sGAG/mg	wet	weight)	 and	 cell-free	 bilayer	 BNC	 scaffolds	 (0.07	 ±	 0.11	 μg	
sGAG/mg	wet	weight).	 sGAG-production	 in	 the	MNC/NC	 group	was	 almost	 12-fold	 higher	
compared	to	the	control	condition.	(Figure	5C)	
  
	
Figure	4.	Performance	of	bilayer	BNC	scaffolds	and	neocartilage	formation	in	vitro.	
Histological	and	immunohistochemical	analysis	of	human	NCs	after	2,	4	and	6	weeks	of	culture	in	vitro	on	bilayer	
BNC	 scaffolds.	 Samples	were	 stained	with	 (A)	 Alcian	 blue	 to	 detect	 deposition	 of	 sGAG	 (PL	=	 porous	 layer).	
Immunohistochemical	staining	was	used	to	detect	cartilage-specific	proteins	such	as	(B)	aggrecan,	(C)	collagen	
type	II	and	(D)	the	dedifferentiation	marker	collagen	type	I.	(E	and	F)	Gene-expression	analysis	of	human	NCs	
seeded	in	bilayer	BNC	scaffolds	and	cultured	in	vitro	for	2,	4	and	6	weeks	(n=4	per	time	point).	Gene-expression	
levels	 of	ACAN,	 COL2A1,	 COL1A1	 and	VCAN	 relative	 to	 the	 housekeeping	 gene	 glyceraldehyde	 3-phosphate	
dehydrogenase	(GAPDH).	Error	bars	represent	the	standard	deviation	of	the	mean.	The	scale	bar	indicates	1	mm.	
	
	
Biomechanical	analysis	
A	typical	stress	relaxation	behavior	was	observed	in	all	bilayer	BNC	scaffolds	(MNC/NC-seeded	
and	cell-free	controls),	and	the	following	measurements	were	determined	for	the	MNC/NC-
seeded	constructs	at	8	weeks	post-implantation;	0.76	±	0.19	MPa	for	Ein,	0.19	±	0.08	MPa	for	
Eeq,	0.16	±	0.07	MPa	for	σmax	and	7.1	±	3.4	seconds	for	t1/2.	A	one-way	ANOVA	was	conducted	
to	compare	the	effect	of	implantation	and	seeding	of	MNC/NCs	on	initial	matrix	stiffness	(i.e.	
Ein)	 of	 the	 constructs	 at	 8	 weeks	 post-implantation.	 There	 was	 a	 significant	 effect	 of	
  
implantation	and	seeding	of	MNC/NCs	on	 instantaneous	modulus	for	the	three	conditions,	
F(2,	23)	=	16.10,	p<0.0001,	ω	=	0.73.	Post	hoc	comparisons	using	the	Tukey	HSD	test	indicated	
that	the	mean	Ein	for	the	MNC/NC	condition	(0.76	±	0.19	MPa)	was	significantly	higher	than	
the	non-implanted	(0.42	±	0.15	MPa)	and	cell-free	conditions	(0.32	±	0.10	MPa)	at	the	p<0.05	
level.	 The	cell-free	 implanted	condition	did	not	 significantly	differ	 from	 the	non-implanted	
condition.	(Figure	5D)	
Moreover,	a	Kruskal–Wallis	test	was	conducted	to	compare	the	effect	of	implantation	
and	seeding	of	MNC/NCs	on	relaxation	kinetics	(i.e.	t1/2)	and	intrinsic	properties	(i.e.	Eeq	and	
σmax)	of	the	constructs	at	8	weeks	post-implantation.	The	median	t1/2	values	of	the	constructs	
were	 significantly	 affected	 by	 the	 implantation	 and	 seeding	 of	 MNC/NCs,	 H(2)	 =	 17.46,	
p<0.001.	However,	Eeq	and	σmax	were	not	significantly	affected	by	the	tested	conditions,	H(2)	
=	4.19,	p	=	0.12	and	H(2)	=	1.12,	p	=	0.57,	respectively.	Post	hoc	comparisons	using	the	Mann–
Whitney	tests	indicated	that	the	median	t1/2	for	the	MNC/NC	condition	was	significantly	higher	
than	the	non-implanted	(U	=	3,	p<0.001,	r	=	-0.74)	and	cell-free	conditions	(U	=	48,	p<0.01,	r	=	
-0.66).	 No	 significant	 differences	 in	 t1/2	 were	 detected	 between	 the	 cell-free	 and	 non-
implanted	conditions.	A	2.4-	and	3.4-fold	higher	Ein	and	t1/2,	respectively,	were	observed	in	
the	MNC/NC-seeded	constructs	compared	to	the	cell-free	group.	Likewise,	a	1.8-	and	3.6-fold	
higher	Ein	and	t1/2,	respectively,	was	observed	in	the	MNC/NC-seeded	constructs	compared	
to	the	non-implanted	group.	(Figure	5D)	
	 	
  
	
Figure	5.	Performance	of	bilayer	BNC	scaffolds	and	neocartilage	formation	in	vivo.	
(A)	 Photographs	 of	 cell-free	 and	 MNC/NC-seeded	 bilayer	 BNC	 scaffolds	 after	 8	 weeks	 of	 subcutaneous	
implantation.	(B)	Histological	evaluation	of	ECM	in	bilayer	BNC	scaffolds	seeded	with	a	combination	of	freshly	
isolated	NCs	and	MNCs	 in	alginate	after	8	weeks	of	subcutaneous	 implantation.	Safranin-O	stain	was	used	to	
examine	proteoglycans	present	in	the	newly	synthesized	ECM,	whereas	immunohistochemical	analysis	was	used	
to	 detect	 type	 II	 collagen.	 (C)	 Cell-free	 and	MNC/NC-seeded	 bilayer	 BNC	 scaffolds	 were	 analysed	 for	 sGAG	
content	after	8	weeks	of	subcutaneous	implantation	(n=4	per	group).	A	two-sample	Kolmogorov-Smirnov	test	
indicated	a	significant	difference	between	mean	sGAG	content	 for	MNC/NC-seeded	and	cell-free	bilayer	BNC	
scaffolds.	 (D)	 Biomechanical	 evaluation	 of	 cell-free	 and	 MNC/NC-seeded	 constructs	 after	 8	 weeks	 of	
subcutaneous	 implantation	 (n=4	 per	 group),	 and	 non-implanted	 bilayer	 BNC	 scaffolds	with	 cell-free	 alginate	
solution	 (n=5).	Post	hoc	comparisons	using	 the	Tukey	HSD	 test	 indicated	 that	 the	mean	Ein	 for	 the	MNC/NC	
condition	 was	 significantly	 higher	 than	 the	 non-implanted	 and	 cell-free	 conditions.	 Moreover,	 post	 hoc	
comparisons	 using	 the	Mann	Whitney	 tests	 indicated	 that	 the	median	 t1/2	 for	 the	MNC/NC	 condition	 was	
significantly	higher	than	the	non-implanted	and	cell-free	conditions.	Error	bars	represent	the	standard	deviation	
of	the	mean.	*,	**	or	***	indicates	p-values	less	than	0.05,	0.01	or	0.001,	respectively.	The	scale	bars	indicate	4	
mm	(A)	and	1	mm	(B).	
  
DISCUSSION	
	
A	novel	bilayer	BNC	scaffold	was	successfully	evaluated	for	auricular	cartilage	TE.	This	study	
demonstrates	 that	 non-pyrogenic	 and	 non-cytotoxic	 bilayer	 BNC	 scaffolds	 offer	 a	 good	
mechanical	stability	and	maintain	a	structural	integrity	while	providing	a	porous	architecture	
that	supports	cell	ingrowth.	Moreover,	bilayer	BNC	scaffolds,	together	with	alginate,	provide	
a	suitable	environment	for	human	nasoseptal	chondrocytes	to	form	cartilage.	
As	shown	by	the	endotoxin	analysis,	the	purification	process	reduced	the	endotoxins	
in	the	bilayer	BNC	scaffolds	to	a	level	well	below	the	endotoxin	limit	set	by	the	FDA	for	medical	
devices	 [352].	 This	 low	 endotoxin	 content	 (0.15	 ±	 0.09	 EU/ml)	 found	 in	 the	 bilayer	 BNC	
scaffolds	is	in	good	agreement	with	our	previous	results	(0.10	EU/ml,	[316]),	where	densified	
BNC	hydrogel	disks	 (i.e.	dense	 layer)	of	 similar	dimensions	were	considered	non-pyrogenic	
after	purification	with	endotoxin-free	water	for	14	days.		
The	 ionic	 liquid	EMIMAc	offers	a	novel	cellulose	solvent	system	to	achieve	a	strong	
interfacial	molecular	bonding	between	 the	 cellulosic	dense	and	porous	 layers.	We	are	not	
aware	of	any	other	methods	that	can	achieve	such	result.	On	the	other	hand,	using	EMIMAc	
increases	the	risk	of	having	cytotoxic	compounds	in	the	bilayer	BNC	scaffolds,	if	these	residues	
are	not	properly	removed	during	the	purification	process.	Since	the	toxicity	of	ionic	liquids	is	
not	 well	 understood,	 the	 use	 of	 EMIMAc	 to	 fabricate	 the	 bilayer	 BNC	 scaffolds	 was	
investigated	with	precaution.	The	cytotoxicity	of	imidazole	ionic	liquids	has	been	studied	in	a	
human	lung	carcinoma	epithelial	cell	line	model,	and	it	was	found	that	the	alkyl-chain	length	
of	the	ionic	liquid	has	an	influence	on	cytotoxicity	[357].	However,	the	cytotoxicity	of	EMIMAc,	
in	particular,	has	not	been	studied	in	eukaryotes.	Consequently,	we	analyzed	the	removal	of	
EMIMAc	 from	 the	 bilayer	 BNC	 scaffolds	 with	 ATR-FTIR	 spectroscopy,	 followed	 by	 in-vitro	
cytotoxicity	testing	with	sensitized	L929	cells.	The	strong	peak	at	wavenumber	1566	cm-1	was	
used	to	detect	EMIMAc	residues	in	the	ATR	spectra	of	bilayer	BNC	scaffolds,	as	it	has	been	
shown	that	this	peak	is	composed	of	two	overlapped	peaks	that	correspond	to	the	carboxyl	
group	of	the	acetate	and	an	underlying	ring	mode	of	the	cation	[355,	356].	Since	the	peak	at	
1566	cm-1	was	found	in	the	ATR	spectra	of	bilayer	BNC	scaffolds	that	had	been	washed	for	1	
and	7	days,	it	was	considered	necessary	to	continue	washing	the	scaffolds	in	endotoxin-free	
water.	The	washing	process	proved	to	be	successful	in	removing	the	EMIMAc	residues,	as	first	
observed	in	the	ATR	spectra	of	samples	that	were	washed	for	14	days.	The	absence	of	this	
peak	confirmed	the	removal	of	EMIMAc	from	the	BNC	bilayer	scaffolds.		
In-vitro	 cytotoxicity	 testing	 supported	 our	 findings	 from	 ATR-FTIR.	 Bilayer	 BNC	
scaffolds	washed	for	7	days	still	had	residues	of	EMIMAc	that	were	highly	cytotoxic	to	L929	
cells	 (cell	 viability:	 18.4	 ±	 3.6%).	 However,	 these	 residues	were	 further	 reduced	 after	 the	
purification	process	with	endotoxin-free	water;	yielding	non-cytotoxic	bilayer	BNC	scaffolds.	
These	results	are	in	good	agreement	with	our	previous	study	which	evaluated	the	cytotoxic	
potential	of	pure	densified	BNC	hydrogel	disks	(i.e.	dense	layer)	and	found	the	material	to	be	
non-cytotoxic	 [316].	 Altogether,	 the	 results	 from	ATR-FTIR	 and	 in	 vitro	 cytotoxicity	 testing	
demonstrated	 that	 EMIMAc	 residues	 were	 successfully	 removed	 from	 the	 bilayer	 BNC	
scaffolds	after	the	purification	process	with	endotoxin-free	water;	whereat	no	peak	at	1566	
cm-1	and	no	cytotoxic	effects	were	observed.	
  
Macroscopic	examination	of	 the	bilayer	BNC	scaffolds	after	 the	 in	vitro	and	 in	vivo	 studies	
revealed	that	the	adhesion	between	the	dense	and	porous	layers	remained	stable,	as	there	
were	 no	 signs	 of	 adhesive	 failure.	We	 postulate	 that	 the	 interfacial	 bonding	 between	 the	
layers	is	like	a	molecular	welding	process.	As	the	BNC-EMIMAc	solution	partly	dissolves	both	
surfaces	at	the	interface,	this	makes	it	possible	for	the	long	chains	of	BNC	to	diffuse	into	both	
layers.	Once	the	dissolved	BNC	 is	precipitated	 in	ethanol,	 the	 interface	structure	 is	 locked,	
which	results	in	a	stable	interfacial	bonding.	We	have	observed	that	when	pulling	the	dense	
and	porous	layers	apart,	the	scaffold	breaks	at	the	porous	layer,	similar	to	a	structural	failure.	
In	contrast,	a	weak	adhesion	would	have	had	resulted	in	an	adhesive	or	cohesive	failure	at	the	
interface.	Based	on	this	observation	we	speculate	that	the	interfacial	bonding	between	the	
layers	is	stronger	than	the	structure	of	the	porous	layer,	although	in	this	study	the	interfacial	
strength	of	the	bilayer	BNC	scaffolds	was	not	measured.	
The	compact	BNC	network	structure	of	the	dense	layer	provided	a	good	mechanical	
stability,	while	the	interconnected	high	porosity	layer	(75%	porosity	with	mean	pore	size	of	50	
±	25	µm)	supported	the	ingrowth	and	homogeneous	distribution	of	NCs	throughout	this	layer.	
In	agreement	with	our	previous	study,	which	evaluated	BNC/alginate	composite	scaffolds	in	
vitro	 [343],	 bilayer	 BNC	 scaffolds	 also	 supported	 the	 redifferentiation	 of	 NCs	 to	 a	 more	
chondrogenic	phenotype,	which	led	to	the	formation	of	neocartilage;	as	demonstrated	by	the	
increase	 in	 gene	 expression	 of	 chondrogenic	 marker	 genes	 ACAN	 and	 COL2A1	 and	
homogeneous	distribution	of	cartilage-specific	ECM	after	6	weeks	of	in	vitro	culture.	Although,	
the	 expression	 of	 dedifferentiation	 marker	 VCAN	 remained	 constantly	 low,	 a	 strong	
expression	of	COL1A1	was	observed	during	the	in	vitro	culture.	The	presence	of	COL2A1	and	
COL1A1	 indicates	a	subpopulation	of	NCs	that	did	not	switch	to	a	chondrogenic	phenotype	
during	3D	culture	in	bilayer	BNC	scaffolds	under	chondrogenic	medium	conditions.		
After	 6	 weeks	 of	 in-vitro	 culture,	 a	 rich	 and	 homogenous	 distribution	 of	 cells	 and	
neocartilage	was	observed	throughout	the	porous	layer	of	the	scaffold,	even	in	the	center,	
which	is	known	to	be	a	critical	region	in	static	3D	culture	due	to	the	limited	supply	of	nutrients	
and	oxygen.	This	outcome	could	have	been	accelerated	by	increasing	the	percentage	of	cells	
retained	in	the	scaffolds	after	cell	seeding,	as	there	was	a	substantial	loss	of	cells	when	these	
were	seeded	in	medium.	Embedding	the	cells	in	alginate	significantly	improved	cell	retention	
in	the	scaffolds	after	seeding.	Alginate	was	chosen,	since	it	has	been	successfully	used	to	seed	
chondrocytes	in	a	scaffold	for	in	vivo	implantation	[358,	359]	and	this	hydrogel	is	well	known	
to	maintain	a	chondrogenic	phenotype	of	human	chondrocytes	and	stimulate	neocartilage	
formation	[348].		
In	 the	 in-vivo	 study	we	explored	 the	application	of	 a	 clinically	 relevant	 strategy,	by	
seeding	 bilayer	 BNC	 scaffolds	with	 a	 low	 number	 of	 freshly	 isolated	 human	 chondrocytes	
combined	with	freshly	isolated	human	mononuclear	cells,	in	order	to	test	the	translation	of	
this	auricular	cartilage	TE	technology	to	the	clinic.	At	8	weeks	post-implantation,	deposition	
of	 cartilage	matrix	 components	 such	 as	 proteoglycan	 and	 type	 II	 collagen	 were	 observed	
predominantly	 in	MNC/NC-seeded	constructs.	The	 strong	Safranin-O	stain	 surrounding	 the	
cells	showed	the	presence	of	proteoglycans	in	the	newly	synthesized	ECM,	while	the	presence	
of	 type	 II	 collagen	 was	 confirmed	 by	 immunohistochemistry.	 These	 results,	 showing	 the	
formation	of	neocartilage	in	the	porous	layer,	were	further	confirmed	by	biochemical	analysis;	
  
where	sGAG-production	in	the	MNC/NC-seeded	bilayer	BNC	scaffolds	was	significantly	higher	
than	the	control	condition	(12-fold).		
The	presence	of	cartilage	matrix	 in	the	bilayer	BNC	scaffolds	was	also	supported	by	
biomechanical	 analysis.	 At	 8	 weeks	 post-implantation,	 a	 significantly	 higher	 initial	 matrix	
stiffness	and	improved	relaxation	kinetics	(i.e.	higher	Ein	and	t1/2	values)	were	observed	in	the	
MNC/NC-seeded	scaffolds	compared	to	the	non-implanted	and	cell-free	conditions.	 In	fact,	
the	effect	size	(i.e.	ω	and	r	>	0.5)	obtained	from	the	Ein	and	t1/2	data	represents	a	large	effect	
by	the	MNC/NC	condition.	However,	there	was	no	significant	difference	in	Eeq	and	σmax	for	
the	 three	 conditions.	 Considering	 the	 improved	 relaxation	 kinetics	 in	 the	MNC/NC-seeded	
constructs,	we	conclude	that	the	ability	of	the	MNC/NC-seeded	scaffolds	to	attract	and	trap	
water	 was	 enhanced	 through	 the	 production	 and	 accumulation	 of	 proteoglycans	 and	
glycosaminoglycans	 in	 the	 bilayer	 BNC	 scaffolds.	 Nevertheless,	 since	 the	 intrinsic	 scaffold	
properties	did	not	improve	in	the	MNC/NC-seeded	constructs	compared	to	the	no	cell	control	
(no	 difference	 in	 Eeq),	 it	 implies	 that	 collagen	matrix	was	 not	 effectively	 produced	 in	 the	
porous	layer.	To	put	the	results	from	the	biomechanical	analysis	in	a	clinical	context,	the	values	
for	 instantaneous	 and	 equilibrium	moduli	measured	 from	 the	MNC/NC-seeded	 constructs	
after	8	weeks	of	implantation	were	8.4-	and	17.4-fold	lower,	respectively,	compared	to	human	
auricular	cartilage	(e.g.	6.4	±	3.2	MPa	for	Ein	and	3.3	±	1.3	MPa	for	Eeq	[329]).	Therefore,	the	
engineered	cartilage	as	such	would	not	be	suitable	for	immediate	ear	cartilage	replacement;	
rather	modifications	in	cell	concentration	and	perhaps	a	longer	implantation	period	needs	to	
be	considered.	
The	present	study	has	certain	limitations.	Firstly,	cell	density	plays	a	critical	role	when	
engineering	 functional	 and	 stable	 cartilage.	 Others	 have	 demonstrated	 that	 cell	 densities	
greater	 than	20	×	106	cells/ml	are	desirable,	while	 low	cell	densities	 resulted	 in	decreased	
cartilage	formation	[360].	During	embryology	of	cartilage,	densely	packed	and	proliferative	
mesenchymal	 cells	 are	 responsible	 for	 depositing	 the	 vast	 amount	 of	 cartilage	 ECM.	 In	
cartilage	 TE,	 early	 phase	 of	 cartilage	 development	 needs	 to	 be	 simulated	 to	 generate	
functional	 and	 stable	 cartilage.	 Therefore,	 in	 order	 to	 enhance	 the	 outcome	 of	 tissue-
engineered	auricular	cartilage,	a	higher	cell	density	is	needed	to	benefit	from	increased	cell-
cell	 contacts	 signaling	 chondrogenic	 ECM	 deposition	 and	 preventing	 the	 dedifferentiation	
process.	Despite	the	limitations	already	stated,	our	findings	support	that	bilayer	BNC	scaffolds	
in	combination	with	alginate	provide	a	suitable	environment	for	MNCs	and	NCs	to	support	the	
synthesis	 of	 neocartilage.	 Of	 equal	 importance,	 the	 use	 of	 freshly	 isolated	 human	
chondrocytes	and	mononuclear	cells	in	the	in	vivo	study	gave	us	an	indication	of	the	potential	
of	this	strategy	to	advance	the	translation	of	cell-aided	treatments	to	the	clinic.	
`	 Most	auricular	cartilage	TE	strategies	have	revolved	around	biodegradable	scaffolds,	
where	the	hypothetical	optimum	has	been	the	scaffold’s	degradation	orchestrated	by	the	neo-
tissue	 formation.	 It	 would	 be	 ideal	 if	 the	 scaffold	 could	 be	 degraded	 by	 the	 time	 the	
neocartilage	has	reached	full	mechanical	strength.	However,	fine-tuning	this	intricate	play	has	
proven	 to	 be	 a	 challenge	 in	 TE.	 If	 the	material	 degrades	 too	 rapidly,	 the	 neocartilage	will	
collapse.	Whereas	if	it	degrades	too	late,	it	could	induce	a	continuous	inflammation	that	would	
affect	the	cartilage	formation	and	when	the	material	is	finally	degraded	it	would	leave	holes	
in	the	tissue,	making	it	more	prone	to	crack	or	collapse.	Thus,	we	aim	for	a	hybrid	implant	–	
  
BNC	well	integrated	with	the	host	and	neo-tissue.	The	non-degradable	BNC	will	provide	long-
term	structural	integrity	after	implantation,	and	has	previously	shown	remarkable	integration	
with	 the	host	 tissue	 in	different	animal	models	 [313,	314,	316,	361].	A	novel	BNC	scaffold	
designed	with	a	bilayer	architecture	that	integrates	mechanical	stability	and	high	porosity	was	
successfully	 fabricated	 and	 evaluated	 for	 auricular	 cartilage	 TE,	 in	 vitro	 and	 in	 vivo.	 In	
conclusion,	 this	 study	 demonstrates	 that	 non-pyrogenic	 and	 non-cytotoxic	 bilayer	 BNC	
scaffolds	can	be	successfully	produced.	Furthermore,	such	scaffolds,	together	with	alginate,	
provide	a	 suitable	environment	 for	 culture-expanded	human	nasoseptal	 chondrocytes	and	
freshly	 isolated	 human	 nasoseptal	 chondrocytes	 combined	 with	 freshly	 isolated	 human	
mononuclear	 cells	 to	 form	 cartilage	 in	 vitro	 and	 in	 vivo.	 Most	 studies	 that	 have	 used	
biodegradable	 materials	 to	 engineer	 auricular	 cartilage	 have	 resulted	 in	 poor	 structural	
integrity	 of	 the	 scaffold	 after	 implantation	 due	 to	 the	 short-lived	 chemical	 stability	 of	 the	
scaffold	material.	This	study	found	that	bilayer	BNC	scaffolds	offer	a	good	mechanical	stability	
and	maintain	a	structural	 integrity	while	providing	a	porous	architecture	that	supports	cell	
ingrowth	 and	 neocartilage	 formation,	 as	 demonstrated	 by	 immunohistochemistry,	
biochemical	and	biomechanical	analyses.	Ongoing	work	 focuses	on	developing	bilayer	BNC	
scaffolds	in	the	shape	of	a	human	auricle,	aiming	to	provide	an	effective	treatment	to	serious	
auricular	defects.	
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Cartilage	plays	an	important	role	in	the	form	and	function	of	the	face	as	it	provides	flexibility	
and	mechanical	support	to	soft	tissues.	Once	damaged,	cartilage	defects	or	deficits	can	lead	
to	functional	problems	and	major	aesthetic	impairment.	Unfortunately,	cartilage	has	a	very	
limited	 capacity	 for	 self-regeneration.	 Currently,	 these	 defects	 are	 reconstructed	 with	
autologous	cartilage	grafts	or	artificial	 implants.	Although	autologous	cartilage	grafting	has	
been	 used	 successfully,	 the	 procedure	 requires	 a	 high	 degree	 of	 surgical	 expertise,	 is	
associated	with	 limited	availability	of	autologous	cartilage	and	can	cause	severe	donor	site	
morbidity.	Besides,	the	alternative	use	of	artificial	implants	is	questioned	in	the	head	and	neck	
area,	since	implants	in	this	area	are	prone	to	induce	a	foreign	body	reaction	and	frequently	
lead	to	extrusion.	[276]	Cartilage	tissue	engineering	offers	a	promising	solution	for	restoring	
missing	 or	 destructed	 cartilage	 and	 has	 the	 potential	 to	 overcome	 limitations	 of	 current	
treatments,	 re-establishing	 unique	 biological	 and	 functional	 properties	 of	 the	 tissue.	 The	
successful	translation	of	tissue-engineering	strategies	to	clinical	application	is	however	limited	
and	mainly	focusses	on	articular	and	tracheal	cartilage	tissue	engineering.	This	thesis	focusses	
on	the	generation	of	a	tissue-engineered	cartilaginous	framework	for	the	reconstruction	of	
cartilage	defects	in	the	face	and	evaluates	the	suitability	of	cells	or	combination	of	cells	on	
natural	scaffolds.	Therefore,	the	following	research	questions	have	been	answered:	
	
Q1	 What	are	the	biomechanical	and	biochemical	characteristics	of	native	facial	cartilages	
(i.e.	ear	and	nasal	cartilages)?	
Q2	 Which	cells	or	combination	of	cells	are	most	suitable	for	cell-based	cartilage	repair	in	
the	head	and	neck	area?	
Q3	 Which	 natural	 scaffolds	 (i.e.	 alginate,	 bacterial	 nanocellulose,	 decellularized	
extracellular	 matrix	 (ECM))	 are	 a	 suitable	 candidate	 for	 future	 cell-based	 cartilage	
repair	in	the	head	and	neck	area?	
	
Cartilage	characteristics	
	
Q1	 What	are	the	biomechanical	and	biochemical	characteristics	of	native	facial	cartilages	
(i.e.	ear	and	nasal	cartilages)?	
	
Replacing	 damaged	 or	 missing	 cartilage	 requires	 an	 accurately	 sculpted	 cartilaginous	
framework	that	provides	sufficient	strength	and	stiffness	to	substitute	for	the	biomechanical	
properties	 of	 the	 damaged	 cartilage	 in	 order	 to	 resist	 tissue	 deformation.	 Moreover,	 a	
cartilage	framework	that	is	too	stiff	may	give	an	unnatural	contour	and	may	cause	shearing	
forces	of	the	overlying	tissue,	resulting	in	graft	failure.	Currently,	costal	cartilage	is	widely	used	
as	 graft	 material	 for	 the	 replacement	 of	 facial	 cartilages.	 However,	 its	 biomechanical	
properties	are	evidently	different	from	that	of	ear	and	nasal	cartilages.	[362]	Ideally,	tissue-
engineered	 cartilage	 should	 overcome	 this	 biomechanical	 mismatch	 and	 possess	 similar	
biomechanical	 properties	 to	 native	 tissue.	 To	 date,	 most	 research	 on	 biomechanical	
characterization	of	native	cartilages	has	been	performed	on	articular	cartilage	(reviewed	by	
Little	et	al.	 [158])	and	only	few	studies	have	characterized	the	biomechanical	properties	of	
human	facial	cartilages,	such	as	ear	[23,	24,	363]	and	nasal	cartilages	[25-30].	However,	these	
  
studies	 were	 relatively	 small	 and	 frequently	 used	 tensile	 behaviour	 to	 reflect	 biomaterial	
properties,	which	requires	large	sample	dimensions	and	complicates	the	translation	towards	
biomechanical	properties	of	tissue-engineered	cartilage	constructs.	Chapters	two	and	three	
present	 the	 equilibrium	 behaviour	 (Eeq)	 of	 stress-relaxation	 indentation	 to	 study	
biomechanical	behaviour	of	native	facial	cartilages	(i.e.	ear,	nasoseptal	and	alar	cartilages)	to	
obtain	 a	 benchmark	 against	 which	 to	 evaluate	 tissue-engineering	 strategies.	 In	 general,	
indentation	Eeq	of	human	adult	facial	cartilages	ranged	from	approximately	1-15	MPa.	(Table	
1)		
	
	
Cartilage	subtype	 Biomechanical	property	 Value	
	 	 	
Ear	cartilage	 Equilibrium	modulus		 4.5	±	1.7	MPa	
Anti-tragus	 Equilibrium	modulus	 7.2	±	4.7	MPa	
Tragus	 Equilibrium	modulus	 5.4	±	2.4	MPa	
Concha	 Equilibrium	modulus	 4.5	±	2.2	MPa	
Anti-helix	 Equilibrium	modulus	 3.6	±	2.1	MPa	
Scapha	 Equilibrium	modulus	 3.1	±	1.0	MPa	
Helix	 Equilibrium	modulus	 2.2	±	1.2	MPa	
	 	 	
Nasal	cartilage	 Equilibrium	modulus	 	
Septum	 Equilibrium	modulus	 15.7	±	7.4	MPa	
Ala	nasi	 Equilibrium	modulus	 1.3	±	0.5	MPa	
	 	 	
Costal	cartilage	 Equilibrium	modulus	 20.0	±	14.7	MPa	[364]	
Articular	cartilage	 Equilibrium	modulus	 3.5	±	1.1	MPa	[156]	
	
Table	1.	Native	human	cartilages.		
The	indentation	equilibrium	modulus,	Eeq,	used	in	our	studies	compares	well	with	that	of	costal	and	articular	
cartilage	using	the	same	test	setup.	
	
	
Ear	and	alar	cartilage	had	significantly	lower	equilibrium	moduli	compared	to	septal	cartilage,	
and	regional	variations	were	observed.	(Table	1)	Griffin	et	al.	have	recently	measured	regional	
biomechanical	behaviour	of	facial	cartilages	using	compressive	Young’s	modulus	on	human	
ear	and	nasal	cartilages	[28,	363],	indicating	similar	results.	Although	cartilage	biomechanical	
behaviour	is	difficult	to	directly	compare	in	various	experimental	setups,	they	similarly	state	
that	 ear	 and	 alar	 cartilage	 have	 lower	 moduli	 compared	 to	 septal	 cartilage,	 with	 helical	
cartilage	being	the	softest	region	of	the	ear.	[28,	363]	To	be	able	to	understand	biomechanical	
behaviour	of	facial	cartilages,	one	should	realise	that	cartilage	biomechanics	are	determined	
by	 ECM	 composition	 and	 architecture.	 In	 hyaline	 cartilage	 (i.e.	 nasoseptal	 cartilage),	
biomechanical	 behaviour	 is	mainly	 the	 consequence	 of	 the	 swelling	 of	 negatively	 charged	
aggregated	 proteoglycans	 trapped	 into	 a	 collagen	 fiber	 network.	 [202]	 The	 biomechanical	
properties	of	ear	and	alar	 cartilage	are	also	 influenced	by	 the	presence	of	 an	elastin	 fiber	
  
network	in	the	ECM.	In	fact,	compressive	biomechanical	integrity	appears	mainly	assigned	by	
elastin,	 whereas	 in	 hyaline	 cartilage	 this	 is	 principally	 provided	 by	 a	 complex	 relationship	
between	the	collagen	network	entrapping	glycosaminoglycans.	[202]	Biomechanically,	elastin	
is	responsible	for	the	physical	properties	of	elasticity,	reversible	extensibility	and	elastic	recoil.	
[144]	 Moreover,	 elastin	 is	 localized	 in	 close	 proximity	 to	 proteoglycans,	 altering	 the	
proteoglycan-ECM	binding	paradigm	we	know	from	hyaline	cartilage,	and	thereby	influencing	
biomechanical	 behaviour.	 [202]	 Therefore,	 elastic	 cartilage	 displays	 a	 distinctly	 different	
response	 to	 load	 compared	 to	 hyaline	 nasal	 cartilage	 which	 exhibits	 high	 resistance	 to	
instantaneous	loads.	[202]		
	 In	chapter	three	it	appeared	that	cell	density	was	significantly	higher	in	alar	cartilage	
than	in	cartilage	obtained	from	the	ear	or	septal	cartilage.	Besides,	alar	chondrocytes	were	
larger,	occupying	a	considerable	part	of	the	ECM.	Although	high	cell	density	does	not	directly	
influence	cartilage	biomechanical	behavior	[162],	lower	volume	of	ECM	fraction	(due	to	higher	
cell	fraction)	is	likely	to	affect	biomechanics.	[176]	
Knowledge	of	the	biochemical	and	biomechanical	properties	of	the	cartilage	ECM	in	
the	head	neck	area	will	benefit	future	tissue	engineering	therapies.	However,	biomechanical	
properties	of	the	ECM	are	not	only	determined	by	the	amount	of	ECM	components,	but	is	also	
considerably	 influenced	by	ECM	fiber	orientation	as	well	as	binding	between	components.	
[301]	Better	insight	into	the	three-dimensional	(3D)	interconnected	ECM	network	will	provide	
valuable	information	for	future	cell-based	therapies.	Especially	when	selecting	and	preparing	
a	3D	scaffold	 (see	below).	Altogether,	we	have	set	a	benchmark	against	which	to	evaluate	
cartilage	tissue-engineering	strategies	in	the	head	and	neck	area.	
	
Cell	sources	
	
Q2	 Which	cells	or	combination	of	cells	are	most	suitable	for	cell-based	cartilage	repair	in	
the	head	and	neck	area?	
	
Monoculture	
Defining	an	appropriate	cell	source	for	successful	cell-based	cartilage	repair	in	the	head	and	
neck	area,	is	crucial.	The	goal	of	creating	clinically	relevant	tissue-engineered	cartilages	places	
specific	 requirements	 on	 the	 cell	 source.	 The	 ideal	 cell	 source	 should	 meet	 specific	
requirements,	 including	 the	 availability	 of	 large	 quantities	 of	 cells	 with	 minimal	 invasive	
accessibility	and	the	ability	to	produce	cartilage	ECM	that	resembles	cartilage	both	in	form	
and	function.		
The	most	obvious	cell	source	for	cartilage	repair	are	chondrocytes	themselves.	However,	to	
generate	a	cartilage	construct	of	reasonable	size,	large	numbers	of	chondrocytes	are	required,	
necessitating	the	use	of	culture-expansion.	In	chapter	four,	the	cartilage-forming	capacity	of	
human	culture-expanded	chondrocytes	from	several	anatomical	locations	(i.e.	articular	joint,	
ear,	 and	 nose)	were	 studied.	 Independent	 on	 their	 origin,	 culture-expanded	 chondrocytes	
dedifferentiate;	 they	 change	 phenotypically	 to	 a	 fibroblast-like	morphology	 and	 lose	 their	
chondrogenic	potential.	[61]	As	a	result,	chondrogenic	gene-expression	is	reduced	as	well	as	
their	ability	to	produce	cartilage	ECM	components.	Redifferentiation	and	thereby	restoration	
  
of	chondrogenic	potential	can	however	be	facilitated	in	the	presence	of	induction	factors,	like	
biological	 or	 biophysical	 stimuli.	 [365]	 However,	 induction	 factors	 can	 enhance	 but	 never	
emulate	the	complex	process	of	cartilage	regeneration	and	may	have	unpredictable	effects	
on	future	clinical	outcome.		
Multipotent	 mesenchymal	 stem	 cells	 (MSCs)	 achieved	 considerable	 attention	 as	
alternative	 cells.	 They	 can	 undergo	 multiple	 population	 doublings	 without	 losing	 their	
chondrogenic	 potential	 and	 have	 the	 capacity	 to	 differentiate	 into	 cartilage	 tissue	 under	
appropriate	culture	conditions.	[64-68]	Furthermore,	MSCs	are	easily	available	from	several	
tissues,	 including	 bone	 marrow	 and	 adipose	 tissue,	 which	 makes	 culture-expansion	
unnecessary.	 However,	 their	 role	 in	 cell-based	 cartilage	 repair	 is	 currently	 debated,	 since	
MSCs	terminally	differentiate	through	the	process	of	endochondral	ossification.	They	produce	
cartilage	 ECM	 that	 is	 unstable	 (chapter	 four)	 and	 predisposed	 to	 mineralization	 and	
ossification	in	vivo.	[69-71,	240,	241]	However,	significant	research	is	required	to	understand	
and	 predict	 MSC	 behavior	 during	 chondrogenic	 differentiation	 and	 to	 prevent	 terminal	
differentiation.	Therefore,	the	single	use	of	either	chondrocytes	or	MSCs	is	being	questioned	
as	appropriated	cell	sources	for	cell-based	cartilage	repair	in	the	head	and	neck	area.	
	
Co-culture	
Currently,	combining	both	cell	sources	holds	great	promise	for	cell-based	cartilage	repair	as	it	
reduces	the	required	number	of	chondrocytes	and	diminishes	many	disadvantages	of	both	
individual	cell	types.	By	decreasing	the	amount	of	chondrocytes	required	(≤	20%	of	the	total	
cell	mixture),	culture-expansion	is	no	longer	necessary,	which	allows	the	use	of	freshly	isolated	
primary	 chondrocytes	 leading	 to	 improved	 cartilage	 formation.	 [76]	 The	 attribution	 of	
chondrocytes	and	stem	cells	are	both	essential	in	co-culture	and	are	further	discussed	below.	
	
(1)	Chondrocytes	
As	the	foundation	of	plastic	reconstructive	surgery	focuses	on	replacing	‘like	tissue	with	like	
tissue’,	it	seems	only	logical	that	for	the	reconstruction	of	cartilage	defects	in	the	head	and	
neck	area,	location	and	type-specific	chondrocytes	are	used.	In	chapter	four	we	emphasize	
that	 only	 chondrocytes	 derived	 from	 elastic	 cartilage	 are	 able	 to	 produce	 an	 elastin-rich	
cartilage	matrix	and	that	chondrocytes	derived	from	hyaline	cartilage	are	not.	Moreover,	the	
properties	 of	 the	 ECM	 of	 location-specific	 hyaline	 chondrocytes	 (i.e.	 nasal	 or	 articular	
chondrocytes)	 are	mutually	 different	 and	 remarkably	 related	 to	 their	 origin.	 Thereby,	 we	
further	 completed	 former	 research	 [56,	 366]	 and	 conclude	 that	 location	 and	 type-specific	
chondrocytes	 ultimately	 result	 in	 cartilage	 regeneration	 of	 similar	 molecular	 nature.	 This	
means	that	for	the	reconstruction	of	cartilage	defects	in	the	head	and	neck	area,	ear	and	nasal	
chondrocytes	 are	 favorably	 used	 to	 repair	 ear	 or	 nasal	 cartilage	 defects	 respectively.	
Unfortunately,	 most	 co-culture	 research	 on	 cartilage	 repair	 has	 been	 performed	 on	
chondrocytes	derived	from	articular	cartilage	and	only	few	studies	studied	the	combination	
of	MSCs	and	non-articular	chondrocytes	such	as	ear	[77-79,	367,	368]	or	nasal	chondrocytes	
[80].	In	chapter	six	we	demonstrate	that	cartilage	constructs	containing	a	combination	of	80	
percent	MSCs	and	20	percent	of	primary	ear	or	nasal	chondrocytes	produce	similar	quantities	
of	 cartilage	matrix	 components	 as	 constructs	 containing	 chondrocytes	 only.	 Therefore,	 80	
  
percent	 of	 the	 chondrocytes	 can	 easily	 be	 replaced	 by	MSCs	without	 influencing	 cartilage	
matrix	 production.	 Co-culture	 supports	 the	 use	 of	 primary	 chondrocytes	 without	 the	
interference	of	 culture-expansion	and	 the	process	of	 redifferentiation,	and	only	 requires	a	
small	tissue	biopsy	of	undamaged	cartilage.	Moreover,	the	use	of	cartilage	remnants	can	be	
considered,	such	as	chondrocytes	derived	from	microtic	cartilage.	[79,	369,	370]	
	
(2)	Stem	cells	
Pluripotent	stem	cells,	like	human	embryonic	stem	cells	(ESCs)	[371]	or	induced	pluripotent	
stem	cells	(iPSCs)	[372],	are	highly	potential	cell	sources	for	tissue	engineering	purposes.	These	
cells	have	unlimited	capacity	for	self-renewal	and	the	ability	to	differentiate	into	any	mature	
cell	 type.	 In	 combination	 with	 chondrocytes,	 pluripotent	 stem	 cells	 improve	 cartilage	
formation	in	vitro	and	in	vivo.	[373-376]	However,	the	use	of	human	ESCs	and	iPSCs	is	currently	
impeded	 by	 the	 risk	 of	 teratoma	 formation	 and	 oncogenicity.	 [377,	 378]	 Moreover,	 the	
application	 of	 human	 ESCs	 raise	 ethical	 concerns	 regarding	 their	 isolation	 from	 human	
embryos.	To	date,	pluripotent	stem	cells	seems	mainly	valuable	for	research	purposes	and	not	
yet	for	clinical	application.	
Stem	 cells	 that	 have	 been	 most	 extensively	 studied	 for	 their	 application	 in	
chondrogenic	 co-cultures	 are	 MSCs.	 Unlike	 pluripotent	 stem	 cells,	 MSCs	 are	 multipotent	
possessing	 committed	 lineage	 differentiation	 potential	 and	 lacking	 unlimited	 self-renewal	
capacity.	They	are	however	(1)	easily	available	from	several	tissues,	including	bone	marrow,	
adipose	tissue,	synovium,	peripheral	blood,	dental	pulp,	placenta,	umbilical	cord,	and	skeletal	
muscle	 [63],	 (2)	 have	 the	 ability	 to	 reconstitute	 cartilage	 tissue	 by	 the	 ability	 to	
chondrogenically	differentiate	[80,	253-262],	and	(3)	possess	chondro-inductive	capacity	that	
enables	chondrocytes	to	facilitate	cartilage	repair	and	regeneration	[379].	To	date,	MSCs	from	
adipose	tissue	(AMSCs)	and	bone	marrow	(BMSCs)	are	best	characterized.	Our	results	from	
chapter	five	and	six	support	a	general	trophic	or	immunomodulatory	role	for	human	AMSCs	
and	BMSCs	on	chondrocytes	in	co-culture,	in	accordance	to	Wu	[246]	and	Maumus	et	al.	[247].	
Although	 both	 cell	 sources	 share	 comparable	 immunomodulatory	 modalities	 and	 their	
immunophenotypes	and	gene-expression	profiles	are	greater	than	90%	identical	[380],	they	
do	not	necessarily	behave	the	same.	Differences	on	molecular	level	have	been	recognized	by	
others,	reviewed	by	Strioga	et	al.	[380]	For	instance,	gene-expression	profiles	of	BMSCs	were	
only	 involved	 in	 WNT-signaling	 and	 differentiation	 pathways,	 whereas	 genes	 expressed	
uniquely	by	AMSCs	were	 responsible	 for	cellular	communication	and	 transcription	control.	
[232]	 In	addition,	18%	of	 the	generated	proteins	were	 found	 to	be	differentially	produced	
between	AMSCs	 and	BSMCs	 [232]:	 compared	 to	BMSCs,	AMSCs	 secrete	 significantly	more	
VEGF-D	[269],	IGF-1	[269,	270],	IL-8	[269]	and	IL-6	[269,	271],	and	significantly	less	SDF-1	[272]	
and	TFGβ1	 [272].	Finally,	dissimilarities	were	also	observed	between	AMSCs	and	BMSCs	 in	
monoculture	in	chapter	four.	These	location-specific	MSCs	possessed	distinctive	proliferation	
capacities	and	a	dissimilar	potential	to	chondrogenically	differentiate.	However,	whether	the	
differences	between	AMSCs	and	BMSCs	are	fully	explained	by	the	uniqueness	of	the	stem	cell	
population,	or	are	 just	 inherent	 to	their	heterogeneity	and	related	to	 isolation	and	culture	
protocols,	remains	unclear.	Most	importantly,	despite	the	minor	differences	between	these	
  
MSC-populations,	AMSCs	and	BMSC	seem	both	appropriate	candidates	for	co-culture	therapy	
in	the	head	and	neck	area.	
However,	only	few	studies	have	directly	compared	their	behavior	in	co-cultures.	[80,	
246,	 247]	 Unfortunately,	 these	 studies	 demonstrate	 conflicting	 outcomes	 and	 have	 never	
translated	 to	 animal	 or	 preclinical	 research.	 Acharya	 et	 al.	 demonstrated	 enhanced	
chondrocyte	 proliferation	 capacity	 and	 improved	 sGAG	 formation	 in	 pellets	 containing	
BMSC/chondrocytes	 compared	 to	 AMSC/chondrocytes.	 [80]	 Besides,	 3	 independent	 co-
culture	 studies	 using	 AMSCs	 showed	 limited	 or	 decreased	 effects	 of	 AMSCs	 on	
chondrogenesis.	 [243-245]	 Such	effect	was	hardly	 seen	 in	 co-culture	 studies	using	BMSCs,	
which	 may	 propose	 that,	 compared	 to	 BMSCs,	 AMSCs	 seem	 less	 efficient	 in	 co-culture.	
Although	 we	 could	 not	 find	 a	 general	 beneficial	 effect	 of	 human	 BMSCs	 in	 co-cultures	
compared	to	human	AMSCs	in	chapter	five,	we	did	show	that	 in	vitro,	BMSC/chondrocytes	
outperformed	 AMSC/chondrocytes	 and	 hypertrophic	 gene	 expression	 was	 lower	 in	
BMSC/chondrocytes.	True	dissimilarities	between	human	AMSCs	and	BMSCs	in	co-culture	are	
unfortunately	hard	to	expose,	as	human	MSC-cultures	are	highly	heterogeneous	and	distinct	
population	 subsets	 probably	 interfere	with	 the	 reciprocal	 communication	 pathways	 in	 co-
culture.	 Therefore,	 the	 purification	 of	 distinct	 subsets	 of	 human	MSCs	might	 enhance	 the	
particular	capability	of	AMSCs	and	BMSCs	in	co-culture	by	eliminating	interfering	cells	with	
limited	potential,	or	even	cells	with	inhibitory	activity.		
Unfortunately,	in	depth	understanding	of	the	cellular	interaction	pathways	between	
MSCs	 and	 chondrocytes	 is	 under	 debate	 in	 literature.	 Numerous	 cellular	 communication	
pathways	have	been	hypothesized	in	order	to	explain	the	beneficial	effect	in	co-cultures	[73]:	
(1)	 Chondrocyte-driven	 MSC-differentiation	 or	 (2)	 MSC-driven	 chondro-induction	 are	
considered	 the	 most	 plausible	 of	 them.	 [81]	 In	 recent	 years,	 the	 trophic	 and	 paracrine	
functions	of	MSCs	appeared	most	 critical	 in	 this	process,	 rather	 than	 simple	 chondrogenic	
differentiation	 of	MSCs	 alone	 as	 stated	 previously.	 [80,	 253-262]	 In	 accordance	 to	 former	
research	 [74,	 246,	 263-268],	we	demonstrate	 (chapter	 five	 and	 six)	 that	 both	AMSCs	 and	
BMSCs	 improve	 chondrocyte	 proliferation	 as	 well	 as	 ECM	 formation,	 which	 suggests	 a	
predominantly	trophic	role	for	MSCs	in	co-culture.	We	emphasize	the	importance	of	paracrine	
signaling	pathways	in	co-culture	comparatively	to	juxtacrine	or	gap-junctional	signaling.	The	
importance	of	direct	cell-cell	contact	is	still	unclear	in	literature.	[263]	Nevertheless,	in	chapter	
five	and	six,	such	signaling	pathways	remained	less	important,	as	co-culture	constructs	were	
made	of	alginate	hydrogel,	 impeding	direct	cell-cell	contact.	Moreover,	 in	pellet	culture	no	
beneficial	 effect	 of	 direct	 cell-cell	 contact	 was	 observed.	 On	 the	 contrary,	 MSC-driven	
chondro-induction	was	less	pronounced	in	Transwell®	system	and	this	effect	was	even	further	
reduced	by	MSC-conditioned	medium.	Although	direct	cell-cell	contact	seems	less	significant	
than	 paracrine	 signaling,	 it	 seems	 correspondingly	 important	 to	 secure	 a	 certain	 cell-cell	
distance	for	optimal	cell	communication.		
	 The	fact	that	MSCs	full	fill	a	trophic	role	in	co-culture	and	have	been	demonstrated	to	
be	immune	privileged,	it	seems	no	longer	necessary	to	use	autologous	MSCs	only.	The	use	of	
allogeneic	MSCs	have	already	been	used	for	the	treatment	of	steroid-resistant	graft-versus-
host	 disease,	 acute	 respiratory	 distress	 syndrome	 and	 Crohn’s	 disease.	 [381]	 Even	 a	 few	
clinical	trials	have	been	commenced	using	allogeneic	MSCs	for	cell-based	cartilage	repair	in	
  
the	joint.	(Reviewed	by	Vonk	et	al.	[381])	The	use	of	allogeneic	MSCs	gives	the	opportunity	to	
generate	“prefabricated”	cell	populations.	Distinct	isolation	and	co-culture	protocols,	as	well	
as	the	effect	of	allogeneic	MSCs	on	several	scaffold	materials,	needs	to	be	further	elucidated	
for	their	possible	future	clinical	use	in	cell-based	cartilage	repair	in	the	head	and	neck	area.	
	 In	conclusion,	the	combination	of	chondrocytes	and	MSCs	holds	great	promise	for	cell-
based	cartilage	repair	in	the	head	and	neck	area.	Location	and	type-specific	chondrocytes	in	
combination	with	generally	available	MSCs	are	specifically	recommended	in	this	thesis.	
	
Scaffolds		
Currently,	 several	3D	 scaffolds	have	been	developed	and	 investigated	 for	 their	use	 in	 cell-
based	cartilage	repair.	[83]	They	can	be	roughly	classified	into	synthetic	and	natural	scaffolds,	
and	numerous	of	them	have	been	introduced	in	the	field	of	cartilage	tissue	engineering.	[83]	
In	 this	 thesis,	 we	 have	 focussed	 on	 natural	 scaffolds	 only.	 In	 particular,	 the	 quality	 and	
suitability	of	alginate,	bacterial	nanocellulose	and	decellularized	ECM	were	studied	for	tissue	
engineering	purposes	in	the	head	and	neck	area.	
	
Q3	 Which	natural	scaffolds	(i.e.	alginate,	bacterial	nanocellulose,	decellularized	ECM)	are	
a	suitable	candidate	for	future	cell-based	cartilage	repair	in	the	head	and	neck	area?	
	
Matrix-derived	scaffolds	
Scaffold	 selection	 have	 been	 an	 important	 pillar	 of	 the	 tissue	 engineering	 process.	 The	
contemporary	concept	of	scaffold	engineering	is	to	mimic	the	natural	micro-architecture	of	
the	3D	ECM	of	the	targeted	tissue	itself.	Scaffold	design	should	thereby	substitute	for	the	cell	
natural	 environment	providing	 instantaneous	 cell	 support	 and	 guiding	 tissue	development	
and	remodelling.	 Intuitively,	native	ECM	has	the	potential	to	be	the	most	 ideal	scaffold	for	
tissue	engineering	and	regenerative	 therapies.	Preservation	of	native	ECM	 is	best	 retained	
through	the	process	of	decellularization.	[93]		
Decellularized	ECM-derived	scaffolds	demonstrate	immediate	functional	support	[382]	
without	evoking	an	adaptive	immune	response	upon	implantation	due	to	absence	of	donor	
cellular	 and	 nuclear	 antigens	 [94].	 Moreover,	 ECM-derived	 scaffolds	 provide	 specific	
structural,	mechanical	and	biological	cues	to	cells	guiding	tissue	regeneration	and	remodeling.	
[82]	The	preparation	as	well	as	the	biocompatibility	of	a	decellularized	cartilaginous	ECM	was	
extensively	 studied	 in	 chapter	 seven.	 In	 fact,	we	were	 the	 first	 to	 evaluate	 structural	 and	
functional	properties	of	decellularized	full-thickness	ear	cartilage	scaffolds.	Ear	cartilage	was	
decellularized	utilizing	the	protocol	of	Kheir	et	al.	[101]	and	modified	by	the	incorporation	of	
a	 24	 hour	 course	 of	 elastase	 (0.03	 U/mL).	 The	mechanism	 by	which	 elastase	 contributed	
decellularization	is	unfortunately	unknown.	Elastin	is	however,	one	of	the	main	ingredients	of	
the	pericellular	matrix	surrounding	chondrocytes	in	elastic	cartilage.	[383]	Degradation	of	this	
matrix	protein	would	logically	disintegrate	the	pericellular	matrix	facilitating	the	outflow	of	
cellular	material.	Moreover,	 elastase	 does	 not	 only	 hydrolyse	 elastin	 proteins,	 but	 is	 also	
involved	 in	 the	cleavage	of	other	matrix	components	such	as	proteoglycans,	collagens	and	
fibronectin.	[384-386]	Breaking	down	these	matrix	components	will	further	weaken	the	tightly	
interconnected	ECM	and	will	likely	enhance	decellularization.	The	decellularization	protocol	
  
described	 in	chapter	 seven	 preserved	native	 collagen	and	elastin	 contents	of	ear	 cartilage	
tissue,	as	well	as	cartilage	major	architecture	and	shape.	
	 Despite	recent	progress	in	cartilage	decellularization,	there	are	some	barriers	that	limit	
potential	clinical	application.	First,	the	ability	to	revitalise	ECM-derived	cartilage	scaffolds	is	
critical	 for	 future	 clinical	 implementation.	 Recellularized	 ECM-derived	 scaffolds	were	 non-
cytotoxic	 and	 had	 the	 capability	 to	 allow	 chondrogenic	 differentiation	 of	 human	 MSCs	
(chapter	seven).	However,	cell	migration	throughout	the	scaffold	was	non-existing	and	needs	
to	 be	 further	 improved	 to	 actually	 revitalize	 and	 thereby	 remodel	 tissue.	 Secondary,	 the	
complexity	of	cartilage	structures	in	the	head	and	neck	area	sets	high	standards	to	scaffold	
design.	 The	 shortage	of	 (allogeneic)	 donors	 and	 the	 inability	 to	 accurately	match	 cartilage	
shape	of	(allogeneic	or	xenogeneic)	donor	facial	cartilages,	impede	its	translation	to	clinical	
therapy.	 [295]	 Altogether,	we	 have	 introduced	 a	method	 to	 decellularized	 cartilage	 tissue	
while	preserving	 its	native	3D	architecture	and	shape,	providing	an	 interesting	scaffold	 for	
cartilage	therapy	in	the	head	and	neck	area.		
	
Matrix-inspired	scaffolds	
Another	way	to	-	at	least	partially	-	mimic	structural	and	functional	characteristics	of	native	
tissue	microenvironment	is	the	generation	of	ECM-inspired	scaffolds.	Basic	requirements	for	
biomimetic	scaffold	engineering	demand	(1)	a	scaffold	with	sufficient	mechanical	strength	to	
retain	size	and	shape	;	(2)	a	3D	structure	that	allows	tissue	regeneration	and	homeostasis	;	
and	(3)	a	biomaterial	that	is	biocompatible	without	introducing	an	inflammatory	response.	In	
this	 thesis	 we	 used	 alginate	 and	 bacterial	 nanocellulose	 scaffolds	 for	 cell-based	 cartilage	
repair.	Their	properties	based	on	these	requirements	are	further	discussed	below.	
	
(1)	Biomechanical	strength	
For	successful	tissue-engineered	cartilage,	the	3D	scaffold	must	provide	sufficient	mechanical	
strength	in	order	to	maintain	size	and	shape	when	subjected	to	the	forces	of	the	implanted	
environment.	Alginate	biomechanical	properties	did	not	match	mechanical	stiffness	of	facial	
cartilages	(1-15	MPa)	and	ranged	from	approximately	1	to	1000	kPa.	[88]	Due	to	its	relatively	
poor	biomechanical	strength,	alginate	itself	is	not	suspected	to	maintain	size	and	shape	after	
direct	 subcutaneous	 implantation.	 Bacterial	 nanocellulose,	 on	 the	 other	 hand,	 has	
biomechanical	properties	that	reaches	values	analogous	to	facial	cartilages.	[155]		
	
(2)	Tissue	regeneration	and	homeostasis	
Biomimetic	scaffold	design	must	provide	a	natural	3D	micro-environment	that	allows	tissue	
regeneration	and	homeostasis.	Cell-scaffold	interactions	are	critical	herein	and	fundamental	
for	initial	cell	attachment,	subsequent	migration,	proliferation,	differentiation,	and	later	tissue	
remodelling.	Alginate	permits	the	encapsulation	of	cells	rather	than	actual	cell	attachment.	
Alginate	 encapsulation	 enables	 homogeneous	 3D	 cell	 distribution	 and	 prevents	 cells	 from	
floating	out.	[387]	Meanwhile,	bacterial	nanocellulose	provides	excellent	cell	attachment	and	
migration,	although	cell	migration	is	limited	to	the	surface	of	the	scaffold	(i.e.	impermeability).	
In	 chapter	 eight	 a	 bilayer	 bacterial	 nanocellulose	 scaffold,	 composed	 of	 a	 dense	 and	 a	
macroporous	nanocellulose	layer,	was	designed	that	enabled	3D	cell	migration.	Both	alginate	
  
[388]	and	bacterial	nanocellulose	scaffolds	[389]	support	tissue	regeneration	and	homeostasis	
of	 several	 tissues	 including	 cartilage.	 Besides,	 in	 order	 to	 secure	 a	 viable	 tissue,	 scaffolds	
should	 facilitate	 diffusion	 of	 oxygen	 and	 nutrients,	 and	 removal	 of	 waste	 products.	 Both	
alginate	 [89,	388]	and	bacterial	nanocellulose	 [92,	390]	have	high	swollen	3D	architecture,	
that	enables	sufficient	nutrient	diffusion	and	oxygen	transfer	to	the	residing	cells.		
	
(3)	Biocompatibility	
Scaffold	biocompatibility	is	crucial	for	the	overall	success	rate	of	a	tissue	engineering	therapy.	
Biocompatibility	 is	 generally	 defined	 as	 “the	 ability	 of	 a	 biomaterial	 to	 perform	 with	 an	
appropriate	host	response	in	a	specific	situation”.	[391]	Moreover,	scaffold	biocompatibility	
not	only	depends	on	the	ability	to	ensure	cell	viability	(i.e.	cytotoxicity).	It	is	also	the	biological	
response	of	host	tissue	to	the	implanted	scaffold	material	that	can	induce	inflammation	along	
with	fibrous	encapsulation	of	the	material	(i.e.	foreign	body	reaction).	The	biocompatibility	of	
highly	purified	alginate	(Cellmed,	Germany)	has	already	been	studied	by	others	and	is	highly	
biocompatible	both	in	vitro	and	in	vivo.	[251]	In	fact,	alginate	is	already	used	for	applications	
such	as	pharmaceutical	applications,	microencapsulation	 technology	and	wound	dressings.	
[388,	392]	The	biocompatibility	of	bacterial	nanocellulose	was	evaluated	in	chapter	eight	and	
more	 intensively	 studied	by	Martínez	Ávila	et	al.	 according	 to	 the	standards	of	 ISO	10993.	
[393]	Bacterial	nanocellulose	scaffold	are	non-cytotoxic	and	non-pyogenic.	[393]	Moreover,	
after	subcutaneous	implantation,	these	scaffolds	induce	minimal	host	response.	[393]	Both	
alginate	and	bacterial	nanocellulose	supported	neocartilage	formation	in	vitro	and	in	vivo	(this	
thesis)	making	 them	 attractive	 biocompatible	 scaffolds	 for	 the	 reconstruction	 of	 cartilage	
defect	in	the	head	and	neck	area.	
Another	 component	 of	 biocompatibility	 is	 biomaterial	 degradation,	 since	 the	 products	 of	
degradation	 can	 possibly	 influence	 biocompatibility	 in	 time.	Neither	 alginate	 nor	 bacterial	
nanocellulose	degrade,	as	mammals	lack	the	enzyme	alginase	or	cellulose	respectively.	They	
rather	slowly	dissolve	in	time.	[388,	394]	Both	alginate	[388]	and	bacterial	nanocellulose	[389]	
have	shown	mild	inflammatory	response	after	subcutaneous	implantation	that	decreased	in	
time.	Moreover,	derivates	of	these	biomaterials	have	already	been	used	safely	as	biomedical	
devices	in	a	clinical	application.	[395,	396]		
In	conclusion,	both	alginate	and	bacterial	nanocellulose	have	characteristics	that	-	at	
least	 partially	 -	 match	 the	 properties	 of	 the	 chondrogenic	 ECM	 itself.	 Alginate	 has	 poor	
biomechanical	properties	and	is	typically	used	as	a	cell-laden	hydrogel,	created	to	encapsulate	
cells.	Infused	into	a	biomechanical	stable	bacterial	nanocellulose	scaffold	could	be	an	excellent	
scaffold	for	future	cell-based	cartilage	repair	in	the	head	and	neck	area.	In	chapter	eight	this	
concept	was	first	introduced,	showing	that	alginate-infused	bacterial	nanocellulose	scaffolds	
are	biocompatible	and	support	neocartilage	formation	both	in	vitro	and	in	vivo.	Therefore,	the	
combination	of	alginate	and	bacterial	nanocellulose	could	provide	a	potential	therapy	for	the	
reconstruction	of	cartilage	defect	in	the	head	and	neck	area.	Especially,	when	we	could	further	
emerge	it	to	a	bioprinting	technology	as	written	below.	
	
	
	
  
Bioprinting	
Recent	 developments	 in	 3D	 bioprinting	 have	 brought	 immense	 excitement	 to	 the	 field	 of	
tissue	 engineering.	 In	 3D	 bioprinting,	 scaffold	 biomaterials	 and	 living	 cells	 are	 accurately	
deposited	in	a	layer-by-layer	fashion.	[397]	Thereby,	3D	bioprinting	has	the	ability	to	control	
spatial	placement	of	 living	cells	 relative	 to	 their	neighboring	cells	or	 scaffold	environment.	
Which	 in	 turn	 provides	 the	 ability	 to	 recreate	 the	 complexity	 of	 living	 tissues	 that	mimic	
natural	micro-architecture	of	the	targeted	tissue	itself.	The	primary	printing	technology	used	
for	 tissue	 engineering	 purposes	 is	 inkjet	 “drop-on-demand”	 bioprinting.	 [398]	 Essentially,	
inkjet	bioprinting	technology	is	based	on	digitally	controlled	ejection	of	drops	of	“bioink”	from	
a	print	head	onto	a	substrate.	These	bioinks	are	the	building	blocks	of	the	regenerated	tissue	
and	 contain	 livings	 cells	 and/or	 scaffold	 biomaterials.	 [399]	 Both	 alginate	 [400,	 401]	 and	
bacterial	 nanocellulose	 [402,	 403]	 have	been	demonstrated	 to	be	excellent	 bioinks	 for	 3D	
bioprinting	purposes.	They	have	shown	good	printability	[400,	404]	and	high	biocompatibility	
[400,	405].	So	far,	the	clinical	application	of	inkjet	bioprinting	has	only	sparsely	been	applied	
in	the	field	of	cartilage	regeneration.	[402,	404,	406]	3D	bioprinting	gives	the	opportunity	to	
tissue	 engineer	 complex	 3D	 tissues	 with	 high	 reproducibility,	 making	 it	 a	 very	 promising	
technique	for	the	reconstruction	of	cartilage	defects	in	the	head	and	neck	area.	
	
Future	perspectives	
Over	 the	 past	 decades,	 there	 has	 been	 significant	 progress	 in	 the	 treatment	 of	 cartilage	
defects	using	tissue	engineering	strategies.	Recently,	the	field	is	slowly	changing	from	bench	
to	bedside	with	a	number	of	clinical	and	preclinical	studies	ongoing	worldwide.	(reviewed	by	
Huang	et	al.	[118])	However,	these	studies	basically	involve	cell-based	articular	cartilage	repair	
instead	of	the	regeneration	of	cartilage	defects	in	the	head	and	neck	area.	Such	translational	
research	necessitates	governmental	oversight	that	guards	efficacy	and	safety	of	 innovative	
cell-based	therapies	in	order	to	protect	and	guarantee	public	health.	Ultimately,	an	one-step	
surgical	therapy	is	preferred	for	the	reconstruction	of	cartilage	defects	in	the	head	and	neck	
area.	
	
Regulatory	aspects	of	clinical	application		
The	 European	Medicines	 Agency	 (EMA)	 and	 the	 Food	 and	 Drug	 Administration	 (FDA)	 are	
responsible	 for	 the	 surveillance	 and	 evaluation	 of	 medicinal	 products	 and	 devices	 in	 the	
European	Union	and	United	States	respectively.	However,	the	lack	of	a	regulatory	framework	
for	 tissue-engineered	 products	 (TEPs)	 has	 significantly	 impeded	 the	 translation	 of	 tissue	
engineering	 therapies	 to	 clinical	 application.	 [407]	 The	 introduction	 of	 Advanced	 Therapy	
Medicinal	Products	(ATMPs)	in	the	European	Union	[408]	and	Human	Cells	and	Tissues	and	
Cellular-	and	Tissue-Based	Products	 (HCT/Ps)	 in	 the	United	States	 [409],	have	substantially	
contributed	to	global	biotechnology	market	growth	[410]	and	provide	a	 legitimate	tool	 for	
overseeing	 TEPs.	 At	 present,	 only	 few	 cell-based	 therapies	 are	 awarded	 marketing	
authorization	by	the	EMA	or	FDA.	[410,	411]	Of	these	TEPs,	CarticelTM,	ChondroCelect®	and	
MACI®	 are	 the	 only	 licensed	 therapies	 for	 the	 reconstruction	 of	 cartilage	 defects.	 These	
advanced	 technologies	 are	 however	 entirely	 focused	 on	 the	 reconstruction	 of	 articular	
  
cartilage	defects.	So	far,	no	TEPs	have	been	authorized	for	the	treatment	of	cartilage	defects	
in	the	head	and	neck	area.		
The	 manufacturing	 of	 TEPs	 that	 comply	 EMA	 or	 FDA	 guidelines	 require	 good	
manufacturing	practices	(GMP)	[412]	along	with	good	laboratory	practices	and	good	clinical	
practices.	As	defined,	GMP-protocols	cover	practically	all	aspects	of	product	manufacturing	
and	“ensure	that	products	are	consistently	produced	and	controlled	to	the	quality	standards	
appropriate	to	their	intended	use”.	[412,	413]	Process	performance	and	product	quality	are	
all	comprised	in	GMP-protocols,	including	the	training	of	qualified	personnel,	the	validation	
and	control	of	materials	and	procedures,	the	identity	and	sterility	of	the	equipment,	facility	
requirements,	 product	 traceability	 and	 reproducibility.	 Considering	 this,	 the	 translation	 of	
fundamental	 cell-based	 therapy	 into	 clinical	 product	 following	 GMP-guidelines	 is	 very	
challenging.	Therefore,	understanding	and	recognition	of	the	regulatory	environment	early	in	
the	development	of	a	cell-based	therapy	is	critical	for	the	overall	success	of	TEPs.	
	
Translation	towards	a	cell-based	therapy	
Tissue	 engineering	 strategies	 could	 technically	 simplify	 and	 thereby	 improve	 the	 surgical	
treatment	of	 cartilage	defect	 in	 the	head	and	neck	area.	Although	our	 research	 could	not	
directly	translate	towards	a	clinical	cell-based	therapy,	 it	has	 identified	potential	 for	future	
translational	 research.	 First,	 the	 combination	 of	 chondrocytes	 and	 MSCs	 has	 held	 great	
promise	for	cell-based	cartilage	repair	in	the	head	and	neck	area.	For	implementation	of	such	
therapy,	an	optimal	cell	density	and	ratio	of	MSCs	to	chondrocytes	is	imperative.	Puelacher	et	
al.	 already	 recommended	 cell	 densities	 greater	 than	 20x106	 cells	 per	milliliter.	 [239]	 That	
means	that	for	the	reconstruction	of	-	for	example	-	the	ear,	one	should	require	140x106	cells	
in	total,	assuming	that	the	volume	of	adult	ear	cartilage	comprises	approximately	7	milliliter	
(data	not	shown).	Using	only	20%	primary	chondrocytes	(at	a	MSC-chondrocyte	ratio	of	4:1)	
as	described	previously,	[74,	246]	a	feasible	amount	of	28x106	chondrocytes	and	112x106	MSCs	
are	necessary.	However,	no	consensus	on	optimal	co-culture	 ratios	 is	yet	available.	Future	
research	needs	to	clarify	if	we	could	increase	cell	density	while	further	reduce	the	number	of	
primary	chondrocytes	without	inhibiting	cartilage	matrix	production	and	stability.		
	 In	the	translation	towards	a	cell-based	therapy,	the	selection	of	a	scaffold	is	crucial	as	
stated	before.	Recent	advances	in	the	field	of	cartilage	tissue	engineering	have	been	driven	
from	 “cell-based”	 towards	 “cell-free”	 regenerative	 therapies.	 [414]	 Acellular	 biomaterials	
mimic	native	ECM	and	thereby	attract	native	progenitor	cells	to	migrate	into	the	biomaterial	
and	 trigger	 chondrogenic	 differentiation.	 To	 date,	 acellular	 biomaterials	 have	 shown	
promising	 regenerative	 effects	 on	 various	 tissues	 (Acellular	 biomaterials:	 an	 evolving	
alternative	to	cell-based	therapies.	Burdick.	2013)	including	articular	cartilage	[415].	However,	
it	is	less	likely	that	these	acellular	biomaterials	have	similar	effect	on	cartilage	defects	in	the	
head	and	neck	area,	as	native	progenitor	cells	are	generally	missing	(i.e.	congenital,	trauma,	
cancer)	 or	 genetically	 diseased	 (i.e.	 congenital	 remnants).	 Therefore,	 for	 future	 cell-based	
cartilage	repair	in	the	head	and	neck	area	a	cellular	3D	scaffold	that	-	at	least	partially	-	mimics	
structural	and	functional	characteristics	of	native	tissue	microenvironment	is	imperative.		
	 In	 conclusion,	 this	 thesis	 has	 focussed	 on	 the	 generation	 of	 a	 tissue-engineered	
cartilaginous	framework	for	the	reconstruction	of	cartilage	defects	in	the	head	and	neck	area	
  
and	has	 identified	potential	 for	 future	 translational	 research.	 For	 cell	 source	 selection,	we	
recommend	 to	 use	 location	 and	 type-specific	 chondrocytes.	 Interestingly,	 80	 percent	 of	
chondrocytes	can	be	replaced	by	MSCs	without	 influencing	cartilage	matrix	production	nor	
stability.	Thereby,	the	use	of	primary	cells	is	warranted,	as	MSCs	can	be	obtained	relatively	
easy	in	larger	numbers.	In	this	co-culture	procedure,	a	general	trophic	or	immunomodulatory	
role	 is	provided	by	MSCs.	For	scaffold	selection,	we	recommend	to	use	a	3D	scaffolds	that	
mimic	 natural	 micro-architecture	 of	 the	 3D	 ECM	 of	 the	 targeted	 tissue	 itself.	 Although	
decellularized	scaffolds	are	intuitively	the	most	ideal	scaffold	for	tissue	engineering	therapies,	
their	application	seems	currently	mainly	valuable	for	research	purposes	and	not	yet	for	clinical	
application	in	the	head	and	neck	area.	Therefore,	we	have	focussed	on	natural	matrix-inspired	
scaffolds	(i.e.	alginate	and	bacterial	nanocellulose).	Both	alginate	and	bacterial	nanocellulose	
have	characteristics	that	-	at	least	partially	-	match	the	properties	of	the	chondrogenic	ECM	
itself.	 The	 combination	 of	 alginate	 and	 bacterial	 nanocellulose	 could	 provide	 a	 potential	
therapy	for	the	reconstruction	of	cartilage	defect	in	the	head	and	neck	area.
  
	 	
  
	 	
  
Chapter	10	
	
Summary	
	
	 	
  
	 	
  
Cartilage	tissue	engineering	can	offer	promising	solutions	for	restoring	cartilage	defects	in	the	
head	 and	 neck	 area	 and	 has	 the	 potential	 to	 overcome	 limitations	 of	 current	 treatments,	
reestablishing	unique	biological	and	functional	properties	of	the	tissue.	This	thesis	focuses	on	
the	requirements	that	are	necessary	for	future	cell-based	cartilage	repair	in	the	head	and	neck	
area.	 Specifically,	 the	 suitability	 of	 cells	 or	 combination	 of	 cells	 on	 natural	 scaffolds	were	
evaluated.		
	 Cartilage	is	a	highly	complex	avascular	tissue	comprising	chondrocytes	surrounded	by	
a	 dense	 extracellular	matrix	 that	 contains	 various	macromolecules	 such	 as	 proteoglycans,	
collagens	and	elastin.	Due	to	its	avascular	nature,	cartilage	has	a	very	limited	capacity	for	self-
repair	once	damaged.	Tissue	engineering	is	a	promising	potential	treatment	modality	for	the	
reconstruction	of	such	defects.	Cartilage	morphology	and	molecular	composition	as	well	as	
the	fundamentals	of	tissue	engineering	are	introduced	in	chapter	one.	
Chapter	 two	 and	 three	 established	 a	 precise	 biomechanical	 and	 biochemical	
characterization	of	native	human	ear	and	nasal	cartilages	(i.e.	nasoseptal	and	alar	cartilages)	
in	order	to	set	a	benchmark	against	which	to	evaluate	cartilage	tissue	engineering	attempts.	
In	general,	indentation	Eeq	of	human	adult	facial	cartilages	ranged	from	approximately	1-15	
MPa.	 Ear	 cartilage	 had	 significantly	 lower	 stiffness	 compared	 to	 nasal	 cartilage,	 although	
regional	 variations	 were	 observed.	 Ear	 cartilage	 biomechanical	 properties	 are	 most	 likely	
related	to	the	presence	of	elastin	in	the	extracellular	matrix.	
Defining	an	appropriate	cell	source	for	successful	cell-based	cartilage	repair	in	the	head	
and	neck	area	is	crucial.	Currently,	cell-based	cartilage	repair	is	predominantly	based	on	two	
distinct	cell	types:	chondrocytes	and	mesenchymal	stem	cells.	However,	their	individual	use	is	
associated	with	specific	disadvantages.	First,	chondrocyte-based	cartilage	repair	is	limited	by	
the	 ability	 to	 obtain	 sufficient	 numbers	 of	 chondrocytes,	 necessitating	 the	 use	 of	 culture-
expansion.	 During	 culture	 expansion,	 chondrocytes	 change	 phenotypically	 to	 a	 fibroblast	
morphology	 and	 lose	 their	 chondrogenic	 potential;	 they	 dedifferentiate.	 Second,	
mesenchymal-stem-cell-based	 cartilage	 repair	 is	 hampered	 by	 the	 phenomenon	 of	
chondrocyte	 hypertrophy.	 During	 chondrogenic	 differentiation,	 they	 undergo	 terminal	
differentiation	through	the	process	of	endochondral	ossification	and	produce	cartilage	that	is	
unstable	 and	 predisposed	 to	 mineralization	 and	 ossification	 in	 vivo.	 In	 chapter	 four,	 the	
cartilage-forming	 capacity	 of	 cells	 from	 several	 anatomical	 locations	 were	 studied.	
Independent	on	their	origin	(i.e.	articular	joint,	ear,	and	nose),	culture-expanded	chondrocytes	
dedifferentiated.	 After	 chondrogenic	 stimulation,	 ear	 and	 nasal	 chondrocytes	 were	 most	
potent	for	cartilage	regeneration	in	vivo.	Moreover,	location	and	type-specific	chondrocytes	
resulted	in	cartilage	regeneration	of	their	original	molecular	nature.	
Currently,	the	combination	of	chondrocytes	and	mesenchymal	stem	cells	holds	great	
promise	for	cell-based	cartilage	repair	as	it	reduces	the	required	number	of	chondrocytes	and	
diminishes	 many	 disadvantages	 of	 the	 individual	 cell	 types.	 Co-cultures	 of	 primary	
chondrocytes	 (i.e.	articular,	ear,	and	nasal	chondrocytes)	and	mesenchymal	stem	cells	 (i.e.	
adipose-tissue-derived	 and	 bone-marrow-derived	 mesenchymal	 stem	 cells)	 were	 further	
elucidated	in	chapter	five	and	six.	Eighty	percent	of	the	chondrocytes	could	be	replaced	by	
mesenchymal	stem	cells	without	 influencing	cartilage	matrix	production	nor	stability.	Clear	
location	and	type-specific	differences	were	observed	in	co-cultures	containing	articular,	ear	
  
or	 nasal	 chondrocytes.	 Meanwhile,	 large	 differences	 between	 adipose-tissue-derived	 and	
bone-marrow-derived	 mesenchymal	 stem	 cells	 in	 co-culture	 were	 hard	 to	 expose.	 In	 co-
culture,	we	found	no	evidence	that	cartilage	formation	was	the	consequence	of	chondrogenic	
lineage	differentiation	of	mesenchymal	stem	cells.	In	contrast,	the	cartilage	matrix	that	was	
formed,	clearly	originated	from	chondrocytes,	which	suggested	a	predominantly	trophic	role	
for	mesenchymal	stem	cells.	The	trophic	and	paracrine	function	of	mesenchymal	stem	cells	
herein	 appeared	 essential	 rather	 than	 mesenchymal	 stem	 cells	 actively	 undergoing	
chondrogenic	differentiation.	We	showed	that	stem	cell	trophic	function	is	a	general	feature	
that	 applies	 to	 both	 adipose-tissue-derived	 and	 bone-marrow-derived	mesenchymal	 stem	
cells.	Co-culture	supports	the	application	of	a	one-stage	cell-based	cartilage	repair	procedure	
for	cartilage	defects	in	the	head	and	neck	area.	Ear	and	nasal	chondrocytes	in	combination	
with	 generally	 available	 mesenchymal	 stem	 cells	 are	 specifically	 recommend	 for	 the	
reconstruction	of	ear	and	nasal	cartilage	defects	respectively.	
For	successful	cartilage	regeneration,	the	properties	of	the	three	dimensional	scaffold	
are	of	equivalent	importance.	The	contemporary	concept	of	scaffold	engineering	is	to	-	at	least	
partially	-	mimic	the	natural	micro-architecture	of	the	three	dimensional	extracellular	matrix	
of	the	targeted	tissue	itself.	Intuitively,	native	extracellular	matrix	has	the	potential	to	be	the	
most	ideal	scaffold	for	tissue	engineering	and	regenerative	therapies.	Preservation	of	native	
extracellular	 matrix	 is	 best	 retained	 through	 the	 process	 of	 decellularization.	 The	
decellularization	protocol	described	 in	chapter	seven	preserved	native	collagen	and	elastin	
contents	 of	 full-thickness	 ear	 cartilage	 tissue,	 as	 well	 as	 cartilage	 major	 architecture	 and	
shape.	Moreover,	decellularized	 scaffolds	were	non-cytotoxic	and	 supported	chondrogenic	
differentiation	 of	 mesenchymal	 stem	 cells	 in	 vitro.	 Thereby,	 we	 have	 introduced	 a	
decellularized	matrix-derived	scaffold	with	potential	therapeutic	benefits.	
	However,	at	this	stage,	the	shortage	of	donors	and	the	inability	to	accurately	match	cartilage	
shape	of	donor	facial	cartilages,	impedes	its	translation	towards	a	clinical	therapy	for	cartilage	
defect	 in	 the	 head	 and	 neck	 area.	 Therefore,	 natural	 scaffolds,	 in	 particular	 alginate	 and	
bacterial	 nanocellulose	 have	 been	 further	 characterized	 for	 their	 use	 in	 cartilage	 tissue	
engineering.	 Both	 alginate	 and	 bacterial	 nanocellulose	 scaffolds	 support	 cartilage	 tissue	
regeneration	and	homeostasis.	Besides,	bacterial	nanocellulose	has	biomechanical	properties	
that	 reaches	 values	 analogous	 to	 facial	 cartilages.	 Alginate,	 on	 the	 other	 hand,	 has	 poor	
biomechanical	properties	and	is	typically	used	as	a	cell-laden	hydrogel,	created	to	encapsulate	
cells.	In	chapter	eight	bacterial	nanocellulose	scaffolds	were	infused	with	cells	encapsulated	
in	alginate.	These	hybrid	scaffolds	were	biocompatible	and	supported	neocartilage	formation	
both	in	vitro	and	in	vivo.	Therefore,	the	combination	of	alginate	and	bacterial	nanocellulose	
could	provide	a	potential	therapy	for	the	reconstruction	of	cartilage	defect	in	the	head	and	
neck	area.		
	 Our	research	has	identified	potential	for	future	translational	research	in	the	head	and	
neck	area.	Tissue	engineering	strategies	could	technically	simplify	and	thereby	improve	the	
surgical	treatment	of	cartilage	defect	in	the	head	and	neck	area.
  
	 	
  
	 	
  
Chapter	11	
	
Nederlandse	samenvatting	
	
	 	
  
	 	
  
Kraakbeendefecten	 in	 het	 hoofd-/halsgebied	 zijn	 een	 uitdagend	 probleem	 voor	 de	
reconstructief	 chirurg.	 Kraakbeen	 tissue	 engineering	 lijkt	 een	 veelbelovende	 alternatieve	
therapie.	 Dit	 proefschrift	 richt	 zich	 op	 de	 verschillende	 aspecten	 van	 kraakbeen	 tissue	
engineering	in	het	hoofd-/halsgebied.	Specifiek	worden	het	gebruik	van	cellen	(of	combinatie	
van	cellen)	op	natuurlijke	scaffolds	of	dragermaterialen	besproken.	
Kraakbeen	is	een	zeer	unieke	vorm	van	bindweefsel	en	zorgt	in	het	hoofd-/hals	gebied	voor	
de	 vorm	 en	 functie	 van	 onder	 andere	 oren	 en	 neus.	 Het	 bestaat	 voor	 een	 fractie	 uit	
chondrocyten	 omgeven	 door	 een	 grote	 hoeveelheid	 extracellulaire	matrix.	 De	 opbouw	en	
structuur	van	deze	matrix	bepaalt	de	eigenschappen	van	het	kraakbeen,	waarbij	grofweg	drie	
typen	onderscheiden	kunnen	worden:	hyalien,	 elastisch	en	 fibrotisch	 kraakbeen.	Wanneer	
kraakbeen	 in	 het	 hoofd-/halsgebied	 beschadigd	 is	 geraakt	 of	 congenitaal	 onvoldoende	
gevormd,	herstelt	het	zich	niet	of	nauwelijks.	Tissue	engineering,	oftewel	de	regeneratie	van	
weefsel	 uit	 levende	 cellen,	 is	 mogelijk	 een	 veelbelovende	 alternatieve	 therapie	 voor	 de	
behandeling	van	deze	defecten.	In	hoofdstuk	één	worden	de	eigenschappen	en	moleculaire	
samenstelling	van	de	verschillende	kraakbeentypen	beschreven.	Daarnaast	wordt	het	concept	
van	 tissue	 engineering	 geïntroduceerd	 en	 welke	 rol	 deze	 zou	 kunnen	 hebben	 bij	 de	
reconstructie	van	kraakbeendefecten	in	het	hoofd-/halsgebied.	
	 Voor	 kraakbeen	 tissue	 engineering	 is	 het	 allereerst	 van	 belang	 de	 intrinsieke	
kenmerken	van	het	oorspronkelijke	weefsel	te	kennen,	zodat	een	benchmark	verkregen	kan	
worden	waarmee	getissue-engineerd	kraakbeen	vergeleken	kan	worden.	In	hoofdstuk	twee	
en	 drie	worden	 de	 biomechanische	 en	 biochemische	 eigenschappen	 van	 humaan	 oor-	 en	
neuskraakbeen	 (septum	 en	 ala	 nasi)	 uitvoerig	 geanalyseerd.	 In	 het	 algemeen	 kon	 gesteld	
worden	dat	de	biomechanische	eigenschappen	 (uitgedrukt	 in	 indentatie	 Eeq)	 van	humaan	
volwassen	 kraakbeen	 van	 het	 aangezicht	 varieerden	 van	 1-15	 MPa.	 Oorkraakbeen	 had	
aanzienlijk	lagere	biomechanische	eigenschappen	in	vergelijking	met	neuskraakbeen,	hoewel	
er	 regionale	 variaties	 werden	 waargenomen	 binnen	 de	 verschillende	 kraakbeentypen.	 De	
biomechanische	 eigenschappen	 van	 oorkraakbeen	 konden	 voornamelijk	 worden	
toegeschreven	 aan	 de	 aanwezigheid	 van	 elastine	 in	 de	 extracellulaire	 matrix	 van	
oorkraakbeen.	
Het	 selecteren	van	cellen	of	een	combinatie	 van	 cellen	 is	 van	 cruciaal	belang	 in	de	
regeneratieve	 geneeskunde.	 Momenteel	 is	 kraakbeen	 tissue	 engineering	 voornamelijk	
gebaseerd	op	twee	verschillende	soorten	cellen,	namelijk:	chondrocyten	en	mesenchymale	
stamcellen.	Wanneer	deze	cellen	echter	onafhankelijk	van	elkaar	worden	gebruikt,	brengt	dat	
tot	 op	 heden	 specifieke	 nadelen	 met	 zich	 mee.	 Allereerst,	 kraakbeen	 tissue	 engineering	
gebaseerd	op	alléén	chondrocyten	wordt	aanzienlijk	beperkt	door	de	hoeveelheid	kraakbeen	
dat	kan	worden	gebiopteerd.	Doordat	de	opbrengst	van	chondrocyten	hierdoor	beperkt	is,	is	
expanderen	(vermenigvuldigen)	van	chondrocyten	in	een	laboratorium	noodzakelijk.	Echter,	
tijdens	het	expanderen	veranderen	chondrocyten	van	vorm	en	 functie	en	verliezen	zij	hun	
kraakbeeneigenschappen:	 zij	 dedifferentiëren.	 Ten	 tweede,	 kraakbeen	 tissue	 engineering	
gebaseerd	op	alléén	mesenchymale	stamcellen	wordt	belemmerd	door	het	feit	dat	stamcellen	
tijdens	het	differentiatieproces	van	stamcel	naar	chondrocyt	niet	in	staat	zijn	kraakbenig	te	
blijven	 en	 uiteindelijk	 terminaal	 differentiëren	 via	 het	 proces	 van	 enchondrale	 ossificatie.	
Terminaal	gedifferentieerd	(of	hypertrofisch)	kraakbeen	is	instabiel	en	heeft	een	grote	kans	
  
te	 mineraliseren	 en	 ossificeren	 in	 vivo.	 In	 hoofdstuk	 vier	 wordt	 de	 kraakbeenvormende	
capaciteit	 van	 verschillende	 cellen	 van	 verschillende	 anatomische	 locaties	 vergeleken.	
Geëxpandeerde	 chondrocyten	 dedifferentieerden	 onafhankelijk	 van	 hun	 origine	 (gewricht,	
oor,	neus).	Na	chondrogene	stimulatie	bleken	chondrocyten	van	oor-	en	neuskraakbeen	het	
meest	 potent	 voor	 kraakbeen	 tissue	 engineering	 in	 vivo.	 Tevens	 waren	 locatie-	 en	
kraakbeentype	 specifieke	 chondrocyten	 in	 staat	 kraakbeen	 te	 produceren	 met	 specifieke	
kraakbeeneigenschappen	en	moleculaire	 samenstelling,	 gerelateerd	aan	de	eigenschappen	
van	het	originele	donorkraakbeen.	Dit	betekent	dat	chondrocyten	van	oor-	en	neuskraakbeen	
het	 meest	 geschikt	 lijken	 voor	 de	 reconstructie	 van	 oor-	 en	 neuskraakbeendefecten	
respectievelijk.	
Recente	 inzichten	 tonen	 dat	 de	 combinatie	 van	 chondrocyten	 en	 mesenchymale	
stamcellen	(“co-kweken”)	een	positief	effect	heeft	op	de	kraakbeenvorming	en	daardoor	een	
veelbelovend	 concept	 lijkt	 voor	 de	 behandeling	 van	 kraakbeendefecten	 in	 het	 hoofd-
/halsgebied.	 “Co-kweken”	 heeft	 een	 aantal	 voordelen	 ten	 opzicht	 van	 het	 onafhankelijk	
gebruik	van	cellen	zoals	eerder	beschreven.	Door	het	combineren	van	cellen,	kan	een	groot	
aantal	 chondrocyten	 vervangen	 worden	 door	 mesenchymale	 stamcellen.	 Hierdoor	 kan	
gebruik	worden	gemaakt	van	primaire	cellen;	cellen	die	direct	ingezet	kunnen	worden	voor	
reconstructiedoeleinden	zonder	een	daar	voorafgaande	 in	vitro	expansie	fase.	In	hoofdstuk	
vijf	 en	 zes	 wordt	 het	 “co-kweken”	 van	 primaire	 chondrocyten	 (gewricht,	 oor,	 neus)	 in	
combinatie	 met	 mesenchymale	 stamcellen	 (vet,	 beenmerg)	 verder	 bestudeerd.	
Kraakbeenproductie	 en	 stabiliteit	werden	 niet	 negatief	 beïnvloed	 door	 het	 vervangen	 van	
tachtig	procent	van	de	chondrocyten	door	mesenchymale	stamcellen.	Kraakbeen	regeneratie	
bleek	 in	 “co-kweek”	 niet	 het	 resultaat	 van	 chondrogene	 differentiatie	 van	mesenchymale	
stamcellen,	maar	eerder	het	gevolg	van	toenemende	kraakbeenproductie	door	chondrocyten	
onder	invloed	van	stamcellen.	Voor	de	mesenchymale	stamcellen	bleek	uiteindelijk	dan	ook	
meer	een	trofische	rol	weggelegd	in	“co-kweek”.	Deze	trofische	functie	werd	in	gelijke	mate	
gezien	bij	zowel	stamcellen	uit	vet	als	uit	beenmerg	en	is	meest	waarschijnlijk	een	algemene	
functie	van	de	stamcel	onafhankelijk	van	zijn	origine.	Dit	in	tegenstelling	tot	de	origine	van	de	
verschillende	 typen	 chondrocyten	 (gewricht,	 oor,	 neus).	 Ook	 in	 “co-kweek”	 waren	 deze	
locatie-	 en	 kraakbeentype	 specifieke	 chondrocyten	 in	 staat	 kraakbeen	 te	 produceren	met	
specifieke	eigenschappen	gerelateerd	aan	het	originele	donorkraakbeen.	De	combinatie	van	
primaire	chondrocyten	en	mesenchymale	stamcellen,	voorkomt	een	periode	van	expansie,	en	
ondersteunt	 de	 mogelijkheid	 om	 in	 de	 toekomst	 een	 één-stap-techniek	 te	 kunnen	
verwezenlijken	 voor	 de	 behandeling	 van	 kraakbeendefect	 in	 het	 hoofd-/halsgebied.	
Chondrocyten	 van	 oor-	 en	 neuskraakbeen	 in	 combinatie	 met	 mesenchymale	 stamcellen	
worden	 hierin	 specifiek	 aangeraden	 voor	 de	 reconstructie	 van	 oor-	 en	
neuskraakbeendefecten	respectievelijk.	
Naast	het	selecteren	van	geschikte	cellen,	is	ook	de	selectie	van	een	scaffold	essentieel	
voor	kraakbeen	tissue	engineering.	Een	ideale	scaffold	heeft	een	driedimensionale	structuur,	
welke	de	micro-architectuur	van	het	oorspronkelijke	weefsel	of	specifiek	-	de	extracellulaire	
matrix	van	het	oorspronkelijke	weefsel	-	zo	veel	mogelijk	nabootst.	Het	lijkt	dan	ook	niet	meer	
dan	 vanzelfsprekend,	 dat	 een	 scaffold	 ontstaan	 vanuit	 de	 oorspronkelijke	 extracellulaire	
matrix	het	meest	geschikt	is	voor	regeneratieve	doeleinden.	Decellularisatie	is	een	manier	om	
  
deze	oorspronkelijke	matrix	te	vergaren.	In	hoofdstuk	zeven	wordt	het	decellularisateprotocol	
van	 bovien	 en	 humaan	 oorkraakbeen	 beschreven.	 Na	 decellularisatie,	 werd	 een	 matrix	
gerealiseerd	waarin	geen	cellen	of	celresten	meer	konden	worden	aangetoond.	Daarnaast,	
kon	 de	 hoeveelheid	 collageen	 en	 elastine	 tijdens	 het	 decellulalarisatieproces	 behouden	
blijven,	evenals	de	vorm	en	architectuur	van	het	 kraakbeen.	Gedecellulariseerd	kraakbeen	
bleek	niet	 cytotoxisch	waardoor	mesenchymale	 stamcellen	 in	 staat	waren	chondrogeen	 te	
differentiëren	na	contact	met	deze	scaffolds.	Gedecellulariseerde	kraakbeenscaffolds	bieden	
daardoor	mogelijk	een	veelbelovende	therapie	voor	de	behandeling	van	kraakbeendefecten	
in	de	toekomst.	
Echter,	de	translatie	van	deze	potentiele	therapie	naar	een	definitieve	behandeling	van	
kraakbeendefecten	 in	 het	 hoofd-/halsgebied,	 lijkt	 heden	 belemmerd	 door	 een	 tekort	 aan	
donoren	 en	 het	 onvermogen	 om	 de	 kraakbeenvorm	 van	 de	 donor	 nauwkeurig	 te	 laten	
overeenkomen	met	de	specifieke	eisen	van	het	te	regenereren	kraakbeen	in	het	aangezicht.	
Naast	gedecellulariseerde	scaffolds	-	scaffolds	die	zijn	geëxtraheerd	vanuit	de	oorspronkelijk	
extracellulaire	 matrix	 -	 zijn	 er	 ook	 scaffolds	 in	 ontwikkeling	 die	 de	 driedimensionale	
architectuur	 van	 oorspronkelijke	 matrix	 zoveel	 mogelijk	 proberen	 na	 te	 bootsen.	 Deze	
scaffolds	kunnen	grofweg	onderverdeeld	worden	in	natuurlijke	en	synthetische	scaffolds.	In	
dit	 proefschrift	 wordt	 specifiek	 gebruik	 gemaakt	 van	 twee	 natuurlijk	 scaffolds,	 te	 weten	
alginaat	en	bacterieel	nanocellulose.	Beide	scaffolds	ondersteunen	kraakbeenregeneratie	en	
–hemostase.	Daarnaast	zijn	de	biomechanische	eigenschappen	van	bacterieel	nanocellulose	
scaffold	 vergelijkbaar	 met	 de	 eigenschappen	 van	 aangezichtskraakbeen,	 zoals	 oor-	 en	
neuskraakbeen.	Deze	biomechanische	eigenschappen	heeft	alginaat	niet.	Alginaat	gel	wordt	
voornamelijk	gebruikt	voor	het	inkapselen	van	levende	cellen,	waarbij	het	alginaat	voor	een	
homogene	distributie	van	cellen	zorgt	en	tevens	voorkomt	dat	cellen	uit	de	gel	kunnen	vallen.	
In	hoofdstuk	acht	worden	scaffolds	van	bacterieel	nanocellulose	geïnfundeerd	met	een	cel-
alginaat	gel.	Deze	hybride	scaffold	bleek	biocompatibel	en	was	in	staat	kraakbeen	regeneratie	
te	ondersteunen	 in	 vitro	en	 in	 vivo.	De	combinatie	van	beide	materialen	 lijkt	dan	ook	een	
potentiële	therapie	voor	de	reconstructie	van	kraakbeendefecten	in	het	hoofd-/halsgebied.	
De	 resultaten	 van	 dit	 proefschrift	 zijn	 een	 belangrijke	 stap	 voor	 de	 toekomstige	
behandeling	 van	 kraakbeendefecten	 in	het	hoofd-/halsgebied.	Door	 gebruik	 te	maken	 van	
tissue-engineering	technieken	kunnen	huidige	chirurgisch	technieken	worden	vereenvoudigd	
wat	 naar	 verwachting	 een	 positieve	 invloed	 zal	 hebben	 op	 de	 behandeling	 van	
kraakbeendefecten	van	heet	aangezicht.
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DANKWOORD	
	
Prof.	dr.	G.J.V.M.	van	Osch	
Allerbeste	 Gerjo.	 ‘Brave	meisjes	 schrijven	 zelden	 geschiedenis’	 is	 het	 eerste	wat	 er	 in	me	
opkomt	als	ik	jou	zou	moeten	beschrijven.	Je	bent	een	ware	inspirator,	totally	on	top	of	your	
game.	Internationaal	gezien	schrikt	men	soms	van	jouw	directheid,	maar	ik	waardeer	in	jou	
het	allermeest	dat	jij	zegt	wat	je	denkt	en	doet	wat	je	zegt	en	daarnaast	keihard	werkt	om	
jouw	beoogde	doelen	te	bereiken.	Je	zou	een	Rotterdammer	kunnen	zijn!	Ik	mis	onze	EAREG-
tripjes	 en	 voortgangsbesprekingen,	 waarbij	 we	 samen	 konden	 brainstormen	 over	 het	
interpreteren	 van	 heden	 behaalde	 resultaten	 en	 filosoferen	 over	 nieuwe	 experimenten.	
Bedankt	 dat	 je	 me	 de	 kans	 hebt	 gegeven	me	 wetenschappelijk	 en	 persoonlijk	 te	 kunnen	
ontwikkelen.		
	
Dr.	ir.	K.S.	Stok	
Dear	 Kathryn,	 dear	 co-promotor.	 Thank	 you	 very	much	 for	 taking	 place	 in	 the	 graduation	
comittee	today	all	the	way	from	Australia.	Please,	be	gentle.	You	have	been	a	great	supervisor	
during	my	PhD-training.	You	have	helped	me	to	understand,	and	 inspired	me	to	enjoy	 the	
principles	 of	 cartilage	 biomechanical	 engineering.	 Your	 knowledge	 in	 this	 field	 has	 no	
boundaries.	For	me,	you	are	just	a	professor	in-the-make!	
	
Commissie	
Beste	prof.	dr.	Mathijssen,	prof.	dr.	Van	Zuijlen	en	prof.	dr.	 ir.	Malda,	 leden	van	de	kleine	
commissie.	Hartelijk	dank	voor	het	kritisch	 lezen	en	beoordelen	van	dit	proefschrift.	Beste	
Irene,	ik	voel	mij	vereerd	dat	ook	jij	hebt	plaatsgenomen	in	mijn	kleine	commissie.	Ik	hoop	dat	
door	 dit	 proefschrift	 de	 liefde	 voor	 fundamenteel	 onderzoek	 ook	 binnen	 de	 plastische	
chirurgie	 een	 beetje	 meer	 is	 aangewakkerd.	 Prof.	 dr.	 Kleinrensink,	 dr.	 Daatema	 en	 dr.	
Hendriks,	dank	voor	uw	bereidheid	om	plaats	te	nemen	in	de	grote	commissie.	
	
EAREG-team	
Team	 EAREG	 -	 team	 Göteborg	 (Paul	 Gatenholm,	 Héctor	Martínez	 Ávila,	 Johan	 Sundberg),	
Zurich	(Ralph	Müller,	Kathryn	Stok,	Luc	Nimeskern),	Ulm	(Nicole	Rotter,	Silke	Schwarz,	Eva-
Maria	 Feldmann),	 Bilthoven	 (Jeanine	 Hendriks,	 Jens	 Riesle,	 Wilco	 de	 Jong)	 and	 Alzenau	
(Annette	Jork)	-	our	multidisciplinary	scientific	collaboration	has	opened	my	eyes	to	new	ideas	
and	methods.	The	EAREG-meetings	were	far	most	the	highlights	of	my	PhD-training.	
	
Et	al.	
Dear	co-authors,	without	you,	this	thesis	would	not	have	been	possible.	Especially	I	would	like	
to	thank	Luc,	Héctor,	Ernst-Jan	and	Lizette.	Dear	Luc,	we	slaved	ourselves	through	a	million	
samples	of	half	a	million	donors	of	6	different	experiments.	We	made	it!	Dear	Héctor.	You	
were	able	to	put	all	our	multidisciplinary	work	and	ideas	into	one	outstanding	paper.	Good	
luck	with	your	new	company.	Hopefully	our	paths	will	cross	again	in	the	future.	Beste	Ernst-
Jan,	 onze	 samenwerking	 begon	 bij	 dat	 ene	 moment:	 ‘Cut	 the	 crap’.	 Lieve	 Lizette,	 het	
ontzettend	harde	werken	als	masterstudent	heeft	uiteindelijk	geleid	tot	een	prachtig	artikel	
  
maar	nog	belangrijker	de	start	van	 jouw	eigen	PhD-training.	Die	 fles	bubbels	gaan	we	ooit	
drinken!	
	
Bastiaan	Tuk	
Daar	waar	het	allemaal	begon.	Beste	Bas,	ik	denk	niet	dat	je	doorhebt	dat	jij	diegene	bent	die	
mij	verliefd	heeft	 laten	worden	op	het	fundamentele	onderzoek.	Wanneer	gaan	we	samen	
brainstormen?	
	
Het	fundament	van	de	16de	
Lieve	Wendy,	Nicole	en	Sandra.	Zonder	jullie	ben	ik	nergens.	Wendy,	Godmother	van	de	
celkweek,	wij	hebben	uren	doorgebracht	in	het	lab	en	jij	hebt	mij	alle	kneepjes	van	het	vak	
geleerd.	Behalve	hoofdrekenen,	want	dat	kan	ik	nog	steeds	niet…	Nicole,	het	is	mij	nog	
steeds	een	raadsel	waarom	iemand	die	zo	secuur	haar	labjournaal	bijhoudt,	toch	zo	
chaotisch	kan	zijn!	Door	jou	hebben	mijn	muisjes	-	mogen	hun	zielen	rusten	in	vrede	-	een	
ontspannen	en	liefdevol	leven	gekend	(behalve	dan	het	muisje	dat	tussen	deksel	en	bak	
terecht	kwam).	Sandra,	je	bent	toch	wel	een	beetje	m’n	moeder	van	de	afdeling.	Zonder	jou	
geen	structuur,	zonder	jou	geen	gezelligheid!	
	
Paranimfen/vakidioten	
Lieve	Caroline	en	Lizette.	Zo	blij	dat	jullie	mijn	paranimfen	zijn!	Caroline,	nu	jouw	lieve	Hanna	
geboren	 is	 en	mijn	 PhD-kindje	 eindelijk	 op	 eigen	 voeten	 kan	 staan,	 kunnen	we	misschien	
eindelijk	 weer	 eens	 de	 tijd	 vinden	 om	 ergens	 een	 goud	 muurtje	 op	 te	 zoeken?!	 Lizette,	
eindelijk	iemand	die	net	zo	slecht	kan	drinken	als	ik.	Wetenschappelijk	gezien	ga	je	wel	door	
het	geluid	en	ben	je	me	nog	net	niet	voorbijgevlogen!	Ik	ga	er	dan	ook	vanuit	dat	jij	vandaag	
de	moeilijke	vragen	voor	je	rekening	neemt?!	
	
Doctoren,	dokters	en	ander	gespuis	
Lieve	lotgenoten	van	de	16de.	Dank	voor	de	gezelligheid	tijdens	CTCR-meetings,	labdag,	cake-
van-de-week,	 congressen	 en	 kweeksessies.	 Lieve	 Marloes	 en	 Nienke,	 onze	 frustraties,	
overwinningen,	 relatieperikelen,	 irritaties	 en	 behaalde	 publicaties	 zijn	 allemaal	 de	 revue	
gepasseerd,	maar	hebben	uiteindelijk	geleid	tot	drie	topboekjes!	Chirurgen	(in	opleiding)	van	
het	 Franciscus	 Gasthuis,	 onder	 jullie	 vleugels	 eindelijk	 dokter	 geworden.	 Lieve	 plastische	
collega’s,	 ik	 ben	 er	 trots	 op	 in	 het	mooiste	 Rotterdam	opgeleid	 te	mogen	worden.	 Plastic	
fantastic!	
	
Vrienden	
Lieve	vrienden:	lieve	oud-huisgenootjes,	‘Mooie	hockeymeisjes’,	hockeyteam,	‘Oude	taartjes’,	
tennisvrienden	en	‘Derde-kerstdag-genoten’.	Eindelijk	meer	tijd	voor	jullie!	
	
Familie	
Wilhelmina	Lange	-	van	Heuvelen,	lieve	oma	Mien,	mater	familias.	Ik	voel	mij	vereert	dat	ik	u	
dan	eindelijk	mijn	promotieboekje	kan	overhandigen,	wetende	dat	u	waarschijnlijk	de	enige	
bent	die	het	zal	 lezen.	Lieve	Lily	en	Peter,	betere	schoonouders	kan	ik	mij	niet	wensen.	De	
  
extra	oppasdagen	hebben	mij	de	mogelijkheid	gegeven	nog	even	de	laatste	puntjes	op	de	‘i’	
te	zetten	(eigenlijk	het	hele	alfabet	nog	even	onder	de	loep	te	nemen…).	Zusters,	allerliefste	
Olga	 en	 Laura.	 Jullie	 zijn	 er	 gewoon	altijd.	 Lieve	papa	en	mama,	 lieve	Bèr	 en	Marjan.	Alle	
ingrediënten	 die	 nodig	 zijn	 voor	 de	 totstandkoming	 van	 dit	 proefschrift	 heb	 ik	 van	 jullie	
gekregen:	doorzettingsvermogen	en	hoge	pijngrens,	ratio	en	een	kritische	blik,	maar	vooral	
het	 denken	 in	 oplossingen.	 Jullie	 steun,	 liefde	 en	 onvoorwaardelijk	 vertrouwen	 werkt	
motiverend!	Dankjewel	voor	alles.	
	
Mijn	allerliefsten	
Allerliefste	Piet	en	Olli,	mijn	allerliefste	en	allerleukste	huisgenootjes.	Als	ik	ook	maar	een	
fractie	van	jullie	energie	had	gehad,	dan	was	dit	promotieboekje	een	lustrum	eerder	af	
geweest.	Lieve	Piet,	alles	is	leuker	met	jou.	 	
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